1	Int	NN	O	int	_	0	SENT_1	[p1l86t83r133b109],
2	.	.	O	.	_	0	SENT_1	[p1l86t83r133b109],

1	J.	NNP	O	J.	nn	2	SENT_2	[p1l149t83r172b109],
2	Cancer	NNP	O	Cancer	_	0	SENT_2	[p1l191t83r309b109],
3	:	:	O	:	_	0	SENT_2	[p1l191t83r309b109],
4	92	CD	NUMBER	92	dep	2	SENT_2	[p1l324t82r370b115],
5	,	,	O	,	_	0	SENT_2	[p1l324t82r370b115],
6	777-783	CD	NUMBER	777-783	number	7	SENT_2	[p1l384t83r512b109],
7	(	CD	NUMBER	(	appos	2	SENT_2	[p1l528t83r625b115],
8	2001	CD	DATE	2001	dep	7	SENT_2	[p1l528t83r625b115],
9	)	CD	NUMBER	)	number	10	SENT_2	[p1l528t83r625b115],
10	©	CD	NUMBER	©	dep	2	SENT_2	[p1l87t131r110b155],
11	2001	CD	DATE	2001	num	14	SENT_2	[p1l131t128r201b155],
12	Wiley-Liss	NNP	O	Wiley-Liss	nn	14	SENT_2	[p1l218t128r392b162],
13	,	,	O	,	_	0	SENT_2	[p1l218t128r392b162],
14	Inc.	NNP	ORGANIZATION	Inc.	dep	10	SENT_2	[p1l407t129r461b154],
15	.	.	O	.	_	0	SENT_2	[p1l407t129r461b154],

1	ROLE	NN	O	role	dep	5	SENT_3	[p1l87t209r227b247],
2	OF	IN	O	of	_	0	SENT_3	[p1l256t209r324b247],
3	GLUTATHIONE	NN	MISC	glutathione	prep_of	1	SENT_3	[p1l352t209r735b247],
4	S-TRANSFERASE	NN	O	s-transferase	dep	5	SENT_3	[p1l764t209r1187b247],
5	P1	NN	O	p1	dep	12	SENT_3	[p1l1215t209r1283b253],
6	,	,	O	,	_	0	SENT_3	[p1l1215t209r1283b253],
7	P-GLYCOPROTEIN	NN	O	p-glycoprotein	dep	12	SENT_3	[p1l1313t209r1776b247],
8	AND	CC	O	and	_	0	SENT_3	[p1l1804t209r1919b246],
9	MULTIDRUG	NN	O	multidrug	conj_and	5	SENT_3	[p1l87t271r411b309],
10	RESISTANCE-ASSOCIATED	NN	O	resistance-associated	nn	11	SENT_3	[p1l439t271r1120b309],
11	PROTEIN	NN	O	protein	dep	5	SENT_3	[p1l1149t271r1377b309],
12	1	CD	NUMBER	1	_	0	SENT_3	[p1l1410t271r1426b308],
13	IN	IN	O	in	amod	12	SENT_3	[p1l1459t271r1515b309],
14	ACQUIRED	VBN	O	acquire	partmod	12	SENT_3	[p1l1543t271r1821b318],

1	DOXORUBICIN	NN	O	doxorubicin	nn	2	SENT_4	[p1l87t346r465b384],
2	RESISTANCE	NN	O	resistance	_	0	SENT_4	[p1l493t346r820b384],

1	Andrew	NNP	PERSON	Andrew	nn	2	SENT_5	[p1l87t432r206b459],
2	HARBOTTLELZ	NNP	PERSON	HARBOTTLELZ	_	0	SENT_5	[p1l220t427r432b464],
3	,	,	O	,	_	0	SENT_5	[p1l220t427r432b464],
4	Ann	NNP	PERSON	Ann	nn	6	SENT_5	[p1l447t433r510b459],
5	K.	NNP	PERSON	K.	nn	6	SENT_5	[p1l524t433r557b459],
6	DALY2	NNP	PERSON	DALY2	conj_and	2	SENT_5	[p1l573t427r677b464],
7	,	,	O	,	_	0	SENT_5	[p1l573t427r677b464],
8	Kathryn	NNP	PERSON	Kathryn	nn	9	SENT_5	[p1l693t432r814b467],
9	ATHERTONLZ	NNP	PERSON	ATHERTONLZ	conj_and	2	SENT_5	[p1l827t427r1016b459],
10	and	CC	O	and	_	0	SENT_5	[p1l1031t432r1083b459],
11	F.	NNP	PERSON	F.	nn	13	SENT_5	[p1l1096t433r1124b459],
12	Charles	NNP	PERSON	Charles	nn	13	SENT_5	[p1l1140t432r1252b459],
13	CAMPBELL1	NNP	O	CAMPBELL1	conj_and	2	SENT_5	[p1l1267t427r1448b459],
14	*	CD	NUMBER	*	num	15	SENT_5	[p1l1267t427r1448b459],
15	1Department	NN	O	1department	dep	2	SENT_5	[p1l89t467r281b506],
16	of	IN	O	of	_	0	SENT_5	[p1l293t473r327b506],
17	Surgical	NNP	O	Surgical	prepc_of	15	SENT_5	[p1l335t473r461b506],
18	Sciences	NNPS	O	Sciences	nsubj	57	SENT_5	[p1l474t473r608b503],
19	,	,	O	,	_	0	SENT_5	[p1l474t473r608b503],
20	The	NNP	O	The	nn	22	SENT_5	[p1l627t473r680b499],
21	Medical	NNP	ORGANIZATION	Medical	nn	22	SENT_5	[p1l693t473r817b499],
22	School	NNP	ORGANIZATION	School	appos	18	SENT_5	[p1l829t473r936b503],
23	,	,	O	,	_	0	SENT_5	[p1l829t473r936b503],
24	University	NNP	ORGANIZATION	University	appos	18	SENT_5	[p1l956t474r1109b506],
25	of	IN	ORGANIZATION	of	_	0	SENT_5	[p1l1122t473r1156b506],
26	Newcastle	NNP	ORGANIZATION	Newcastle	prep_of	24	SENT_5	[p1l1162t473r1323b503],
27	,	,	O	,	_	0	SENT_5	[p1l1162t473r1323b503],
28	Newcastle	NNP	ORGANIZATION	Newcastle	appos	18	SENT_5	[p1l1339t473r1493b499],
29	upon	IN	O	upon	_	0	SENT_5	[p1l1507t482r1580b506],
30	Tyne	NNP	PERSON	Tyne	prep_upon	28	SENT_5	[p1l1596t474r1672b506],
31	,	,	O	,	_	0	SENT_5	[p1l1596t474r1672b506],
32	United	NNP	LOCATION	United	nn	34	SENT_5	[p1l1692t473r1791b499],
33	Kingdom	NNP	LOCATION	Kingdom	nn	34	SENT_5	[p1l1803t473r1940b506],
34	2Department	NN	O	2department	appos	18	SENT_5	[p1l87t506r281b546],
35	of	IN	O	of	_	0	SENT_5	[p1l293t512r327b546],
36	Pharmacological	JJ	ORGANIZATION	pharmacological	amod	37	SENT_5	[p1l334t512r595b546],
37	Sciences	NNPS	ORGANIZATION	Sciences	prep_of	34	SENT_5	[p1l607t512r741b543],
38	,	,	O	,	_	0	SENT_5	[p1l607t512r741b543],
39	The	NNP	O	The	nn	41	SENT_5	[p1l760t512r813b538],
40	Medical	NNP	ORGANIZATION	Medical	nn	41	SENT_5	[p1l826t512r950b538],
41	School	NNP	ORGANIZATION	School	appos	18	SENT_5	[p1l963t512r1070b543],
42	,	,	O	,	_	0	SENT_5	[p1l963t512r1070b543],
43	University	NNP	ORGANIZATION	University	appos	18	SENT_5	[p1l1090t513r1242b546],
44	of	IN	ORGANIZATION	of	_	0	SENT_5	[p1l1256t512r1290b546],
45	Newcastle	NNP	ORGANIZATION	Newcastle	prep_of	43	SENT_5	[p1l1296t512r1456b543],
46	,	,	O	,	_	0	SENT_5	[p1l1296t512r1456b543],
47	Newcastle	NNP	ORGANIZATION	Newcastle	appos	18	SENT_5	[p1l1472t512r1626b539],
48	upon	IN	O	upon	_	0	SENT_5	[p1l1641t521r1713b546],
49	Tyne	NNP	PERSON	Tyne	prep_upon	47	SENT_5	[p1l1729t513r1805b546],
50	,	,	O	,	_	0	SENT_5	[p1l1729t513r1805b546],
51	United	NNP	ORGANIZATION	United	nn	57	SENT_5	[p1l1825t512r1925b539],
52	Kingdom	NNP	ORGANIZATION	Kingdom	nn	57	SENT_5	[p1l1936t512r2073b546],
53	11	CD	NUMBER	11	num	57	SENT_5	[p1l1373t83r1413b95],
54	*	CD	NUMBER	*	num	57	SENT_5	[p1l1373t83r1413b95],
55	"	``	O	"	punct	57	SENT_5	[p1l1373t83r1413b95],
56	p	NN	O	p	nn	57	SENT_5	[p1l1427t94r1444b100],
57	G	NN	O	g	xcomp	17	SENT_5	[p1l1427t94r1444b100],
58	+	CC	O	+	_	0	SENT_5	[p1l1427t94r1444b100],
59	Publication	NN	O	publication	conj_+	15	SENT_5	[p1l1488t81r1606b98],
60	of	IN	O	of	_	0	SENT_5	[p1l1616t81r1637b98],
61	the	DT	O	the	det	63	SENT_5	[p1l1644t81r1678b98],
62	International	NNP	ORGANIZATION	International	nn	63	SENT_5	[p1l1688t81r1822b98],
63	Union	NNP	ORGANIZATION	Union	prep_of	59	SENT_5	[p1l1834t81r1896b98],
64	Against	IN	ORGANIZATION	against	_	0	SENT_5	[p1l1906t81r1988b102],
65	Cancer	NNP	ORGANIZATION	Cancer	prep_against	63	SENT_5	[p1l1997t81r2071b98],

1	While	IN	O	while	mark	15	SENT_6	[p1l97t707r310b759],
2	P-glycoprotein	NN	O	p-glycoprotein	nn	5	SENT_6	[p1l336t706r842b776],
3	(	CD	NUMBER	(	num	5	SENT_6	[p1l869t706r1055b776],
4	Pgp	NN	O	pgp	nn	5	SENT_6	[p1l869t706r1055b776],
5	)	NN	O	)	nsubjpass	15	SENT_6	[p1l869t706r1055b776],
6	and	CC	O	and	_	0	SENT_6	[p1l1079t707r1201b759],
7	multidrug	JJ	O	multidrug	amod	9	SENT_6	[p1l1229t707r1574b776],
8	resistanceassociated	JJ	O	resistanceassociated	amod	9	SENT_6	[p1l1598t706r2145b759, p1l20t780r227b833],
9	protein	NN	O	protein	conj_and	5	SENT_6	[p1l267t780r517b850],
10	I	PRP	O	I	nsubj	11	SENT_6	[p1l567t781r580b833],
11	(	VBP	O	(	rcmod	9	SENT_6	[p1l629t780r889b850],
12	MRPI	NN	O	mrpus	nn	13	SENT_6	[p1l629t780r889b850],
13	)	NN	O	)	dobj	11	SENT_6	[p1l629t780r889b850],
14	are	VBP	O	be	auxpass	15	SENT_6	[p1l926t797r1037b833],
15	known	VBN	O	know	advcl	29	SENT_6	[p1l1074t781r1299b833],
16	to	TO	O	to	aux	18	SENT_6	[p1l1335t786r1408b833],
17	be	VB	O	be	cop	18	SENT_6	[p1l1445t781r1525b833],
18	important	JJ	O	important	xcomp	15	SENT_6	[p1l1562t780r1918b850],
19	in	IN	O	in	_	0	SENT_6	[p1l1953t780r2009b833],
20	acquired	VBN	O	acquire	amod	22	SENT_6	[p1l2047t797r2145b833, p1l20t855r241b925],
21	doxorubicin	NN	O	doxorubicin	nn	22	SENT_6	[p1l311t855r724b908],
22	resistance	NN	O	resistance	prep_in	18	SENT_6	[p1l796t855r1164b920],
23	,	,	O	,	_	0	SENT_6	[p1l796t855r1164b920],
24	the	DT	O	the	det	25	SENT_6	[p1l1231t856r1345b908],
25	role	NN	O	role	nsubj	29	SENT_6	[p1l1415t856r1549b908],
26	of	IN	O	of	_	0	SENT_6	[p1l1617t855r1688b908],
27	glutathione	NN	O	glutathione	nn	28	SENT_6	[p1l1748t855r2145b925],
28	S-transferases	NNS	O	s-transferase	prep_of	25	SENT_6	[p1l18t929r505b982],
29	(	VBP	O	(	_	0	SENT_6	[p1l547t929r760b999],
30	GST	NN	O	gst	nn	31	SENT_6	[p1l547t929r760b999],
31	)	NN	O	)	nsubj	33	SENT_6	[p1l547t929r760b999],
32	remains	VBZ	O	remain	cop	33	SENT_6	[p1l806t929r1084b982],
33	unclear	JJ	O	unclear	ccomp	29	SENT_6	[p1l1127t929r1402b982],
34	.	.	O	.	_	0	SENT_6	[p1l1127t929r1402b982],

1	Our	PRP$	O	we	poss	2	SENT_7	[p1l1446t929r1587b982],
2	study	NN	O	study	nsubj	3	SENT_7	[p1l1627t929r1814b998],
3	assessed	VBD	O	assess	_	0	SENT_7	[p1l1854t929r2144b982],
4	roles	NNS	O	role	dobj	3	SENT_7	[p1l22t1003r188b1056],
5	of	IN	O	of	_	0	SENT_7	[p1l216t1003r286b1056],
6	these	DT	O	these	det	8	SENT_7	[p1l304t1003r492b1056],
7	3	CD	NUMBER	3	num	8	SENT_7	[p1l521t1003r552b1056],
8	factors	NNS	O	factor	prep_of	4	SENT_7	[p1l582t1003r822b1056],
9	in	IN	O	in	_	0	SENT_7	[p1l850t1003r907b1055],
10	a	DT	O	a	det	18	SENT_7	[p1l936t1019r974b1056],
11	human	JJ	O	human	amod	18	SENT_7	[p1l1001t1003r1237b1056],
12	drug-sensitive	JJ	O	drug-sensitive	amod	18	SENT_7	[p1l1267t1003r1752b1072],
13	carcinoma	NN	O	carcinoma	nn	18	SENT_7	[p1l1779t1003r2148b1056],
14	cell	NN	O	cell	nn	18	SENT_7	[p1l20t1077r133b1130],
15	line	NN	O	line	nn	18	SENT_7	[p1l181t1077r301b1130],
16	(	NN	O	(	nn	18	SENT_7	[p1l346t1077r614b1146],
17	HEp2	NN	O	hep2	nn	18	SENT_7	[p1l346t1077r614b1146],
18	)	NN	O	)	prep_in	3	SENT_7	[p1l346t1077r614b1146],
19	,	,	O	,	_	0	SENT_7	[p1l346t1077r614b1146],
20	a	DT	O	a	det	21	SENT_7	[p1l659t1093r697b1130],
21	subclone	NN	O	subclone	nsubj	22	SENT_7	[p1l739t1077r1043b1130],
22	made	VBD	O	make	dep	3	SENT_7	[p1l1089t1077r1281b1130],
23	resistant	JJ	O	resistant	acomp	22	SENT_7	[p1l1327t1077r1627b1130],
24	by	IN	O	by	_	0	SENT_7	[p1l1672t1077r1750b1146],
25	prolonged	JJ	O	prolonged	amod	26	SENT_7	[p1l1793t1077r2144b1146],
26	incubation	NN	O	incubation	prep_by	23	SENT_7	[p1l21t1151r383b1203],
27	in	IN	O	in	_	0	SENT_7	[p1l428t1151r484b1203],
28	doxorubicin	NN	O	doxorubicin	nn	31	SENT_7	[p1l528t1150r941b1203],
29	(	CD	NUMBER	(	num	31	SENT_7	[p1l986t1150r1313b1220],
30	HEp2A	NN	O	hep2a	nn	31	SENT_7	[p1l986t1150r1313b1220],
31	)	NN	O	)	prep_in	22	SENT_7	[p1l986t1150r1313b1220],
32	,	,	O	,	_	0	SENT_7	[p1l986t1150r1313b1220],
33	and	CC	O	and	_	0	SENT_7	[p1l1356t1151r1477b1203],
34	HEp2	NN	O	hep2	nn	35	SENT_7	[p1l1524t1150r1712b1220],
35	cells	NNS	O	cell	nsubj	37	SENT_7	[p1l1755t1151r1903b1203],
36	stably	RB	O	stably	advmod	37	SENT_7	[p1l1944t1151r2148b1219],
37	transfected	VBN	O	transfect	conj_and	3	SENT_7	[p1l18t1224r412b1277],
38	with	IN	O	with	_	0	SENT_7	[p1l440t1224r590b1277],
39	human	JJ	O	human	amod	40	SENT_7	[p1l622t1225r858b1277],
40	GSTPI	NN	O	gstpus	prep_with	37	SENT_7	[p1l889t1224r1155b1277],
41	.	.	O	.	_	0	SENT_7	[p1l889t1224r1155b1277],

1	Drug-resistant	JJ	O	drug-resistant	amod	3	SENT_8	[p1l1188t1224r1691b1294],
2	HEp2A	NN	O	hep2a	nn	3	SENT_8	[p1l1722t1224r1971b1294],
3	cells	NNS	O	cell	nsubj	4	SENT_8	[p1l1998t1225r2146b1277],
4	showed	VBD	O	show	_	0	SENT_8	[p1l20t1300r279b1352],
5	greater	JJR	O	greater	amod	8	SENT_8	[p1l315t1305r576b1369],
6	total	JJ	O	total	amod	8	SENT_8	[p1l605t1300r767b1352],
7	GST	NN	O	gst	nn	8	SENT_8	[p1l804t1299r960b1352],
8	activity	NN	O	activity	dobj	4	SENT_8	[p1l994t1299r1266b1368],
9	,	,	O	,	_	0	SENT_8	[p1l994t1299r1266b1368],
10	GSTP	NN	O	gstp	nn	13	SENT_8	[p1l1303t1299r1507b1352],
11	class	NN	O	class	nn	13	SENT_8	[p1l1543t1300r1701b1352],
12	enzyme	NN	O	enzyme	nn	13	SENT_8	[p1l1734t1316r2007b1368],
13	expression	NN	O	expression	dobj	4	SENT_8	[p1l2042t1316r2145b1352, p1l21t1373r328b1443],
14	,	,	O	,	_	0	SENT_8	[p1l2042t1316r2145b1352, p1l21t1373r328b1443],
15	Pgp	NN	ORGANIZATION	pgp	nn	16	SENT_8	[p1l365t1373r491b1443],
16	expression	NN	O	expression	dobj	4	SENT_8	[p1l524t1373r916b1443],
17	,	,	O	,	_	0	SENT_8	[p1l524t1373r916b1443],
18	MRPI	NN	O	mrpus	nn	20	SENT_8	[p1l953t1373r1141b1425],
19	transcript	NN	O	transcript	nn	20	SENT_8	[p1l1185t1373r1531b1443],
20	expression	NN	O	expression	conj_and	8	SENT_8	[p1l1563t1373r1954b1443],
21	,	,	O	,	_	0	SENT_8	[p1l1563t1373r1954b1443],
22	drug	NN	O	drug	nn	23	SENT_8	[p1l1988t1373r2147b1442],
23	efflux	NN	O	efflux	conj_and	8	SENT_8	[p1l20t1447r212b1500],
24	and	CC	O	and	_	0	SENT_8	[p1l242t1447r363b1500],
25	at	IN	O	at	advmod	8	SENT_8	[p1l397t1453r465b1500],
26	least	JJS	O	least	pobj	25	SENT_8	[p1l498t1447r657b1500],
27	I3-fold	RB	O	i3-fold	advmod	28	SENT_8	[p1l700t1447r922b1500],
28	greater	JJR	O	greater	amod	29	SENT_8	[p1l956t1453r1217b1516],
29	resistance	NN	O	resistance	conj_and	8	SENT_8	[p1l1248t1447r1596b1500],
30	to	TO	O	to	_	0	SENT_8	[p1l1626t1453r1698b1500],
31	doxorubicin	NN	O	doxorubicin	prep_to	29	SENT_8	[p1l1730t1447r2144b1500],
32	than	IN	O	than	_	0	SENT_8	[p1l18t1521r172b1574],
33	the	DT	O	the	det	37	SENT_8	[p1l202t1521r315b1574],
34	parent	NN	O	parent	nn	37	SENT_8	[p1l347t1527r576b1590],
35	HEp2	NN	O	hep2	nn	37	SENT_8	[p1l608t1521r796b1590],
36	cell	NN	O	cell	nn	37	SENT_8	[p1l827t1521r941b1574],
37	line	NN	O	line	prep_than	4	SENT_8	[p1l975t1521r1114b1574],
38	.	.	O	.	_	0	SENT_8	[p1l975t1521r1114b1574],

1	GSTM	NNP	O	GSTM	nn	4	SENT_9	[p1l1146t1521r1366b1574],
2	class	NN	O	class	nn	4	SENT_9	[p1l1399t1521r1558b1574],
3	enzyme	NN	O	enzyme	nn	4	SENT_9	[p1l1587t1537r1860b1590],
4	expression	NN	O	expression	nsubj	6	SENT_9	[p1l1890t1537r2145b1590, p1l20t1595r154b1647],
5	was	VBD	O	be	cop	6	SENT_9	[p1l177t1611r306b1647],
6	similar	JJ	O	similar	_	0	SENT_9	[p1l329t1595r567b1647],
7	in	IN	O	in	_	0	SENT_9	[p1l589t1594r645b1647],
8	both	DT	O	both	det	10	SENT_9	[p1l672t1595r827b1647],
9	cell	NN	O	cell	nn	10	SENT_9	[p1l853t1595r966b1647],
10	types	NNS	O	type	prep_in	6	SENT_9	[p1l989t1601r1193b1664],
11	,	,	O	,	_	0	SENT_9	[p1l989t1601r1193b1664],
12	while	IN	O	while	mark	18	SENT_9	[p1l1214t1595r1398b1647],
13	GSTA	NN	O	gsta	nn	15	SENT_9	[p1l1422t1594r1638b1647],
14	class	NN	O	class	nn	15	SENT_9	[p1l1660t1595r1818b1647],
15	enzymes	NNS	O	enzyme	nsubjpass	18	SENT_9	[p1l1841t1611r2146b1663],
16	were	VBD	O	be	auxpass	18	SENT_9	[p1l17t1685r191b1721],
17	not	RB	O	not	neg	18	SENT_9	[p1l218t1674r333b1721],
18	detected	VBN	O	detect	advcl	6	SENT_9	[p1l357t1669r683b1721],
19	.	.	O	.	_	0	SENT_9	[p1l357t1669r683b1721],

1	In	IN	O	in	_	0	SENT_10	[p1l713t1669r773b1721],
2	the	DT	O	the	det	5	SENT_10	[p1l798t1669r911b1721],
3	resistant	JJ	O	resistant	amod	5	SENT_10	[p1l939t1668r1240b1721],
4	HEp2A	NN	O	hep2a	nn	5	SENT_10	[p1l1267t1668r1516b1738],
5	cells	NNS	O	cell	prep_in	10	SENT_10	[p1l1540t1669r1708b1733],
6	,	,	O	,	_	0	SENT_10	[p1l1540t1669r1708b1733],
7	cytotoxicity	NN	O	cytotoxicity	nsubjpass	10	SENT_10	[p1l1734t1668r2148b1737],
8	was	VBD	O	be	auxpass	10	SENT_10	[p1l17t1760r147b1796],
9	markedly	RB	O	markedly	advmod	10	SENT_10	[p1l175t1744r503b1812],
10	enhanced	VBN	O	enhance	_	0	SENT_10	[p1l528t1744r858b1796],
11	by	IN	O	by	_	0	SENT_10	[p1l888t1744r967b1812],
12	the	DT	O	the	det	15	SENT_10	[p1l989t1744r1103b1796],
13	PgplMRP	NN	O	pgplmrp	nn	15	SENT_10	[p1l1133t1743r1447b1813],
14	inhibitor	NN	O	inhibitor	nn	15	SENT_10	[p1l1476t1743r1775b1796],
15	verapamil	NN	O	verapamil	agent	10	SENT_10	[p1l1797t1743r2144b1813],
16	at	IN	O	at	_	0	SENT_10	[p1l20t1823r87b1870],
17	low	JJ	O	low	amod	19	SENT_10	[p1l124t1817r245b1870],
18	doxorubicin	NN	O	doxorubicin	nn	19	SENT_10	[p1l279t1817r692b1870],
19	concentrations	NNS	O	concentration	prep_at	15	SENT_10	[p1l731t1817r1271b1870],
20	.	.	O	.	_	0	SENT_10	[p1l731t1817r1271b1870],

1	The	DT	O	the	det	4	SENT_11	[p1l1309t1817r1445b1870],
2	GST	NN	O	gst	nn	4	SENT_11	[p1l1482t1817r1639b1870],
3	inhibitor	NN	O	inhibitor	nn	4	SENT_11	[p1l1676t1817r1975b1870],
4	curcumin	NN	O	curcumin	nsubj	6	SENT_11	[p1l2010t1834r2145b1870, p1l20t1891r232b1944],
5	also	RB	O	also	advmod	6	SENT_11	[p1l268t1891r401b1944],
6	enhanced	VBD	O	enhance	_	0	SENT_11	[p1l437t1891r767b1944],
7	cytotoxicity	NN	O	cytotoxicity	dobj	6	SENT_11	[p1l805t1891r1218b1960],
8	in	IN	O	in	_	0	SENT_11	[p1l1253t1891r1309b1943],
9	HEp2A	NN	O	hep2a	nn	10	SENT_11	[p1l1349t1891r1599b1960],
10	cells	NNS	O	cell	prep_in	6	SENT_11	[p1l1632t1891r1780b1944],
11	when	WRB	O	when	advmod	18	SENT_11	[p1l1812t1891r1997b1944],
12	the	DT	O	the	det	15	SENT_11	[p1l2032t1891r2146b1944],
13	PgpIMRP	NN	O	pgpimrp	nn	15	SENT_11	[p1l23t1965r337b2034],
14	efflux	NN	O	efflux	nn	15	SENT_11	[p1l373t1965r566b2018],
15	barrier	NN	O	barrier	nsubjpass	22	SENT_11	[p1l601t1965r845b2018],
16	had	VBD	O	have	aux	18	SENT_11	[p1l879t1965r999b2018],
17	been	VBN	O	be	auxpass	18	SENT_11	[p1l1038t1965r1201b2018],
18	reversed	VBN	O	reverse	advcl	6	SENT_11	[p1l1240t1965r1539b2018],
19	by	IN	O	by	_	0	SENT_11	[p1l1578t1965r1657b2034],
20	verapamil	NN	O	verapamil	agent	18	SENT_11	[p1l1687t1965r2034b2034],
21	or	CC	O	or	_	0	SENT_11	[p1l2072t1981r2148b2018],
22	overcome	VBN	O	overcome	advcl	6	SENT_11	[p1l20t2055r370b2091],
23	by	IN	O	by	_	0	SENT_11	[p1l410t2039r488b2107],
24	high	JJ	O	high	amod	26	SENT_11	[p1l526t2039r666b2108],
25	doxorubicin	NN	O	doxorubicin	nn	26	SENT_11	[p1l706t2038r1119b2091],
26	concentrations	NNS	O	concentration	prep_by	22	SENT_11	[p1l1159t2039r1700b2091],
27	.	.	O	.	_	0	SENT_11	[p1l1159t2039r1700b2091],

1	In	IN	O	in	_	0	SENT_12	[p1l1743t2039r1802b2091],
2	addition	NN	O	addition	prep_in	5	SENT_12	[p1l1841t2039r2145b2103],
3	,	,	O	,	_	0	SENT_12	[p1l1841t2039r2145b2103],
4	curcumin	NN	O	curcumin	nsubj	5	SENT_12	[p1l20t2112r347b2165],
5	had	VBD	O	have	_	0	SENT_12	[p1l386t2113r506b2165],
6	a	DT	O	a	det	8	SENT_12	[p1l544t2129r581b2165],
7	chemosensitising	NN	O	chemosensitising	nn	8	SENT_12	[p1l615t2112r1212b2182],
8	effect	NN	O	effect	dobj	5	SENT_12	[p1l1245t2112r1439b2165],
9	at	IN	O	at	_	0	SENT_12	[p1l1473t2118r1541b2165],
10	low	JJ	O	low	amod	12	SENT_12	[p1l1578t2113r1697b2165],
11	doxorubicin	NN	O	doxorubicin	nn	12	SENT_12	[p1l1730t2112r2144b2165],
12	concentrations	NNS	O	concentration	prep_at	8	SENT_12	[p1l20t2187r542b2240],
13	in	IN	O	in	_	0	SENT_12	[p1l585t2187r641b2239],
14	HEp2	NN	O	hep2	nn	15	SENT_12	[p1l688t2187r876b2257],
15	cells	NNS	O	cell	prep_in	5	SENT_12	[p1l919t2188r1086b2240],
16	.	.	O	.	_	0	SENT_12	[p1l919t2188r1086b2240],

1	Stable	JJ	O	stable	amod	2	SENT_13	[p1l1130t2187r1347b2240],
2	transfection	NN	O	transfection	nsubj	9	SENT_13	[p1l1387t2187r1805b2240],
3	of	IN	O	of	_	0	SENT_13	[p1l1849t2187r1920b2240],
4	HEp2	NN	O	hep2	nn	5	SENT_13	[p1l1957t2187r2145b2257],
5	cells	NNS	O	cell	prep_of	2	SENT_13	[p1l20t2261r168b2314],
6	with	IN	O	with	_	0	SENT_13	[p1l208t2261r358b2314],
7	human	JJ	O	human	amod	8	SENT_13	[p1l404t2261r641b2314],
8	GSTPI	NN	O	gstpus	prep_with	5	SENT_13	[p1l686t2261r920b2314],
9	increases	VBZ	O	increase	_	0	SENT_13	[p1l977t2261r1296b2314],
10	doxorubicin	NN	O	doxorubicin	nn	11	SENT_13	[p1l1338t2261r1751b2314],
11	resistance	NN	O	resistance	dobj	9	SENT_13	[p1l1798t2261r2146b2314],
12	3-fold	RB	O	3-fold	advmod	9	SENT_13	[p1l21t2335r212b2388],
13	over	IN	O	over	_	0	SENT_13	[p1l243t2351r400b2388],
14	control	NN	O	control	nn	15	SENT_13	[p1l426t2335r676b2388],
15	cells	NNS	O	cell	prep_over	9	SENT_13	[p1l707t2335r874b2388],
16	.	.	O	.	_	0	SENT_13	[p1l707t2335r874b2388],

1	Our	PRP$	O	we	poss	2	SENT_14	[p1l905t2335r1046b2388],
2	study	NN	O	study	nsubj	3	SENT_14	[p1l1072t2335r1259b2404],
3	indicates	VBZ	O	indicate	_	0	SENT_14	[p1l1287t2335r1593b2388],
4	involvement	NN	O	involvement	dobj	3	SENT_14	[p1l1623t2335r2055b2388],
5	of	IN	O	of	_	0	SENT_14	[p1l2083t2335r2153b2388],
6	GSTP	NN	O	gstp	nn	7	SENT_14	[p1l21t2409r225b2462],
7	enzymes	NNS	O	enzyme	prep_of	4	SENT_14	[p1l253t2425r559b2478],
8	as	RB	O	as	_	0	SENT_14	[p1l585t2425r654b2462],
9	well	RB	O	well	_	0	SENT_14	[p1l678t2409r816b2462],
10	as	IN	O	as	_	0	SENT_14	[p1l845t2425r913b2462],
11	efflux	NN	O	efflux	nn	12	SENT_14	[p1l941t2409r1133b2462],
12	mechanisms	NNS	O	mechanism	dobj	3	SENT_14	[p1l1160t2409r1591b2462],
13	in	IN	O	in	_	0	SENT_14	[p1l1619t2409r1676b2461],
14	the	DT	O	the	det	17	SENT_14	[p1l1703t2409r1817b2462],
15	acquired	VBN	O	acquire	amod	17	SENT_14	[p1l1844t2409r2144b2478],
16	doxorubicin-resistance	JJ	O	doxorubicin-resistance	amod	17	SENT_14	[p1l20t2482r814b2535],
17	phenotype	NN	O	phenotype	prep_in	12	SENT_14	[p1l845t2483r1232b2552],
18	.	.	O	.	_	0	SENT_14	[p1l845t2483r1232b2552],

1	©	RB	O	©	advmod	2	SENT_15	[p1l19t2564r66b2611],
2	2001	CD	DATE	2001	_	0	SENT_15	[p1l106t2558r250b2610],
3	Wiley-Liss	NNP	O	Wiley-Liss	dep	2	SENT_15	[p1l286t2558r610b2625],
4	,	,	O	,	_	0	SENT_15	[p1l286t2558r610b2625],
5	Inc.	NNP	ORGANIZATION	Inc.	appos	3	SENT_15	[p1l643t2560r751b2610],
6	.	.	O	.	_	0	SENT_15	[p1l643t2560r751b2610],

1	Key	NN	O	key	nn	2	SENT_16	[p1l19t2697r146b2763],
2	words	NNS	O	word	_	0	SENT_16	[p1l177t2697r392b2749],
3	:	:	O	:	_	0	SENT_16	[p1l177t2697r392b2749],
4	acquired	VBN	O	acquire	amod	5	SENT_16	[p1l455t2696r725b2764],
5	resistance	NN	O	resistance	dep	2	SENT_16	[p1l754t2698r1076b2758],
6	;	:	O	;	_	0	SENT_16	[p1l754t2698r1076b2758],
7	doxorubicin	NN	O	doxorubicin	dep	5	SENT_16	[p1l1111t2696r1495b2758],
8	;	:	O	;	_	0	SENT_16	[p1l1111t2696r1495b2758],
9	glutathione	NN	O	glutathione	nn	10	SENT_16	[p1l1529t2696r1870b2764],
10	Stransferases	NNS	O	stransferase	dep	7	SENT_16	[p1l1903t2697r2144b2749, p1l6t2772r251b2839],
11	;	:	O	;	_	0	SENT_16	[p1l1903t2697r2144b2749, p1l6t2772r251b2839],
12	transporters	NNS	O	transporter	dep	10	SENT_16	[p1l284t2781r653b2839],

1	Doxorubicin	NN	O	doxorubicin	nsubj	4	SENT_17	[p1l98t2983r500b3039],
2	is	VBZ	O	be	cop	4	SENT_17	[p1l532t2983r581b3039],
3	an	DT	O	a	det	4	SENT_17	[p1l617t3001r689b3039],
4	anthracycline	NN	O	anthracycline	_	0	SENT_17	[p1l723t2983r1149b3055],
5	antibiotic	JJ	O	antibiotic	amod	4	SENT_17	[p1l1184t2983r1498b3049],
6	,	,	O	,	_	0	SENT_17	[p1l1184t2983r1498b3049],
7	useful	JJ	O	useful	amod	4	SENT_17	[p1l1533t2983r1727b3039],
8	in	IN	O	in	_	0	SENT_17	[p1l1760t2983r1820b3038],
9	the	DT	O	the	det	10	SENT_17	[p1l1852t2983r1947b3039],
10	treatment	NN	O	treatment	prep_in	7	SENT_17	[p1l1980t2991r2144b3039, p1l18t3075r177b3123],
11	of	IN	O	of	_	0	SENT_17	[p1l211t3066r280b3123],
12	diverse	JJ	O	diverse	amod	13	SENT_17	[p1l309t3066r537b3123],
13	malignancies	NNS	O	malignancy	prep_of	10	SENT_17	[p1l571t3066r1007b3139],
14	,	,	O	,	_	0	SENT_17	[p1l571t3066r1007b3139],
15	which	WDT	O	which	nsubj	16	SENT_17	[p1l1045t3066r1238b3123],
16	exerts	VBZ	O	exert	rcmod	4	SENT_17	[p1l1272t3075r1459b3123],
17	cytotoxic	JJ	O	cytotoxic	amod	18	SENT_17	[p1l1495t3066r1788b3139],
18	effects	NNS	O	effect	dobj	16	SENT_17	[p1l1825t3066r2033b3123],
19	by	IN	O	by	_	0	SENT_17	[p1l2068t3067r2146b3139],
20	interaction	NN	O	interaction	prep_by	16	SENT_17	[p1l18t3151r358b3207],
21	with	IN	O	with	_	0	SENT_17	[p1l387t3151r527b3207],
22	topoisomerase	NN	O	topoisomerase	nn	23	SENT_17	[p1l555t3151r1014b3223],
23	II1	NN	O	ii1	prep_with	20	SENT_17	[p1l1043t3140r1120b3206],
24	and	CC	O	and	_	0	SENT_17	[p1l1156t3151r1268b3207],
25	production	NN	O	production	conj_and	23	SENT_17	[p1l1295t3151r1641b3223],
26	of	IN	O	of	_	0	SENT_17	[p1l1670t3151r1739b3207],
27	reactive	JJ	O	reactive	amod	29	SENT_17	[p1l1762t3151r2013b3207],
28	oxygen	NN	O	oxygen	nn	29	SENT_17	[p1l2043t3169r2144b3207, p1l18t3252r171b3307],
29	species	NNS	O	species	prep_of	20	SENT_17	[p1l212t3235r486b3307],
30	,2	CD	NUMBER	,2	npadvmod	16	SENT_17	[p1l212t3235r486b3307],
31	through	IN	O	through	_	0	SENT_17	[p1l525t3235r772b3307],
32	the	DT	O	the	det	34	SENT_17	[p1l810t3235r905b3290],
33	redox	NN	O	redox	nn	34	SENT_17	[p1l943t3235r1124b3290],
34	cycling	NN	O	cycling	prep_through	16	SENT_17	[p1l1163t3235r1395b3307],
35	of	IN	O	of	_	0	SENT_17	[p1l1435t3235r1504b3290],
36	its	PRP$	O	its	poss	38	SENT_17	[p1l1536t3235r1608b3290],
37	quinone	NN	O	quinone	nn	38	SENT_17	[p1l1649t3235r1903b3307],
38	group	NN	O	group	prep_of	34	SENT_17	[p1l1943t3252r2142b3307],
39	.	.	O	.	_	0	SENT_17	[p1l1943t3252r2142b3307],

1	Doxorubicin	NN	O	doxorubicin	dep	142	SENT_18	[p1l18t3318r420b3373],
2	preferentially	RB	O	preferentially	dep	142	SENT_18	[p1l441t3318r869b3390],
3	partitions	NNS	O	partition	dep	142	SENT_18	[p1l891t3318r1189b3390],
4	to	TO	O	to	dep	142	SENT_18	[p1l1213t3326r1272b3373],
5	membranes	NNS	O	membrane	dep	142	SENT_18	[p1l1295t3318r1708b3383],
6	,3	CD	NUMBER	,3	dep	142	SENT_18	[p1l1295t3318r1708b3383],
7	where	WRB	O	where	dep	142	SENT_18	[p1l1732t3318r1924b3373],
8	it	PRP	O	it	dep	142	SENT_18	[p1l1947t3318r1990b3373],
9	may	MD	O	may	dep	142	SENT_18	[p1l2011t3336r2146b3390],
10	cause	VB	O	cause	dep	142	SENT_18	[p1l19t3418r193b3455],
11	lipid	NN	O	lipid	dep	142	SENT_18	[p1l214t3400r359b3472],
12	peroxidation	NN	O	peroxidation	dep	142	SENT_18	[p1l377t3400r780b3472],
13	through	IN	O	through	dep	142	SENT_18	[p1l799t3400r1046b3472],
14	reactive	JJ	O	reactive	dep	142	SENT_18	[p1l1065t3400r1316b3455],
15	oxygen	NN	O	oxygen	dep	142	SENT_18	[p1l1337t3418r1570b3472],
16	species	NNS	O	species	dep	142	SENT_18	[p1l1593t3400r1816b3472],
17	generated	VBN	O	generate	dep	142	SENT_18	[p1l1839t3400r2147b3472],
18	by	IN	O	by	dep	142	SENT_18	[p1l17t3483r96b3555],
19	redox	NN	O	redox	dep	142	SENT_18	[p1l128t3483r308b3539],
20	cycling	NN	O	cycling	dep	142	SENT_18	[p1l342t3483r618b3555],
21	}	NN	O	}	dep	142	SENT_18	[p1l342t3483r618b3555],
22	In	IN	O	in	dep	142	SENT_18	[p1l655t3485r720b3538],
23	certain	JJ	O	certain	dep	142	SENT_18	[p1l753t3483r968b3539],
24	tumors	NNS	O	tumor	dep	142	SENT_18	[p1l1000t3492r1237b3549],
25	,	,	O	,	_	0	SENT_18	[p1l1000t3492r1237b3549],
26	however	RB	O	however	dep	142	SENT_18	[p1l1272t3483r1563b3549],
27	,	,	O	,	_	0	SENT_18	[p1l1272t3483r1563b3549],
28	the	DT	O	the	dep	142	SENT_18	[p1l1599t3483r1694b3539],
29	ATP	NN	O	atp	dep	142	SENT_18	[p1l1727t3483r2146b3555],
30	—	NN	O	—	dep	142	SENT_18	[p1l1727t3483r2146b3555],
31	binding	NN	O	binding	dep	142	SENT_18	[p1l1727t3483r2146b3555],
32	cassette	NN	O	cassette	dep	142	SENT_18	[p1l19t3575r264b3622],
33	transmembrane	NN	O	transmembrane	dep	142	SENT_18	[p1l291t3567r780b3622],
34	molecules	NNS	O	molecule	dep	142	SENT_18	[p1l807t3566r1127b3622],
35	P-glycoprotein	NN	O	p-glycoprotein	dep	142	SENT_18	[p1l1155t3566r1628b3638],
36	(	CD	NUMBER	(	dep	142	SENT_18	[p1l1657t3567r1846b3638],
37	Pgp	NNP	O	Pgp	dep	142	SENT_18	[p1l1657t3567r1846b3638],
38	)	NNP	O	)	dep	142	SENT_18	[p1l1657t3567r1846b3638],
39	,	,	O	,	_	0	SENT_18	[p1l1657t3567r1846b3638],
40	which	WDT	O	which	dep	142	SENT_18	[p1l1876t3566r2069b3622],
41	is	VBZ	O	be	dep	142	SENT_18	[p1l2095t3566r2145b3622],
42	encoded	VBN	O	encode	dep	142	SENT_18	[p1l19t3650r283b3705],
43	by	IN	O	by	dep	142	SENT_18	[p1l312t3650r390b3722],
44	the	DT	O	the	dep	142	SENT_18	[p1l422t3650r517b3705],
45	MDRI	NN	ORGANIZATION	mdrus	dep	142	SENT_18	[p1l546t3650r754b3704],
46	gene	NN	O	gene	dep	142	SENT_18	[p1l792t3667r956b3722],
47	,	,	O	,	_	0	SENT_18	[p1l792t3667r956b3722],
48	and	CC	O	and	dep	142	SENT_18	[p1l992t3650r1104b3705],
49	multidrug	JJ	O	multidrug	dep	142	SENT_18	[p1l1135t3650r1447b3722],
50	resistance-associated	JJ	O	resistance-associated	dep	142	SENT_18	[p1l1478t3650r2147b3705],
51	protein	NN	O	protein	dep	142	SENT_18	[p1l17t3733r243b3805],
52	(	CD	NUMBER	(	dep	142	SENT_18	[p1l292t3733r547b3801],
53	MRPI	NN	O	mrpus	dep	142	SENT_18	[p1l292t3733r547b3801],
54	)	NN	O	)	dep	142	SENT_18	[p1l292t3733r547b3801],
55	may	MD	O	may	dep	142	SENT_18	[p1l596t3750r731b3804],
56	cause	VB	O	cause	dep	142	SENT_18	[p1l779t3750r954b3788],
57	rapid	JJ	O	rapid	dep	142	SENT_18	[p1l1000t3733r1164b3805],
58	drug	NN	O	drug	dep	142	SENT_18	[p1l1211t3733r1353b3805],
59	efﬂux	NN	O	efﬂux	dep	142	SENT_18	[p1l1402t3733r1586b3788],
60	and	CC	O	and	dep	142	SENT_18	[p1l1635t3733r1747b3788],
61	diminished	VBD	O	diminish	dep	142	SENT_18	[p1l1794t3733r2147b3788],
62	cytotoxicity	NN	O	cytotoxicity	dep	142	SENT_18	[p2l19t12r488b84],
63	.4	CD	NUMBER	.4	dep	142	SENT_18	[p2l19t12r488b84],
64	a5	NN	O	a5	dep	142	SENT_18	[p2l19t12r488b84],
65	Glutathione	NN	O	glutathione	dep	142	SENT_18	[p2l526t12r900b67],
66	S	NN	O	s	dep	142	SENT_18	[p2l936t12r1375b68],
67	—	CD	NUMBER	—	dep	142	SENT_18	[p2l936t12r1375b68],
68	transferases	NNS	O	transferase	dep	142	SENT_18	[p2l936t12r1375b68],
69	(	VBP	O	(	dep	142	SENT_18	[p2l1415t12r1643b80],
70	GSTs	NNS	O	gst	dep	142	SENT_18	[p2l1415t12r1643b80],
71	)	CD	NUMBER	)	dep	142	SENT_18	[p2l1415t12r1643b80],
72	are	VBP	O	be	dep	142	SENT_18	[p2l1682t30r1776b67],
73	multifunctional	JJ	O	multifunctional	dep	142	SENT_18	[p2l1811t12r2144b67, p2l18t94r198b149],
74	proteins	NNS	O	protein	dep	142	SENT_18	[p2l243t94r497b166],
75	categorised	VBN	O	categorise	dep	142	SENT_18	[p2l546t94r907b166],
76	in	IN	O	in	dep	142	SENT_18	[p2l953t94r1013b149],
77	alpha	NN	O	alpha	dep	142	SENT_18	[p2l1060t94r1231b166],
78	(	CD	NUMBER	(	dep	142	SENT_18	[p2l1278t94r1552b163],
79	GSTA	NN	O	gsta	dep	142	SENT_18	[p2l1278t94r1552b163],
80	)	NN	O	)	dep	142	SENT_18	[p2l1278t94r1552b163],
81	,	,	O	,	_	0	SENT_18	[p2l1278t94r1552b163],
82	mu	NN	O	mu	dep	142	SENT_18	[p2l1601t112r1701b149],
83	(	NN	O	(	dep	142	SENT_18	[p2l1750t94r2037b162],
84	GSTM	NN	O	gstm	dep	142	SENT_18	[p2l1750t94r2037b162],
85	)	NN	O	)	dep	142	SENT_18	[p2l1750t94r2037b162],
86	,	,	O	,	_	0	SENT_18	[p2l1750t94r2037b162],
87	pi	NN	O	pi	dep	142	SENT_18	[p2l2086t94r2146b166],
88	(	NN	O	(	dep	142	SENT_18	[p2l21t178r321b246],
89	GSTP1	NN	O	gstp1	dep	142	SENT_18	[p2l21t178r321b246],
90	)	NN	O	)	dep	142	SENT_18	[p2l21t178r321b246],
91	,	,	O	,	_	0	SENT_18	[p2l21t178r321b246],
92	and	CC	O	and	dep	142	SENT_18	[p2l355t177r467b233],
93	theta	NN	O	theta	dep	142	SENT_18	[p2l495t177r650b233],
94	classes	NNS	O	class	dep	142	SENT_18	[p2l678t177r914b243],
95	,	,	O	,	_	0	SENT_18	[p2l678t177r914b243],
96	which	WDT	O	which	dep	142	SENT_18	[p2l946t177r1139b233],
97	detoxicate	VBP	O	detoxicate	dep	142	SENT_18	[p2l1169t177r1494b233],
98	various	JJ	O	various	dep	142	SENT_18	[p2l1523t177r1754b233],
99	substrates	NNS	O	substrate	dep	142	SENT_18	[p2l1788t177r2146b233],
100	.6	CD	NUMBER	.6	dep	142	SENT_18	[p2l1788t177r2146b233],
101	Human	JJ	O	human	dep	142	SENT_18	[p2l18t262r251b317],
102	GSTP1	NN	O	gstp1	dep	142	SENT_18	[p2l294t261r519b317],
103	reduces	VBZ	O	reduce	dep	142	SENT_18	[p2l568t261r808b317],
104	cytotoxic	JJ	O	cytotoxic	dep	142	SENT_18	[p2l853t260r1146b333],
105	effects	NNS	O	effect	dep	142	SENT_18	[p2l1190t260r1399b317],
106	of	IN	O	of	dep	142	SENT_18	[p2l1444t260r1512b317],
107	doxorubicin	NN	O	doxorubicin	dep	142	SENT_18	[p2l1550t260r1934b317],
108	when	WRB	O	when	dep	142	SENT_18	[p2l1976t261r2147b317],
109	transfected	VBN	O	transfect	dep	142	SENT_18	[p2l18t345r367b401],
110	into	IN	O	into	dep	142	SENT_18	[p2l402t345r523b401],
111	S.	NNP	O	S.	dep	142	SENT_18	[p2l560t346r610b402],
112	cervisiae7	NN	O	cervisiae7	dep	142	SENT_18	[p2l655t334r969b401],
113	or	CC	O	or	dep	142	SENT_18	[p2l1008t363r1073b401],
114	into	IN	O	into	dep	142	SENT_18	[p2l1107t345r1228b401],
115	NIH3T3	NN	O	nih3t3	dep	142	SENT_18	[p2l1265t345r1529b401],
116	cells	NNS	O	cell	dep	142	SENT_18	[p2l1570t345r1760b401],
117	.8	CD	NUMBER	.8	dep	142	SENT_18	[p2l1570t345r1760b401],
118	Peroxidase	NN	O	peroxidase	dep	142	SENT_18	[p2l1798t345r2146b401],
119	activity	NN	O	activity	dep	142	SENT_18	[p2l20t429r255b500],
120	of	IN	O	of	dep	142	SENT_18	[p2l281t429r350b484],
121	GST	NN	O	gst	dep	142	SENT_18	[p2l370t429r517b484],
122	could	MD	O	could	dep	142	SENT_18	[p2l543t429r718b484],
123	serve	VB	O	serve	dep	142	SENT_18	[p2l744t446r908b484],
124	to	TO	O	to	dep	142	SENT_18	[p2l932t437r992b484],
125	reduce	VB	O	reduce	dep	142	SENT_18	[p2l1016t429r1228b484],
126	doxorubicin-induced	JJ	O	doxorubicin-induced	dep	142	SENT_18	[p2l1253t429r1916b484],
127	peroxides	NNS	O	peroxide	dep	142	SENT_18	[p2l1939t446r2144b501, p2l18t512r143b567],
128	and	CC	O	and	dep	142	SENT_18	[p2l178t512r290b567],
129	conjugate	NN	O	conjugate	dep	142	SENT_18	[p2l322t512r629b584],
130	metabolites	NNS	O	metabolite	dep	142	SENT_18	[p2l661t512r1075b567],
131	.9	CD	NUMBER	.9	dep	142	SENT_18	[p2l661t512r1075b567],
132	Glutathione	NN	O	glutathione	dep	142	SENT_18	[p2l1109t512r1803b567],
133	—	NN	O	—	dep	142	SENT_18	[p2l1109t512r1803b567],
134	mediated	VBD	O	mediate	dep	142	SENT_18	[p2l1109t512r1803b567],
135	resistance	NN	O	resistance	dep	142	SENT_18	[p2l1832t512r2146b567],
136	may	MD	O	may	dep	142	SENT_18	[p2l18t612r153b667],
137	also	RB	O	also	dep	142	SENT_18	[p2l179t594r303b650],
138	be	VB	O	be	dep	142	SENT_18	[p2l327t594r400b650],
139	linked	VBN	O	link	dep	142	SENT_18	[p2l425t594r623b650],
140	to	TO	O	to	dep	142	SENT_18	[p2l646t603r705b650],
141	other	JJ	O	other	dep	142	SENT_18	[p2l730t594r893b650],
142	mechanisms	NNS	O	mechanism	_	0	SENT_18	[p2l915t594r1324b650],
143	.	.	O	.	_	0	SENT_18	[p2l915t594r1324b650],

1	MRP1	NN	O	mrp1	nsubjpass	3	SENT_19	[p2l1351t595r1551b650],
2	is	VBZ	O	be	auxpass	3	SENT_19	[p2l1582t594r1631b650],
3	associated	VBN	O	associate	_	0	SENT_19	[p2l1658t594r1984b650],
4	with	IN	O	with	_	0	SENT_19	[p2l2007t594r2147b650],
5	anthracycline	NN	O	anthracycline	nn	6	SENT_19	[p2l20t679r446b751],
6	resistance	NN	O	resistance	prep_with	3	SENT_19	[p2l472t667r847b735],
7	”	CD	NUMBER	”	num	8	SENT_19	[p2l472t667r847b735],
8	)	NN	O	)	dep	6	SENT_19	[p2l472t667r847b735],
9	and	CC	O	and	_	0	SENT_19	[p2l876t679r988b735],
10	mediates	VBZ	O	mediate	conj_and	3	SENT_19	[p2l1013t679r1293b735],
11	efﬂux	NN	O	efﬂux	dobj	10	SENT_19	[p2l1322t679r1505b735],
12	of	IN	O	of	_	0	SENT_19	[p2l1533t679r1602b734],
13	glutathione	NN	O	glutathione	nn	14	SENT_19	[p2l1624t679r1980b751],
14	conjugates	NNS	O	conjugate	prep_of	11	SENT_19	[p2l2007t697r2144b735, p2l11t762r315b834],
15	.	.	O	.	_	0	SENT_19	[p2l2007t697r2144b735, p2l11t762r315b834],

1	“	NN	O	“	nn	3	SENT_20	[p2l2007t697r2144b735, p2l11t762r315b834],
2	Glutathione	NN	O	glutathione	nn	3	SENT_20	[p2l348t762r721b818],
3	conjugates	NNS	O	conjugate	nsubj	6	SENT_20	[p2l749t762r1086b834],
4	of	IN	O	of	_	0	SENT_20	[p2l1115t762r1184b818],
5	doxorubicin	NN	O	doxorubicin	prep_of	3	SENT_20	[p2l1206t762r1590b818],
6	show	VBP	O	show	_	0	SENT_20	[p2l1618t763r1782b818],
7	high	JJ	O	high	amod	8	SENT_20	[p2l1808t762r1949b834],
8	afﬁnities	NNS	O	afﬁnities	dobj	6	SENT_20	[p2l1977t762r2144b818, p2l18t846r147b901],
9	toward	IN	O	toward	_	0	SENT_20	[p2l179t846r399b901],
10	the	DT	O	the	det	12	SENT_20	[p2l429t846r524b901],
11	MRP1	NN	O	mrp1	nn	12	SENT_20	[p2l554t846r754b900],
12	pump	NN	O	pump	prep_toward	6	SENT_20	[p2l790t863r988b918],
13	,	,	O	,	_	0	SENT_20	[p2l790t863r988b918],
14	while	IN	O	while	mark	20	SENT_20	[p2l1021t846r1196b901],
15	unmodiﬁed	JJ	O	unmodiﬁed	amod	16	SENT_20	[p2l1225t846r1589b901],
16	doxorubicin	NN	O	doxorubicin	nsubj	20	SENT_20	[p2l1618t846r2002b901],
17	is	VBZ	O	be	cop	20	SENT_20	[p2l2031t846r2081b901],
18	a	DT	O	a	det	20	SENT_20	[p2l2115t863r2148b901],
19	poor	JJ	O	poor	amod	20	SENT_20	[p2l17t946r164b1001],
20	substrate	NN	O	substrate	advcl	6	SENT_20	[p2l194t929r550b984],
21	.	.	O	.	_	0	SENT_20	[p2l194t929r550b984],

1	”	NN	O	”	_	0	SENT_21	[p2l194t929r550b984],

1	Evolution	NN	O	evolution	nsubj	10	SENT_22	[p2l97t1027r411b1083],
2	of	IN	O	of	_	0	SENT_22	[p2l452t1027r521b1083],
3	drug	NN	O	drug	nn	4	SENT_22	[p2l556t1028r698b1099],
4	resistance	NN	O	resistance	prep_of	1	SENT_22	[p2l739t1027r1052b1083],
5	remains	VBZ	O	remain	cop	10	SENT_22	[p2l1091t1027r1341b1083],
6	a	DT	O	a	det	10	SENT_22	[p2l1385t1045r1417b1083],
7	principal	NN	O	principal	nn	10	SENT_22	[p2l1455t1027r1755b1099],
8	,	,	O	,	_	0	SENT_22	[p2l1455t1027r1755b1099],
9	unresolved	JJ	O	unresolved	amod	10	SENT_22	[p2l1797t1027r2147b1083],
10	cause	NN	O	cause	_	0	SENT_22	[p2l19t1128r193b1166],
11	of	IN	O	of	_	0	SENT_22	[p2l227t1111r296b1166],
12	cancer	NN	O	cancer	nn	13	SENT_22	[p2l323t1128r531b1166],
13	treatment	NN	O	treatment	prep_of	10	SENT_22	[p2l562t1119r862b1166],
14	failure	NN	O	failure	dep	18	SENT_22	[p2l894t1111r1175b1166],
15	.13	CD	NUMBER	.13	num	14	SENT_22	[p2l894t1111r1175b1166],
16	While	IN	O	while	dep	18	SENT_22	[p2l1209t1111r1403b1166],
17	Pgp	NNP	ORGANIZATION	Pgp	nsubj	18	SENT_22	[p2l1436t1112r1557b1183],
18	has	VBZ	O	have	advcl	35	SENT_22	[p2l1590t1111r1693b1166],
19	a	DT	O	a	det	21	SENT_22	[p2l1729t1128r1762b1166],
20	wellestablished	JJ	O	wellestablished	amod	21	SENT_22	[p2l1794t1111r2144b1166, p2l18t1194r208b1249],
21	role	NN	O	role	dobj	18	SENT_22	[p2l226t1194r349b1249],
22	in	IN	O	in	_	0	SENT_22	[p2l369t1194r430b1249],
23	acquired	VBN	O	acquire	amod	25	SENT_22	[p2l451t1194r723b1266],
24	doxorubicin	NN	O	doxorubicin	nn	25	SENT_22	[p2l744t1194r1127b1249],
25	resistance	NN	O	resistance	prep_in	21	SENT_22	[p2l1146t1194r1537b1260],
26	,	,	O	,	_	0	SENT_22	[p2l1146t1194r1537b1260],
27	”	IN	O	”	_	0	SENT_22	[p2l1146t1194r1537b1260],
28	the	DT	O	the	det	29	SENT_22	[p2l1557t1194r1653b1249],
29	contribution	NN	O	contribution	prep_”	35	SENT_22	[p2l1674t1194r2062b1249],
30	of	IN	O	of	_	0	SENT_22	[p2l2083t1194r2152b1249],
31	GST	NN	O	gst	nn	32	SENT_22	[p2l19t1278r167b1334],
32	enzymes	NNS	O	enzyme	prep_of	29	SENT_22	[p2l208t1296r482b1350],
33	is	VBZ	O	be	cop	35	SENT_22	[p2l525t1278r574b1333],
34	less	RBR	O	less	advmod	35	SENT_22	[p2l617t1278r732b1333],
35	clear	JJ	O	clear	rcmod	10	SENT_22	[p2l775t1278r943b1333],
36	.	.	O	.	_	0	SENT_22	[p2l775t1278r943b1333],

1	Moscow	NNP	LOCATION	Moscow	nsubj	52	SENT_23	[p2l988t1279r1260b1333],
2	et	FW	O	et	nn	3	SENT_23	[p2l1302t1289r1359b1333],
3	al.	FW	O	al.	nsubj	5	SENT_23	[p2l1397t1266r1536b1333],
4	15	CD	NUMBER	15	dep	3	SENT_23	[p2l1397t1266r1536b1333],
5	found	VBD	O	find	rcmod	1	SENT_23	[p2l1580t1278r1764b1333],
6	that	IN	O	that	complm	21	SENT_23	[p2l1804t1278r1923b1333],
7	stable	JJ	O	stable	amod	8	SENT_23	[p2l1965t1278r2146b1333],
8	transformation	NN	O	transformation	nsubj	21	SENT_23	[p2l18t1361r486b1417],
9	of	IN	O	of	_	0	SENT_23	[p2l527t1361r595b1417],
10	the	DT	O	the	det	15	SENT_23	[p2l629t1361r724b1417],
11	MCF	NN	O	mcf	nn	15	SENT_23	[p2l763t1362r994b1417],
12	—	NN	O	—	nn	15	SENT_23	[p2l763t1362r994b1417],
13	7	CD	NUMBER	7	num	15	SENT_23	[p2l763t1362r994b1417],
14	cell	NN	O	cell	nn	15	SENT_23	[p2l1037t1361r1149b1417],
15	line	NN	O	line	prep_of	8	SENT_23	[p2l1188t1361r1305b1417],
16	by	IN	O	by	_	0	SENT_23	[p2l1344t1361r1423b1433],
17	a	DT	O	a	det	20	SENT_23	[p2l1464t1379r1497b1417],
18	GSTP1	NN	O	gstp1	nn	20	SENT_23	[p2l1536t1362r1760b1417],
19	expression	NN	O	expression	nn	20	SENT_23	[p2l1808t1361r2146b1433],
20	vector	NN	O	vector	prep_by	15	SENT_23	[p2l18t1453r217b1500],
21	gave	VBD	O	give	ccomp	5	SENT_23	[p2l252t1462r399b1516],
22	no	DT	O	no	det	23	SENT_23	[p2l435t1462r511b1500],
23	protection	NN	O	protection	dobj	21	SENT_23	[p2l547t1444r870b1516],
24	against	IN	O	against	_	0	SENT_23	[p2l906t1444r1130b1516],
25	doxorubicin	NN	O	doxorubicin	prep_against	21	SENT_23	[p2l1165t1444r1565b1510],
26	,	,	O	,	_	0	SENT_23	[p2l1165t1444r1565b1510],
27	while	IN	O	while	mark	33	SENT_23	[p2l1603t1444r1778b1500],
28	in	IN	O	in	_	0	SENT_23	[p2l1813t1444r1874b1499],
29	another	DT	O	another	det	30	SENT_23	[p2l1910t1444r2148b1500],
30	study	NN	O	study	prep_in	33	SENT_23	[p2l21t1528r188b1600],
31	GSTP1	NN	O	gstp1	nsubjpass	33	SENT_23	[p2l222t1528r446b1584],
32	was	VBD	O	be	auxpass	33	SENT_23	[p2l485t1545r605b1584],
33	found	VBN	O	find	advcl	21	SENT_23	[p2l638t1528r823b1584],
34	to	TO	O	to	aux	35	SENT_23	[p2l854t1536r913b1584],
35	give	VB	O	give	xcomp	33	SENT_23	[p2l946t1528r1080b1600],
36	no	DT	O	no	det	38	SENT_23	[p2l1111t1545r1188b1584],
37	additional	JJ	O	additional	amod	38	SENT_23	[p2l1222t1528r1538b1584],
38	protection	NN	O	protection	dobj	35	SENT_23	[p2l1568t1528r1891b1600],
39	against	IN	O	against	_	0	SENT_23	[p2l1924t1528r2148b1600],
40	doxorubicin	NN	O	doxorubicin	prep_against	38	SENT_23	[p2l19t1612r402b1668],
41	over	IN	O	over	_	0	SENT_23	[p2l436t1630r576b1668],
42	Pgp	NN	O	pgp	prep_over	35	SENT_23	[p2l608t1613r729b1685],
43	alone	RB	O	alone	advmod	42	SENT_23	[p2l765t1612r1011b1668],
44	.16	CD	NUMBER	.16	npadvmod	45	SENT_23	[p2l765t1612r1011b1668],
45	More	RBR	O	more	advmod	35	SENT_23	[p2l1044t1613r1215b1668],
46	recently	RB	DATE	recently	advmod	35	SENT_23	[p2l1247t1612r1520b1684],
47	,	,	O	,	_	0	SENT_23	[p2l1247t1612r1520b1684],
48	Beaumont	NNP	LOCATION	Beaumont	dep	51	SENT_23	[p2l1556t1613r1884b1668],
49	er	FW	O	er	nn	51	SENT_23	[p2l1917t1623r1974b1668],
50	al.	FW	O	al.	nn	51	SENT_23	[p2l2004t1600r2144b1668],
51	”	FW	O	”	dep	35	SENT_23	[p2l2004t1600r2144b1668],
52	investigated	VBD	O	investigate	_	0	SENT_23	[p2l18t1696r403b1768],
53	the	DT	O	the	det	54	SENT_23	[p2l433t1696r529b1751],
54	role	NN	O	role	dobj	52	SENT_23	[p2l559t1696r682b1751],
55	of	IN	O	of	_	0	SENT_23	[p2l715t1696r784b1751],
56	glutathione	NN	O	glutathione	nn	57	SENT_23	[p2l811t1696r1166b1768],
57	S	NN	O	s	prep_of	54	SENT_23	[p2l1199t1696r1638b1752],
58	—	CD	NUMBER	—	num	59	SENT_23	[p2l1199t1696r1638b1752],
59	transferases	NNS	O	transferase	tmod	52	SENT_23	[p2l1199t1696r1638b1752],
60	in	IN	O	in	_	0	SENT_23	[p2l1671t1696r1732b1750],
61	doxorubicin	NN	O	doxorubicin	nn	62	SENT_23	[p2l1763t1696r2147b1751],
62	resistance	NN	O	resistance	prep_in	59	SENT_23	[p2l7t1778r322b1835],
63	of	IN	O	of	_	0	SENT_23	[p2l362t1778r431b1834],
64	4	CD	NUMBER	4	num	69	SENT_23	[p2l463t1779r501b1834],
65	human	JJ	O	human	amod	69	SENT_23	[p2l539t1778r756b1835],
66	colorectal	JJ	O	colorectal	amod	69	SENT_23	[p2l795t1778r1109b1835],
67	cancer	NN	O	cancer	nn	69	SENT_23	[p2l1148t1796r1357b1835],
68	cell	NN	O	cell	nn	69	SENT_23	[p2l1394t1778r1507b1835],
69	lines	NNS	O	line	prep_of	62	SENT_23	[p2l1545t1778r1711b1835],
70	.	.	O	.	_	0	SENT_23	[p2l1545t1778r1711b1835],

1	Higher	JJR	O	higher	amod	4	SENT_24	[p2l1752t1778r1976b1851],
2	total	JJ	O	total	amod	4	SENT_24	[p2l2012t1778r2152b1835],
3	GST	NN	O	gst	nn	4	SENT_24	[p2l9t1863r157b1919],
4	activity	NN	O	activity	nsubjpass	11	SENT_24	[p2l181t1862r417b1935],
5	and	CC	O	and	_	0	SENT_24	[p2l441t1863r554b1919],
6	a	DT	O	a	det	9	SENT_24	[p2l577t1880r610b1919],
7	unique	JJ	O	unique	amod	9	SENT_24	[p2l630t1862r847b1935],
8	GSTA	NN	O	gsta	nn	9	SENT_24	[p2l870t1863r1077b1919],
9	band	NN	O	band	conj_and	4	SENT_24	[p2l1097t1863r1253b1919],
10	were	VBD	O	be	auxpass	11	SENT_24	[p2l1274t1880r1428b1919],
11	found	VBN	O	find	_	0	SENT_24	[p2l1450t1862r1636b1919],
12	in	IN	O	in	_	0	SENT_24	[p2l1657t1862r1717b1918],
13	doxorubicinresistant	JJ	O	doxorubicinresistant	amod	15	SENT_24	[p2l1740t1862r2150b1919, p2l7t1947r275b2003],
14	CaCo2	NN	O	caco2	nn	15	SENT_24	[p2l301t1947r512b2020],
15	cells	NNS	O	cell	prep_in	11	SENT_24	[p2l539t1946r681b2003],
16	in	IN	O	in	_	0	SENT_24	[p2l709t1946r770b2002],
17	comparison	NN	O	comparison	prep_in	15	SENT_24	[p2l797t1946r1170b2019],
18	with	IN	O	with	_	0	SENT_24	[p2l1196t1946r1337b2003],
19	drug-sensitive	JJ	O	drug-sensitive	amod	21	SENT_24	[p2l1364t1946r1816b2019],
20	cell	NN	O	cell	nn	21	SENT_24	[p2l1843t1946r1956b2003],
21	lines	NNS	O	line	prep_with	11	SENT_24	[p2l1983t1946r2150b2013],
22	,	,	O	,	_	0	SENT_24	[p2l1983t1946r2150b2013],
23	but	CC	O	but	_	0	SENT_24	[p2l6t2031r109b2087],
24	GST	NN	O	gst	nn	25	SENT_24	[p2l150t2031r298b2087],
25	inhibitors	NNS	O	inhibitor	nsubj	28	SENT_24	[p2l339t2031r643b2087],
26	did	VBD	O	do	aux	28	SENT_24	[p2l686t2031r787b2087],
27	not	RB	O	not	neg	28	SENT_24	[p2l826t2039r928b2087],
28	potentiate	VB	O	potentiate	conj_but	11	SENT_24	[p2l966t2031r1282b2104],
29	doxorubicin	NN	O	doxorubicin	nn	30	SENT_24	[p2l1324t2031r1710b2087],
30	cytotoxity	NN	O	cytotoxity	dobj	28	SENT_24	[p2l1750t2031r2151b2103],
31	.	.	O	.	_	0	SENT_24	[p2l1750t2031r2151b2103],

1	”	NN	O	”	nsubjpass	26	SENT_25	[p2l1750t2031r2151b2103],
2	Using	VBG	O	use	partmod	1	SENT_25	[p2l7t2115r196b2188],
3	a	DT	O	a	det	6	SENT_25	[p2l230t2133r264b2171],
4	more	RBR	O	more	advmod	5	SENT_25	[p2l293t2133r456b2171],
5	selective	JJ	O	selective	amod	6	SENT_25	[p2l490t2115r767b2171],
6	approach	NN	O	approach	dobj	2	SENT_25	[p2l800t2115r1092b2188],
7	by	IN	O	by	_	0	SENT_25	[p2l1121t2115r1200b2188],
8	retroviral	JJ	O	retroviral	amod	9	SENT_25	[p2l1231t2115r1529b2171],
9	transfer	NN	O	transfer	prep_by	6	SENT_25	[p2l1560t2115r1806b2171],
10	of	IN	O	of	_	0	SENT_25	[p2l1836t2115r1905b2171],
11	MDR1	NN	O	mdr1	prep_of	9	SENT_25	[p2l1931t2115r2146b2170],
12	alone	RB	O	alone	advmod	11	SENT_25	[p2l9t2198r179b2254],
13	or	CC	O	or	_	0	SENT_25	[p2l209t2216r274b2254],
14	MDR1	NN	O	mdr1	prep_of	9	SENT_25	[p2l299t2199r514b2254],
15	and	CC	O	and	_	0	SENT_25	[p2l550t2198r664b2254],
16	GSTP1	NN	O	gstp1	conj_and	14	SENT_25	[p2l692t2198r918b2255],
17	together	RB	O	together	advmod	2	SENT_25	[p2l953t2198r1216b2271],
18	to	TO	O	to	_	0	SENT_25	[p2l1243t2207r1302b2254],
19	a	DT	O	a	det	22	SENT_25	[p2l1332t2216r1365b2254],
20	single	JJ	O	single	amod	22	SENT_25	[p2l1395t2198r1582b2271],
21	cell	NN	O	cell	nn	22	SENT_25	[p2l1611t2198r1724b2254],
22	line	NN	O	line	prep_to	2	SENT_25	[p2l1752t2198r1887b2265],
23	,	,	O	,	_	0	SENT_25	[p2l1752t2198r1887b2265],
24	GSTP1	NN	O	gstp1	appos	22	SENT_25	[p2l1919t2198r2146b2255],
25	was	VBD	O	be	auxpass	26	SENT_25	[p2l8t2300r129b2339],
26	found	VBN	O	find	ccomp	42	SENT_25	[p2l154t2282r340b2338],
27	to	TO	O	to	aux	28	SENT_25	[p2l362t2291r422b2338],
28	confer	VB	O	confer	xcomp	26	SENT_25	[p2l447t2282r651b2339],
29	no	DT	O	no	det	32	SENT_25	[p2l673t2300r750b2338],
30	additional	JJ	O	additional	amod	32	SENT_25	[p2l776t2282r1094b2339],
31	doxorubicin	NN	O	doxorubicin	nn	32	SENT_25	[p2l1118t2282r1504b2339],
32	resistance	NN	O	resistance	dobj	28	SENT_25	[p2l1526t2282r1842b2339],
33	over	IN	O	over	_	0	SENT_25	[p2l1867t2300r2008b2338],
34	Pgp	NN	ORGANIZATION	pgp	prep_over	28	SENT_25	[p2l2029t2284r2152b2355],
35	alone	RB	O	alone	advmod	34	SENT_25	[p2l9t2367r256b2423],
36	.18	CD	NUMBER	.18	pobj	35	SENT_25	[p2l9t2367r256b2423],
37	Conversely	RB	O	conversely	advmod	28	SENT_25	[p2l298t2367r679b2439],
38	,	,	O	,	_	0	SENT_25	[p2l298t2367r679b2439],
39	doxorubicin	NN	O	doxorubicin	nn	40	SENT_25	[p2l723t2366r1109b2423],
40	cytotoxicity	NN	O	cytotoxicity	nsubjpass	42	SENT_25	[p2l1149t2366r1530b2439],
41	was	VBD	O	be	auxpass	42	SENT_25	[p2l1571t2384r1692b2423],
42	enhanced	VBN	O	enhance	_	0	SENT_25	[p2l1733t2366r2035b2423],
43	by	IN	O	by	_	0	SENT_25	[p2l2073t2367r2152b2439],
44	transfection	NN	O	transfection	agent	42	SENT_25	[p2l7t2451r386b2507],
45	of	IN	O	of	_	0	SENT_25	[p2l407t2451r476b2507],
46	cells	NNS	O	cell	prep_of	44	SENT_25	[p2l493t2451r635b2507],
47	with	IN	O	with	_	0	SENT_25	[p2l659t2451r800b2507],
48	an	DT	O	a	det	50	SENT_25	[p2l822t2468r894b2507],
49	antisense	JJ	O	antisense	amod	50	SENT_25	[p2l917t2451r1207b2507],
50	vector	NN	O	vector	prep_with	42	SENT_25	[p2l1229t2459r1429b2507],
51	against	IN	O	against	_	0	SENT_25	[p2l1451t2451r1676b2524],
52	GSTP1	NN	O	gstp1	prep_against	50	SENT_25	[p2l1697t2451r2008b2507],
53	.19	CD	NUMBER	.19	num	52	SENT_25	[p2l1697t2451r2008b2507],
54	The	DT	O	the	det	55	SENT_25	[p2l2029t2451r2152b2507],
55	interaction	NN	O	interaction	nsubj	69	SENT_25	[p2l7t2535r350b2591],
56	between	IN	O	between	_	0	SENT_25	[p2l377t2535r645b2591],
57	GST	NN	O	gst	nn	58	SENT_25	[p2l675t2535r823b2591],
58	expression	NN	O	expression	prep_between	55	SENT_25	[p2l853t2535r1211b2608],
59	,	,	O	,	_	0	SENT_25	[p2l853t2535r1211b2608],
60	conjugation	NN	O	conjugation	prep_between	55	SENT_25	[p2l1244t2535r1621b2608],
61	and	CC	O	and	_	0	SENT_25	[p2l1651t2535r1764b2591],
62	MRP1mediated	JJ	O	mrp1mediated	amod	63	SENT_25	[p2l1792t2535r2150b2591, p2l8t2619r203b2675],
63	efﬂux	NN	O	efﬂux	prep_between	55	SENT_25	[p2l224t2619r408b2675],
64	of	IN	O	of	_	0	SENT_25	[p2l430t2619r499b2675],
65	drug	NN	O	drug	nn	66	SENT_25	[p2l516t2619r659b2692],
66	conjugates	NNS	O	conjugate	prep_of	63	SENT_25	[p2l681t2619r1021b2692],
67	may	MD	O	may	aux	69	SENT_25	[p2l1043t2637r1179b2692],
68	be	VB	O	be	cop	69	SENT_25	[p2l1200t2619r1274b2675],
69	important	JJ	O	important	rcmod	52	SENT_25	[p2l1295t2619r1607b2692],
70	in	IN	O	in	_	0	SENT_25	[p2l1627t2619r1687b2674],
71	determination	NN	O	determination	prep_in	69	SENT_25	[p2l1709t2619r2153b2675],
72	of	IN	O	of	_	0	SENT_25	[p2l8t2702r78b2758],
73	drug	NN	O	drug	nn	74	SENT_25	[p2l103t2702r247b2775],
74	resistance	NN	O	resistance	prep_of	71	SENT_25	[p2l276t2702r671b2758],
75	.	.	O	.	_	0	SENT_25	[p2l276t2702r671b2758],

1	”	NN	O	”	nsubj	11	SENT_26	[p2l276t2702r671b2758],
2	However	RB	O	however	advmod	1	SENT_26	[p2l700t2703r1010b2769],
3	,	,	O	,	_	0	SENT_26	[p2l700t2703r1010b2769],
4	information	NN	O	information	nsubj	11	SENT_26	[p2l1043t2702r1421b2758],
5	relating	VBG	O	relate	partmod	4	SENT_26	[p2l1450t2702r1694b2775],
6	to	TO	O	to	_	0	SENT_26	[p2l1724t2711r1784b2758],
7	MRP1	NN	O	mrp1	nn	8	SENT_26	[p2l1814t2703r2015b2758],
8	expression	NN	O	expression	prep_to	5	SENT_26	[p2l2053t2720r2150b2758, p2l7t2786r274b2859],
9	has	VBZ	O	have	aux	11	SENT_26	[p2l302t2786r406b2842],
10	been	VBN	O	be	aux	11	SENT_26	[p2l435t2786r587b2842],
11	lacking	VBG	O	lack	_	0	SENT_26	[p2l616t2786r850b2859],
12	in	IN	O	in	_	0	SENT_26	[p2l880t2786r940b2842],
13	previous	JJ	O	previous	amod	14	SENT_26	[p2l968t2786r1242b2859],
14	studies	NNS	O	study	prep_in	11	SENT_26	[p2l1276t2786r1658b2843],
15	.15	CD	NUMBER	.15	number	16	SENT_26	[p2l1276t2786r1658b2843],
16	—	CD	NUMBER	—	num	17	SENT_26	[p2l1276t2786r1658b2843],
17	19	CD	NUMBER	19	dep	11	SENT_26	[p2l1276t2786r1658b2843],

1	Our	PRP$	O	we	poss	2	SENT_27	[p2l89t2886r212b2943],
2	study	NN	O	study	nsubj	4	SENT_27	[p2l251t2886r420b2959],
3	has	VBZ	O	have	aux	4	SENT_27	[p2l457t2886r561b2942],
4	used	VBN	O	use	_	0	SENT_27	[p2l599t2886r746b2942],
5	a	DT	O	a	det	7	SENT_27	[p2l784t2904r817b2942],
6	representative	JJ	O	representative	amod	7	SENT_27	[p2l852t2886r1302b2959],
7	model	NN	O	model	dobj	4	SENT_27	[p2l1339t2886r1538b2942],
8	to	TO	O	to	aux	9	SENT_27	[p2l1575t2894r1635b2942],
9	investigate	VB	O	investigate	xcomp	4	SENT_27	[p2l1673t2886r2019b2959],
10	the	DT	O	the	det	12	SENT_27	[p2l2056t2886r2152b2942],
11	relative	JJ	O	relative	amod	12	SENT_27	[p2l7t2970r246b3027],
12	roles	NNS	O	role	dobj	9	SENT_27	[p2l273t2970r426b3026],
13	of	IN	O	of	_	0	SENT_27	[p2l456t2970r526b3026],
14	GST	NN	O	gst	nn	15	SENT_27	[p2l548t2971r697b3027],
15	enzymes	NNS	O	enzyme	prep_of	12	SENT_27	[p2l725t2988r1021b3043],
16	,	,	O	,	_	0	SENT_27	[p2l725t2988r1021b3043],
17	Pgp	NNP	ORGANIZATION	Pgp	prep_of	12	SENT_27	[p2l1051t2972r1173b3043],
18	and	CC	O	and	_	0	SENT_27	[p2l1203t2970r1316b3026],
19	MRP1	NN	O	mrp1	prep_of	12	SENT_27	[p2l1341t2971r1543b3026],
20	in	IN	O	in	_	0	SENT_27	[p2l1577t2970r1638b3026],
21	acquired	VBN	O	acquire	amod	23	SENT_27	[p2l1666t2970r1940b3043],
22	doxorubicin	NN	O	doxorubicin	nn	23	SENT_27	[p2l1968t2970r2150b3026, p2l7t3054r234b3111],
23	resistance	NN	O	resistance	prep_in	9	SENT_27	[p2l263t3054r595b3111],
24	.	.	O	.	_	0	SENT_27	[p2l263t3054r595b3111],

1	GST	NN	O	gst	nsubjpass	11	SENT_28	[p2l632t3055r797b3121],
2	,	,	O	,	_	0	SENT_28	[p2l632t3055r797b3121],
3	Pgp	NNP	ORGANIZATION	Pgp	nsubjpass	11	SENT_28	[p2l831t3056r953b3127],
4	and	CC	O	and	_	0	SENT_28	[p2l987t3055r1100b3111],
5	MRP1	NN	O	mrp1	nn	6	SENT_28	[p2l1130t3055r1331b3110],
6	expression	NN	O	expression	nsubjpass	11	SENT_28	[p2l1369t3054r1711b3127],
7	and	CC	O	and	_	0	SENT_28	[p2l1744t3055r1856b3111],
8	function	NN	O	function	conj_and	1	SENT_28	[p2l1887t3054r2153b3111],
9	have	VBP	O	have	aux	11	SENT_28	[p2l7t3139r157b3195],
10	been	VBN	O	be	auxpass	11	SENT_28	[p2l184t3139r335b3195],
11	studied	VBN	O	study	_	0	SENT_28	[p2l365t3139r593b3195],
12	in	IN	O	in	_	0	SENT_28	[p2l620t3139r680b3194],
13	a	DT	O	a	det	22	SENT_28	[p2l709t3156r743b3195],
14	drug-sensitive	JJ	O	drug-sensitive	amod	22	SENT_28	[p2l770t3139r1223b3212],
15	human	JJ	O	human	amod	22	SENT_28	[p2l1250t3139r1468b3195],
16	laryngeal	NN	O	laryngeal	nn	22	SENT_28	[p2l1495t3139r1792b3212],
17	carcinoma	NN	O	carcinoma	nn	22	SENT_28	[p2l1820t3139r2154b3195],
18	cell	NN	O	cell	nn	22	SENT_28	[p2l8t3223r121b3279],
19	line	NN	O	line	nn	22	SENT_28	[p2l166t3223r284b3279],
20	(	NN	O	(	nn	22	SENT_28	[p2l332t3223r566b3296],
21	HEp2	NN	O	hep2	nn	22	SENT_28	[p2l332t3223r566b3296],
22	)	NN	O	)	prep_in	11	SENT_28	[p2l332t3223r566b3296],
23	and	CC	O	and	_	0	SENT_28	[p2l615t3223r728b3279],
24	a	DT	O	a	det	25	SENT_28	[p2l773t3240r807b3279],
25	subclone	NN	O	subclone	nsubj	26	SENT_28	[p2l853t3223r1133b3279],
26	made	VBD	O	make	conj_and	11	SENT_28	[p2l1178t3223r1350b3279],
27	resistant	JJ	O	resistant	acomp	26	SENT_28	[p2l1394t3223r1662b3279],
28	by	IN	O	by	_	0	SENT_28	[p2l1704t3223r1783b3295],
29	prolonged	JJ	O	prolonged	amod	30	SENT_28	[p2l1827t3223r2153b3296],
30	culture	NN	O	culture	prep_by	27	SENT_28	[p2l8t3307r228b3363],
31	in	IN	O	in	_	0	SENT_28	[p2l265t3307r326b3362],
32	doxorubicin	NN	O	doxorubicin	nn	35	SENT_28	[p2l363t3307r750b3363],
33	(	CD	NUMBER	(	num	35	SENT_28	[p2l788t3307r1100b3380],
34	HEp2A	NN	O	hep2a	nn	35	SENT_28	[p2l788t3307r1100b3380],
35	)	NN	O	)	prep_in	26	SENT_28	[p2l788t3307r1100b3380],
36	,	,	O	,	_	0	SENT_28	[p2l788t3307r1100b3380],
37	together	RB	O	together	_	0	SENT_28	[p2l1140t3307r1403b3380],
38	with	IN	O	with	_	0	SENT_28	[p2l1438t3307r1579b3363],
39	HEp2	NN	O	hep2	nn	40	SENT_28	[p2l1615t3307r1800b3380],
40	subclones	NNS	O	subclone	prep_together_with	26	SENT_28	[p2l1840t3307r2151b3363],
41	stably	RB	O	stably	advmod	42	SENT_28	[p2l10t3390r197b3463],
42	transfected	VBN	O	transfect	partmod	40	SENT_28	[p2l223t3390r574b3446],
43	with	IN	O	with	_	0	SENT_28	[p2l599t3390r740b3446],
44	GSTP1	NN	O	gstp1	prep_with	42	SENT_28	[p2l766t3390r1015b3447],
45	.	.	O	.	_	0	SENT_28	[p2l766t3390r1015b3447],

1	The	DT	O	the	det	2	SENT_29	[p2l1044t3390r1167b3446],
2	contribution	NN	O	contribution	nsubjpass	15	SENT_29	[p2l1193t3390r1584b3446],
3	of	IN	O	of	_	0	SENT_29	[p2l1609t3390r1679b3446],
4	both	CC	O	both	preconj	5	SENT_29	[p2l1697t3390r1839b3446],
5	GST	NN	O	gst	prep_of	2	SENT_29	[p2l1865t3391r2014b3447],
6	and	CC	O	and	_	0	SENT_29	[p2l2040t3390r2153b3446],
7	the	DT	O	the	det	9	SENT_29	[p2l7t3474r103b3530],
8	transporter	NN	O	transporter	nn	9	SENT_29	[p2l146t3483r494b3547],
9	proteins	NNS	O	protein	conj_and	5	SENT_29	[p2l533t3474r790b3547],
10	to	TO	O	to	_	0	SENT_29	[p2l834t3483r893b3530],
11	doxorubicin	NN	O	doxorubicin	nn	12	SENT_29	[p2l937t3474r1323b3530],
12	resistance	NN	O	resistance	prep_to	2	SENT_29	[p2l1364t3474r1680b3531],
13	has	VBZ	O	have	aux	15	SENT_29	[p2l1722t3474r1826b3531],
14	been	VBN	O	be	auxpass	15	SENT_29	[p2l1868t3474r2019b3531],
15	assessed	VBN	O	assess	_	0	SENT_29	[p2l2063t3492r2151b3530, p2l10t3559r212b3615],
16	by	IN	O	by	_	0	SENT_29	[p2l236t3559r315b3631],
17	determining	VBG	O	determine	agent	15	SENT_29	[p2l343t3558r728b3631],
18	the	DT	O	the	det	19	SENT_29	[p2l755t3559r851b3615],
19	effects	NNS	O	effect	dobj	17	SENT_29	[p2l878t3558r1088b3615],
20	of	IN	O	of	_	0	SENT_29	[p2l1117t3558r1186b3615],
21	inhibitors	NNS	O	inhibitor	prep_of	19	SENT_29	[p2l1207t3558r1511b3615],
22	of	IN	O	of	_	0	SENT_29	[p2l1541t3558r1610b3615],
23	GST	NN	O	gst	prep_of	21	SENT_29	[p2l1632t3559r1781b3615],
24	and	CC	O	and	_	0	SENT_29	[p2l1808t3558r1921b3615],
25	efﬂux	NN	O	efﬂux	prep_of	21	SENT_29	[p2l1948t3558r2150b3625],
26	,	,	O	,	_	0	SENT_29	[p2l1948t3558r2150b3625],
27	alone	RB	O	alone	advmod	15	SENT_29	[p2l9t3643r179b3699],
28	and	CC	O	and	_	0	SENT_29	[p2l210t3643r323b3699],
29	in	IN	O	in	conj_and	27	SENT_29	[p2l352t3643r413b3698],
30	combination	NN	O	combination	pobj	29	SENT_29	[p2l442t3643r859b3709],
31	,	,	O	,	_	0	SENT_29	[p2l442t3643r859b3709],
32	on	IN	O	on	_	0	SENT_29	[p2l892t3660r969b3699],
33	doxorubicin	NN	O	doxorubicin	nn	34	SENT_29	[p2l999t3643r1385b3699],
34	cytotoxicity	NN	O	cytotoxicity	prep_on	15	SENT_29	[p2l1414t3643r1812b3715],
35	.	.	O	.	_	0	SENT_29	[p2l1414t3643r1812b3715],

1	MATERIAL	NN	O	material	_	0	SENT_30	[p3l639t109r984b155],
2	AND	CC	O	and	rcmod	1	SENT_30	[p3l1019t109r1162b156],
3	METHODS	NNS	O	method	dep	1	SENT_30	[p3l1198t109r1518b156],

1	Cell	NN	O	cell	nn	2	SENT_31	[p3l11t199r141b256],
2	culture	NN	O	culture	_	0	SENT_31	[p3l170t199r393b256],

1	HEp2A	NN	O	hep2a	dep	128	SENT_32	[p3l88t300r332b372],
2	cells	NNS	O	cell	dep	128	SENT_32	[p3l373t299r516b355],
3	had	VBD	O	have	dep	128	SENT_32	[p3l558t299r673b355],
4	been	VBN	O	be	dep	128	SENT_32	[p3l712t299r863b355],
5	previously	RB	DATE	previously	dep	128	SENT_32	[p3l902t299r1240b372],
6	isolated	VBN	O	isolate	dep	128	SENT_32	[p3l1281t299r1530b355],
7	by	IN	O	by	dep	128	SENT_32	[p3l1569t299r1648b372],
8	culture	NN	O	culture	dep	128	SENT_32	[p3l1690t299r1910b355],
9	of	IN	O	of	dep	128	SENT_32	[p3l1952t299r2021b355],
10	the	DT	O	the	dep	128	SENT_32	[p3l2056t299r2152b355],
11	parent	NN	O	parent	dep	128	SENT_32	[p3l6t392r208b456],
12	drug-sensitive	JJ	O	drug-sensitive	dep	128	SENT_32	[p3l247t383r700b456],
13	HEp2	NN	O	hep2	dep	128	SENT_32	[p3l741t384r925b456],
14	human	JJ	O	human	dep	128	SENT_32	[p3l966t384r1183b440],
15	laryngeal	NN	O	laryngeal	dep	128	SENT_32	[p3l1223t384r1520b456],
16	carcinoma	NN	O	carcinoma	dep	128	SENT_32	[p3l1561t383r1895b440],
17	line	NN	O	line	dep	128	SENT_32	[p3l1934t383r2052b440],
18	in	IN	O	in	dep	128	SENT_32	[p3l2092t383r2153b439],
19	incremental	JJ	O	incremental	dep	128	SENT_32	[p3l7t468r385b524],
20	concentrations	NNS	O	concentration	dep	128	SENT_32	[p3l406t468r871b524],
21	of	IN	O	of	dep	128	SENT_32	[p3l894t468r963b524],
22	doxorubicin	NN	O	doxorubicin	dep	128	SENT_32	[p3l978t468r1364b524],
23	for	IN	O	for	dep	128	SENT_32	[p3l1384t468r1478b524],
24	15	CD	DURATION	15	dep	128	SENT_32	[p3l1503t467r1570b524],
25	months	NNS	NUMBER	month	dep	128	SENT_32	[p3l1593t468r1907b524],
26	.20	NN	NUMBER	.20	dep	128	SENT_32	[p3l1593t468r1907b524],
27	For	IN	O	for	dep	128	SENT_32	[p3l1926t469r2038b524],
28	the	DT	O	the	dep	128	SENT_32	[p3l2056t468r2152b524],
29	studies	NNS	O	study	dep	128	SENT_32	[p3l10t552r227b608],
30	described	VBN	O	describe	dep	128	SENT_32	[p3l255t552r561b608],
31	in	IN	O	in	dep	128	SENT_32	[p3l585t552r646b607],
32	this	DT	O	this	dep	128	SENT_32	[p3l670t552r783b608],
33	manuscript	NN	O	manuscript	dep	128	SENT_32	[p3l809t552r1182b625],
34	,	,	O	,	_	0	SENT_32	[p3l809t552r1182b625],
35	HEp2	NN	O	hep2	dep	128	SENT_32	[p3l1210t552r1395b625],
36	and	CC	O	and	dep	128	SENT_32	[p3l1422t552r1535b608],
37	HEp2A	NN	O	hep2a	dep	128	SENT_32	[p3l1559t552r1803b625],
38	cells	NNS	O	cell	dep	128	SENT_32	[p3l1829t552r1972b608],
39	were	VBD	O	be	dep	128	SENT_32	[p3l1999t570r2152b608],
40	grown	VBN	O	grow	dep	128	SENT_32	[p3l8t653r211b708],
41	in	IN	O	in	dep	128	SENT_32	[p3l237t635r297b691],
42	DMEM	NNP	O	DMEM	dep	128	SENT_32	[p3l322t636r588b702],
43	,	,	O	,	_	0	SENT_32	[p3l322t636r588b702],
44	nutrition	NN	O	nutrition	dep	128	SENT_32	[p3l617t635r892b691],
45	mix	NN	O	mix	dep	128	SENT_32	[p3l917t635r1040b691],
46	F-12	NN	O	f-12	dep	128	SENT_32	[p3l1065t636r1215b691],
47	(	CD	NUMBER	(	dep	128	SENT_32	[p3l1243t635r1399b705],
48	Life	NNP	ORGANIZATION	Life	dep	128	SENT_32	[p3l1243t635r1399b705],
49	Technologies	NNPS	ORGANIZATION	Technologies	dep	128	SENT_32	[p3l1425t635r1874b708],
50	,	,	O	,	_	0	SENT_32	[p3l1425t635r1874b708],
51	Paisley	NNP	PERSON	Paisley	dep	128	SENT_32	[p3l1902t635r2150b708],
52	,	,	O	,	_	0	SENT_32	[p3l1902t635r2150b708],
53	UK	NNP	LOCATION	UK	dep	128	SENT_32	[p3l7t720r165b789],
54	)	NNP	O	)	dep	128	SENT_32	[p3l7t720r165b789],
55	,	,	O	,	_	0	SENT_32	[p3l7t720r165b789],
56	supplemented	VBN	O	supplement	dep	128	SENT_32	[p3l196t719r639b792],
57	with	IN	O	with	dep	128	SENT_32	[p3l663t719r804b775],
58	10	CD	PERCENT	10	dep	128	SENT_32	[p3l836t719r970b776],
59	%	NN	PERCENT	%	dep	128	SENT_32	[p3l836t719r970b776],
60	FCS	NN	O	fc	dep	128	SENT_32	[p3l998t719r1136b776],
61	(	CD	NUMBER	(	dep	128	SENT_32	[p3l1167t719r1322b789],
62	Life	NNP	ORGANIZATION	Life	dep	128	SENT_32	[p3l1167t719r1322b789],
63	Technologies	NNPS	ORGANIZATION	Technologies	dep	128	SENT_32	[p3l1348t719r1823b792],
64	)	NN	O	)	dep	128	SENT_32	[p3l1348t719r1823b792],
65	,	,	O	,	_	0	SENT_32	[p3l1348t719r1823b792],
66	penicillin	NN	O	penicillin	dep	128	SENT_32	[p3l1850t719r2153b792],
67	50	CD	NUMBER	50	dep	128	SENT_32	[p3l9t803r86b860],
68	units/ml	NNS	O	units/ml	dep	128	SENT_32	[p3l109t803r389b870],
69	,	,	O	,	_	0	SENT_32	[p3l109t803r389b870],
70	streptomycin	NN	O	streptomycin	dep	128	SENT_32	[p3l418t803r834b876],
71	50	CD	NUMBER	50	dep	128	SENT_32	[p3l859t803r936b860],
72	mg/ml	NN	O	mg/ml	dep	128	SENT_32	[p3l960t803r1185b876],
73	,	,	O	,	_	0	SENT_32	[p3l960t803r1185b876],
74	2	CD	NUMBER	2	dep	128	SENT_32	[p3l1213t804r1249b859],
75	mM	NN	O	mm	dep	128	SENT_32	[p3l1274t805r1405b859],
76	L-glutamine	NN	O	l-glutamine	dep	128	SENT_32	[p3l1429t803r1842b876],
77	,	,	O	,	_	0	SENT_32	[p3l1429t803r1842b876],
78	1	CD	PERCENT	1	dep	128	SENT_32	[p3l1877t804r1971b860],
79	%	NN	PERCENT	%	dep	128	SENT_32	[p3l1877t804r1971b860],
80	(	CD	NUMBER	(	dep	128	SENT_32	[p3l2001t804r2150b873],
81	v/v	NN	O	v/v	dep	128	SENT_32	[p3l2001t804r2150b873],
82	)	CD	NUMBER	)	dep	128	SENT_32	[p3l2001t804r2150b873],
83	nonessential	JJ	O	nonessential	dep	128	SENT_32	[p3l7t887r403b944],
84	amino	NN	O	amino	dep	128	SENT_32	[p3l443t887r639b944],
85	acids	NNS	O	acid	dep	128	SENT_32	[p3l679t887r839b944],
86	and	CC	O	and	dep	128	SENT_32	[p3l880t887r993b944],
87	10	CD	NUMBER	10	dep	128	SENT_32	[p3l1038t888r1108b944],
88	IU/500	CD	NUMBER	iu/500	dep	128	SENT_32	[p3l1146t887r1371b944],
89	ml	NN	O	ml	dep	128	SENT_32	[p3l1409t887r1492b943],
90	bovine	JJ	O	bovine	dep	128	SENT_32	[p3l1528t887r1746b944],
91	insulin	NN	O	insulin	dep	128	SENT_32	[p3l1784t887r2001b944],
92	and	CC	O	and	dep	128	SENT_32	[p3l2040t888r2153b944],
93	maintained	VBN	O	maintain	dep	128	SENT_32	[p3l7t971r364b1027],
94	in	IN	O	in	dep	128	SENT_32	[p3l407t971r467b1026],
95	humidiﬁed	JJ	O	humidiﬁed	dep	128	SENT_32	[p3l510t971r858b1027],
96	5	CD	PERCENT	5	dep	128	SENT_32	[p3l902t971r1003b1027],
97	%	NN	PERCENT	%	dep	128	SENT_32	[p3l902t971r1003b1027],
98	CO2	NN	O	co2	dep	128	SENT_32	[p3l1051t971r1190b1044],
99	at	IN	O	at	dep	128	SENT_32	[p3l1236t979r1292b1027],
100	37	CD	NUMBER	37	dep	128	SENT_32	[p3l1336t971r1515b1037],
101	°	CD	NUMBER	°	dep	128	SENT_32	[p3l1336t971r1515b1037],
102	C	NN	O	c	dep	128	SENT_32	[p3l1336t971r1515b1037],
103	,	,	O	,	_	0	SENT_32	[p3l1336t971r1515b1037],
104	as	IN	O	as	dep	128	SENT_32	[p3l1564t988r1625b1027],
105	previously	RB	DATE	previously	dep	128	SENT_32	[p3l1670t971r2008b1043],
106	described	VBN	O	describe	dep	128	SENT_32	[p3l2053t971r2150b1027, p3l10t1055r316b1112],
107	.20	CD	NUMBER	.20	dep	128	SENT_32	[p3l2053t971r2150b1027, p3l10t1055r316b1112],
108	Cells	NNS	O	cell	dep	128	SENT_32	[p3l343t1055r503b1112],
109	were	VBD	O	be	dep	128	SENT_32	[p3l532t1073r686b1112],
110	grown	VBN	O	grow	dep	128	SENT_32	[p3l713t1073r916b1129],
111	in	IN	O	in	dep	128	SENT_32	[p3l942t1055r1002b1111],
112	75	CD	NUMBER	75	dep	128	SENT_32	[p3l1029t1055r1103b1112],
113	cm2	NN	O	cm2	dep	128	SENT_32	[p3l1134t1043r1260b1112],
114	ﬂasks	NNS	O	ﬂasks	dep	128	SENT_32	[p3l1288t1055r1466b1112],
115	for	IN	O	for	dep	128	SENT_32	[p3l1494t1055r1587b1112],
116	Western	NN	MISC	western	dep	128	SENT_32	[p3l1611t1057r1878b1112],
117	blotting	NN	O	blotting	dep	128	SENT_32	[p3l1903t1055r2152b1129],
118	and	CC	O	and	dep	128	SENT_32	[p3l9t1139r122b1195],
119	transport	NN	O	transport	dep	128	SENT_32	[p3l142t1147r427b1212],
120	studies	NNS	O	study	dep	128	SENT_32	[p3l449t1139r666b1195],
121	and	CC	O	and	dep	128	SENT_32	[p3l690t1139r803b1195],
122	in	IN	O	in	dep	128	SENT_32	[p3l823t1139r883b1195],
123	96	CD	NUMBER	96	dep	128	SENT_32	[p3l904t1139r981b1196],
124	multiwell	JJ	O	multiwell	dep	128	SENT_32	[p3l1002t1139r1308b1195],
125	plates	NNS	O	plate	dep	128	SENT_32	[p3l1328t1139r1512b1212],
126	for	IN	O	for	dep	128	SENT_32	[p3l1535t1139r1628b1195],
127	toxicity	NN	O	toxicity	dep	128	SENT_32	[p3l1647t1139r1890b1212],
128	studies	NNS	O	study	_	0	SENT_32	[p3l1914t1139r2149b1195],
129	.	.	O	.	_	0	SENT_32	[p3l1914t1139r2149b1195],

1	Cytotoxicity	NN	O	cytotoxicity	nn	2	SENT_33	[p3l11t1298r395b1369],
2	assay	NN	O	assay	_	0	SENT_33	[p3l423t1316r600b1369],

1	Doxorubicin	NN	O	doxorubicin	nn	2	SENT_34	[p3l88t1398r493b1454],
2	cytotoxicity	NN	O	cytotoxicity	nsubjpass	4	SENT_34	[p3l536t1398r917b1471],
3	was	VBD	O	be	auxpass	4	SENT_34	[p3l960t1416r1081b1454],
4	assessed	VBN	O	assess	_	0	SENT_34	[p3l1127t1398r1396b1454],
5	by	IN	O	by	_	0	SENT_34	[p3l1437t1398r1515b1471],
6	the	DT	O	the	det	7	SENT_34	[p3l1558t1398r1654b1454],
7	MTT	NNP	O	MTT	agent	4	SENT_34	[p3l1696t1399r1864b1453],
8	(	CD	NUMBER	(	number	9	SENT_34	[p3l1909t1398r2150b1467, p3l8t1488r818b1561],
9	3	CD	NUMBER	3	num	11	SENT_34	[p3l1909t1398r2150b1467, p3l8t1488r818b1561],
10	[	NN	O	[	nn	11	SENT_34	[p3l1909t1398r2150b1467, p3l8t1488r818b1561],
11	4,5dimethylthiazol-2-yl	NN	O	4,5dimethylthiazol-2-yl	dobj	4	SENT_34	[p3l1909t1398r2150b1467, p3l8t1488r818b1561],
12	]	CD	NUMBER	]	number	13	SENT_34	[p3l1909t1398r2150b1467, p3l8t1488r818b1561],
13	-2,5	CD	NUMBER	-2,5	num	17	SENT_34	[p3l1909t1398r2150b1467, p3l8t1488r818b1561],
14	diphenyltetrazolium	NN	O	diphenyltetrazolium	nn	17	SENT_34	[p3l889t1488r1536b1561],
15	bromide	NN	O	bromide	nn	17	SENT_34	[p3l1600t1488r1891b1557],
16	)	NN	O	)	nn	17	SENT_34	[p3l1600t1488r1891b1557],
17	assay	NN	O	assay	dep	11	SENT_34	[p3l1962t1506r2150b1561],
18	,	,	O	,	_	0	SENT_34	[p3l1962t1506r2150b1561],
19	which	WDT	O	which	nsubj	20	SENT_34	[p3l8t1579r202b1636],
20	measures	VBZ	O	measure	rcmod	17	SENT_34	[p3l243t1597r539b1635],
21	the	DT	O	the	det	22	SENT_34	[p3l582t1579r678b1635],
22	ability	NN	O	ability	dobj	20	SENT_34	[p3l721t1579r922b1652],
23	of	IN	O	of	_	0	SENT_34	[p3l965t1579r1034b1635],
24	viable	JJ	O	viable	amod	25	SENT_34	[p3l1070t1579r1264b1636],
25	cells	NNS	O	cell	prep_of	22	SENT_34	[p3l1306t1579r1449b1636],
26	to	TO	O	to	aux	27	SENT_34	[p3l1492t1588r1552b1635],
27	reduce	VB	O	reduce	xcomp	4	SENT_34	[p3l1593t1579r1806b1636],
28	a	DT	O	a	det	32	SENT_34	[p3l1849t1597r1882b1635],
29	soluble	JJ	O	soluble	amod	32	SENT_34	[p3l1925t1579r2152b1635],
30	yellow	JJ	O	yellow	amod	32	SENT_34	[p3l7t1670r224b1743],
31	tetrazolium	NN	O	tetrazolium	nn	32	SENT_34	[p3l251t1670r617b1727],
32	salt	NN	O	salt	iobj	27	SENT_34	[p3l646t1671r753b1727],
33	(	CD	NUMBER	(	num	34	SENT_34	[p3l782t1671r998b1740],
34	MTT	NNP	O	MTT	dobj	27	SENT_34	[p3l782t1671r998b1740],
35	)	CD	NUMBER	)	num	34	SENT_34	[p3l782t1671r998b1740],
36	to	TO	O	to	_	0	SENT_34	[p3l1028t1679r1087b1727],
37	insoluble	JJ	O	insoluble	amod	40	SENT_34	[p3l1115t1670r1408b1727],
38	purple	JJ	O	purple	amod	40	SENT_34	[p3l1434t1671r1638b1743],
39	formazan	NN	O	formazan	nn	40	SENT_34	[p3l1666t1670r1967b1727],
40	crysGrant	NN	O	crysgrant	prep_to	34	SENT_34	[p3l1995t1688r2151b1743, p3l80t1924r241b1973],

1	sponsor	NN	O	sponsor	_	0	SENT_35	[p3l262t1939r496b1988],
2	:	:	O	:	_	0	SENT_35	[p3l262t1939r496b1988],
3	UK	NNP	LOCATION	UK	nn	6	SENT_35	[p3l520t1925r623b1973],
4	Cancer	NNP	O	Cancer	nn	6	SENT_35	[p3l642t1924r844b1973],
5	Research	NNP	O	Research	nn	6	SENT_35	[p3l862t1923r1123b1973],
6	Campaign	NNP	O	Campaign	dep	1	SENT_35	[p3l1143t1923r1452b1988],
7	;	:	O	;	_	0	SENT_35	[p3l1143t1923r1452b1988],
8	Grant	NNP	O	Grant	nn	9	SENT_35	[p3l1476t1924r1637b1973],
9	number	NN	O	number	dep	6	SENT_35	[p3l1656t1923r1887b1973],
10	:	:	O	:	_	0	SENT_35	[p3l1656t1923r1887b1973],
11	SP2446	NN	O	sp2446	dep	9	SENT_35	[p3l1914t1923r2154b1973],
12	/	:	O	/	punct	9	SENT_35	[p3l1914t1923r2154b1973],

1	*	NN	O	*	nn	2	SENT_36	[p3l83t2238r577b2302],
2	Correspondence	NN	O	correspondence	_	0	SENT_36	[p3l83t2238r577b2302],
3	to	TO	O	to	_	0	SENT_36	[p3l607t2246r676b2288],
4	:	:	O	:	_	0	SENT_36	[p3l607t2246r676b2288],
5	Department	NNP	O	Department	prep_to	2	SENT_36	[p3l710t2239r1048b2302],
6	of	IN	O	of	_	0	SENT_36	[p3l1077t2238r1139b2288],
7	Surgery	NNP	O	Surgery	prep_of	5	SENT_36	[p3l1165t2239r1403b2303],
8	,	,	O	,	_	0	SENT_36	[p3l1165t2239r1403b2303],
9	Institute	NNP	ORGANIZATION	Institute	appos	5	SENT_36	[p3l1436t2238r1668b2288],
10	of	IN	ORGANIZATION	of	_	0	SENT_36	[p3l1699t2238r1760b2288],
11	Clinical	JJ	ORGANIZATION	clinical	amod	12	SENT_36	[p3l1786t2238r2009b2288],
12	Science	NN	ORGANIZATION	science	prep_of	9	SENT_36	[p3l2041t2238r2151b2288, p3l8t2325r152b2368],
13	,	,	O	,	_	0	SENT_36	[p3l2041t2238r2151b2288, p3l8t2325r152b2368],
14	Grosvenor	NNP	LOCATION	Grosvenor	nn	15	SENT_36	[p3l181t2309r482b2359],
15	Road	NNP	LOCATION	Road	appos	12	SENT_36	[p3l506t2309r670b2368],
16	,	,	O	,	_	0	SENT_36	[p3l506t2309r670b2368],
17	Belfast	NNP	LOCATION	Belfast	appos	12	SENT_36	[p3l699t2309r915b2368],
18	,	,	O	,	_	0	SENT_36	[p3l699t2309r915b2368],
19	BT12	NN	O	bt12	nn	20	SENT_36	[p3l943t2309r1103b2358],
20	6BJ	NN	O	6bj	appos	12	SENT_36	[p3l1131t2309r1255b2368],
21	,	,	O	,	_	0	SENT_36	[p3l1131t2309r1255b2368],
22	Northern	NNP	LOCATION	Northern	nn	23	SENT_36	[p3l1283t2309r1540b2359],
23	Ireland	NNP	LOCATION	Ireland	appos	12	SENT_36	[p3l1566t2309r1780b2359],
24	.	.	O	.	_	0	SENT_36	[p3l1566t2309r1780b2359],

1	Fax	NN	O	fax	_	0	SENT_37	[p3l7t2380r128b2428],
2	:	:	O	:	_	0	SENT_37	[p3l7t2380r128b2428],
3	+44	CD	NUMBER	+44	number	4	SENT_37	[p3l166t2379r731b2429],
4	—	CD	NUMBER	—	num	5	SENT_37	[p3l166t2379r731b2429],
5	28	CD	NUMBER	28	dep	1	SENT_37	[p3l166t2379r731b2429],
6	—	CD	NUMBER	—	number	7	SENT_37	[p3l166t2379r731b2429],
7	9032	CD	NUMBER	9032	num	9	SENT_37	[p3l166t2379r731b2429],
8	—	CD	NUMBER	—	number	9	SENT_37	[p3l166t2379r731b2429],
9	1811	CD	DATE	1811	dep	5	SENT_37	[p3l166t2379r731b2429],
10	.	.	O	.	_	0	SENT_37	[p3l166t2379r731b2429],

1	E	NN	O	e	nn	3	SENT_38	[p3l760t2379r968b2428],
2	—	CD	NUMBER	—	num	3	SENT_38	[p3l760t2379r968b2428],
3	mail	NN	O	mail	_	0	SENT_38	[p3l760t2379r968b2428],
4	:	:	O	:	_	0	SENT_38	[p3l760t2379r968b2428],
5	F.C.Campbell@qub.ac.uk	NN	O	f.c.campbell@qub.ac.uk	dep	3	SENT_38	[p3l999t2379r1744b2443],

1	Received	VBN	O	receive	_	0	SENT_39	[p3l79t2594r344b2643],
2	11	CD	DATE	11	dobj	1	SENT_39	[p3l382t2594r438b2643],
3	August	NNP	DATE	August	tmod	1	SENT_39	[p3l476t2594r682b2658],
4	2000	CD	DATE	2000	num	3	SENT_39	[p3l713t2594r870b2652],
5	;	:	O	;	_	0	SENT_39	[p3l713t2594r870b2652],
6	Revised	VBN	O	revise	parataxis	1	SENT_39	[p3l905t2594r1134b2643],
7	15	CD	DATE	15	dobj	6	SENT_39	[p3l1172t2594r1232b2644],
8	December	NNP	DATE	December	tmod	7	SENT_39	[p3l1266t2594r1560b2643],
9	2000	CD	DATE	2000	num	8	SENT_39	[p3l1591t2594r1748b2653],
10	;	:	O	;	_	0	SENT_39	[p3l1591t2594r1748b2653],
11	Accepted	JJ	O	accepted	amod	12	SENT_39	[p3l1783t2594r2052b2658],
12	25	CD	NUMBER	25	dep	7	SENT_39	[p3l2084t2594r2149b2644],

1	January	NNP	DATE	January	_	0	SENT_40	[p3l7t2684r227b2747],
2	2001	CD	DATE	2001	dep	1	SENT_40	[p3l255t2683r389b2732],

1	778	CD	NUMBER	778	_	0	SENT_41	[p3l502t2939r556b2965],
2	HARBOTTLE	NNP	O	HARBOTTLE	nn	4	SENT_41	[p3l1393t2945r1565b2965],
3	ET	NNP	O	ET	nn	4	SENT_41	[p3l1575t2945r1612b2965],
4	AL.	NNP	O	AL.	dep	1	SENT_41	[p3l1617t2945r1657b2965],
5	.	.	O	.	_	0	SENT_41	[p3l1617t2945r1657b2965],

1	tals	NNS	O	tal	nsubj	4	SENT_42	[p3l8t3070r191b3126],
2	.21	CD	NUMBER	.21	num	3	SENT_42	[p3l8t3070r191b3126],
3	Cells	NNS	O	cell	dep	1	SENT_42	[p3l218t3070r378b3126],
4	grown	VBN	O	grow	_	0	SENT_42	[p3l402t3088r604b3143],
5	in	IN	O	in	_	0	SENT_42	[p3l625t3070r686b3125],
6	75	CD	NUMBER	75	num	10	SENT_42	[p3l708t3070r782b3126],
7	cm2	NN	O	cm2	nn	10	SENT_42	[p3l807t3058r933b3126],
8	tissue	NN	O	tissue	nn	10	SENT_42	[p3l955t3070r1135b3126],
9	culture	NN	O	culture	nn	10	SENT_42	[p3l1158t3070r1378b3126],
10	ﬂasks	NNS	O	ﬂasks	prep_in	4	SENT_42	[p3l1401t3070r1578b3126],
11	were	VBD	O	be	auxpass	12	SENT_42	[p3l1602t3088r1754b3126],
12	trypsinised	VBN	O	trypsinise	rcmod	10	SENT_42	[p3l1776t3070r2143b3143],
13	,	,	O	,	_	0	SENT_42	[p3l1776t3070r2143b3143],
14	seeded	VBN	O	seed	conj_and	12	SENT_42	[p3l11t3153r225b3209],
15	into	IN	O	into	_	0	SENT_42	[p3l249t3153r370b3209],
16	ﬂat-bottom	JJ	O	ﬂat-bottom	amod	20	SENT_42	[p3l396t3153r751b3209],
17	96-well	JJ	O	96-well	amod	20	SENT_42	[p3l775t3153r1016b3210],
18	tissue	NN	O	tissue	nn	20	SENT_42	[p3l1040t3153r1221b3209],
19	culture	NN	O	culture	nn	20	SENT_42	[p3l1246t3153r1466b3209],
20	plates	NNS	O	plate	prep_into	14	SENT_42	[p3l1489t3153r1673b3226],
21	and	CC	O	and	_	0	SENT_42	[p3l1701t3153r1813b3209],
22	incubated	VBN	O	incubate	conj_and	12	SENT_42	[p3l1837t3153r2147b3209],
23	overnight	JJ	TIME	overnight	dobj	22	SENT_42	[p3l9t3237r329b3310],
24	.	.	O	.	_	0	SENT_42	[p3l9t3237r329b3310],

1	Cells	NNS	O	cell	nsubjpass	4	SENT_43	[p3l356t3237r516b3294],
2	were	VBD	O	be	auxpass	4	SENT_43	[p3l539t3255r692b3294],
3	then	RB	O	then	advmod	4	SENT_43	[p3l713t3237r849b3293],
4	treated	VBN	O	treat	_	0	SENT_43	[p3l870t3237r1087b3294],
5	with	IN	O	with	_	0	SENT_43	[p3l1108t3237r1248b3294],
6	doxorubicin	NN	O	doxorubicin	nn	8	SENT_43	[p3l1269t3237r1654b3293],
7	(	CD	NUMBER	(	num	8	SENT_43	[p3l1678t3237r1922b3310],
8	Sigma	NNP	O	Sigma	prep_with	4	SENT_43	[p3l1678t3237r1922b3310],
9	,	,	O	,	_	0	SENT_43	[p3l1678t3237r1922b3310],
10	Poole	NNP	PERSON	Poole	nn	12	SENT_43	[p3l1945t3237r2143b3304],
11	,	,	O	,	_	0	SENT_43	[p3l1945t3237r2143b3304],
12	UK	NNP	LOCATION	UK	appos	8	SENT_43	[p3l8t3322r146b3391],
13	)	CD	NUMBER	)	num	12	SENT_43	[p3l8t3322r146b3391],
14	(	CD	NUMBER	(	number	15	SENT_43	[p3l177t3322r232b3391],
15	1	CD	NUMBER	1	num	16	SENT_43	[p3l177t3322r232b3391],
16	nM	NN	O	nm	dep	12	SENT_43	[p3l264t3323r372b3377],
17	to	TO	O	to	_	0	SENT_43	[p3l398t3330r458b3378],
18	100	CD	NUMBER	100	num	19	SENT_43	[p3l491t3322r601b3378],
19	p	NN	O	p	prep_to	4	SENT_43	[p3l632t3322r774b3394],
20	,	,	O	,	_	0	SENT_43	[p3l632t3322r774b3394],
21	M	NN	O	m	dep	4	SENT_43	[p3l632t3322r774b3394],
22	)	NN	O	)	dobj	21	SENT_43	[p3l632t3322r774b3394],
23	alone	RB	O	alone	advmod	21	SENT_43	[p3l803t3321r973b3378],
24	or	CC	O	or	_	0	SENT_43	[p3l1000t3339r1064b3378],
25	in	IN	O	in	conj_or	21	SENT_43	[p3l1088t3321r1149b3377],
26	combination	NN	O	combination	pobj	25	SENT_43	[p3l1174t3321r1573b3378],
27	with	IN	O	with	_	0	SENT_43	[p3l1598t3321r1739b3378],
28	the	DT	O	the	det	29	SENT_43	[p3l1763t3322r1859b3378],
29	Pgp	NNP	O	Pgp	prep_with	25	SENT_43	[p3l1884t3323r2006b3394],
30	and	CC	O	and	_	0	SENT_43	[p3l2034t3321r2147b3378],
31	GST	NN	O	gst	nn	32	SENT_43	[p3l10t3406r158b3462],
32	inhibitors	NNS	O	inhibitor	conj_and	29	SENT_43	[p3l182t3406r505b3472],
33	,	,	O	,	_	0	SENT_43	[p3l182t3406r505b3472],
34	verapamil	NN	O	verapamil	nsubj	42	SENT_43	[p3l532t3406r850b3479],
35	(	CD	NUMBER	(	num	42	SENT_43	[p3l877t3406r1128b3479],
36	Sigma	NNP	O	Sigma	nn	42	SENT_43	[p3l877t3406r1128b3479],
37	)	CD	NUMBER	)	num	42	SENT_43	[p3l877t3406r1128b3479],
38	(	CD	NUMBER	(	num	42	SENT_43	[p3l1157t3405r1215b3475],
39	5	CD	NUMBER	5	num	42	SENT_43	[p3l1157t3405r1215b3475],
40	p.	NN	O	p.	nn	42	SENT_43	[p3l1248t3406r1410b3478],
41	M	NN	O	m	nn	42	SENT_43	[p3l1248t3406r1410b3478],
42	)	NN	O	)	xcomp	4	SENT_43	[p3l1248t3406r1410b3478],
43	,	,	O	,	_	0	SENT_43	[p3l1248t3406r1410b3478],
44	curcumin	NN	O	curcumin	dep	52	SENT_43	[p3l1437t3406r1738b3462],
45	(	CD	NUMBER	(	num	52	SENT_43	[p3l1764t3406r2015b3479],
46	Sigma	NNP	O	Sigma	nn	52	SENT_43	[p3l1764t3406r2015b3479],
47	)	CD	NUMBER	)	num	52	SENT_43	[p3l1764t3406r2015b3479],
48	(	CD	NUMBER	(	num	52	SENT_43	[p3l2044t3406r2143b3475],
49	25	CD	NUMBER	25	num	52	SENT_43	[p3l2044t3406r2143b3475],
50	p.	NN	O	p.	nn	52	SENT_43	[p3l14t3490r155b3562],
51	M	NN	O	m	nn	52	SENT_43	[p3l14t3490r155b3562],
52	)	NN	O	)	conj_and	4	SENT_43	[p3l14t3490r155b3562],
53	and	CC	O	and	_	0	SENT_43	[p3l193t3490r305b3546],
54	ethacrynic	JJ	O	ethacrynic	amod	55	SENT_43	[p3l339t3490r668b3563],
55	acid	NN	O	acid	dep	63	SENT_43	[p3l705t3490r835b3546],
56	(	CD	NUMBER	(	num	63	SENT_43	[p3l870t3490r1122b3563],
57	Sigma	NNP	O	Sigma	nn	63	SENT_43	[p3l870t3490r1122b3563],
58	)	CD	NUMBER	)	num	63	SENT_43	[p3l870t3490r1122b3563],
59	(	CD	NUMBER	(	num	63	SENT_43	[p3l1160t3489r1259b3559],
60	25	CD	NUMBER	25	num	63	SENT_43	[p3l1160t3489r1259b3559],
61	p.	NN	O	p.	nn	63	SENT_43	[p3l1301t3490r1461b3562],
62	M	NN	O	m	nn	63	SENT_43	[p3l1301t3490r1461b3562],
63	)	NN	O	)	conj_and	4	SENT_43	[p3l1301t3490r1461b3562],
64	.	.	O	.	_	0	SENT_43	[p3l1301t3490r1461b3562],

1	Inhibitors	NNS	O	inhibitor	nsubjpass	3	SENT_44	[p3l1498t3490r1806b3546],
2	were	VBD	O	be	auxpass	3	SENT_44	[p3l1842t3507r1995b3546],
3	dissolved	VBN	O	dissolve	ccomp	8	SENT_44	[p3l2029t3490r2144b3546, p3l11t3574r217b3630],
4	in	IN	O	in	_	0	SENT_44	[p3l247t3574r308b3629],
5	DMSO	NN	ORGANIZATION	dmso	prep_in	3	SENT_44	[p3l339t3574r586b3640],
6	,	,	O	,	_	0	SENT_44	[p3l339t3574r586b3640],
7	then	RB	O	then	nsubj	8	SENT_44	[p3l621t3574r757b3630],
8	added	VBD	O	add	_	0	SENT_44	[p3l790t3574r979b3630],
9	to	TO	O	to	_	0	SENT_44	[p3l1009t3582r1068b3630],
10	media	NNS	O	media	prep_to	8	SENT_44	[p3l1101t3574r1311b3630],
11	.	.	O	.	_	0	SENT_44	[p3l1101t3574r1311b3630],

1	Control	NN	O	control	nn	2	SENT_45	[p3l1348t3574r1590b3630],
2	cells	NNS	O	cell	nsubjpass	4	SENT_45	[p3l1622t3574r1765b3630],
3	were	VBD	O	be	auxpass	4	SENT_45	[p3l1799t3592r1951b3630],
4	incubated	VBN	O	incubate	_	0	SENT_45	[p3l1984t3574r2144b3630, p3l7t3656r181b3712],
5	with	IN	O	with	prep	4	SENT_45	[p3l209t3656r350b3712],
6	either	CC	O	either	prep	4	SENT_45	[p3l379t3656r560b3712],
7	medium	NN	O	medium	dep	6	SENT_45	[p3l587t3656r849b3712],
8	alone	RB	O	alone	advmod	7	SENT_45	[p3l879t3656r1065b3723],
9	,	,	O	,	_	0	SENT_45	[p3l879t3656r1065b3723],
10	verapamil	NN	O	verapamil	dep	6	SENT_45	[p3l1098t3656r1433b3729],
11	,	,	O	,	_	0	SENT_45	[p3l1098t3656r1433b3729],
12	curcumin	NN	O	curcumin	dep	6	SENT_45	[p3l1465t3656r1783b3723],
13	,	,	O	,	_	0	SENT_45	[p3l1465t3656r1783b3723],
14	ethacrynic	JJ	O	ethacrynic	amod	15	SENT_45	[p3l1815t3656r2145b3729],
15	acid	NN	O	acid	dep	6	SENT_45	[p3l10t3740r141b3796],
16	or	CC	O	or	_	0	SENT_45	[p3l164t3758r230b3796],
17	dimethyl	JJ	O	dimethyl	amod	18	SENT_45	[p3l252t3740r534b3813],
18	sulphoxide	NN	O	sulphoxide	dep	6	SENT_45	[p3l560t3740r907b3813],
19	(	CD	NUMBER	(	num	21	SENT_45	[p3l933t3741r1230b3810],
20	DMSO	NN	ORGANIZATION	dmso	nn	21	SENT_45	[p3l933t3741r1230b3810],
21	)	NN	O	)	dep	18	SENT_45	[p3l933t3741r1230b3810],
22	.	.	O	.	_	0	SENT_45	[p3l933t3741r1230b3810],

1	Cells	NNS	O	cell	nsubjpass	3	SENT_46	[p3l1258t3740r1418b3797],
2	were	VBD	O	be	auxpass	3	SENT_46	[p3l1444t3758r1597b3797],
3	incubated	VBN	O	incubate	_	0	SENT_46	[p3l1620t3740r1931b3796],
4	for	IN	O	for	_	0	SENT_46	[p3l1954t3740r2046b3796],
5	24	CD	NUMBER	24	prep_for	3	SENT_46	[p3l2069t3741r2146b3796],

1	hr	NN	DURATION	hr	_	0	SENT_47	[p4l8t12r90b79],
2	,	,	O	,	_	0	SENT_47	[p4l8t12r90b79],
3	fresh	JJ	O	fresh	amod	4	SENT_47	[p4l115t12r273b69],
4	medium	NN	O	medium	appos	1	SENT_47	[p4l294t12r556b69],
5	containing	VBG	O	contain	partmod	4	SENT_47	[p4l576t12r911b85],
6	MT	NN	O	mt	nn	7	SENT_47	[p4l933t14r1051b68],
7	T	NN	O	t	dobj	5	SENT_47	[p4l1053t14r1100b68],
8	(	CD	NUMBER	(	number	9	SENT_47	[p4l1124t12r1242b82],
9	0.5	CD	NUMBER	0.5	num	11	SENT_47	[p4l1124t12r1242b82],
10	mg/ml	NN	O	mg/ml	nn	11	SENT_47	[p4l1267t13r1499b85],
11	)	NN	O	)	nsubjpass	13	SENT_47	[p4l1267t13r1499b85],
12	was	VBD	O	be	auxpass	13	SENT_47	[p4l1523t30r1643b69],
13	substituted	VBN	O	substitute	rcmod	7	SENT_47	[p4l1669t12r2012b69],
14	and	CC	O	and	_	0	SENT_47	[p4l2034t13r2147b69],
15	cells	NNS	O	cell	nsubjpass	18	SENT_47	[p4l9t97r151b153],
16	were	VBD	O	be	auxpass	18	SENT_47	[p4l180t114r333b153],
17	then	RB	O	then	advmod	18	SENT_47	[p4l360t97r496b153],
18	incubated	VBN	O	incubate	conj_and	13	SENT_47	[p4l522t97r832b153],
19	for	IN	O	for	_	0	SENT_47	[p4l858t97r951b153],
20	4	CD	DURATION	4	num	21	SENT_47	[p4l975t97r1013b152],
21	hr	NN	DURATION	hr	prep_for	18	SENT_47	[p4l1039t97r1106b152],
22	at	IN	O	at	_	0	SENT_47	[p4l1132t105r1188b153],
23	37	CD	NUMBER	37	number	24	SENT_47	[p4l1215t97r1392b153],
24	°	CD	NUMBER	°	prep_at	21	SENT_47	[p4l1215t97r1392b153],
25	C.	NNP	MISC	C.	nn	26	SENT_47	[p4l1215t97r1392b153],
26	Medium	NNP	MISC	Medium	nsubjpass	28	SENT_47	[p4l1422t97r1694b153],
27	was	VBD	O	be	auxpass	28	SENT_47	[p4l1720t114r1840b153],
28	removed	VBN	O	remove	rcmod	24	SENT_47	[p4l1867t97r2147b153],
29	and	CC	O	and	_	0	SENT_47	[p4l10t181r123b237],
30	the	DT	O	the	det	33	SENT_47	[p4l151t181r247b237],
31	purple	JJ	O	purple	amod	33	SENT_47	[p4l275t181r479b254],
32	formazan	NN	O	formazan	nn	33	SENT_47	[p4l509t181r810b237],
33	crystals	NNS	O	crystal	prep_for	18	SENT_47	[p4l839t181r1080b254],
34	dissolved	VBN	O	dissolve	partmod	33	SENT_47	[p4l1112t181r1412b237],
35	in	IN	O	in	_	0	SENT_47	[p4l1441t181r1502b236],
36	DMSO	NN	ORGANIZATION	dmso	prep_in	34	SENT_47	[p4l1530t181r1776b237],
37	.	.	O	.	_	0	SENT_47	[p4l1530t181r1776b237],

1	The	DT	O	the	det	2	SENT_48	[p4l1809t181r1932b237],
2	plates	NNS	O	plate	nsubjpass	4	SENT_48	[p4l1960t181r2145b254],
3	were	VBD	O	be	auxpass	4	SENT_48	[p4l9t283r162b321],
4	examined	VBN	O	examine	_	0	SENT_48	[p4l187t265r496b321],
5	on	IN	O	on	_	0	SENT_48	[p4l520t283r598b321],
6	a	DT	O	a	det	8	SENT_48	[p4l623t283r656b321],
7	plate	NN	O	plate	nn	8	SENT_48	[p4l678t265r832b338],
8	reader	NN	O	reader	prep_on	4	SENT_48	[p4l855t265r1056b321],
9	(	CD	NUMBER	(	num	12	SENT_48	[p4l1081t265r1411b338],
10	Dynatech	NNP	ORGANIZATION	Dynatech	nn	12	SENT_48	[p4l1081t265r1411b338],
11	MR5000	NNP	O	MR5000	nn	12	SENT_48	[p4l1434t265r1717b321],
12	Sussex	NNP	ORGANIZATION	Sussex	dep	8	SENT_48	[p4l1743t265r1979b331],
13	,	,	O	,	_	0	SENT_48	[p4l1743t265r1979b331],
14	UK	NNP	LOCATION	UK	appos	8	SENT_48	[p4l2006t266r2144b334],
15	)	CD	NUMBER	)	num	14	SENT_48	[p4l2006t266r2144b334],
16	with	IN	O	with	_	0	SENT_48	[p4l9t348r149b404],
17	a	DT	O	a	det	19	SENT_48	[p4l183t366r217b404],
18	test	NN	O	test	nn	19	SENT_48	[p4l248t356r358b404],
19	wavelength	NN	O	wavelength	prep_with	14	SENT_48	[p4l391t348r758b421],
20	of	IN	O	of	_	0	SENT_48	[p4l792t348r861b404],
21	570	CD	NUMBER	570	num	22	SENT_48	[p4l889t348r1006b405],
22	nm	NN	O	nm	prep_of	19	SENT_48	[p4l1039t366r1140b404],
23	against	IN	O	against	_	0	SENT_48	[p4l1174t348r1399b421],
24	a	DT	O	a	det	26	SENT_48	[p4l1432t366r1465b404],
25	DMSO	NN	ORGANIZATION	dmso	nn	26	SENT_48	[p4l1496t348r1725b405],
26	blank	NN	O	blank	prep_against	22	SENT_48	[p4l1758t348r1951b404],
27	.	.	O	.	_	0	SENT_48	[p4l1758t348r1951b404],

1	Each	DT	O	each	det	2	SENT_49	[p4l1988t348r2147b404],
2	assay	NN	O	assay	nsubjpass	9	SENT_49	[p4l10t450r179b505],
3	was	VBD	O	be	auxpass	4	SENT_49	[p4l211t450r331b489],
4	carried	VBN	O	carry	_	0	SENT_49	[p4l365t432r585b489],
5	out	RP	O	out	prt	4	SENT_49	[p4l617t441r717b488],
6	in	IN	O	in	_	0	SENT_49	[p4l747t432r807b488],
7	triplicate	NN	O	triplicate	prep_in	4	SENT_49	[p4l838t432r1121b505],
8	and	CC	O	and	_	0	SENT_49	[p4l1153t432r1266b488],
9	compared	VBN	O	compare	conj_and	4	SENT_49	[p4l1297t432r1611b505],
10	with	IN	O	with	_	0	SENT_49	[p4l1642t432r1782b489],
11	a	DT	O	a	det	14	SENT_49	[p4l1814t450r1847b488],
12	standard	JJ	O	standard	amod	14	SENT_49	[p4l1879t432r2147b489],
13	growth	NN	O	growth	nn	14	SENT_49	[p4l9t517r234b590],
14	curve	NN	O	curve	prep_with	9	SENT_49	[p4l263t535r454b574],
15	.	.	O	.	_	0	SENT_49	[p4l263t535r454b574],

1	Eﬁlux	NN	MISC	eﬁlux	_	0	SENT_50	[p4l7t672r195b744],
2	transport	NN	O	transport	nn	3	SENT_50	[p4l224t683r522b744],
3	studies	NNS	O	study	dep	1	SENT_50	[p4l548t672r768b728],
4	in	IN	O	in	_	0	SENT_50	[p4l800t674r857b728],
5	HEp2	NN	O	hep2	nn	8	SENT_50	[p4l884t672r1069b744],
6	and	CC	O	and	_	0	SENT_50	[p4l1100t672r1222b728],
7	HEp2A	NN	O	hep2a	conj_and	5	SENT_50	[p4l1245t672r1479b744],
8	cells	NNS	O	cell	prep_in	3	SENT_50	[p4l1511t672r1655b728],

1	Efﬂux	NN	O	efﬂux	nn	2	SENT_51	[p4l88t772r287b828],
2	transport	NN	O	transport	nsubjpass	17	SENT_51	[p4l313t780r597b845],
3	of	IN	O	of	_	0	SENT_51	[p4l622t772r691b828],
4	doxorubicin	NN	O	doxorubicin	prep_of	2	SENT_51	[p4l712t772r1114b838],
5	,	,	O	,	_	0	SENT_51	[p4l712t772r1114b838],
6	which	WDT	O	which	nsubj	12	SENT_51	[p4l1143t772r1336b828],
7	is	VBZ	O	be	cop	12	SENT_51	[p4l1361t772r1411b828],
8	a	DT	O	a	det	12	SENT_51	[p4l1439t790r1473b828],
9	ﬂuorescent	JJ	O	ﬂuorescent	amod	12	SENT_51	[p4l1498t772r1848b828],
10	Pglycoprotein	NN	O	pglycoprotein	nn	12	SENT_51	[p4l1872t772r2144b845, p4l8t855r234b928],
11	(	NN	O	(	nn	12	SENT_51	[p4l259t856r431b928],
12	Pgp	NN	O	pgp	rcmod	2	SENT_51	[p4l259t856r431b928],
13	)	CD	NUMBER	)	num	14	SENT_51	[p4l259t856r431b928],
14	substrate	NN	O	substrate	dep	12	SENT_51	[p4l459t855r757b922],
15	,	,	O	,	_	0	SENT_51	[p4l459t855r757b922],
16	was	VBD	O	be	auxpass	17	SENT_51	[p4l783t873r904b911],
17	assessed	VBN	O	assess	_	0	SENT_51	[p4l931t855r1200b911],
18	by	IN	O	by	_	0	SENT_51	[p4l1221t855r1300b928],
19	ﬂow	NN	O	ﬂow	nn	20	SENT_51	[p4l1325t855r1463b912],
20	cytometry	NN	O	cytometry	agent	17	SENT_51	[p4l1488t855r1889b928],
21	.	.	O	.	_	0	SENT_51	[p4l1488t855r1889b928],

1	”	NN	O	”	nn	2	SENT_52	[p4l1488t855r1889b928],
2	Studies	NNS	O	study	nsubjpass	4	SENT_52	[p4l1914t855r2145b912],
3	were	VBD	O	be	auxpass	4	SENT_52	[p4l9t957r162b995],
4	carried	VBN	O	carry	conj_and	4	SENT_52	[p4l193t939r413b995],
5	out	RP	O	out	prt	4	SENT_52	[p4l443t948r544b995],
6	with	IN	O	with	_	0	SENT_52	[p4l573t939r713b995],
7	and	CC	O	and	_	0	SENT_52	[p4l744t939r857b995],
8	without	IN	O	without	_	0	SENT_52	[p4l886t939r1130b995],
9	the	DT	O	the	det	11	SENT_52	[p4l1159t939r1254b995],
10	Pgp/MRP	NN	O	pgp/mrp	nn	11	SENT_52	[p4l1284t939r1599b1012],
11	inhibitors	NNS	O	inhibitor	prep_without	4	SENT_52	[p4l1629t939r1951b1006],
12	,	,	O	,	_	0	SENT_52	[p4l1629t939r1951b1006],
13	verapamil	NN	O	verapamil	conj_and	11	SENT_52	[p4l1984t957r2144b995, p4l8t1023r189b1096],
14	and	CC	O	and	_	0	SENT_52	[p4l231t1023r344b1079],
15	cyclosporine	NN	O	cyclosporine	conj_and	11	SENT_52	[p4l384t1023r790b1096],
16	A	DT	O	a	det	19	SENT_52	[p4l831t1024r887b1079],
17	(	CD	NUMBER	(	num	19	SENT_52	[p4l929t1023r1199b1096],
18	Sigma	NNP	O	Sigma	nn	19	SENT_52	[p4l929t1023r1199b1096],
19	)	NN	O	)	prep_with	4	SENT_52	[p4l929t1023r1199b1096],
20	.	.	O	.	_	0	SENT_52	[p4l929t1023r1199b1096],

1	Brieﬂy	NNP	O	Brieﬂy	nsubj	8	SENT_53	[p4l1243t1023r1481b1096],
2	,	,	O	,	_	0	SENT_53	[p4l1243t1023r1481b1096],
3	HEp2	NN	O	hep2	conj_and	1	SENT_53	[p4l1525t1024r1709b1096],
4	and	CC	O	and	_	0	SENT_53	[p4l1751t1023r1864b1079],
5	HEp2A	NN	O	hep2a	nn	6	SENT_53	[p4l1904t1024r2147b1096],
6	cells	NNS	O	cell	conj_and	1	SENT_53	[p4l9t1108r152b1164],
7	were	VBD	O	be	aux	8	SENT_53	[p4l178t1126r331b1164],
8	grown	VBN	O	grow	_	0	SENT_53	[p4l357t1126r559b1180],
9	to	TO	O	to	_	0	SENT_53	[p4l583t1117r643b1164],
10	80	CD	PERCENT	80	number	11	SENT_53	[p4l671t1108r810b1164],
11	%	NN	PERCENT	%	amod	12	SENT_53	[p4l671t1108r810b1164],
12	conﬂuence	NN	O	conﬂuence	prep_to	8	SENT_53	[p4l838t1108r1183b1164],
13	in	IN	O	in	_	0	SENT_53	[p4l1207t1108r1268b1163],
14	75	CD	NUMBER	75	num	16	SENT_53	[p4l1293t1108r1367b1164],
15	cm2	NN	O	cm2	nn	16	SENT_53	[p4l1396t1096r1522b1164],
16	ﬂasks	NNS	O	ﬂasks	prep_in	12	SENT_53	[p4l1548t1108r1744b1174],
17	,	,	O	,	_	0	SENT_53	[p4l1548t1108r1744b1174],
18	trypsinized	VBN	O	trypsinize	dep	8	SENT_53	[p4l1772t1108r2143b1180],
19	,	,	O	,	_	0	SENT_53	[p4l1772t1108r2143b1180],
20	resuspended	VBN	O	resuspend	conj_or	20	SENT_53	[p4l8t1192r404b1265],
21	in	IN	O	in	_	0	SENT_53	[p4l435t1192r496b1247],
22	6	CD	NUMBER	6	num	23	SENT_53	[p4l529t1192r565b1248],
23	X	NN	O	x	prep_in	20	SENT_53	[p4l607t1197r654b1245],
24	1.5	CD	NUMBER	1.5	num	27	SENT_53	[p4l703t1191r789b1248],
25	ml	NN	O	ml	nn	27	SENT_53	[p4l825t1192r908b1247],
26	microfuge	NN	O	microfuge	nn	27	SENT_53	[p4l940t1192r1268b1265],
27	tubes	NNS	O	tube	dep	23	SENT_53	[p4l1300t1192r1643b1248],
28	/	:	O	/	punct	23	SENT_53	[p4l1300t1192r1643b1248],
29	ﬂask	NN	O	ﬂask	dep	23	SENT_53	[p4l1300t1192r1643b1248],
30	in	IN	O	in	prep	29	SENT_53	[p4l1674t1192r1734b1247],
31	growth	NN	O	growth	nn	32	SENT_53	[p4l1767t1192r1992b1265],
32	medium	NN	O	medium	pobj	30	SENT_53	[p4l2023t1209r2144b1248, p4l9t1276r172b1332],
33	only	RB	O	only	advmod	32	SENT_53	[p4l207t1276r364b1349],
34	,	,	O	,	_	0	SENT_53	[p4l207t1276r364b1349],
35	or	CC	O	or	_	0	SENT_53	[p4l403t1294r468b1332],
36	doxorubicin	NN	O	doxorubicin	conj_or	30	SENT_53	[p4l503t1276r888b1332],
37	(	CD	NUMBER	(	num	36	SENT_53	[p4l926t1276r1027b1345],
38	20	CD	NUMBER	20	num	41	SENT_53	[p4l926t1276r1027b1345],
39	p.	NN	O	p.	nn	41	SENT_53	[p4l1068t1277r1210b1348],
40	M	NN	O	m	nn	41	SENT_53	[p4l1068t1277r1210b1348],
41	)	NN	O	)	dep	36	SENT_53	[p4l1068t1277r1210b1348],
42	in	IN	O	in	_	0	SENT_53	[p4l1247t1276r1308b1331],
43	medium	NN	O	medium	prep_in	41	SENT_53	[p4l1343t1276r1621b1342],
44	,	,	O	,	_	0	SENT_53	[p4l1343t1276r1621b1342],
45	either	CC	O	either	dep	41	SENT_53	[p4l1660t1276r1841b1332],
46	alone	RB	O	alone	conj	41	SENT_53	[p4l1876t1276r2046b1332],
47	or	CC	O	or	_	0	SENT_53	[p4l2082t1294r2148b1332],
48	with	IN	O	with	_	0	SENT_53	[p4l9t1359r149b1415],
49	Verapamil	NNP	O	Verapamil	prep_with	20	SENT_53	[p4l190t1359r508b1432],
50	(	CD	NUMBER	(	num	49	SENT_53	[p4l551t1359r610b1429],
51	5	CD	NUMBER	5	num	52	SENT_53	[p4l551t1359r610b1429],
52	MM	NN	O	mm	dep	20	SENT_53	[p4l659t1360r801b1431],
53	)	NN	O	)	nn	59	SENT_53	[p4l659t1360r801b1431],
54	or	CC	O	or	_	0	SENT_53	[p4l845t1377r910b1415],
55	cyclosporine	NN	O	cyclosporine	conj_or	53	SENT_53	[p4l950t1359r1357b1432],
56	(	CD	NUMBER	(	num	59	SENT_53	[p4l1401t1360r1459b1428],
57	3	CD	NUMBER	3	num	59	SENT_53	[p4l1401t1360r1459b1428],
58	pg/ml	NN	O	pg/ml	nn	59	SENT_53	[p4l1509t1359r1744b1432],
59	)	NN	O	)	dobj	8	SENT_53	[p4l1509t1359r1744b1432],
60	.	.	O	.	_	0	SENT_53	[p4l1509t1359r1744b1432],

1	Cells	NNS	O	cell	nsubjpass	3	SENT_54	[p4l1790t1359r1950b1416],
2	were	VBD	O	be	auxpass	3	SENT_54	[p4l1993t1377r2146b1416],
3	preloaded	VBN	O	preload	conj_or	3	SENT_54	[p4l8t1443r323b1516],
4	by	IN	O	by	_	0	SENT_54	[p4l349t1443r428b1516],
5	incubation	NN	O	incubation	agent	3	SENT_54	[p4l456t1443r792b1499],
6	in	IN	O	in	_	0	SENT_54	[p4l820t1443r880b1499],
7	substrate	NN	O	substrate	prep_in	5	SENT_54	[p4l910t1443r1208b1510],
8	,	,	O	,	_	0	SENT_54	[p4l910t1443r1208b1510],
9	with	IN	O	with	_	0	SENT_54	[p4l1238t1443r1379b1500],
10	or	CC	O	or	_	0	SENT_54	[p4l1407t1461r1473b1499],
11	without	IN	O	without	_	0	SENT_54	[p4l1499t1443r1742b1500],
12	inhibitor	NN	O	inhibitor	prep_with	3	SENT_54	[p4l1769t1443r2060b1510],
13	,	,	O	,	_	0	SENT_54	[p4l1769t1443r2060b1510],
14	at	IN	O	at	_	0	SENT_54	[p4l2092t1452r2148b1499],
15	37	CD	NUMBER	37	number	16	SENT_54	[p4l11t1528r171b1584],
16	°	CD	NUMBER	°	num	17	SENT_54	[p4l11t1528r171b1584],
17	C	NN	O	c	prep_at	3	SENT_54	[p4l11t1528r171b1584],
18	for	IN	O	for	_	0	SENT_54	[p4l218t1527r311b1583],
19	30	CD	DURATION	30	num	20	SENT_54	[p4l357t1528r433b1584],
20	min	NN	DURATION	min	prep_for	17	SENT_54	[p4l479t1527r617b1584],
21	.	.	O	.	_	0	SENT_54	[p4l479t1527r617b1584],

1	Cells	NNS	O	cell	nsubjpass	4	SENT_55	[p4l668t1527r828b1584],
2	were	VBD	O	be	auxpass	4	SENT_55	[p4l876t1545r1029b1584],
3	then	RB	O	then	advmod	4	SENT_55	[p4l1075t1527r1211b1583],
4	pelleted	VBN	O	pellete	_	0	SENT_55	[p4l1256t1527r1509b1600],
5	by	IN	O	by	_	0	SENT_55	[p4l1554t1527r1632b1600],
6	centrifugation	NN	O	centrifugation	agent	4	SENT_55	[p4l1679t1527r2143b1600],
7	,	,	O	,	_	0	SENT_55	[p4l1679t1527r2143b1600],
8	resuspended	VBN	O	resuspend	conj_and	4	SENT_55	[p4l8t1612r404b1684],
9	in	IN	O	in	_	0	SENT_55	[p4l438t1611r499b1667],
10	growth	NN	O	growth	nn	11	SENT_55	[p4l535t1612r760b1684],
11	medium	NN	O	medium	prep_in	8	SENT_55	[p4l795t1611r1057b1668],
12	and	CC	O	and	_	0	SENT_55	[p4l1093t1611r1206b1668],
13	maintained	VBD	O	maintain	conj_and	4	SENT_55	[p4l1241t1611r1596b1668],
14	at	IN	O	at	_	0	SENT_55	[p4l1632t1620r1688b1668],
15	4	CD	NUMBER	4	number	16	SENT_55	[p4l1722t1612r1844b1668],
16	°	CD	NUMBER	°	num	17	SENT_55	[p4l1722t1612r1844b1668],
17	C	NN	O	c	prep_at	13	SENT_55	[p4l1722t1612r1844b1668],
18	for	IN	O	for	_	0	SENT_55	[p4l1881t1611r1974b1668],
19	1	CD	DURATION	1	num	21	SENT_55	[p4l2016t1612r2039b1667],
20	hr	NN	DURATION	hr	nn	21	SENT_55	[p4l2081t1611r2148b1667],
21	(	NN	O	(	prep_for	17	SENT_55	[p4l11t1696r490b1765],
22	accumulation	NN	O	accumulation	dep	21	SENT_55	[p4l11t1696r490b1765],
23	)	CD	NUMBER	)	num	22	SENT_55	[p4l11t1696r490b1765],
24	or	CC	O	or	_	0	SENT_55	[p4l519t1713r584b1752],
25	in	IN	O	in	conj_or	22	SENT_55	[p4l608t1696r669b1751],
26	growth	NN	O	growth	nn	27	SENT_55	[p4l696t1696r921b1769],
27	medium	NN	O	medium	pobj	25	SENT_55	[p4l946t1696r1208b1752],
28	with	IN	O	with	_	0	SENT_55	[p4l1233t1696r1374b1752],
29	or	CC	O	or	_	0	SENT_55	[p4l1401t1713r1466b1752],
30	without	IN	O	without	_	0	SENT_55	[p4l1491t1696r1734b1752],
31	inhibitors	NNS	O	inhibitor	prep_with	13	SENT_55	[p4l1759t1696r2063b1752],
32	at	IN	O	at	_	0	SENT_55	[p4l2092t1704r2148b1752],
33	37	CD	NUMBER	37	number	34	SENT_55	[p4l11t1780r171b1836],
34	°	CD	NUMBER	°	dep	35	SENT_55	[p4l11t1780r171b1836],
35	C	NN	O	c	amod	45	SENT_55	[p4l11t1780r171b1836],
36	in	IN	O	in	_	0	SENT_55	[p4l198t1780r259b1835],
37	5	CD	PERCENT	5	number	38	SENT_55	[p4l286t1780r386b1836],
38	%	NN	PERCENT	%	amod	39	SENT_55	[p4l286t1780r386b1836],
39	CO2	NN	O	co2	prep_in	35	SENT_55	[p4l416t1780r555b1853],
40	for	IN	O	for	_	0	SENT_55	[p4l582t1780r675b1836],
41	1	CD	DURATION	1	prep_for	39	SENT_55	[p4l707t1780r730b1835],
42	hr	NN	DURATION	hr	nn	45	SENT_55	[p4l762t1780r829b1835],
43	(	NN	O	(	nn	45	SENT_55	[p4l856t1780r1108b1849],
44	efﬂux	NN	O	efﬂux	nn	45	SENT_55	[p4l856t1780r1108b1849],
45	)	NN	O	)	prep_at	13	SENT_55	[p4l856t1780r1108b1849],
46	.	.	O	.	_	0	SENT_55	[p4l856t1780r1108b1849],

1	At	IN	O	at	_	0	SENT_56	[p4l1138t1780r1217b1836],
2	the	DT	O	the	det	3	SENT_56	[p4l1242t1780r1338b1836],
3	end	NN	O	end	prep_at	13	SENT_56	[p4l1365t1780r1478b1836],
4	of	IN	O	of	_	0	SENT_56	[p4l1505t1780r1573b1836],
5	the	DT	O	the	det	9	SENT_56	[p4l1594t1780r1690b1836],
6	accumulation	NN	O	accumulation	nn	9	SENT_56	[p4l1718t1780r2147b1836],
7	or	CC	O	or	_	0	SENT_56	[p4l9t1881r75b1919],
8	efﬂux	NN	O	efﬂux	nn	9	SENT_56	[p4l109t1863r293b1919],
9	periods	NNS	O	period	prep_of	3	SENT_56	[p4l327t1863r579b1936],
10	,	,	O	,	_	0	SENT_56	[p4l327t1863r579b1936],
11	cells	NNS	O	cell	nsubjpass	13	SENT_56	[p4l618t1863r760b1919],
12	were	VBD	O	be	auxpass	13	SENT_56	[p4l797t1881r951b1919],
13	washed	VBN	O	wash	_	0	SENT_56	[p4l987t1863r1225b1919],
14	and	CC	O	and	_	0	SENT_56	[p4l1261t1863r1374b1919],
15	placed	VBN	O	place	conj_and	13	SENT_56	[p4l1407t1863r1616b1936],
16	in	IN	O	in	_	0	SENT_56	[p4l1650t1863r1711b1919],
17	cold	JJ	O	cold	amod	18	SENT_56	[p4l1746t1863r1882b1919],
18	Hank	NNP	PERSON	Hank	poss	40	SENT_56	[p4l1917t1863r2145b1919],
19	’s	POS	O	’s	_	0	SENT_56	[p4l1917t1863r2145b1919],
20	buffered	VBN	O	buffer	dep	40	SENT_56	[p4l7t1947r279b2003],
21	saline	NN	O	saline	nn	22	SENT_56	[p4l305t1947r487b2003],
22	solution	NN	O	solution	nsubj	25	SENT_56	[p4l515t1947r769b2003],
23	(	CD	NUMBER	(	num	25	SENT_56	[p4l795t1948r1043b2017],
24	HBSS	NN	O	hbss	nn	25	SENT_56	[p4l795t1948r1043b2017],
25	)	NN	O	)	xcomp	20	SENT_56	[p4l795t1948r1043b2017],
26	with	IN	O	with	_	0	SENT_56	[p4l1070t1947r1210b2003],
27	10	CD	PERCENT	10	number	28	SENT_56	[p4l1242t1947r1376b2004],
28	%	NN	PERCENT	%	amod	29	SENT_56	[p4l1242t1947r1376b2004],
29	FCS	NN	O	fc	prep_with	25	SENT_56	[p4l1403t1947r1540b2004],
30	on	IN	O	on	_	0	SENT_56	[p4l1570t1965r1647b2003],
31	ice	NN	O	ice	prep_on	29	SENT_56	[p4l1672t1947r1763b2003],
32	and	CC	O	and	_	0	SENT_56	[p4l1789t1947r1902b2003],
33	kept	VBD	O	keep	conj_and	20	SENT_56	[p4l1925t1947r2063b2020],
34	in	IN	O	in	_	0	SENT_56	[p4l2086t1947r2147b2003],
35	the	DT	O	the	det	36	SENT_56	[p4l8t2031r104b2087],
36	dark	JJ	O	dark	prep_in	33	SENT_56	[p4l130t2031r271b2088],
37	until	IN	O	until	_	0	SENT_56	[p4l293t2031r438b2087],
38	ﬂow	NN	O	ﬂow	prep_until	33	SENT_56	[p4l464t2031r602b2088],
39	cytometric	JJ	O	cytometric	amod	40	SENT_56	[p4l628t2031r967b2104],
40	analysis	NN	O	analysis	prep_in	13	SENT_56	[p4l994t2031r1265b2104],
41	.	.	O	.	_	0	SENT_56	[p4l994t2031r1265b2104],

1	Samples	NNS	O	sample	nsubjpass	3	SENT_57	[p4l1296t2031r1562b2104],
2	were	VBD	O	be	auxpass	3	SENT_57	[p4l1588t2049r1741b2088],
3	analysed	VBN	O	analyse	_	0	SENT_57	[p4l1767t2031r2045b2104],
4	on	IN	O	on	_	0	SENT_57	[p4l2069t2049r2147b2087],
5	a	DT	O	a	det	8	SENT_57	[p4l10t2133r43b2172],
6	FACSscan	NN	O	facsscan	nn	8	SENT_57	[p4l86t2116r428b2172],
7	ﬂow	NN	O	ﬂow	nn	8	SENT_57	[p4l474t2115r612b2172],
8	cytometer	NN	O	cytometer	prep_on	3	SENT_57	[p4l659t2124r979b2188],
9	(	CD	NUMBER	(	num	11	SENT_57	[p4l1024t2116r1274b2185],
10	Becton	NNP	PERSON	Becton	nn	11	SENT_57	[p4l1024t2116r1274b2185],
11	Dickinson	NNP	PERSON	Dickinson	tmod	3	SENT_57	[p4l1318t2115r1663b2182],
12	,	,	O	,	_	0	SENT_57	[p4l1318t2115r1663b2182],
13	Oxford	NNP	LOCATION	Oxford	nn	15	SENT_57	[p4l1713t2115r1958b2182],
14	,	,	O	,	_	0	SENT_57	[p4l1713t2115r1958b2182],
15	UK	NNP	LOCATION	UK	appos	11	SENT_57	[p4l2005t2116r2144b2185],
16	)	CD	NUMBER	)	num	15	SENT_57	[p4l2005t2116r2144b2185],
17	equipped	VBN	O	equip	partmod	15	SENT_57	[p4l9t2200r301b2273],
18	with	IN	O	with	_	0	SENT_57	[p4l331t2200r472b2256],
19	a	DT	O	a	det	23	SENT_57	[p4l503t2217r536b2256],
20	488	CD	NUMBER	488	num	23	SENT_57	[p4l564t2200r680b2256],
21	nm	NN	O	nm	nn	23	SENT_57	[p4l713t2217r815b2255],
22	argon	NNP	O	argon	nn	23	SENT_57	[p4l845t2217r1024b2273],
23	laser	NN	O	laser	prep_with	17	SENT_57	[p4l1054t2200r1219b2256],
24	.	.	O	.	_	0	SENT_57	[p4l1054t2200r1219b2256],

1	The	DT	O	the	det	3	SENT_58	[p4l1253t2200r1376b2256],
2	orange	JJ	O	orange	amod	3	SENT_58	[p4l1407t2217r1622b2273],
3	ﬂuorescence	NN	O	ﬂuorescence	nsubjpass	7	SENT_58	[p4l1654t2200r2051b2256],
4	of	IN	O	of	_	0	SENT_58	[p4l2082t2200r2151b2256],
5	doxorubicin	NN	O	doxorubicin	prep_of	3	SENT_58	[p4l9t2284r394b2340],
6	was	VBD	O	be	auxpass	7	SENT_58	[p4l431t2302r551b2340],
7	assessed	VBN	O	assess	_	0	SENT_58	[p4l590t2284r859b2340],
8	on	IN	O	on	_	0	SENT_58	[p4l895t2302r972b2340],
9	ﬂuorescence	NN	O	ﬂuorescence	nn	10	SENT_58	[p4l1009t2284r1407b2340],
10	channel	NN	O	channel	prep_on	7	SENT_58	[p4l1444t2284r1690b2340],
11	2	CD	NUMBER	2	number	13	SENT_58	[p4l1727t2284r1764b2339],
12	at	IN	O	at	quantmod	13	SENT_58	[p4l1802t2292r1857b2340],
13	575	CD	NUMBER	575	num	15	SENT_58	[p4l1893t2284r2007b2340],
14	nm	NN	O	nm	nn	15	SENT_58	[p4l2046t2302r2148b2339],
15	wavelength	NN	O	wavelength	dep	7	SENT_58	[p4l9t2367r392b2440],
16	.	.	O	.	_	0	SENT_58	[p4l9t2367r392b2440],

1	Samples	NNS	O	sample	nsubjpass	3	SENT_59	[p4l452t2367r717b2440],
2	were	VBD	O	be	auxpass	3	SENT_59	[p4l773t2385r926b2423],
3	gated	VBN	O	gate	_	0	SENT_59	[p4l980t2367r1152b2440],
4	to	TO	O	to	aux	5	SENT_59	[p4l1204t2375r1264b2423],
5	exclude	VB	O	exclude	xcomp	3	SENT_59	[p4l1319t2367r1565b2423],
6	cell	NN	O	cell	nn	7	SENT_59	[p4l1619t2367r1732b2423],
7	debris	NN	O	debris	dobj	5	SENT_59	[p4l1786t2367r1978b2423],
8	and	CC	O	and	_	0	SENT_59	[p4l2034t2367r2147b2423],
9	clumps	NNS	O	clump	dobj	5	SENT_59	[p4l9t2451r254b2524],
10	.	.	O	.	_	0	SENT_59	[p4l9t2451r254b2524],

1	A	DT	O	a	det	2	SENT_60	[p4l302t2452r358b2507],
2	minimum	NN	O	minimum	nsubjpass	7	SENT_60	[p4l403t2451r714b2507],
3	of	IN	O	of	_	0	SENT_60	[p4l758t2451r827b2507],
4	10,000	CD	NUMBER	10,000	num	5	SENT_60	[p4l874t2451r1084b2518],
5	events	NNS	O	event	prep_of	2	SENT_60	[p4l1129t2459r1330b2507],
6	were	VBD	O	be	auxpass	7	SENT_60	[p4l1376t2469r1529b2507],
7	assayed	VBN	O	assay	_	0	SENT_60	[p4l1576t2451r1822b2524],
8	for	IN	O	for	_	0	SENT_60	[p4l1866t2451r1959b2507],
9	each	DT	O	each	det	10	SENT_60	[p4l2002t2451r2147b2507],
10	sample	NN	O	sample	prep_for	7	SENT_60	[p4l11t2535r249b2608],
11	.	.	O	.	_	0	SENT_60	[p4l11t2535r249b2608],

1	Experiments	NNS	O	experiment	nsubjpass	3	SENT_61	[p4l282t2535r684b2608],
2	were	VBD	O	be	auxpass	3	SENT_61	[p4l715t2553r868b2592],
3	carried	VBN	O	carry	_	0	SENT_61	[p4l898t2535r1119b2591],
4	out	RP	O	out	prt	3	SENT_61	[p4l1148t2544r1248b2591],
5	in	IN	O	in	_	0	SENT_61	[p4l1276t2535r1337b2591],
6	triplicate	NN	O	triplicate	prep_in	3	SENT_61	[p4l1365t2535r1664b2608],
7	.	.	O	.	_	0	SENT_61	[p4l1365t2535r1664b2608],

1	Glutathione	NN	O	glutathione	_	0	SENT_62	[p4l11t2690r388b2747],
2	S-transferase	NN	O	s-transferase	nn	3	SENT_62	[p4l421t2690r848b2762],
3	activity	NN	O	activity	dep	1	SENT_62	[p4l878t2692r1112b2762],

1	Cells	NNS	O	cell	nsubjpass	3	SENT_63	[p4l89t2789r250b2846],
2	were	VBD	O	be	auxpass	3	SENT_63	[p4l272t2807r424b2845],
3	harvested	VBN	O	harvest	_	0	SENT_63	[p4l444t2789r751b2845],
4	from	IN	O	from	_	0	SENT_63	[p4l770t2789r925b2845],
5	conﬂuent	JJ	O	conﬂuent	amod	10	SENT_63	[p4l944t2789r1242b2845],
6	75	CD	NUMBER	75	tmod	5	SENT_63	[p4l1261t2789r1334b2846],
7	cm2	NN	O	cm2	nn	10	SENT_63	[p4l1359t2778r1485b2845],
8	tissue	NN	O	tissue	nn	10	SENT_63	[p4l1505t2789r1685b2845],
9	culture	NN	O	culture	nn	10	SENT_63	[p4l1706t2790r1925b2845],
10	ﬂasks	NNS	O	ﬂasks	prep_from	3	SENT_63	[p4l1947t2789r2144b2856],
11	,	,	O	,	_	0	SENT_63	[p4l1947t2789r2144b2856],
12	washed	VBN	O	wash	partmod	10	SENT_63	[p4l9t2873r248b2929],
13	and	CC	O	and	_	0	SENT_63	[p4l279t2873r391b2929],
14	resuspended	VBN	O	resuspend	conj_and	12	SENT_63	[p4l420t2873r815b2946],
15	in	IN	O	in	_	0	SENT_63	[p4l845t2873r905b2928],
16	PBS	NNP	O	PBS	prep_in	12	SENT_63	[p4l934t2873r1091b2929],
17	.	.	O	.	_	0	SENT_63	[p4l934t2873r1091b2929],

1	Cytosolic	JJ	MISC	cytosolic	amod	3	SENT_64	[p4l1126t2873r1429b2946],
2	protein	NN	O	protein	nn	3	SENT_64	[p4l1460t2873r1686b2946],
3	extracts	NNS	O	extract	nsubjpass	5	SENT_64	[p4l1716t2881r1961b2929],
4	were	VBD	O	be	auxpass	5	SENT_64	[p4l1993t2891r2146b2929],
5	prepared	VBN	O	prepare	_	0	SENT_64	[p4l8t2956r287b3029],
6	following	VBG	O	follow	_	0	SENT_64	[p4l325t2956r634b3029],
7	cell	NN	O	cell	nn	8	SENT_64	[p4l673t2956r786b3012],
8	lysis	NN	O	lysis	prep_following	5	SENT_64	[p4l824t2956r968b3029],
9	by	IN	O	by	_	0	SENT_64	[p4l1006t2956r1085b3029],
10	sonication	NN	O	sonication	prep_by	8	SENT_64	[p4l1126t2956r1451b3012],
11	by	IN	O	by	_	0	SENT_64	[p4l1488t2956r1566b3029],
12	centrifugation	NN	O	centrifugation	agent	5	SENT_64	[p4l1605t2956r2053b3029],
13	at	IN	O	at	_	0	SENT_64	[p4l2092t2965r2148b3012],
14	15,000	CD	NUMBER	15,000	num	15	SENT_64	[p4l16t3040r226b3107],
15	rpm	NN	O	rpm	prep_at	5	SENT_64	[p4l253t3058r383b3113],
16	at	IN	O	at	_	0	SENT_64	[p4l410t3049r466b3096],
17	4	CD	NUMBER	4	number	18	SENT_64	[p4l492t3041r614b3097],
18	°	CD	NUMBER	°	num	19	SENT_64	[p4l492t3041r614b3097],
19	C	NN	O	c	prep_at	15	SENT_64	[p4l492t3041r614b3097],
20	for	IN	O	for	_	0	SENT_64	[p4l643t3040r736b3096],
21	30	CD	DURATION	30	num	22	SENT_64	[p4l764t3041r839b3097],
22	min	NN	DURATION	min	prep_for	19	SENT_64	[p4l867t3040r990b3096],
23	to	TO	O	to	aux	24	SENT_64	[p4l1017t3049r1077b3096],
24	yield	VB	O	yield	xcomp	5	SENT_64	[p4l1105t3040r1264b3113],
25	cytosol	NN	O	cytosol	dobj	24	SENT_64	[p4l1291t3040r1520b3113],
26	in	IN	O	in	_	0	SENT_64	[p4l1548t3040r1608b3096],
27	the	DT	O	the	det	28	SENT_64	[p4l1635t3040r1731b3096],
28	supernatant	NN	O	supernatant	prep_in	24	SENT_64	[p4l1761t3049r2142b3113],
29	.	.	O	.	_	0	SENT_64	[p4l1761t3049r2142b3113],

1	Total	JJ	O	total	amod	4	SENT_65	[p4l8t3125r175b3181],
2	glutathione	NN	O	glutathione	nn	4	SENT_65	[p4l210t3124r568b3197],
3	S-transferase	NN	MISC	s-transferase	nn	4	SENT_65	[p4l602t3124r1014b3181],
4	activity	NN	O	activity	nsubjpass	6	SENT_65	[p4l1049t3124r1285b3197],
5	was	VBD	O	be	auxpass	6	SENT_65	[p4l1320t3142r1440b3181],
6	assessed	VBN	O	assess	_	0	SENT_65	[p4l1477t3124r1746b3181],
7	by	IN	O	by	prep	6	SENT_65	[p4l1777t3125r1856b3197],
8	spectrophotometric	JJ	O	spectrophotometric	amod	9	SENT_65	[p4l1893t3133r2144b3197, p4l7t3209r393b3282],
9	assay	NN	O	assay	dep	18	SENT_65	[p4l430t3226r599b3281],
10	of	IN	O	of	_	0	SENT_65	[p4l635t3209r704b3265],
11	glutathione	NN	O	glutathione	nn	12	SENT_65	[p4l733t3209r1091b3282],
12	conjugation	NN	O	conjugation	prep_of	9	SENT_65	[p4l1125t3209r1502b3282],
13	of	IN	O	of	_	0	SENT_65	[p4l1536t3209r1605b3265],
14	1	CD	NUMBER	1	number	15	SENT_65	[p4l1642t3209r2144b3275, p4l8t3293r420b3348],
15	—	CD	NUMBER	—	prep_of	12	SENT_65	[p4l1642t3209r2144b3275, p4l8t3293r420b3348],
16	chloro2	NN	O	chloro2	dep	18	SENT_65	[p4l1642t3209r2144b3275, p4l8t3293r420b3348],
17	,4	CD	NUMBER	,4	num	16	SENT_65	[p4l1642t3209r2144b3275, p4l8t3293r420b3348],
18	dinitrobenzene	NN	O	dinitrobenzene	dep	22	SENT_65	[p4l1642t3209r2144b3275, p4l8t3293r420b3348],
19	(	CD	NUMBER	(	num	20	SENT_65	[p4l452t3293r799b3361],
20	CDNB	NN	O	cdnb	dep	18	SENT_65	[p4l452t3293r799b3361],
21	)	CD	NUMBER	)	num	22	SENT_65	[p4l452t3293r799b3361],
22	.23	CD	NUMBER	.23	dep	7	SENT_65	[p4l452t3293r799b3361],

1	Immunoblotting	NN	O	immunoblotting	_	0	SENT_66	[p4l7t3446r518b3518],

1	Crude	JJ	O	crude	amod	2	SENT_67	[p5l89t20r282b77],
2	membrane	NN	O	membrane	nsubjpass	7	SENT_67	[p5l314t20r650b76],
3	and	CC	O	and	_	0	SENT_67	[p5l683t20r796b76],
4	cytosolic	JJ	O	cytosolic	amod	5	SENT_67	[p5l827t20r1113b93],
5	fractions	NNS	O	fraction	conj_and	2	SENT_67	[p5l1146t20r1422b76],
6	were	VBD	O	be	auxpass	7	SENT_67	[p5l1456t38r1609b77],
7	prepared	VBN	O	prepare	_	0	SENT_67	[p5l1640t20r1920b93],
8	as	IN	O	as	mark	9	SENT_67	[p5l1952t38r2013b76],
9	described	VBN	O	describe	advcl	7	SENT_67	[p5l2047t20r2144b76, p5l11t105r239b161],
10	by	IN	O	by	_	0	SENT_67	[p5l274t105r353b177],
11	Germann	NNP	PERSON	Germann	prep_by	9	SENT_67	[p5l392t105r687b161],
12	et	FW	O	et	nn	13	SENT_67	[p5l725t116r783b161],
13	al.	FW	O	al.	dep	11	SENT_67	[p5l817t93r959b161],
14	24	CD	NUMBER	24	dep	13	SENT_67	[p5l817t93r959b161],
15	for	IN	O	for	_	0	SENT_67	[p5l997t105r1090b161],
16	analysis	NN	O	analysis	prep_for	9	SENT_67	[p5l1127t105r1380b177],
17	of	IN	O	of	_	0	SENT_67	[p5l1420t105r1489b161],
18	P	NN	O	p	nn	20	SENT_67	[p5l1521t105r1996b177],
19	—	CD	NUMBER	—	num	20	SENT_67	[p5l1521t105r1996b177],
20	glycoprotein	NN	O	glycoprotein	prep_of	16	SENT_67	[p5l1521t105r1996b177],
21	and	CC	O	and	_	0	SENT_67	[p5l2034t105r2147b161],
22	glutathione	NN	O	glutathione	nn	24	SENT_67	[p5l9t188r367b261],
23	S-transferase	NN	MISC	s-transferase	nn	24	SENT_67	[p5l394t188r806b245],
24	expression	NN	O	expression	conj_and	20	SENT_67	[p5l834t188r1191b261],
25	,	,	O	,	_	0	SENT_67	[p5l834t188r1191b261],
26	respectively	RB	O	respectively	advmod	9	SENT_67	[p5l1220t188r1623b261],
27	.	.	O	.	_	0	SENT_67	[p5l1220t188r1623b261],

1	Cells	NNS	O	cell	nsubjpass	12	SENT_68	[p5l1654t188r1815b245],
2	were	VBD	O	be	auxpass	4	SENT_68	[p5l1844t206r1997b245],
3	mechanically	RB	O	mechanically	advmod	4	SENT_68	[p5l2024t206r2144b245, p5l9t273r335b345],
4	disaggregated	VBN	O	disaggregate	_	0	SENT_68	[p5l363t273r823b346],
5	,	,	O	,	_	0	SENT_68	[p5l363t273r823b346],
6	washed	VBN	O	wash	conj_and	4	SENT_68	[p5l853t273r1092b329],
7	twice	RB	O	twice	advmod	6	SENT_68	[p5l1117t273r1289b329],
8	in	IN	O	in	_	0	SENT_68	[p5l1315t273r1376b328],
9	cold	JJ	O	cold	amod	10	SENT_68	[p5l1403t273r1539b329],
10	PBS	NNP	O	PBS	prep_in	6	SENT_68	[p5l1565t273r1722b339],
11	,	,	O	,	_	0	SENT_68	[p5l1565t273r1722b339],
12	resuspended	VBN	O	resuspend	conj_and	4	SENT_68	[p5l1751t273r2147b345],
13	in	IN	O	in	_	0	SENT_68	[p5l8t357r69b412],
14	cold	JJ	O	cold	amod	17	SENT_68	[p5l100t357r236b413],
15	hypotonic	JJ	O	hypotonic	amod	17	SENT_68	[p5l265t357r583b430],
16	lysis	NN	O	lysis	nn	17	SENT_68	[p5l616t357r758b430],
17	buffer	NN	O	buffer	prep_in	12	SENT_68	[p5l790t357r986b413],
18	(	CD	NUMBER	(	number	19	SENT_68	[p5l1018t357r1120b426],
19	10	CD	NUMBER	10	num	21	SENT_68	[p5l1018t357r1120b426],
20	mM	NN	O	mm	nn	21	SENT_68	[p5l1150t358r1281b412],
21	Tris-HCl	NN	O	tris-hcl	dep	17	SENT_68	[p5l1313t357r1600b413],
22	pH	NN	O	ph	dep	17	SENT_68	[p5l1630t358r1726b430],
23	7.5	CD	NUMBER	7.5	num	22	SENT_68	[p5l1758t357r1873b424],
24	,	,	O	,	_	0	SENT_68	[p5l1758t357r1873b424],
25	10	CD	NUMBER	10	num	27	SENT_68	[p5l1913t357r1983b413],
26	mM	NN	O	mm	nn	27	SENT_68	[p5l2015t358r2146b412],
27	NaCl	NN	O	nacl	appos	22	SENT_68	[p5l8t440r193b507],
28	,	,	O	,	_	0	SENT_68	[p5l8t440r193b507],
29	1	CD	NUMBER	1	num	32	SENT_68	[p5l224t441r247b496],
30	mM	NN	O	mm	nn	32	SENT_68	[p5l274t442r405b496],
31	MgCl2	NN	O	mgcl2	nn	32	SENT_68	[p5l425t440r686b513],
32	)	NN	O	)	appos	17	SENT_68	[p5l425t440r686b513],
33	,	,	O	,	_	0	SENT_68	[p5l425t440r686b513],
34	and	CC	O	and	_	0	SENT_68	[p5l711t440r823b496],
35	incubated	VBN	O	incubate	conj_and	4	SENT_68	[p5l843t440r1154b496],
36	on	IN	O	on	_	0	SENT_68	[p5l1174t458r1251b496],
37	ice	NN	O	ice	prep_on	35	SENT_68	[p5l1271t440r1363b496],
38	for	IN	O	for	_	0	SENT_68	[p5l1383t440r1476b496],
39	15	CD	DURATION	15	num	40	SENT_68	[p5l1502t440r1569b497],
40	min	NN	DURATION	min	prep_for	37	SENT_68	[p5l1593t440r1732b496],
41	.	.	O	.	_	0	SENT_68	[p5l1593t440r1732b496],

1	The	DT	O	the	det	3	SENT_69	[p5l1756t440r1878b496],
2	swollen	JJ	O	swollen	amod	3	SENT_69	[p5l1901t440r2147b496],
3	cells	NNS	O	cell	nsubjpass	6	SENT_69	[p5l9t524r151b580],
4	were	VBD	O	be	auxpass	6	SENT_69	[p5l180t542r333b581],
5	mechanically	RB	O	mechanically	advmod	6	SENT_69	[p5l360t524r785b597],
6	disrupted	VBN	O	disrupt	_	0	SENT_69	[p5l813t524r1109b597],
7	in	IN	O	in	_	0	SENT_69	[p5l1136t524r1196b580],
8	a	DT	O	a	det	10	SENT_69	[p5l1224t542r1257b580],
9	glass	NN	O	glass	nn	10	SENT_69	[p5l1283t524r1439b597],
10	homogenizer	NN	O	homogenizer	prep_in	6	SENT_69	[p5l1466t524r1885b597],
11	and	CC	O	and	_	0	SENT_69	[p5l1912t524r2025b581],
12	the	DT	O	the	det	13	SENT_69	[p5l2050t524r2146b580],
13	nuclei	NNS	O	nucleus	nsubjpass	46	SENT_69	[p5l9t608r202b665],
14	removed	VBN	O	remove	partmod	13	SENT_69	[p5l233t609r513b665],
15	by	IN	O	by	_	0	SENT_69	[p5l542t609r620b681],
16	centrifugation	NN	O	centrifugation	agent	14	SENT_69	[p5l653t608r1100b681],
17	at	IN	O	at	_	0	SENT_69	[p5l1132t617r1188b665],
18	400	CD	NUMBER	400	num	20	SENT_69	[p5l1217t609r1335b665],
19	X	NN	O	x	nn	20	SENT_69	[p5l1375t614r1422b662],
20	g	NN	O	g	prep_at	14	SENT_69	[p5l1463t626r1499b681],
21	for	IN	O	for	_	0	SENT_69	[p5l1531t608r1624b665],
22	10	CD	DURATION	10	num	23	SENT_69	[p5l1661t609r1731b665],
23	min	NN	DURATION	min	prep_for	20	SENT_69	[p5l1762t608r1885b664],
24	at	IN	O	at	_	0	SENT_69	[p5l1918t617r1973b665],
25	4	CD	NUMBER	4	number	26	SENT_69	[p5l2002t609r2142b665],
26	°	CD	NUMBER	°	prep_at	23	SENT_69	[p5l2002t609r2142b665],
27	C.	NNP	O	C.	nn	29	SENT_69	[p5l2002t609r2142b665],
28	The	NNP	O	The	nn	29	SENT_69	[p5l8t693r131b749],
29	pellet	NN	O	pellet	tmod	26	SENT_69	[p5l151t693r330b765],
30	obtained	VBN	O	obtain	partmod	29	SENT_69	[p5l351t693r625b749],
31	by	IN	O	by	_	0	SENT_69	[p5l645t693r724b766],
32	subsequent	JJ	O	subsequent	amod	33	SENT_69	[p5l748t693r1102b766],
33	centrifugation	NN	O	centrifugation	agent	30	SENT_69	[p5l1123t693r1570b766],
34	at	IN	O	at	_	0	SENT_69	[p5l1593t701r1648b749],
35	30,000	CD	NUMBER	30,000	num	37	SENT_69	[p5l1671t693r1887b759],
36	X	NN	O	x	nn	37	SENT_69	[p5l1918t698r1965b746],
37	g	NN	O	g	prep_at	30	SENT_69	[p5l1996t710r2032b766],
38	for	IN	O	for	_	0	SENT_69	[p5l2055t693r2148b749],
39	30	CD	DURATION	30	num	40	SENT_69	[p5l11t777r86b833],
40	min	NN	DURATION	min	prep_for	37	SENT_69	[p5l125t777r248b832],
41	at	IN	O	at	_	0	SENT_69	[p5l288t785r344b833],
42	4	CD	NUMBER	4	number	43	SENT_69	[p5l381t777r504b833],
43	°	CD	NUMBER	°	num	44	SENT_69	[p5l381t777r504b833],
44	C	NN	O	c	prep_at	40	SENT_69	[p5l381t777r504b833],
45	was	VBD	O	be	auxpass	46	SENT_69	[p5l544t794r665b833],
46	used	VBN	O	use	conj_and	6	SENT_69	[p5l705t777r851b833],
47	as	IN	O	as	_	0	SENT_69	[p5l891t794r952b833],
48	the	DT	O	the	det	51	SENT_69	[p5l993t777r1088b833],
49	crude	JJ	O	crude	amod	51	SENT_69	[p5l1128t777r1303b833],
50	membrane	NN	O	membrane	nn	51	SENT_69	[p5l1342t777r1678b833],
51	fraction	NN	O	fraction	prep_as	46	SENT_69	[p5l1718t777r1981b833],
52	.	.	O	.	_	0	SENT_69	[p5l1718t777r1981b833],

1	The	DT	O	the	det	2	SENT_70	[p5l2024t777r2146b833],
2	supernatant	NN	O	supernatant	nsubj	6	SENT_70	[p5l11t869r377b934],
3	from	IN	O	from	_	0	SENT_70	[p5l407t861r561b917],
4	this	DT	O	this	det	5	SENT_70	[p5l591t861r703b917],
5	process	NN	O	process	prep_from	2	SENT_70	[p5l734t879r971b934],
6	yielded	VBD	O	yield	_	0	SENT_70	[p5l1004t861r1238b934],
7	the	DT	O	the	det	9	SENT_70	[p5l1268t861r1364b917],
8	cytosolic	JJ	O	cytosolic	amod	9	SENT_70	[p5l1395t861r1681b934],
9	fraction	NN	O	fraction	dobj	6	SENT_70	[p5l1713t861r1976b917],
10	.	.	O	.	_	0	SENT_70	[p5l1713t861r1976b917],

1	Protein	NN	O	protein	nn	2	SENT_71	[p5l2010t862r2144b917, p5l8t944r127b1000],
2	concentrations	NNS	O	concentration	nsubjpass	4	SENT_71	[p5l169t944r633b1000],
3	were	VBD	O	be	auxpass	4	SENT_71	[p5l677t962r830b1001],
4	determined	VBN	O	determine	_	0	SENT_71	[p5l873t944r1232b1000],
5	using	VBG	O	use	xcomp	4	SENT_71	[p5l1273t944r1444b1017],
6	the	DT	O	the	det	8	SENT_71	[p5l1487t944r1583b1000],
7	Bradford	NNP	LOCATION	Bradford	nn	8	SENT_71	[p5l1625t944r1913b1000],
8	assay	NN	O	assay	dobj	5	SENT_71	[p5l1956t962r2144b1017],
9	,	,	O	,	_	0	SENT_71	[p5l1956t962r2144b1017],
10	using	VBG	O	use	xcomp	4	SENT_71	[p5l8t1028r179b1101],
11	bovine	JJ	O	bovine	amod	13	SENT_71	[p5l208t1028r425b1084],
12	serum	NN	O	serum	nn	13	SENT_71	[p5l457t1046r649b1085],
13	albumin	NN	O	albumin	dobj	10	SENT_71	[p5l679t1028r938b1084],
14	as	IN	O	as	_	0	SENT_71	[p5l968t1046r1030b1084],
15	a	DT	O	a	det	16	SENT_71	[p5l1062t1046r1095b1084],
16	standard	NN	O	standard	prep_as	10	SENT_71	[p5l1125t1028r1408b1085],
17	.	.	O	.	_	0	SENT_71	[p5l1125t1028r1408b1085],

1	For	IN	O	for	_	0	SENT_72	[p5l88t1129r200b1184],
2	Pgp	NN	O	pgp	nn	4	SENT_72	[p5l231t1130r353b1201],
3	expression	NN	O	expression	nn	4	SENT_72	[p5l388t1128r728b1201],
4	studies	NNS	O	study	prep_for	9	SENT_72	[p5l764t1128r999b1195],
5	,	,	O	,	_	0	SENT_72	[p5l764t1128r999b1195],
6	crude	JJ	O	crude	amod	8	SENT_72	[p5l1036t1128r1211b1184],
7	membrane	NN	O	membrane	nn	8	SENT_72	[p5l1244t1128r1580b1184],
8	preparations	NNS	O	preparation	nsubj	9	SENT_72	[p5l1613t1128r2007b1201],
9	(	VBP	O	(	dep	15	SENT_72	[p5l2044t1129r2146b1198],
10	20	CD	NUMBER	20	num	13	SENT_72	[p5l2044t1129r2146b1198],
11	p.	NN	O	p.	nn	13	SENT_72	[p5l14t1212r285b1285],
12	g/well	NN	O	g/well	nn	13	SENT_72	[p5l14t1212r285b1285],
13	)	NN	O	)	dobj	9	SENT_72	[p5l14t1212r285b1285],
14	were	VBD	O	be	aux	15	SENT_72	[p5l314t1230r466b1269],
15	applied	VBN	O	apply	_	0	SENT_72	[p5l494t1212r727b1285],
16	to	TO	O	to	_	0	SENT_72	[p5l753t1221r812b1268],
17	a	DT	O	a	det	21	SENT_72	[p5l840t1230r874b1268],
18	6	CD	PERCENT	6	number	19	SENT_72	[p5l900t1212r1000b1269],
19	%	NN	PERCENT	%	amod	21	SENT_72	[p5l900t1212r1000b1269],
20	SDS-polyacrylamide	NN	O	sds-polyacrylamide	nn	21	SENT_72	[p5l1031t1212r1700b1285],
21	minigel	NN	O	minigel	prep_to	15	SENT_72	[p5l1726t1212r1986b1285],
22	,	,	O	,	_	0	SENT_72	[p5l1726t1212r1986b1285],
23	separated	VBN	O	separate	dep	15	SENT_72	[p5l2018t1230r2144b1285, p5l10t1297r203b1353],
24	by	IN	O	by	_	0	SENT_72	[p5l231t1297r309b1369],
25	electrophoresis	NN	O	electrophoresis	prep_by	23	SENT_72	[p5l340t1296r840b1369],
26	,	,	O	,	_	0	SENT_72	[p5l340t1296r840b1369],
27	then	RB	O	then	advmod	28	SENT_72	[p5l873t1297r1009b1353],
28	transferred	VBN	O	transfer	dep	15	SENT_72	[p5l1038t1296r1384b1353],
29	to	TO	O	to	_	0	SENT_72	[p5l1413t1305r1472b1353],
30	a	DT	O	a	det	34	SENT_72	[p5l1505t1314r1538b1353],
31	0.45	CD	NUMBER	0.45	num	34	SENT_72	[p5l1566t1296r1700b1353],
32	um	NN	O	um	nn	34	SENT_72	[p5l1739t1314r1848b1369],
33	nitrocellulose	NN	O	nitrocellulose	nn	34	SENT_72	[p5l1877t1296r2144b1353, p5l9t1381r198b1437],
34	membrane	NN	O	membrane	prep_to	28	SENT_72	[p5l225t1381r561b1437],
35	(	CD	NUMBER	(	num	36	SENT_72	[p5l591t1381r969b1454],
36	Hybond-C	NN	O	hybond-c	nsubj	15	SENT_72	[p5l591t1381r969b1454],
37	,	,	O	,	_	0	SENT_72	[p5l591t1381r969b1454],
38	Amersham	NNP	LOCATION	Amersham	appos	36	SENT_72	[p5l998t1381r1731b1447],
39	.	.	O	.	_	0	SENT_72	[p5l998t1381r1731b1447],

1	—	NN	O	—	_	0	SENT_73	[p5l998t1381r1731b1447],
2	.	.	O	.	_	0	SENT_73	[p5l998t1381r1731b1447],

1	Pharmacia	NNP	PERSON	Pharmacia	nn	5	SENT_74	[p5l998t1381r1731b1447],
2	,	,	O	,	_	0	SENT_74	[p5l998t1381r1731b1447],
3	Bucks	NNP	O	Bucks	appos	5	SENT_74	[p5l1760t1381r1976b1447],
4	,	,	O	,	_	0	SENT_74	[p5l1760t1381r1976b1447],
5	UK	NNP	LOCATION	UK	nsubj	31	SENT_74	[p5l2006t1381r2144b1450],
6	)	CD	NUMBER	)	num	5	SENT_74	[p5l2006t1381r2144b1450],
7	at	IN	O	at	_	0	SENT_74	[p5l10t1473r65b1521],
8	40	CD	NUMBER	40	num	9	SENT_74	[p5l95t1465r173b1521],
9	mA	NN	O	ma	prep_at	5	SENT_74	[p5l205t1465r323b1520],
10	for	IN	O	for	_	0	SENT_74	[p5l355t1465r447b1521],
11	16	CD	DURATION	16	num	12	SENT_74	[p5l485t1465r554b1521],
12	hr	NN	DURATION	hr	prep_for	9	SENT_74	[p5l586t1465r653b1520],
13	at	IN	O	at	_	0	SENT_74	[p5l684t1473r739b1521],
14	4	CD	NUMBER	4	number	15	SENT_74	[p5l769t1465r909b1521],
15	°	CD	NUMBER	°	prep_at	12	SENT_74	[p5l769t1465r909b1521],
16	C.	NNP	O	C.	nn	18	SENT_74	[p5l769t1465r909b1521],
17	Nonspeciﬁc	NNP	O	Nonspeciﬁc	nn	18	SENT_74	[p5l944t1465r1324b1538],
18	binding	NN	O	binding	nsubjpass	20	SENT_74	[p5l1356t1465r1599b1538],
19	was	VBD	O	be	auxpass	20	SENT_74	[p5l1632t1482r1752b1521],
20	blocked	VBN	O	block	rcmod	15	SENT_74	[p5l1784t1465r2038b1521],
21	by	IN	O	by	_	0	SENT_74	[p5l2067t1465r2146b1537],
22	incubation	NN	O	incubation	agent	20	SENT_74	[p5l8t1549r345b1605],
23	of	IN	O	of	_	0	SENT_74	[p5l368t1549r437b1605],
24	the	DT	O	the	det	25	SENT_74	[p5l455t1549r550b1605],
25	nitrocellulose	NN	O	nitrocellulose	prep_of	22	SENT_74	[p5l573t1549r1007b1605],
26	for	IN	O	for	_	0	SENT_74	[p5l1031t1549r1123b1605],
27	1	CD	DURATION	1	num	28	SENT_74	[p5l1152t1549r1175b1604],
28	hr	NN	DURATION	hr	prep_for	25	SENT_74	[p5l1204t1549r1271b1604],
29	in	IN	O	in	_	0	SENT_74	[p5l1292t1549r1352b1604],
30	Tris	NNP	O	Tris	prep_in	28	SENT_74	[p5l1375t1549r1500b1605],
31	buffered	VBD	O	buffer	ccomp	49	SENT_74	[p5l1523t1549r1795b1605],
32	saline	NN	O	saline	nn	34	SENT_74	[p5l1819t1549r2001b1605],
33	(	NN	O	(	nn	34	SENT_74	[p5l2026t1550r2146b1622],
34	pH	NN	O	ph	dobj	31	SENT_74	[p5l2026t1550r2146b1622],
35	7.5	CD	NUMBER	7.5	num	36	SENT_74	[p5l10t1635r132b1703],
36	)	NN	O	)	dep	34	SENT_74	[p5l10t1635r132b1703],
37	with	IN	O	with	_	0	SENT_74	[p5l173t1635r313b1691],
38	0.5	CD	PERCENT	0.5	number	39	SENT_74	[p5l351t1635r512b1691],
39	%	NN	PERCENT	%	amod	40	SENT_74	[p5l351t1635r512b1691],
40	tween	NN	O	tween	prep_with	36	SENT_74	[p5l553t1643r743b1691],
41	(	CD	NUMBER	(	num	43	SENT_74	[p5l783t1635r1026b1703],
42	TBST	NN	O	tbst	nn	43	SENT_74	[p5l783t1635r1026b1703],
43	)	NN	O	)	dep	36	SENT_74	[p5l783t1635r1026b1703],
44	+	CC	O	+	_	0	SENT_74	[p5l1075t1640r1123b1687],
45	5	CD	PERCENT	5	number	46	SENT_74	[p5l1170t1635r1270b1691],
46	%	NN	PERCENT	%	amod	47	SENT_74	[p5l1170t1635r1270b1691],
47	w/v	NN	O	w/v	conj_+	34	SENT_74	[p5l1312t1635r1447b1701],
48	,	,	O	,	_	0	SENT_74	[p5l1312t1635r1447b1701],
49	dried	VBD	O	dry	_	0	SENT_74	[p5l1488t1635r1651b1690],
50	milk	NN	O	milk	nn	52	SENT_74	[p5l1688t1635r1835b1690],
51	(	CD	NUMBER	(	num	52	SENT_74	[p5l1874t1635r2144b1703],
52	Marvel	NNP	O	Marvel	nsubj	49	SENT_74	[p5l1874t1635r2144b1703],
53	,	,	O	,	_	0	SENT_74	[p5l1874t1635r2144b1703],
54	Premier	NNP	O	Premier	nn	55	SENT_74	[p5l9t1720r263b1776],
55	Beverages	NNPS	O	Beverages	appos	52	SENT_74	[p5l288t1721r637b1793],
56	,	,	O	,	_	0	SENT_74	[p5l288t1721r637b1793],
57	Stafford	NNP	LOCATION	Stafford	appos	52	SENT_74	[p5l669t1720r944b1786],
58	,	,	O	,	_	0	SENT_74	[p5l669t1720r944b1786],
59	UK	NNP	LOCATION	UK	nn	60	SENT_74	[p5l974t1721r1130b1789],
60	)	NNP	O	)	appos	52	SENT_74	[p5l974t1721r1130b1789],
61	.	.	O	.	_	0	SENT_74	[p5l974t1721r1130b1789],

1	The	DT	O	the	det	2	SENT_75	[p5l1161t1720r1283b1776],
2	membrane	NN	O	membrane	nsubjpass	5	SENT_75	[p5l1310t1720r1646b1776],
3	was	VBD	O	be	auxpass	5	SENT_75	[p5l1674t1738r1794b1776],
4	then	RB	O	then	advmod	5	SENT_75	[p5l1822t1720r1958b1776],
5	incubated	VBN	O	incubate	_	0	SENT_75	[p5l1985t1720r2145b1776, p5l8t1806r182b1862],
6	with	IN	O	with	_	0	SENT_75	[p5l214t1806r354b1862],
7	the	DT	O	the	det	8	SENT_75	[p5l386t1806r482b1862],
8	C219	NN	O	c219	prep_with	5	SENT_75	[p5l515t1806r684b1863],
9	monoclonal	JJ	O	monoclonal	amod	12	SENT_75	[p5l718t1806r1095b1862],
10	antibody	NN	O	antibody	nn	12	SENT_75	[p5l1129t1806r1405b1879],
11	(	NN	O	(	nn	12	SENT_75	[p5l1441t1806r1657b1875],
12	MAb	NN	O	mab	dep	8	SENT_75	[p5l1441t1806r1657b1875],
13	)	CD	NUMBER	)	number	14	SENT_75	[p5l1441t1806r1657b1875],
14	(	CD	NUMBER	(	dep	8	SENT_75	[p5l1694t1806r2012b1875],
15	Centocor	NNP	ORGANIZATION	Centocor	nn	16	SENT_75	[p5l1694t1806r2012b1875],
16	Diagnostics	NNPS	ORGANIZATION	Diagnostics	dep	14	SENT_75	[p5l2043t1806r2145b1861, p5l11t1891r323b1964],
17	,	,	O	,	_	0	SENT_75	[p5l2043t1806r2145b1861, p5l11t1891r323b1964],
18	Malvern	NNP	LOCATION	Malvern	appos	8	SENT_75	[p5l348t1891r635b1958],
19	,	,	O	,	_	0	SENT_75	[p5l348t1891r635b1958],
20	PA	NN	ORGANIZATION	pa	nn	21	SENT_75	[p5l661t1892r786b1961],
21	)	NN	O	)	appos	18	SENT_75	[p5l661t1892r786b1961],
22	for	IN	O	for	_	0	SENT_75	[p5l811t1891r903b1948],
23	2	CD	DURATION	2	num	24	SENT_75	[p5l925t1892r961b1947],
24	hr	NN	DURATION	hr	prep_for	21	SENT_75	[p5l984t1892r1066b1958],
25	,	,	O	,	_	0	SENT_75	[p5l984t1892r1066b1958],
26	followed	VBN	O	follow	_	0	SENT_75	[p5l1092t1891r1375b1948],
27	by	IN	O	by	prepc_followed_by	5	SENT_75	[p5l1396t1892r1475b1964],
28	3	CD	NUMBER	3	num	29	SENT_75	[p5l1500t1892r1532b1948],
29	washes	NNS	O	wash	pobj	5	SENT_75	[p5l1559t1892r1786b1948],
30	for	IN	O	for	_	0	SENT_75	[p5l1810t1891r1903b1948],
31	15	CD	DURATION	15	num	32	SENT_75	[p5l1932t1891r1998b1948],
32	min	NN	DURATION	min	prep_for	29	SENT_75	[p5l2025t1891r2148b1947],
33	each	DT	O	each	dep	32	SENT_75	[p5l10t1977r155b2034],
34	in	IN	O	in	_	0	SENT_75	[p5l179t1977r240b2033],
35	TBST	NN	O	tbst	prep_in	29	SENT_75	[p5l265t1978r475b2034],
36	.	.	O	.	_	0	SENT_75	[p5l265t1978r475b2034],

1	Membranes	NNS	O	membrane	nsubjpass	4	SENT_76	[p5l503t1978r879b2034],
2	were	VBD	O	be	auxpass	4	SENT_76	[p5l906t1995r1059b2034],
3	then	RB	O	then	advmod	4	SENT_76	[p5l1085t1978r1221b2034],
4	incubated	VBN	O	incubate	_	0	SENT_76	[p5l1246t1977r1556b2034],
5	for	IN	O	for	_	0	SENT_76	[p5l1581t1977r1674b2034],
6	60	CD	DURATION	60	num	7	SENT_76	[p5l1699t1977r1775b2034],
7	min	NN	DURATION	min	prep_for	4	SENT_76	[p5l1801t1977r1923b2033],
8	with	IN	O	with	_	0	SENT_76	[p5l1949t1977r2089b2034],
9	a	DT	O	a	det	11	SENT_76	[p5l2116t1995r2149b2034],
10	biotin-conjugated	JJ	O	biotin-conjugated	amod	11	SENT_76	[p5l8t2063r574b2136],
11	goat	NN	O	goat	prep_with	7	SENT_76	[p5l627t2072r763b2136],
12	anti-mouse	JJ	O	anti-mouse	amod	14	SENT_76	[p5l817t2063r1169b2119],
13	secondary	JJ	O	secondary	amod	14	SENT_76	[p5l1224t2063r1544b2136],
14	antibody	NN	O	antibody	tmod	4	SENT_76	[p5l1600t2063r1876b2136],
15	(	CD	NUMBER	(	num	14	SENT_76	[p5l1931t2063r2144b2133],
16	Dako	NNP	PERSON	Dako	nn	20	SENT_76	[p5l1931t2063r2144b2133],
17	,	,	O	,	_	0	SENT_76	[p5l1931t2063r2144b2133],
18	Glostrup	NNP	O	Glostrup	appos	20	SENT_76	[p5l11t2149r305b2222],
19	,	,	O	,	_	0	SENT_76	[p5l11t2149r305b2222],
20	Denmark	NNP	LOCATION	Denmark	dep	14	SENT_76	[p5l341t2149r680b2219],
21	)	CD	NUMBER	)	num	20	SENT_76	[p5l341t2149r680b2219],
22	.	.	O	.	_	0	SENT_76	[p5l341t2149r680b2219],

1	After	IN	O	after	_	0	SENT_77	[p5l717t2149r887b2205],
2	3	CD	NUMBER	3	num	4	SENT_77	[p5l920t2150r952b2206],
3	further	JJ	O	further	amod	4	SENT_77	[p5l990t2149r1207b2206],
4	washes	NNS	O	wash	prep_after	12	SENT_77	[p5l1239t2149r1466b2206],
5	in	IN	O	in	_	0	SENT_77	[p5l1501t2149r1562b2205],
6	TBST	NN	O	tbst	prep_in	4	SENT_77	[p5l1595t2150r1806b2216],
7	,	,	O	,	_	0	SENT_77	[p5l1595t2150r1806b2216],
8	the	DT	O	the	det	9	SENT_77	[p5l1842t2149r1938b2205],
9	nitrocellulose	NN	O	nitrocellulose	nsubjpass	12	SENT_77	[p5l1971t2149r2145b2205, p5l10t2235r292b2291],
10	was	VBD	O	be	auxpass	12	SENT_77	[p5l323t2253r443b2292],
11	ﬁnally	RB	O	ﬁnally	advmod	12	SENT_77	[p5l475t2235r677b2308],
12	incubated	VBN	O	incubate	_	0	SENT_77	[p5l707t2235r1018b2291],
13	with	IN	O	with	_	0	SENT_77	[p5l1047t2235r1187b2291],
14	a	DT	O	a	det	18	SENT_77	[p5l1218t2253r1251b2291],
15	StreptAvidin	NNP	MISC	StreptAvidin	nn	18	SENT_77	[p5l1282t2235r1692b2308],
16	Biotinhorseradish	NNP	MISC	Biotinhorseradish	nn	18	SENT_77	[p5l1722t2235r2145b2291, p5l9t2322r204b2378],
17	peroxidase	NN	O	peroxidase	nn	18	SENT_77	[p5l233t2322r579b2395],
18	complex	NN	O	complex	prep_with	12	SENT_77	[p5l610t2322r883b2395],
19	for	IN	O	for	_	0	SENT_77	[p5l914t2322r1007b2378],
20	60	CD	DURATION	60	num	21	SENT_77	[p5l1037t2322r1113b2378],
21	min	NN	DURATION	min	prep_for	18	SENT_77	[p5l1144t2322r1267b2377],
22	(	CD	NUMBER	(	num	23	SENT_77	[p5l1300t2322r1538b2391],
23	Dako	NNP	PERSON	Dako	dep	21	SENT_77	[p5l1300t2322r1538b2391],
24	)	CD	NUMBER	)	num	23	SENT_77	[p5l1300t2322r1538b2391],
25	.	.	O	.	_	0	SENT_77	[p5l1300t2322r1538b2391],

1	Following	VBG	O	follow	_	0	SENT_78	[p5l1573t2322r1900b2395],
2	further	JJ	O	further	prep_following	8	SENT_78	[p5l1931t2322r2149b2378],
3	washing	VBG	O	wash	partmod	2	SENT_78	[p5l10t2408r292b2481],
4	,	,	O	,	_	0	SENT_78	[p5l10t2408r292b2481],
5	protein	NN	O	protein	nn	6	SENT_78	[p5l336t2408r563b2481],
6	expression	NN	O	expression	nsubjpass	8	SENT_78	[p5l606t2408r946b2481],
7	was	VBD	O	be	auxpass	8	SENT_78	[p5l990t2426r1110b2464],
8	visualised	VBN	O	visualise	dep	20	SENT_78	[p5l1155t2408r1474b2464],
9	using	VBG	O	use	xcomp	8	SENT_78	[p5l1515t2408r1687b2481],
10	an	DT	O	a	det	13	SENT_78	[p5l1732t2426r1804b2464],
11	enhanced	VBN	O	enhance	amod	13	SENT_78	[p5l1847t2408r2148b2464],
12	chemoluminescence	NN	O	chemoluminescence	nn	13	SENT_78	[p5l10t2494r658b2550],
13	system	NN	O	system	dobj	9	SENT_78	[p5l699t2502r918b2566],
14	according	VBG	O	accord	_	0	SENT_78	[p5l957t2494r1268b2567],
15	to	TO	O	to	prepc_according_to	9	SENT_78	[p5l1307t2502r1366b2550],
16	the	DT	O	the	det	17	SENT_78	[p5l1405t2494r1501b2550],
17	manufacturer	NN	O	manufacturer	poss	19	SENT_78	[p5l1539t2494r2021b2550],
18	’s	POS	O	’s	_	0	SENT_78	[p5l1539t2494r2021b2550],
19	instructions	NNS	O	instruction	pobj	9	SENT_78	[p5l2061t2494r2145b2549, p5l12t2579r317b2636],
20	(	VBP	O	(	_	0	SENT_78	[p5l364t2580r720b2649],
21	ECL-Plus	NN	O	ecl-plus	nsubj	20	SENT_78	[p5l364t2580r720b2649],
22	,	,	O	,	_	0	SENT_78	[p5l364t2580r720b2649],
23	Amersham	NNP	LOCATION	Amersham	appos	21	SENT_78	[p5l765t2579r1523b2649],
24	.	.	O	.	_	0	SENT_78	[p5l765t2579r1523b2649],

1	—	NN	O	—	_	0	SENT_79	[p5l765t2579r1523b2649],
2	.	.	O	.	_	0	SENT_79	[p5l765t2579r1523b2649],

1	Pharmacia	NNP	LOCATION	Pharmacia	nn	2	SENT_80	[p5l765t2579r1523b2649],
2	)	NNP	O	)	_	0	SENT_80	[p5l765t2579r1523b2649],
3	.	.	O	.	_	0	SENT_80	[p5l765t2579r1523b2649],

1	Intensity	NN	O	intensity	nsubjpass	3	SENT_81	[p5l1570t2579r1848b2652],
2	was	VBD	O	be	auxpass	3	SENT_81	[p5l1892t2597r2012b2636],
3	assessed	VBN	O	assess	_	0	SENT_81	[p5l2058t2597r2145b2636, p5l12t2665r213b2722],
4	semiquantitatively	RB	O	semiquantitatively	advmod	3	SENT_81	[p5l237t2665r824b2738],
5	by	IN	O	by	_	0	SENT_81	[p5l845t2666r923b2738],
6	densitometry	NN	O	densitometry	agent	3	SENT_81	[p5l946t2665r1361b2738],
7	by	IN	O	by	_	0	SENT_81	[p5l1382t2666r1461b2738],
8	capturing	VBG	O	capture	agent	3	SENT_81	[p5l1483t2665r1783b2738],
9	the	DT	O	the	det	10	SENT_81	[p5l1805t2666r1901b2722],
10	images	NNS	O	image	dobj	8	SENT_81	[p5l1922t2665r2146b2738],
11	using	VBG	O	use	xcomp	8	SENT_81	[p5l9t2751r180b2824],
12	a	DT	O	a	det	14	SENT_81	[p5l211t2769r244b2808],
13	Kodak	NNP	O	Kodak	nn	14	SENT_81	[p5l272t2751r484b2807],
14	DC40	NN	O	dc40	nsubj	16	SENT_81	[p5l510t2752r699b2808],
15	digital	JJ	O	digital	amod	16	SENT_81	[p5l729t2751r930b2824],
16	camera	NN	O	camera	xcomp	11	SENT_81	[p5l959t2769r1189b2808],
17	and	CC	O	and	_	0	SENT_81	[p5l1218t2751r1330b2807],
18	analysing	VBG	O	analyse	agent	3	SENT_81	[p5l1359t2751r1662b2824],
19	band	NN	O	band	nn	20	SENT_81	[p5l1690t2751r1846b2807],
20	intensity	NN	O	intensity	dobj	18	SENT_81	[p5l1873t2751r2147b2824],
21	using	VBG	O	use	xcomp	18	SENT_81	[p5l9t2837r180b2910],
22	Kodak	NNP	ORGANIZATION	Kodak	nn	23	SENT_81	[p5l212t2837r424b2893],
23	1D	NN	O	1d	dobj	21	SENT_81	[p5l460t2838r546b2893],
24	digital	JJ	O	digital	amod	26	SENT_81	[p5l578t2837r780b2910],
25	software	NN	O	software	nn	26	SENT_81	[p5l813t2837r1084b2893],
26	(	NN	O	(	dobj	8	SENT_81	[p5l1116t2837r1354b2906],
27	Kodak	NNP	ORGANIZATION	Kodak	nn	30	SENT_81	[p5l1116t2837r1354b2906],
28	Scientiﬁc	NNP	ORGANIZATION	Scientiﬁc	nn	30	SENT_81	[p5l1384t2837r1681b2894],
29	Imaging	NNP	ORGANIZATION	Imaging	nn	30	SENT_81	[p5l1712t2837r1977b2910],
30	Systems	NNPS	ORGANIZATION	Systems	dep	26	SENT_81	[p5l2009t2838r2145b2910, p5l9t2931r176b2990],
31	,	,	O	,	_	0	SENT_81	[p5l2009t2838r2145b2910, p5l9t2931r176b2990],
32	Rochester	NNP	LOCATION	Rochester	appos	26	SENT_81	[p5l210t2923r545b2990],
33	,	,	O	,	_	0	SENT_81	[p5l210t2923r545b2990],
34	NY	NNP	O	NY	nn	35	SENT_81	[p5l579t2924r736b2993],
35	)	NNP	O	)	appos	32	SENT_81	[p5l579t2924r736b2993],
36	.	.	O	.	_	0	SENT_81	[p5l579t2924r736b2993],

1	All	DT	O	all	det	2	SENT_82	[p5l771t2923r871b2979],
2	values	NNS	O	value	nsubjpass	12	SENT_82	[p5l903t2923r1104b2979],
3	were	VBD	O	be	auxpass	4	SENT_82	[p5l1137t2941r1290b2979],
4	compared	VBN	O	compare	_	0	SENT_82	[p5l1322t2923r1636b2996],
5	between	IN	O	between	_	0	SENT_82	[p5l1665t2923r1932b2979],
6	HEp2	NN	O	hep2	nn	9	SENT_82	[p5l1962t2924r2147b2996],
7	and	CC	O	and	_	0	SENT_82	[p5l11t3010r124b3066],
8	HEp2A	NN	O	hep2a	nn	9	SENT_82	[p5l148t3010r391b3083],
9	cells	NNS	O	cell	prep_between	4	SENT_82	[p5l417t3010r559b3066],
10	and	CC	O	and	_	0	SENT_82	[p5l588t3010r700b3066],
11	were	VBD	O	be	auxpass	12	SENT_82	[p5l725t3028r878b3066],
12	calculated	VBN	O	calculate	conj_and	4	SENT_82	[p5l904t3010r1227b3066],
13	as	IN	O	as	_	0	SENT_82	[p5l1253t3028r1314b3066],
14	the	DT	O	the	det	15	SENT_82	[p5l1341t3010r1436b3066],
15	average	NN	O	average	prep_as	12	SENT_82	[p5l1464t3028r1709b3083],
16	of	IN	O	of	_	0	SENT_82	[p5l1735t3010r1804b3066],
17	3	CD	NUMBER	3	num	19	SENT_82	[p5l1826t3010r1858b3066],
18	separate	JJ	O	separate	amod	19	SENT_82	[p5l1890t3018r2147b3083],
19	experiments	NNS	O	experiment	prep_of	15	SENT_82	[p5l10t3097r416b3170],
20	.	.	O	.	_	0	SENT_82	[p5l10t3097r416b3170],

1	For	IN	O	for	_	0	SENT_83	[p6l89t22r201b76],
2	studies	NNS	O	study	prep_for	9	SENT_83	[p6l230t20r447b77],
3	on	IN	O	on	_	0	SENT_83	[p6l478t38r555b76],
4	GST	NN	O	gst	nn	5	SENT_83	[p6l585t21r733b77],
5	expression	NN	O	expression	prep_on	2	SENT_83	[p6l763t20r1120b93],
6	,	,	O	,	_	0	SENT_83	[p6l763t20r1120b93],
7	cytosol	NN	O	cytosol	nn	8	SENT_83	[p6l1152t20r1381b93],
8	proteins	NNS	O	protein	nsubj	9	SENT_83	[p6l1409t20r1664b93],
9	(	VBP	O	(	_	0	SENT_83	[p6l1697t21r1840b90],
10	100	CD	NUMBER	100	num	13	SENT_83	[p6l1697t21r1840b90],
11	p.	NN	O	p.	nn	13	SENT_83	[p6l1874t20r2145b93],
12	g/well	NN	O	g/well	nn	13	SENT_83	[p6l1874t20r2145b93],
13	)	NN	O	)	nsubjpass	15	SENT_83	[p6l1874t20r2145b93],
14	were	VBD	O	be	auxpass	15	SENT_83	[p6l10t124r163b163],
15	applied	VBN	O	apply	ccomp	9	SENT_83	[p6l206t106r439b179],
16	to	TO	O	to	_	0	SENT_83	[p6l480t115r539b162],
17	a	DT	O	a	det	21	SENT_83	[p6l583t124r616b163],
18	12	CD	PERCENT	12	number	19	SENT_83	[p6l664t107r798b163],
19	%	NN	PERCENT	%	amod	21	SENT_83	[p6l664t107r798b163],
20	SDS-polyacrylamide	NN	O	sds-polyacrylamide	nn	21	SENT_83	[p6l845t106r1513b179],
21	gel	NN	O	gel	prep_to	15	SENT_83	[p6l1556t106r1650b179],
22	and	CC	O	and	_	0	SENT_83	[p6l1693t106r1806b163],
23	separated	JJ	O	separated	conj_and	21	SENT_83	[p6l1849t106r2148b179],
24	overnight	JJ	TIME	overnight	amod	23	SENT_83	[p6l10t192r316b265],
25	at	IN	O	at	_	0	SENT_83	[p6l353t201r408b248],
26	45	CD	NUMBER	45	num	27	SENT_83	[p6l443t192r518b249],
27	V	NN	O	v	prep_at	15	SENT_83	[p6l558t193r630b259],
28	,	,	O	,	_	0	SENT_83	[p6l558t193r630b259],
29	using	VBG	O	use	xcomp	15	SENT_83	[p6l669t192r840b265],
30	rat	NN	O	rat	nn	32	SENT_83	[p6l877t201r961b248],
31	liver	NN	O	liver	nn	32	SENT_83	[p6l997t192r1142b248],
32	cytosol	NN	O	cytosol	dobj	29	SENT_83	[p6l1178t192r1407b265],
33	as	IN	O	as	_	0	SENT_83	[p6l1445t210r1506b248],
34	a	DT	O	a	det	36	SENT_83	[p6l1546t210r1579b248],
35	positive	JJ	O	positive	amod	36	SENT_83	[p6l1613t192r1865b265],
36	control	NN	O	control	prep_as	32	SENT_83	[p6l1903t192r2143b248],
37	.	.	O	.	_	0	SENT_83	[p6l1903t192r2143b248],

1	Transfer	NN	O	transfer	dep	10	SENT_84	[p6l9t279r281b335],
2	to	TO	O	to	_	0	SENT_84	[p6l307t287r366b335],
3	a	DT	O	a	det	7	SENT_84	[p6l397t297r430b335],
4	0.45	CD	NUMBER	0.45	num	7	SENT_84	[p6l457t279r591b335],
5	um	NN	O	um	nn	7	SENT_84	[p6l628t297r738b351],
6	nitrocellulose	NN	O	nitrocellulose	nn	7	SENT_84	[p6l765t279r1199b335],
7	membrane	NN	O	membrane	prep_to	1	SENT_84	[p6l1227t279r1564b335],
8	(	CD	NUMBER	(	num	10	SENT_84	[p6l1594t279r1876b352],
9	Hybond	NN	O	hybond	nn	10	SENT_84	[p6l1594t279r1876b352],
10	C	NN	O	c	dep	48	SENT_84	[p6l1904t279r1971b345],
11	,	,	O	,	_	0	SENT_84	[p6l1904t279r1971b345],
12	Amersham	NNP	LOCATION	Amersham	nn	14	SENT_84	[p6l2002t279r2145b334, p6l10t365r240b420],
13	Pharmacia	NNP	LOCATION	Pharmacia	nn	14	SENT_84	[p6l266t365r627b433],
14	)	NN	O	)	nsubjpass	16	SENT_84	[p6l266t365r627b433],
15	was	VBD	O	be	auxpass	16	SENT_84	[p6l657t383r777b421],
16	carried	VBN	O	carry	parataxis	48	SENT_84	[p6l807t365r1028b420],
17	out	RP	O	out	prt	16	SENT_84	[p6l1054t373r1155b420],
18	at	IN	O	at	_	0	SENT_84	[p6l1183t373r1238b420],
19	60	CD	NUMBER	60	num	20	SENT_84	[p6l1265t365r1341b421],
20	V	NN	O	v	prep_at	16	SENT_84	[p6l1369t366r1424b420],
21	for	IN	O	for	_	0	SENT_84	[p6l1452t365r1545b420],
22	4	CD	DURATION	4	num	23	SENT_84	[p6l1570t365r1607b420],
23	hr	NN	DURATION	hr	prep_for	20	SENT_84	[p6l1634t365r1701b420],
24	at	IN	O	at	_	0	SENT_84	[p6l1728t373r1784b420],
25	4	CD	NUMBER	4	number	26	SENT_84	[p6l1809t365r1949b421],
26	°	CD	NUMBER	°	prep_at	16	SENT_84	[p6l1809t365r1949b421],
27	C.	NNP	O	C.	tmod	16	SENT_84	[p6l1809t365r1949b421],
28	After	IN	O	after	amod	27	SENT_84	[p6l1980t365r2149b420],
29	blocking	VBG	O	block	xcomp	16	SENT_84	[p6l8t450r287b523],
30	nonspeciﬁc	JJ	O	nonspeciﬁc	amod	32	SENT_84	[p6l311t450r673b523],
31	protein	NN	O	protein	nn	32	SENT_84	[p6l695t450r921b523],
32	binding	NN	O	binding	dobj	29	SENT_84	[p6l942t450r1185b523],
33	overnight	JJ	TIME	overnight	amod	32	SENT_84	[p6l1210t450r1515b523],
34	in	IN	O	in	_	0	SENT_84	[p6l1536t450r1597b505],
35	TBST	NN	PERCENT	tbst	prep_in	32	SENT_84	[p6l1619t450r1813b506],
36	+5	CD	PERCENT	+5	num	37	SENT_84	[p6l1844t449r2003b506],
37	%	NN	PERCENT	%	tmod	29	SENT_84	[p6l1844t449r2003b506],
38	W/V	NN	O	w/v	nsubj	39	SENT_84	[p6l2030t450r2147b506],
39	dried	VBD	O	dry	rcmod	37	SENT_84	[p6l10t535r173b592],
40	milk	NN	O	milk	dobj	39	SENT_84	[p6l195t535r342b591],
41	(	CD	NUMBER	(	num	40	SENT_84	[p6l366t536r663b605],
42	Marvel	NNP	O	Marvel	tmod	39	SENT_84	[p6l366t536r663b605],
43	)	CD	NUMBER	)	num	42	SENT_84	[p6l366t536r663b605],
44	,	,	O	,	_	0	SENT_84	[p6l366t536r663b605],
45	the	DT	O	the	det	46	SENT_84	[p6l689t536r785b592],
46	nitrocellulose	NN	O	nitrocellulose	nsubjpass	48	SENT_84	[p6l808t535r1242b592],
47	was	VBD	O	be	auxpass	48	SENT_84	[p6l1266t553r1386b592],
48	incubated	VBN	O	incubate	_	0	SENT_84	[p6l1411t535r1722b592],
49	for	IN	O	for	_	0	SENT_84	[p6l1744t535r1837b592],
50	1	CD	DURATION	1	num	51	SENT_84	[p6l1866t536r1889b591],
51	hr	NN	DURATION	hr	prep_for	48	SENT_84	[p6l1919t536r1985b591],
52	with	IN	O	with	_	0	SENT_84	[p6l2007t535r2148b592],
53	the	DT	O	the	det	55	SENT_84	[p6l9t621r105b678],
54	primary	JJ	O	primary	amod	55	SENT_84	[p6l137t621r389b694],
55	antibodies	NNS	O	antibody	prep_with	51	SENT_84	[p6l424t621r748b678],
56	against	IN	O	against	_	0	SENT_84	[p6l785t621r1009b694],
57	GSTA	NNP	ORGANIZATION	GSTA	prep_against	55	SENT_84	[p6l1042t622r1265b688],
58	,	,	O	,	_	0	SENT_84	[p6l1042t622r1265b688],
59	GSTM	NNP	ORGANIZATION	GSTM	prep_against	55	SENT_84	[p6l1302t622r1521b678],
60	and	CC	O	and	_	0	SENT_84	[p6l1556t622r1668b678],
61	GSTP	NNP	O	GSTP	prep_against	55	SENT_84	[p6l1701t622r1894b678],
62	classes	NNS	O	class	dobj	48	SENT_84	[p6l1927t622r2146b678],
63	(	CD	NUMBER	(	num	62	SENT_84	[p6l12t707r226b777],
64	raised	VBN	O	raise	dep	62	SENT_84	[p6l12t707r226b777],
65	against	IN	O	against	_	0	SENT_84	[p6l256t707r480b780],
66	GSTA1	NN	O	gsta1	nn	70	SENT_84	[p6l509t708r772b774],
67	,	,	O	,	_	0	SENT_84	[p6l509t708r772b774],
68	GSTM1b	NN	O	gstm1b	dep	70	SENT_84	[p6l805t707r1121b774],
69	,	,	O	,	_	0	SENT_84	[p6l805t707r1121b774],
70	GSTP1	NN	O	gstp1	prep_against	64	SENT_84	[p6l1154t708r1404b774],
71	,	,	O	,	_	0	SENT_84	[p6l1154t708r1404b774],
72	respectively	RB	O	respectively	advmod	64	SENT_84	[p6l1434t707r1838b780],
73	,	,	O	,	_	0	SENT_84	[p6l1434t707r1838b780],
74	and	CC	O	and	_	0	SENT_84	[p6l1871t707r1984b763],
75	supplied	VBN	O	supply	dep	62	SENT_84	[p6l2014t725r2145b780, p6l9t793r169b866],
76	by	IN	O	by	_	0	SENT_84	[p6l193t793r272b866],
77	Prof.	NNP	O	Prof.	nn	78	SENT_84	[p6l299t793r451b849],
78	J	NNP	O	J	prep_by	75	SENT_84	[p6l481t795r511b850],
79	.	.	O	.	_	0	SENT_84	[p6l517t795r604b849],

1	D.	NNP	PERSON	D.	nn	2	SENT_85	[p6l517t795r604b849],
2	Hayes	NNP	PERSON	Hayes	_	0	SENT_85	[p6l635t795r850b866],
3	,	,	O	,	_	0	SENT_85	[p6l635t795r850b866],
4	University	NNP	ORGANIZATION	University	appos	2	SENT_85	[p6l880t793r1216b866],
5	of	IN	ORGANIZATION	of	_	0	SENT_85	[p6l1244t793r1313b849],
6	Dundee	NNP	ORGANIZATION	Dundee	prep_of	4	SENT_85	[p6l1334t793r1599b860],
7	,	,	O	,	_	0	SENT_85	[p6l1334t793r1599b860],
8	Scotland	NNP	LOCATION	Scotland	appos	2	SENT_85	[p6l1630t793r1949b862],
9	)	CD	NUMBER	)	num	8	SENT_85	[p6l1630t793r1949b862],
10	.	.	O	.	_	0	SENT_85	[p6l1630t793r1949b862],

1	Antibody	NN	O	antibody	nn	2	SENT_86	[p6l1980t793r2145b849, p6l9t879r167b952],
2	binding	NN	O	binding	nsubjpass	4	SENT_86	[p6l197t879r441b952],
3	was	VBD	O	be	auxpass	4	SENT_86	[p6l472t897r593b936],
4	detected	VBN	O	detect	_	0	SENT_86	[p6l626t879r891b935],
5	by	IN	O	by	_	0	SENT_86	[p6l920t879r999b952],
6	use	NN	O	use	agent	4	SENT_86	[p6l1029t897r1135b935],
7	of	IN	O	of	_	0	SENT_86	[p6l1167t879r1235b935],
8	Biotin-conjugated	JJ	MISC	biotin-conjugated	amod	9	SENT_86	[p6l1261t879r1839b952],
9	antibody	NN	O	antibody	prep_of	6	SENT_86	[p6l1870t879r2147b952],
10	and	CC	O	and	_	0	SENT_86	[p6l11t966r124b1022],
11	ECL	NN	ORGANIZATION	ecl	nn	12	SENT_86	[p6l151t966r302b1022],
12	detection	NN	O	detection	conj_and	9	SENT_86	[p6l331t966r622b1022],
13	as	IN	O	as	mark	14	SENT_86	[p6l653t984r714b1022],
14	described	VBN	O	describe	advcl	4	SENT_86	[p6l745t966r1051b1022],
15	for	IN	O	for	_	0	SENT_86	[p6l1079t966r1172b1022],
16	Pgp	NNP	O	Pgp	prep_for	14	SENT_86	[p6l1199t967r1338b1039],
17	.	.	O	.	_	0	SENT_86	[p6l1199t967r1338b1039],

1	Reverse	JJ	O	reverse	amod	5	SENT_87	[p6l7t1153r260b1207],
2	transcriptase	NN	O	transcriptase	nn	5	SENT_87	[p6l292t1153r710b1222],
3	polymerase	NN	O	polymerase	nn	5	SENT_87	[p6l733t1151r1107b1222],
4	chain	NN	O	chain	nn	5	SENT_87	[p6l1138t1150r1312b1207],
5	reaction	NN	O	reaction	_	0	SENT_87	[p6l1344t1153r1606b1207],
6	(	CD	NUMBER	(	num	9	SENT_87	[p6l1638t1152r1957b1220],
7	RT-PCR	NN	O	rt-pcr	nn	9	SENT_87	[p6l1638t1152r1957b1220],
8	)	NN	O	)	nn	9	SENT_87	[p6l1638t1152r1957b1220],
9	assay	NN	O	assay	dep	5	SENT_87	[p6l10t1255r186b1308],
10	of	IN	O	of	_	0	SENT_87	[p6l215t1237r288b1308],
11	MDRI	NN	O	mdrus	prep_of	9	SENT_87	[p6l301t1237r510b1292],
12	and	CC	O	and	_	0	SENT_87	[p6l544t1236r666b1293],
13	MRP1	NN	O	mrp1	conj_and	11	SENT_87	[p6l688t1237r888b1292],

1	Total	JJ	O	total	amod	2	SENT_88	[p6l90t1336r256b1392],
2	RNA	NN	O	rna	nsubjpass	4	SENT_88	[p6l285t1337r453b1392],
3	was	VBD	O	be	auxpass	4	SENT_88	[p6l482t1354r602b1392],
4	extracted	VBN	O	extract	_	0	SENT_88	[p6l633t1336r925b1392],
5	from	IN	O	from	_	0	SENT_88	[p6l953t1336r1108b1392],
6	HEp2A	NN	O	hep2a	nn	9	SENT_88	[p6l1135t1337r1378b1409],
7	and	CC	O	and	_	0	SENT_88	[p6l1408t1336r1521b1392],
8	HEp2	NN	O	hep2	nn	9	SENT_88	[p6l1549t1337r1733b1409],
9	cells	NNS	O	cell	prep_from	4	SENT_88	[p6l1763t1336r1905b1392],
10	by	IN	O	by	_	0	SENT_88	[p6l1935t1336r2013b1409],
11	use	NN	O	use	agent	4	SENT_88	[p6l2042t1354r2147b1392],
12	of	IN	O	of	_	0	SENT_88	[p6l10t1423r80b1479],
13	an	DT	O	a	det	15	SENT_88	[p6l104t1441r176b1479],
14	RNAzol	NN	O	rnazol	nn	15	SENT_88	[p6l204t1423r469b1479],
15	kit	NN	O	kit	prep_of	11	SENT_88	[p6l497t1423r581b1479],
16	(	CD	NUMBER	(	dep	15	SENT_88	[p6l610t1423r1002b1496],
17	Biogenesis	NNP	O	Biogenesis	nn	21	SENT_88	[p6l610t1423r1002b1496],
18	,	,	O	,	_	0	SENT_88	[p6l610t1423r1002b1496],
19	Poole	NNP	PERSON	Poole	appos	21	SENT_88	[p6l1033t1423r1230b1489],
20	,	,	O	,	_	0	SENT_88	[p6l1033t1423r1230b1489],
21	UK	NNP	LOCATION	UK	dep	16	SENT_88	[p6l1261t1424r1400b1492],
22	)	CD	NUMBER	)	num	21	SENT_88	[p6l1261t1424r1400b1492],
23	according	VBG	O	accord	_	0	SENT_88	[p6l1432t1423r1743b1496],
24	to	TO	O	to	prepc_according_to	4	SENT_88	[p6l1772t1431r1831b1479],
25	the	DT	O	the	det	26	SENT_88	[p6l1861t1423r1956b1479],
26	manufacturer	NN	O	manufacturer	poss	28	SENT_88	[p6l1985t1441r2145b1479, p6l9t1509r353b1565],
27	’s	POS	O	’s	_	0	SENT_88	[p6l1985t1441r2145b1479, p6l9t1509r353b1565],
28	instructions	NNS	O	instruction	pobj	4	SENT_88	[p6l377t1509r765b1565],
29	.	.	O	.	_	0	SENT_88	[p6l377t1509r765b1565],

1	Total	JJ	O	total	amod	3	SENT_89	[p6l791t1509r958b1565],
2	RNA	NN	O	rna	nn	3	SENT_89	[p6l980t1509r1148b1565],
3	(	NN	O	(	nsubj	8	SENT_89	[p6l1173t1509r1228b1578],
4	1	CD	NUMBER	1	num	6	SENT_89	[p6l1173t1509r1228b1578],
5	ug	NN	O	ug	nn	6	SENT_89	[p6l1262t1510r1372b1582],
6	)	NN	O	)	dep	3	SENT_89	[p6l1262t1510r1372b1582],
7	was	VBD	O	be	cop	8	SENT_89	[p6l1398t1527r1518b1565],
8	reverse	JJ	O	reverse	dep	16	SENT_89	[p6l1541t1527r1771b1565],
9	transcribed	VBN	O	transcribe	partmod	8	SENT_89	[p6l1793t1509r2148b1565],
10	in	IN	O	in	_	0	SENT_89	[p6l9t1595r70b1650],
11	the	DT	O	the	det	12	SENT_89	[p6l94t1595r190b1651],
12	presence	NN	O	presence	prep_in	9	SENT_89	[p6l213t1612r493b1667],
13	of	IN	O	of	_	0	SENT_89	[p6l519t1595r588b1651],
14	random	JJ	O	random	amod	15	SENT_89	[p6l606t1595r851b1651],
15	hexamers	NNS	O	hexamer	prep_of	12	SENT_89	[p6l874t1595r1178b1651],
16	(	VBP	O	(	_	0	SENT_89	[p6l1207t1595r1371b1664],
17	ﬁnal	JJ	O	ﬁnal	amod	18	SENT_89	[p6l1207t1595r1371b1664],
18	concentration	NN	O	concentration	dobj	16	SENT_89	[p6l1397t1595r1831b1651],
19	2.5	CD	NUMBER	2.5	num	22	SENT_89	[p6l1856t1594r1950b1651],
20	p.	NN	O	p.	nn	22	SENT_89	[p6l1983t1595r2144b1667],
21	M	NN	O	m	nn	22	SENT_89	[p6l1983t1595r2144b1667],
22	)	NN	O	)	nsubj	16	SENT_89	[p6l1983t1595r2144b1667],
23	,	,	O	,	_	0	SENT_89	[p6l1983t1595r2144b1667],
24	using	VBG	O	use	partmod	16	SENT_89	[p6l9t1680r180b1753],
25	MuLV	NN	O	mulv	nsubj	28	SENT_89	[p6l208t1682r424b1737],
26	reverse	JJ	O	reverse	amod	28	SENT_89	[p6l452t1698r681b1737],
27	transcriptase	NN	O	transcriptase	nn	28	SENT_89	[p6l709t1680r1112b1753],
28	(	NN	O	(	xcomp	24	SENT_89	[p6l1143t1680r1261b1750],
29	2.5	CD	NUMBER	2.5	num	30	SENT_89	[p6l1143t1680r1261b1750],
30	U/p	NN	O	u/p	dep	28	SENT_89	[p6l1292t1681r1471b1753],
31	.	.	O	.	_	0	SENT_89	[p6l1292t1681r1471b1753],

1	l	NN	O	l	nn	2	SENT_90	[p6l1292t1681r1471b1753],
2	)	NN	O	)	_	0	SENT_90	[p6l1292t1681r1471b1753],
3	in	IN	O	in	_	0	SENT_90	[p6l1500t1680r1561b1736],
4	a	DT	O	a	det	6	SENT_90	[p6l1590t1698r1623b1737],
5	total	JJ	O	total	amod	6	SENT_90	[p6l1649t1680r1789b1737],
6	volume	NN	O	volume	prep_in	2	SENT_90	[p6l1817t1681r2055b1737],
7	of	IN	O	of	_	0	SENT_90	[p6l2084t1680r2153b1737],
8	20	CD	NUMBER	20	num	9	SENT_90	[p6l11t1767r87b1823],
9	ul	NN	O	ul	prep_of	2	SENT_90	[p6l113t1766r181b1839],
10	per	IN	O	per	_	0	SENT_90	[p6l201t1784r304b1839],
11	sample	NN	O	sample	prep_per	9	SENT_90	[p6l325t1767r563b1839],
12	.	.	O	.	_	0	SENT_90	[p6l325t1767r563b1839],

1	To	TO	O	to	aux	2	SENT_91	[p6l588t1768r674b1823],
2	ensure	VB	O	ensure	purpcl	42	SENT_91	[p6l696t1784r902b1823],
3	that	IN	O	that	complm	6	SENT_91	[p6l923t1767r1042b1823],
4	ampliﬁcation	NN	O	ampliﬁcation	nsubj	6	SENT_91	[p6l1063t1766r1483b1839],
5	was	VBD	O	be	aux	6	SENT_91	[p6l1503t1784r1624b1823],
6	occurring	VBG	O	occur	ccomp	2	SENT_91	[p6l1647t1766r1950b1839],
7	in	IN	O	in	_	0	SENT_91	[p6l1971t1766r2031b1822],
8	the	DT	O	the	det	10	SENT_91	[p6l2051t1767r2147b1823],
9	linear	JJ	O	linear	amod	10	SENT_91	[p6l10t1852r191b1908],
10	phase	NN	O	phase	prep_in	6	SENT_91	[p6l214t1852r413b1925],
11	,	,	O	,	_	0	SENT_91	[p6l214t1852r413b1925],
12	samples	NNS	O	sample	nsubjpass	42	SENT_91	[p6l443t1852r695b1925],
13	of	IN	O	of	_	0	SENT_91	[p6l723t1852r792b1908],
14	3	CD	NUMBER	3	num	15	SENT_91	[p6l813t1853r845b1909],
15	gal	NN	O	gal	prep_of	12	SENT_91	[p6l879t1852r947b1924],
16	and	CC	O	and	_	0	SENT_91	[p6l974t1852r1087b1908],
17	5	CD	NUMBER	5	num	18	SENT_91	[p6l1112t1852r1145b1909],
18	pd	NN	O	pd	prep_of	12	SENT_91	[p6l1179t1852r1265b1924],
19	,	,	O	,	_	0	SENT_91	[p6l1179t1852r1265b1924],
20	which	WDT	O	which	nsubj	21	SENT_91	[p6l1293t1852r1487b1909],
21	represented	VBD	O	represent	rcmod	18	SENT_91	[p6l1511t1852r1879b1925],
22	6	CD	PERCENT	6	number	26	SENT_91	[p6l1905t1852r2005b1909],
23	%	NN	PERCENT	%	dep	26	SENT_91	[p6l1905t1852r2005b1909],
24	and	CC	O	and	_	0	SENT_91	[p6l2035t1852r2148b1908],
25	10	CD	PERCENT	10	dobj	21	SENT_91	[p6l17t1938r151b1995],
26	%	NN	PERCENT	%	dobj	21	SENT_91	[p6l17t1938r151b1995],
27	of	IN	O	of	_	0	SENT_91	[p6l181t1938r250b1994],
28	reverse	JJ	O	reverse	prep_of	26	SENT_91	[p6l268t1956r498b1994],
29	transcribed	VBN	O	transcribe	partmod	28	SENT_91	[p6l524t1938r879b1994],
30	cDNA	NN	O	cdna	nn	31	SENT_91	[p6l904t1939r1111b1994],
31	mix	NN	O	mix	dobj	29	SENT_91	[p6l1136t1938r1275b2005],
32	,	,	O	,	_	0	SENT_91	[p6l1136t1938r1275b2005],
33	respectively	RB	O	respectively	advmod	29	SENT_91	[p6l1302t1938r1706b2011],
34	,	,	O	,	_	0	SENT_91	[p6l1302t1938r1706b2011],
35	from	IN	O	from	_	0	SENT_91	[p6l1734t1938r1889b1994],
36	each	DT	O	each	prep_from	29	SENT_91	[p6l1913t1938r2058b1994],
37	of	IN	O	of	_	0	SENT_91	[p6l2084t1938r2153b1994],
38	the	DT	O	the	det	40	SENT_91	[p6l9t2024r105b2080],
39	cell	NN	O	cell	nn	40	SENT_91	[p6l139t2024r252b2080],
40	lines	NNS	O	line	prep_of	36	SENT_91	[p6l285t2024r432b2080],
41	were	VBD	O	be	auxpass	42	SENT_91	[p6l467t2042r620b2080],
42	analysed	VBN	O	analyse	_	0	SENT_91	[p6l655t2024r948b2097],
43	.	.	O	.	_	0	SENT_91	[p6l655t2024r948b2097],

1	Samples	NNS	O	sample	nsubjpass	3	SENT_92	[p6l987t2024r1252b2097],
2	were	VBD	O	be	auxpass	3	SENT_92	[p6l1288t2042r1441b2081],
3	added	VBN	O	add	_	0	SENT_92	[p6l1476t2024r1664b2080],
4	to	TO	O	to	_	0	SENT_92	[p6l1696t2033r1755b2080],
5	Gene	NNP	PERSON	Gene	nn	8	SENT_92	[p6l1790t2024r1956b2081],
6	Amp	NNP	PERSON	Amp	nn	8	SENT_92	[p6l1989t2025r2146b2097],
7	PCR	NN	O	pcr	nn	8	SENT_92	[p6l9t2111r160b2167],
8	buffer	NN	O	buffer	prep_to	3	SENT_92	[p6l189t2111r385b2167],
9	II	CD	NUMBER	ii	num	12	SENT_92	[p6l414t2112r465b2166],
10	(	CD	NUMBER	(	num	12	SENT_92	[p6l498t2111r730b2180],
11	Perkin	NNP	PERSON	Perkin	nn	12	SENT_92	[p6l498t2111r730b2180],
12	Elmer	NNP	PERSON	Elmer	dobj	3	SENT_92	[p6l760t2111r971b2177],
13	,	,	O	,	_	0	SENT_92	[p6l760t2111r971b2177],
14	Santa	NNP	LOCATION	Santa	nn	15	SENT_92	[p6l1007t2111r1182b2167],
15	Clara	NNP	LOCATION	Clara	dobj	3	SENT_92	[p6l1212t2111r1400b2177],
16	,	,	O	,	_	0	SENT_92	[p6l1212t2111r1400b2177],
17	CA	NNP	LOCATION	CA	nn	18	SENT_92	[p6l1435t2111r1587b2180],
18	)	NNP	O	)	dobj	3	SENT_92	[p6l1435t2111r1587b2180],
19	,	,	O	,	_	0	SENT_92	[p6l1435t2111r1587b2180],
20	2.5	CD	NUMBER	2.5	num	22	SENT_92	[p6l1621t2111r1715b2167],
21	mM	NN	O	mm	nn	22	SENT_92	[p6l1749t2112r1880b2166],
22	MgCl2	NN	O	mgcl2	dobj	3	SENT_92	[p6l1911t2111r2144b2184],
23	,	,	O	,	_	0	SENT_92	[p6l1911t2111r2144b2184],
24	0.25	CD	NUMBER	0.25	num	26	SENT_92	[p6l10t2196r144b2253],
25	mM	NN	O	mm	nn	26	SENT_92	[p6l192t2198r323b2252],
26	DTNP	NN	O	dtnp	dobj	3	SENT_92	[p6l367t2198r592b2263],
27	,	,	O	,	_	0	SENT_92	[p6l367t2198r592b2263],
28	1.25	CD	NUMBER	1.25	num	31	SENT_92	[p6l647t2196r773b2253],
29	units	NNS	O	unit	nn	31	SENT_92	[p6l821t2197r973b2253],
30	Taq	NN	O	taq	nn	31	SENT_92	[p6l1019t2198r1142b2270],
31	polymerase	NN	O	polymerase	dobj	3	SENT_92	[p6l1185t2197r1553b2270],
32	(	CD	NUMBER	(	num	39	SENT_92	[p6l1600t2197r1925b2270],
33	Amplitaq	NNP	ORGANIZATION	Amplitaq	nn	39	SENT_92	[p6l1600t2197r1925b2270],
34	Gold	NNP	ORGANIZATION	Gold	nn	39	SENT_92	[p6l1970t2197r2144b2263],
35	,	,	O	,	_	0	SENT_92	[p6l1970t2197r2144b2263],
36	Perkin	NNP	PERSON	Perkin	appos	39	SENT_92	[p6l9t2282r217b2339],
37	Elmer	NNP	PERSON	Elmer	nn	39	SENT_92	[p6l246t2283r464b2352],
38	)	NN	O	)	nn	39	SENT_92	[p6l246t2283r464b2352],
39	primers	NNS	O	primer	dep	31	SENT_92	[p6l495t2282r737b2355],
40	and	CC	O	and	_	0	SENT_92	[p6l770t2283r882b2339],
41	DEPC	NN	O	depc	nn	42	SENT_92	[p6l911t2282r1360b2339],
42	—	NN	O	—	dobj	3	SENT_92	[p6l911t2282r1360b2339],
43	treated	VBN	O	treat	partmod	12	SENT_92	[p6l911t2282r1360b2339],
44	H20	NN	O	h20	dobj	43	SENT_92	[p6l1388t2283r1550b2356],
45	,	,	O	,	_	0	SENT_92	[p6l1388t2283r1550b2356],
46	to	TO	O	to	aux	47	SENT_92	[p6l1582t2291r1642b2339],
47	provide	VB	O	provide	xcomp	43	SENT_92	[p6l1671t2282r1915b2355],
48	a	DT	O	a	det	51	SENT_92	[p6l1946t2300r1979b2339],
49	ﬁnal	JJ	O	ﬁnal	amod	51	SENT_92	[p6l2008t2282r2147b2339],
50	total	JJ	O	total	amod	51	SENT_92	[p6l9t2368r150b2425],
51	volume	NN	O	volume	dobj	47	SENT_92	[p6l178t2369r417b2425],
52	of	IN	O	of	_	0	SENT_92	[p6l446t2368r515b2425],
53	50	CD	NUMBER	50	num	54	SENT_92	[p6l539t2368r615b2425],
54	ul	NN	O	ul	prep_of	51	SENT_92	[p6l649t2368r733b2441],
55	.	.	O	.	_	0	SENT_92	[p6l649t2368r733b2441],

1	For	IN	O	for	_	0	SENT_93	[p6l765t2370r877b2425],
2	the	DT	O	the	det	4	SENT_93	[p6l903t2369r999b2425],
3	GAPDH	NN	O	gapdh	nn	4	SENT_93	[p6l1030t2370r1302b2425],
4	control	NN	O	control	prep_for	11	SENT_93	[p6l1326t2369r1567b2435],
5	,	,	O	,	_	0	SENT_93	[p6l1326t2369r1567b2435],
6	the	DT	O	the	det	7	SENT_93	[p6l1599t2368r1694b2425],
7	primers	NNS	O	primer	nsubj	11	SENT_93	[p6l1722t2368r1964b2441],
8	were	VBD	O	be	cop	11	SENT_93	[p6l1994t2386r2147b2425],
9	5	CD	NUMBER	5	number	10	SENT_93	[p6l11t2452r68b2511],
10	’	CD	NUMBER	’	num	11	SENT_93	[p6l11t2452r68b2511],
11	AGTCAACGGATTTGGTCGTA	NN	O	agtcaacggatttggtcgta	_	0	SENT_93	[p6l127t2455r1217b2511],
12	3	CD	NUMBER	3	dep	11	SENT_93	[p6l1272t2452r1328b2511],
13	'	''	O	'	_	0	SENT_93	[p6l1272t2452r1328b2511],
14	and	CC	O	and	_	0	SENT_93	[p6l1389t2454r1502b2511],
15	5	CD	NUMBER	5	number	16	SENT_93	[p6l1556t2452r1613b2511],
16	’	CD	NUMBER	’	num	18	SENT_93	[p6l1556t2452r1613b2511],
17	AAATGAGC	NN	O	aaatgagc	nn	18	SENT_93	[p6l1672t2455r2145b2511],
18	—	NN	O	—	dep	11	SENT_93	[p6l1672t2455r2145b2511],

1	CCCAGCCTTCT	NN	ORGANIZATION	cccagccttct	nn	3	SENT_94	[p6l10t2540r591b2597],
2	3	CD	NUMBER	3	num	3	SENT_94	[p6l632t2538r688b2597],
3	’	NN	O	’	_	0	SENT_94	[p6l632t2538r688b2597],
4	at	IN	O	at	_	0	SENT_94	[p6l734t2549r790b2596],
5	a	DT	O	a	det	7	SENT_94	[p6l828t2558r862b2596],
6	ﬁnal	JJ	O	ﬁnal	amod	7	SENT_94	[p6l900t2540r1039b2596],
7	concentration	NN	O	concentration	prep_at	3	SENT_94	[p6l1078t2540r1512b2596],
8	of	IN	O	of	_	0	SENT_94	[p6l1552t2540r1620b2596],
9	0.0216	CD	NUMBER	0.0216	num	10	SENT_94	[p6l1654t2540r1871b2597],
10	p.M.	NN	O	p.m.	prep_of	3	SENT_94	[p6l1915t2542r2049b2612],
11	.	.	O	.	_	0	SENT_94	[p6l1915t2542r2049b2612],

1	A	DT	O	a	det	2	SENT_95	[p6l2091t2541r2147b2596],
2	product	NN	O	product	nsubjpass	7	SENT_95	[p6l9t2626r253b2699],
3	of	IN	O	of	_	0	SENT_95	[p6l283t2626r352b2682],
4	310	CD	NUMBER	310	num	5	SENT_95	[p6l377t2627r493b2683],
5	bp	NN	O	bp	prep_of	2	SENT_95	[p6l521t2626r599b2699],
6	was	VBD	O	be	auxpass	7	SENT_95	[p6l630t2644r750b2683],
7	obtained	VBN	O	obtain	_	0	SENT_95	[p6l782t2626r1071b2682],
8	.	.	O	.	_	0	SENT_95	[p6l782t2626r1071b2682],

1	For	IN	O	for	_	0	SENT_96	[p6l1104t2628r1215b2682],
2	MDRI	NN	O	mdrus	prep_for	9	SENT_96	[p6l1239t2627r1471b2693],
3	,	,	O	,	_	0	SENT_96	[p6l1239t2627r1471b2693],
4	the	DT	O	the	det	5	SENT_96	[p6l1503t2626r1599b2682],
5	primers	NNS	O	primer	nsubj	9	SENT_96	[p6l1627t2626r1869b2699],
6	were	VBD	O	be	cop	9	SENT_96	[p6l1900t2644r2053b2682],
7	5	CD	NUMBER	5	number	8	SENT_96	[p6l2084t2624r2141b2683],
8	’	CD	NUMBER	’	num	9	SENT_96	[p6l2084t2624r2141b2683],
9	GAGGAAAGCACACATCTTTGG	NN	O	gaggaaagcacacatctttgg	_	0	SENT_96	[p6l11t2713r1171b2769],
10	3	CD	NUMBER	3	num	11	SENT_96	[p6l1202t2711r1258b2769],
11	’	NN	O	’	dep	9	SENT_96	[p6l1202t2711r1258b2769],
12	and	CC	O	and	_	0	SENT_96	[p6l1295t2713r1408b2769],
13	5	CD	NUMBER	5	number	14	SENT_96	[p6l1437t2711r1494b2769],
14	’	CD	NUMBER	’	num	15	SENT_96	[p6l1437t2711r1494b2769],
15	TGTGGGCTGCTGAT	NN	O	tgtgggctgctgat	conj_and	9	SENT_96	[p6l1530t2713r2145b2769, p6l11t2799r172b2855],

1	ATT	NN	O	att	nn	3	SENT_97	[p6l174t2799r328b2854],
2	T	NN	O	t	nn	3	SENT_97	[p6l330t2800r377b2854],
3	TGG	NN	O	tgg	_	0	SENT_97	[p6l379t2799r543b2855],
4	3	CD	NUMBER	3	num	5	SENT_97	[p6l571t2796r627b2855],
5	’	NN	O	’	dep	3	SENT_97	[p6l571t2796r627b2855],
6	at	IN	O	at	_	0	SENT_97	[p6l661t2808r716b2855],
7	a	DT	O	a	det	9	SENT_97	[p6l743t2816r776b2855],
8	ﬁnal	JJ	O	ﬁnal	amod	9	SENT_97	[p6l802t2799r942b2855],
9	concentration	NN	O	concentration	prep_at	5	SENT_97	[p6l969t2799r1403b2855],
10	of	IN	O	of	_	0	SENT_97	[p6l1430t2799r1499b2855],
11	0.125	CD	NUMBER	0.125	num	12	SENT_97	[p6l1521t2798r1694b2855],
12	p.M.	NN	O	p.m.	prep_of	9	SENT_97	[p6l1730t2800r1863b2871],
13	.	.	O	.	_	0	SENT_97	[p6l1730t2800r1863b2871],

1	A	DT	O	a	det	2	SENT_98	[p6l1893t2799r1949b2854],
2	product	NN	O	product	nsubjpass	7	SENT_98	[p6l1974t2799r2145b2872, p6l9t2893r107b2941],
3	of	IN	O	of	_	0	SENT_98	[p6l150t2885r219b2941],
4	220	CD	NUMBER	220	num	5	SENT_98	[p6l257t2885r374b2941],
5	bp	NN	O	bp	prep_of	2	SENT_98	[p6l417t2885r495b2958],
6	was	VBD	O	be	auxpass	7	SENT_98	[p6l540t2902r660b2941],
7	obtained	VBN	O	obtain	_	0	SENT_98	[p6l706t2885r995b2941],
8	.	.	O	.	_	0	SENT_98	[p6l706t2885r995b2941],

1	For	IN	O	for	_	0	SENT_99	[p6l1042t2886r1153b2941],
2	MRP1	NN	O	mrp1	prep_for	8	SENT_99	[p6l1192t2885r1410b2950],
3	,	,	O	,	_	0	SENT_99	[p6l1192t2885r1410b2950],
4	the	DT	O	the	det	5	SENT_99	[p6l1461t2885r1556b2941],
5	primers	NNS	O	primer	nsubj	8	SENT_99	[p6l1599t2885r1841b2958],
6	were	VBD	O	be	cop	8	SENT_99	[p6l1886t2902r2039b2941],
7	5	CD	NUMBER	5	number	8	SENT_99	[p6l2084t2882r2141b2941],
8	’	CD	NUMBER	’	_	0	SENT_99	[p6l2084t2882r2141b2941],
9	CTGTTTTGTTTTCGGGTT	NNP	O	CTGTTTTGTTTTCGGGTT	nn	10	SENT_99	[p6l10t2971r943b3027],
10	CC	NN	O	cc	dep	8	SENT_99	[p6l946t2971r1049b3027],
11	3	CD	NUMBER	3	num	12	SENT_99	[p6l1094t2968r1150b3027],
12	’	NN	O	’	dep	8	SENT_99	[p6l1094t2968r1150b3027],
13	and	CC	O	and	_	0	SENT_99	[p6l1199t2971r1312b3027],
14	5	CD	NUMBER	5	conj_and	8	SENT_99	[p6l1354t2968r1411b3027],
15	'	''	O	'	_	0	SENT_99	[p6l1354t2968r1411b3027],
16	GATGGTGGACTG	NNP	O	GATGGTGGACTG	dep	14	SENT_99	[p6l1460t2971r2145b3027],
17	—	CD	NUMBER	—	num	16	SENT_99	[p6l1460t2971r2145b3027],

1	GATGAGGT	NN	ORGANIZATION	gatgaggt	nn	3	SENT_100	[p6l11t3057r453b3113],
2	3	CD	NUMBER	3	num	3	SENT_100	[p6l483t3054r539b3113],
3	’	NN	O	’	_	0	SENT_100	[p6l483t3054r539b3113],
4	at	IN	O	at	_	0	SENT_100	[p6l575t3065r631b3113],
5	a	DT	O	a	det	7	SENT_100	[p6l659t3074r693b3113],
6	ﬁnal	JJ	O	ﬁnal	amod	7	SENT_100	[p6l720t3056r859b3113],
7	concentration	NN	O	concentration	prep_at	3	SENT_100	[p6l888t3056r1323b3113],
8	of	IN	O	of	_	0	SENT_100	[p6l1352t3056r1420b3113],
9	0.125	CD	NUMBER	0.125	num	10	SENT_100	[p6l1444t3056r1617b3113],
10	p.M.	NN	O	p.m.	prep_of	3	SENT_100	[p6l1655t3058r1788b3129],
11	.	.	O	.	_	0	SENT_100	[p6l1655t3058r1788b3129],

1	A	DT	O	a	det	2	SENT_101	[p6l1820t3057r1876b3112],
2	product	NN	O	product	nsubjpass	7	SENT_101	[p6l1903t3056r2148b3129],
3	of	IN	O	of	_	0	SENT_101	[p6l10t3142r80b3198],
4	287	CD	NUMBER	287	num	5	SENT_101	[p6l104t3143r219b3199],
5	bp	NN	O	bp	prep_of	2	SENT_101	[p6l249t3142r327b3215],
6	was	VBD	O	be	auxpass	7	SENT_101	[p6l358t3160r478b3199],
7	obtained	VBN	O	obtain	_	0	SENT_101	[p6l510t3142r799b3199],
8	.	.	O	.	_	0	SENT_101	[p6l510t3142r799b3199],

1	Primer	NN	O	primer	nn	2	SENT_102	[p6l89t3243r308b3299],
2	speciﬁcities	NNS	O	speciﬁcities	nsubjpass	8	SENT_102	[p6l332t3243r704b3316],
3	for	IN	O	for	_	0	SENT_102	[p6l729t3243r821b3299],
4	MDR1	NN	O	mdr1	prep_for	2	SENT_102	[p6l842t3243r1056b3298],
5	and	CC	O	and	_	0	SENT_102	[p6l1088t3243r1201b3299],
6	MRP1	NN	O	mrp1	conj_and	4	SENT_102	[p6l1222t3243r1423b3298],
7	were	VBD	O	be	auxpass	8	SENT_102	[p6l1453t3261r1607b3299],
8	assessed	VBN	O	assess	_	0	SENT_102	[p6l1632t3243r1900b3299],
9	against	IN	O	against	_	0	SENT_102	[p6l1924t3243r2149b3316],
10	known	VBN	O	know	amod	12	SENT_102	[p6l9t3329r226b3385],
11	gene	NN	O	gene	nn	12	SENT_102	[p6l263t3346r411b3402],
12	sequences	NNS	O	sequence	prep_against	8	SENT_102	[p6l451t3346r787b3402],
13	.	.	O	.	_	0	SENT_102	[p6l451t3346r787b3402],

1	MDR1	NN	O	mdr1	nn	2	SENT_103	[p6l827t3329r1041b3384],
2	primers	NNS	O	primer	nsubj	4	SENT_103	[p6l1083t3329r1325b3401],
3	were	VBD	O	be	cop	4	SENT_103	[p6l1364t3346r1517b3385],
4	complementary	JJ	O	complementary	_	0	SENT_103	[p6l1555t3329r2050b3402],
5	to	TO	O	to	_	0	SENT_103	[p6l2087t3337r2146b3385],
6	MDR1	NN	O	mdr1	prep_to	4	SENT_103	[p6l9t3415r223b3470],
7	but	CC	O	but	_	0	SENT_103	[p6l260t3415r363b3471],
8	not	RB	O	not	_	0	SENT_103	[p6l393t3423r494b3471],
9	MRP1	NN	O	mrp1	nn	11	SENT_103	[p6l524t3415r725b3470],
10	gene	NN	O	gene	nn	11	SENT_103	[p6l764t3432r912b3487],
11	sequences	NNS	O	sequence	conj_negcc	6	SENT_103	[p6l946t3432r1282b3487],
12	.	.	O	.	_	0	SENT_103	[p6l946t3432r1282b3487],

1	Similarly	RB	O	similarly	advmod	6	SENT_104	[p6l1320t3414r1632b3487],
2	,	,	O	,	_	0	SENT_104	[p6l1320t3414r1632b3487],
3	MRP1	NN	O	mrp1	nn	4	SENT_104	[p6l1665t3415r1866b3470],
4	primers	NNS	O	primer	nsubj	6	SENT_104	[p6l1903t3414r2146b3487],
5	were	VBD	O	be	cop	6	SENT_104	[p6l10t3518r163b3557],
6	complementary	JJ	O	complementary	_	0	SENT_104	[p6l184t3501r680b3573],
7	to	TO	O	to	_	0	SENT_104	[p6l701t3509r760b3557],
8	MRP1	NN	O	mrp1	prep_to	6	SENT_104	[p6l781t3501r982b3556],
9	but	CC	O	but	_	0	SENT_104	[p6l1009t3500r1111b3557],
10	not	RB	O	not	_	0	SENT_104	[p6l1131t3509r1232b3557],
11	MDR1	NN	O	mdr1	prep_to	6	SENT_104	[p6l1251t3501r1465b3556],
12	and	CC	O	and	_	0	SENT_104	[p6l1494t3501r1607b3557],
13	other	JJ	O	other	amod	16	SENT_104	[p6l1628t3501r1791b3557],
14	MRP	NN	O	mrp	nn	16	SENT_104	[p6l1810t3502r1978b3556],
15	gene	NN	O	gene	nn	16	SENT_104	[p6l1999t3518r2147b3573],
16	sequences	NNS	O	sequence	conj_negcc	8	SENT_104	[p6l12t3586r348b3641],
17	.	.	O	.	_	0	SENT_104	[p6l12t3586r348b3641],

1	For	IN	O	for	_	0	SENT_105	[p7l89t22r201b77],
2	MDR1	NN	O	mdr1	nn	3	SENT_105	[p7l242t21r456b76],
3	analysis	NN	O	analysis	prep_for	9	SENT_105	[p7l508t21r779b94],
4	,	,	O	,	_	0	SENT_105	[p7l508t21r779b94],
5	the	DT	O	the	det	7	SENT_105	[p7l825t21r921b77],
6	master	NN	O	master	nn	7	SENT_105	[p7l964t29r1178b77],
7	mix	NN	O	mix	nsubjpass	9	SENT_105	[p7l1219t21r1341b76],
8	was	VBD	O	be	auxpass	9	SENT_105	[p7l1385t39r1506b77],
9	optimised	VBN	O	optimise	_	0	SENT_105	[p7l1552t21r1865b94],
10	to	TO	O	to	aux	11	SENT_105	[p7l1908t30r1967b77],
11	give	VB	O	give	xcomp	9	SENT_105	[p7l2012t21r2147b94],
12	co-ampliﬁcation	NN	O	co-ampliﬁcation	dobj	11	SENT_105	[p7l10t107r534b180],
13	of	IN	O	of	_	0	SENT_105	[p7l564t107r633b163],
14	GAPDH	NN	O	gapdh	prep_of	12	SENT_105	[p7l658t107r930b163],
15	and	CC	O	and	_	0	SENT_105	[p7l962t107r1075b163],
16	MDR1	NN	O	mdr1	prep_of	12	SENT_105	[p7l1103t107r1340b163],
17	.	.	O	.	_	0	SENT_105	[p7l1103t107r1340b163],

1	The	DT	O	the	det	3	SENT_106	[p7l1373t107r1496b163],
2	annealing	NN	O	annealing	nn	3	SENT_106	[p7l1527t107r1834b180],
3	temperature	NN	O	temperature	nsubj	7	SENT_106	[p7l1864t115r2145b180, p7l9t201r132b249],
4	was	VBD	O	be	cop	7	SENT_106	[p7l159t210r279b249],
5	55	CD	NUMBER	55	num	7	SENT_106	[p7l309t192r470b249],
6	°	NN	O	°	nn	7	SENT_106	[p7l309t192r470b249],
7	C	NN	O	c	_	0	SENT_106	[p7l309t192r470b249],
8	for	IN	O	for	_	0	SENT_106	[p7l498t192r591b249],
9	40	CD	NUMBER	40	num	10	SENT_106	[p7l615t193r693b249],
10	cycles	NNS	O	cycle	prep_for	7	SENT_106	[p7l721t193r917b265],
11	after	IN	O	after	_	0	SENT_106	[p7l947t192r1092b249],
12	activating	VBG	O	activate	prepc_after	7	SENT_106	[p7l1118t192r1430b265],
13	the	DT	O	the	det	15	SENT_106	[p7l1457t192r1553b249],
14	Amplitaq	NNP	ORGANIZATION	Amplitaq	nn	15	SENT_106	[p7l1579t192r1881b265],
15	Gold	NNP	ORGANIZATION	Gold	dobj	12	SENT_106	[p7l1908t192r2066b249],
16	at	IN	O	at	_	0	SENT_106	[p7l2093t201r2149b249],
17	95	CD	NUMBER	95	number	18	SENT_106	[p7l11t278r172b335],
18	°	CD	NUMBER	°	num	19	SENT_106	[p7l11t278r172b335],
19	C	NN	O	c	prep_at	15	SENT_106	[p7l11t278r172b335],
20	for	IN	O	for	_	0	SENT_106	[p7l211t278r304b335],
21	12	CD	DURATION	12	num	22	SENT_106	[p7l348t279r418b334],
22	min	NN	DURATION	min	prep_for	12	SENT_106	[p7l456t278r596b345],
23	,	,	O	,	_	0	SENT_106	[p7l456t278r596b345],
24	as	IN	O	as	mark	25	SENT_106	[p7l638t296r699b335],
25	recommended	VBN	O	recommend	dep	22	SENT_106	[p7l738t278r1192b335],
26	by	IN	O	by	_	0	SENT_106	[p7l1228t279r1307b351],
27	the	DT	O	the	det	28	SENT_106	[p7l1345t279r1441b335],
28	supplier	NN	O	supplier	prep_by	25	SENT_106	[p7l1481t278r1751b351],
29	.	.	O	.	_	0	SENT_106	[p7l1481t278r1751b351],

1	For	IN	O	for	_	0	SENT_107	[p7l1792t280r1904b335],
2	MRP1	NN	O	mrp1	nn	3	SENT_107	[p7l1940t279r2140b334],
3	analysis	NN	O	analysis	prep_for	9	SENT_107	[p7l11t364r283b437],
4	,	,	O	,	_	0	SENT_107	[p7l11t364r283b437],
5	the	DT	O	the	det	7	SENT_107	[p7l321t364r416b420],
6	master	NN	O	master	nn	7	SENT_107	[p7l451t373r664b420],
7	mix	NN	O	mix	nsubjpass	9	SENT_107	[p7l698t364r820b420],
8	was	VBD	O	be	auxpass	9	SENT_107	[p7l855t382r975b421],
9	optimised	VBN	O	optimise	_	0	SENT_107	[p7l1013t364r1327b437],
10	to	TO	O	to	aux	11	SENT_107	[p7l1361t373r1420b420],
11	give	VB	O	give	xcomp	9	SENT_107	[p7l1457t364r1592b437],
12	ampliﬁcation	NN	O	ampliﬁcation	dobj	11	SENT_107	[p7l1628t364r2048b437],
13	of	IN	O	of	_	0	SENT_107	[p7l2084t364r2153b420],
14	GAPDH	NN	O	gapdh	prep_of	12	SENT_107	[p7l11t451r284b507],
15	and	CC	O	and	_	0	SENT_107	[p7l313t450r425b506],
16	MRP1	NN	O	mrp1	prep_of	12	SENT_107	[p7l452t451r653b506],
17	in	IN	O	in	_	0	SENT_107	[p7l687t450r748b506],
18	separate	JJ	O	separate	amod	19	SENT_107	[p7l778t459r1036b523],
19	tubes	NNS	O	tube	prep_in	11	SENT_107	[p7l1064t450r1247b507],
20	.	.	O	.	_	0	SENT_107	[p7l1064t450r1247b507],

1	The	DT	O	the	det	3	SENT_108	[p7l1279t450r1401b506],
2	annealing	NN	O	annealing	nn	3	SENT_108	[p7l1431t450r1738b523],
3	temperature	NN	O	temperature	nsubj	7	SENT_108	[p7l1766t459r2147b523],
4	was	VBD	O	be	cop	7	SENT_108	[p7l10t554r130b592],
5	50	CD	NUMBER	50	number	6	SENT_108	[p7l156t536r317b593],
6	°	CD	NUMBER	°	dep	7	SENT_108	[p7l156t536r317b593],
7	C	NN	O	c	_	0	SENT_108	[p7l156t536r317b593],
8	for	IN	O	for	_	0	SENT_108	[p7l342t536r434b592],
9	30	CD	NUMBER	30	num	10	SENT_108	[p7l457t537r533b593],
10	cycles	NNS	O	cycle	prep_for	7	SENT_108	[p7l557t536r753b609],
11	after	IN	O	after	_	0	SENT_108	[p7l779t536r924b592],
12	activating	VBG	O	activate	prepc_after	7	SENT_108	[p7l946t536r1258b609],
13	the	DT	O	the	det	15	SENT_108	[p7l1282t536r1377b592],
14	Amplitaq	NNP	ORGANIZATION	Amplitaq	nn	15	SENT_108	[p7l1400t536r1702b609],
15	Gold	NNP	ORGANIZATION	Gold	dobj	12	SENT_108	[p7l1725t536r1883b593],
16	at	IN	O	at	_	0	SENT_108	[p7l1907t544r1962b592],
17	95	CD	NUMBER	95	number	18	SENT_108	[p7l1985t536r2146b593],
18	°	CD	NUMBER	°	num	19	SENT_108	[p7l1985t536r2146b593],
19	C	NN	O	c	prep_at	12	SENT_108	[p7l1985t536r2146b593],
20	for	IN	O	for	_	0	SENT_108	[p7l10t623r102b679],
21	12	CD	DURATION	12	num	22	SENT_108	[p7l137t623r207b678],
22	min	NN	DURATION	min	prep_for	19	SENT_108	[p7l237t623r375b679],
23	.	.	O	.	_	0	SENT_108	[p7l237t623r375b679],

1	GLUTATHIONE	NN	O	glutathione	nn	2	SENT_109	[p7l243t760r449b781],
2	S-TRANSFERASES	NN	O	s-transferase	_	0	SENT_109	[p7l459t760r702b781],
3	AND	CC	O	and	_	0	SENT_109	[p7l714t760r776b780],
4	DRUG	NN	O	drug	nn	5	SENT_109	[p7l787t760r869b781],
5	TRANSPORTERS	NN	O	transporter	conj_and	2	SENT_109	[p7l879t760r1101b781],
6	IN	IN	O	in	_	0	SENT_109	[p7l1112t760r1143b781],
7	DOXORUBICIN	NNP	O	DOXORUBICIN	prep_in	5	SENT_109	[p7l1153t760r1356b781],
8	RESISTANCE	NN	O	resistance	dep	2	SENT_109	[p7l1367t760r1543b781],
9	779	CD	NUMBER	779	num	8	SENT_109	[p7l1862t754r1916b781],

1	.	.	O	.	_	0	SENT_110	[p7l350t1485r729b1523],

1	—	NN	O	—	_	0	SENT_111	[p7l350t1485r729b1523],
2	.	.	O	.	_	0	SENT_111	[p7l350t1485r729b1523],

1	O	NN	O	o	_	0	SENT_112	[p7l350t1485r729b1523],
2	.	.	O	.	_	0	SENT_112	[p7l350t1485r729b1523],

1	—	NN	O	—	_	0	SENT_113	[p7l350t1485r729b1523],
2	.	.	O	.	_	0	SENT_113	[p7l350t1485r729b1523],

1	DoxorubicinAlone	NNP	O	DoxorubicinAlone	_	0	SENT_114	[p7l350t1485r729b1523],

1	Percentage	NN	O	percentage	_	0	SENT_115	[p7l10t1584r75b1809],
2	of	IN	O	of	_	0	SENT_115	[p7l10t1520r60b1568],
3	Control	NN	O	control	nn	4	SENT_115	[p7l10t1347r60b1510],
4	Absorbance	NN	O	absorbance	prep_of	1	SENT_115	[p7l10t1088r63b1333],

1	-	:	O	-	_	0	SENT_116	[p7l352t1558r432b1598],
2	ﬂ	NN	O	ﬂ	_	0	SENT_116	[p7l352t1558r432b1598],
3	--	:	O	--	_	0	SENT_116	[p7l352t1558r432b1598],
4	Doxorubioin	NN	O	doxorubioin	dep	2	SENT_116	[p7l442t1556r661b1593],
5	+	CC	O	+	_	0	SENT_116	[p7l442t1556r661b1593],
6	Vetaparnl	NN	O	vetaparnl	conj_+	2	SENT_116	[p7l673t1556r832b1606],
7	2	CD	NUMBER	2	number	8	SENT_116	[p7l154t1601r193b1640],
8	°	CD	NUMBER	°	num	9	SENT_116	[p7l154t1601r193b1640],
9	-9	CD	NUMBER	-9	dep	6	SENT_116	[p7l352t1626r819b1666],
10	.	.	O	.	_	0	SENT_116	[p7l352t1626r819b1666],

1	—	NN	O	—	_	0	SENT_117	[p7l352t1626r819b1666],
2	.	.	O	.	_	0	SENT_117	[p7l352t1626r819b1666],

1	Doxorubicin	NN	O	doxorubicin	_	0	SENT_118	[p7l352t1626r819b1666],
2	+	CC	O	+	cc	3	SENT_118	[p7l352t1626r819b1666],
3	Curc1nrin	NN	O	curc1nrin	dep	1	SENT_118	[p7l352t1626r819b1666],

1	«	RB	O	«	advmod	2	SENT_119	[p7l350t1703r432b1736],
2	-9	CD	NUMBER	-9	_	0	SENT_119	[p7l350t1703r432b1736],
3	-	:	O	-	_	0	SENT_119	[p7l350t1703r432b1736],
4	»	CD	NUMBER	»	num	5	SENT_119	[p7l350t1703r432b1736],
5	Doxo1ul3icin	NN	O	doxo1ul3icin	dep	2	SENT_119	[p7l442t1699r658b1739],
6	+	CC	O	+	_	0	SENT_119	[p7l442t1699r658b1739],
7	Cl	NN	O	cl	dep	2	SENT_119	[p7l670t1699r821b1739],
8	!	.	O	!	_	0	SENT_119	[p7l670t1699r821b1739],

1	l'	NN	O	l'	_	0	SENT_120	[p7l670t1699r821b1739],
2	C	NN	O	c	dep	1	SENT_120	[p7l670t1699r821b1739],
3	'	''	O	'	_	0	SENT_120	[p7l670t1699r821b1739],
4	.	.	O	.	_	0	SENT_120	[p7l670t1699r821b1739],

1	l'tin	NN	O	l'tin	_	0	SENT_121	[p7l670t1699r821b1739],
2	+	CC	O	+	cc	3	SENT_121	[p7l829t1705r851b1734],
3	Verapamil	NN	O	verapamil	dep	1	SENT_121	[p7l863t1699r1022b1749],

1	Doxorubicin	NN	O	doxorubicin	_	0	SENT_122	[p7l786t1937r1054b1987],
2	Concentration	NN	O	concentration	nn	3	SENT_122	[p7l1068t1937r1366b1987],
3	MM	NN	O	mm	dep	1	SENT_122	[p7l1382t1939r1453b1994],

1	-	:	O	-	_	0	SENT_123	[p7l1397t2158r1477b2199],
2	o	NN	O	o	_	0	SENT_123	[p7l1397t2158r1477b2199],
3	-	:	O	-	_	0	SENT_123	[p7l1397t2158r1477b2199],
4	Doxoniaizin	NNP	O	Doxoniaizin	dep	2	SENT_123	[p7l1487t2154r1676b2195],
5	Alone	RB	O	alone	advmod	4	SENT_123	[p7l1683t2154r1774b2195],

1	100	CD	NUMBER	100	_	0	SENT_124	[p7l239t2210r304b2255],
2	"	``	O	"	punct	1	SENT_124	[p7l332t2227r348b2252],
3	.	.	O	.	_	0	SENT_124	[p7l1397t2244r1703b2285],

1	—	NN	O	—	_	0	SENT_125	[p7l1397t2244r1703b2285],
2	.	.	O	.	_	0	SENT_125	[p7l1397t2244r1703b2285],

1	I	PRP	O	I	_	0	SENT_126	[p7l1397t2244r1703b2285],
2	.	.	O	.	_	0	SENT_126	[p7l1397t2244r1703b2285],

1	—	NN	O	—	_	0	SENT_127	[p7l1397t2244r1703b2285],
2	.	.	O	.	_	0	SENT_127	[p7l1397t2244r1703b2285],

1	Doxonbicin	NN	O	doxonbicin	_	0	SENT_128	[p7l1397t2244r1703b2285],
2	+	CC	O	+	_	0	SENT_128	[p7l1397t2244r1703b2285],
3	Veraparml	NNP	O	Veraparml	conj_+	1	SENT_128	[p7l1717t2244r1876b2296],
4	-9	CD	NUMBER	-9	num	3	SENT_128	[p7l1397t2340r1477b2379],
5	-	:	O	-	_	0	SENT_128	[p7l1397t2340r1477b2379],
6	Doxorubicin	NN	O	doxorubicin	dep	1	SENT_128	[p7l1487t2335r1676b2377],
7	+	CC	O	+	_	0	SENT_128	[p7l1683t2342r1703b2371],
8	Curcumin	NN	O	curcumin	conj_+	6	SENT_128	[p7l1715t2333r1866b2377],
9	-9	CD	NUMBER	-9	num	8	SENT_128	[p7l1397t2427r1479b2465],
10	-	:	O	-	_	0	SENT_128	[p7l1397t2427r1479b2465],
11	Doxorobicin	NN	O	doxorobicin	dep	1	SENT_128	[p7l1489t2425r1676b2467],
12	+	CC	O	+	_	0	SENT_128	[p7l1683t2434r1705b2460],
13	CIrcunin	NN	O	circunin	conj_+	11	SENT_128	[p7l1717t2425r1895b2467],
14	+	CC	O	+	cc	15	SENT_128	[p7l1717t2425r1895b2467],
15	Veraparml	NN	O	veraparml	dep	1	SENT_128	[p7l1907t2423r2066b2477],

1	Percentage	NN	O	percentage	_	0	SENT_129	[p7l102t2940r171b3167],
2	of	IN	O	of	_	0	SENT_129	[p7l104t2878r157b2928],
3	Control	NN	O	control	nn	4	SENT_129	[p7l102t2707r157b2868],
4	Absorbance	NN	O	absorbance	prep_of	1	SENT_129	[p7l100t2449r157b2689],

1	Doxorubicin	NN	O	doxorubicin	_	0	SENT_130	[p7l895t3292r1163b3347],
2	Concentration	NN	O	concentration	nn	3	SENT_130	[p7l1177t3292r1473b3349],
3	MM	NN	O	mm	dep	1	SENT_130	[p7l1489t3294r1560b3355],

1	FIGURE	NN	O	figure	nsubj	13	SENT_131	[p8l79t63r299b116],
2	1	CD	NUMBER	1	number	3	SENT_131	[p8l345t62r375b115],
3	—	CD	NUMBER	—	num	4	SENT_131	[p8l397t95r436b100],
4	Effects	NNS	O	effect	dep	1	SENT_131	[p8l455t63r666b115],
5	of	IN	O	of	_	0	SENT_131	[p8l711t63r776b115],
6	Pgp	NNP	ORGANIZATION	Pgp	prep_of	4	SENT_131	[p8l814t64r929b131],
7	and	CC	O	and	_	0	SENT_131	[p8l974t63r1081b115],
8	GST	NN	O	gst	nn	9	SENT_131	[p8l1124t63r1264b116],
9	inhibitors	NNS	O	inhibitor	conj_and	1	SENT_131	[p8l1307t63r1593b115],
10	on	IN	O	on	_	0	SENT_131	[p8l1639t80r1712b115],
11	doXorubicin	NN	O	doxorubicin	nn	12	SENT_131	[p8l1755t63r2141b115],
12	—	NN	O	—	prep_on	9	SENT_131	[p8l1755t63r2141b115],
13	induced	VBD	O	induce	_	0	SENT_131	[p8l8t138r246b190],
14	cytotoxicity	NN	O	cytotoxicity	dobj	13	SENT_131	[p8l286t138r644b206],
15	in	IN	O	in	_	0	SENT_131	[p8l683t138r741b189],
16	(	CD	NUMBER	(	prep_in	14	SENT_131	[p8l781t139r863b203],
17	a	DT	O	a	det	20	SENT_131	[p8l781t139r863b203],
18	)	NN	O	)	nn	20	SENT_131	[p8l781t139r863b203],
19	HEp2A	NN	O	hep2a	nn	20	SENT_131	[p8l904t138r1133b206],
20	cells	NNS	O	cell	tmod	13	SENT_131	[p8l1173t138r1307b190],
21	and	CC	O	and	_	0	SENT_131	[p8l1350t138r1456b190],
22	(	NN	O	(	nn	23	SENT_131	[p8l1496t138r1578b203],
23	b	NN	O	b	tmod	13	SENT_131	[p8l1496t138r1578b203],
24	)	CD	NUMBER	)	num	26	SENT_131	[p8l1496t138r1578b203],
25	HEp2	NN	O	hep2	nn	26	SENT_131	[p8l1619t138r1793b206],
26	cells	NNS	O	cell	dep	20	SENT_131	[p8l1833t138r1984b190],
27	.	.	O	.	_	0	SENT_131	[p8l1833t138r1984b190],

1	The	DT	O	the	det	2	SENT_132	[p8l2027t138r2143b190],
2	percentage	NN	O	percentage	nsubjpass	7	SENT_132	[p8l8t219r334b280],
3	of	IN	O	of	_	0	SENT_132	[p8l359t211r424b264],
4	surviving	VBG	O	survive	amod	5	SENT_132	[p8l446t211r726b280],
5	cells	NNS	O	cell	prep_of	2	SENT_132	[p8l752t211r886b264],
6	is	VBZ	O	be	auxpass	7	SENT_132	[p8l912t211r959b264],
7	indicated	VBN	O	indicate	_	0	SENT_132	[p8l984t211r1260b264],
8	by	IN	O	by	_	0	SENT_132	[p8l1282t211r1357b280],
9	the	DT	O	the	det	10	SENT_132	[p8l1381t212r1471b264],
10	percentage	NN	O	percentage	agent	7	SENT_132	[p8l1495t220r1821b280],
11	of	IN	O	of	_	0	SENT_132	[p8l1847t211r1912b264],
12	control	NN	O	control	nn	13	SENT_132	[p8l1932t211r2143b264],
13	absorbance	NN	O	absorbance	prep_of	10	SENT_132	[p8l10t286r362b338],
14	.	.	O	.	_	0	SENT_132	[p8l10t286r362b338],

1	The	DT	O	the	det	2	SENT_133	[p8l390t286r506b338],
2	effects	NNS	O	effect	nsubj	24	SENT_133	[p8l532t285r729b338],
3	of	IN	O	of	_	0	SENT_133	[p8l757t285r822b338],
4	Verapamil	NNP	MISC	Verapamil	prep_of	2	SENT_133	[p8l842t285r1142b354],
5	(	CD	NUMBER	(	num	4	SENT_133	[p8l1169t285r1225b350],
6	5	CD	NUMBER	5	num	9	SENT_133	[p8l1169t285r1225b350],
7	p.	NN	O	p.	nn	9	SENT_133	[p8l1258t286r1410b353],
8	M	NN	O	m	nn	9	SENT_133	[p8l1258t286r1410b353],
9	)	NN	O	)	dep	4	SENT_133	[p8l1258t286r1410b353],
10	,	,	O	,	_	0	SENT_133	[p8l1258t286r1410b353],
11	curcumin	NN	O	curcumin	conj_and	4	SENT_133	[p8l1438t286r1722b338],
12	(	CD	NUMBER	(	num	11	SENT_133	[p8l1749t285r1841b350],
13	25	CD	NUMBER	25	num	16	SENT_133	[p8l1749t285r1841b350],
14	p.	NN	O	p.	nn	16	SENT_133	[p8l1875t286r2009b353],
15	M	NN	O	m	nn	16	SENT_133	[p8l1875t286r2009b353],
16	)	NN	O	)	dep	11	SENT_133	[p8l1875t286r2009b353],
17	and	CC	O	and	_	0	SENT_133	[p8l2037t286r2144b338],
18	verapamil	NN	O	verapamil	nn	19	SENT_133	[p8l8t359r309b427],
19	(	NN	O	(	conj_and	4	SENT_133	[p8l331t359r386b424],
20	5	CD	NUMBER	5	number	21	SENT_133	[p8l331t359r386b424],
21	}	CD	NUMBER	}	dep	19	SENT_133	[p8l414t360r548b427],
22	LM	NNP	O	LM	dep	21	SENT_133	[p8l414t360r548b427],
23	)	CD	NUMBER	)	num	22	SENT_133	[p8l414t360r548b427],
24	combined	VBN	O	combine	dep	32	SENT_133	[p8l571t359r867b412],
25	with	IN	O	with	_	0	SENT_133	[p8l886t359r1019b412],
26	curcumin	NN	O	curcumin	prep_with	24	SENT_133	[p8l1039t359r1322b412],
27	(	CD	NUMBER	(	num	26	SENT_133	[p8l1344t359r1437b424],
28	25	CD	NUMBER	25	num	30	SENT_133	[p8l1344t359r1437b424],
29	MM	NN	O	mm	nn	30	SENT_133	[p8l1465t360r1599b427],
30	)	NN	O	)	nsubjpass	32	SENT_133	[p8l1465t360r1599b427],
31	were	VBD	O	be	auxpass	32	SENT_133	[p8l1621t376r1765b412],
32	determined	VBN	O	determine	_	0	SENT_133	[p8l1786t359r2139b412],
33	.	.	O	.	_	0	SENT_133	[p8l1786t359r2139b412],

1	Each	DT	O	each	det	2	SENT_134	[p8l8t433r158b486],
2	point	NN	O	point	nsubj	5	SENT_134	[p8l184t433r339b501],
3	is	VBZ	O	be	cop	5	SENT_134	[p8l366t433r412b485],
4	the	DT	O	the	det	5	SENT_134	[p8l441t433r531b486],
5	mean	NN	O	mean	_	0	SENT_134	[p8l559t450r721b486],
6	of	IN	O	of	_	0	SENT_134	[p8l749t433r814b485],
7	triplicate	NN	O	triplicate	nn	8	SENT_134	[p8l836t433r1103b501],
8	determinations	NNS	O	determination	prep_of	5	SENT_134	[p8l1131t433r1593b486],
9	.	.	O	.	_	0	SENT_134	[p8l1131t433r1593b486],

1	TABLE	NN	O	table	_	0	SENT_135	[p8l126t654r320b694],
2	I	PRP	O	I	nsubj	3	SENT_135	[p8l351t654r416b694],
3	—	VBP	O	—	rcmod	1	SENT_135	[p8l351t654r416b694],
4	DOXORUBICIN	NN	O	doxorubicin	nn	6	SENT_135	[p8l431t654r835b695],
5	IC50	NN	O	ic50	nn	6	SENT_135	[p8l865t654r979b695],
6	VALUES	NNS	O	value	dobj	3	SENT_135	[p8l1009t654r1233b695],
7	IN	IN	O	in	_	0	SENT_135	[p8l1266t655r1326b694],
8	HEp	NN	O	hep	prep_in	6	SENT_135	[p8l1356t655r1460b706],
9	AND	CC	O	and	_	0	SENT_135	[p8l1491t655r1614b694],
10	HEp2A	NN	O	hep2a	nn	11	SENT_135	[p8l1645t654r1821b706],
11	CELLS	NNS	O	cell	conj_and	8	SENT_135	[p8l1852t654r2024b695],

1	CHEMOSENSITIZED	JJ	O	chemosensitized	_	0	SENT_136	[p8l255t712r788b752],
2	BY	IN	O	by	_	0	SENT_136	[p8l820t712r898b751],
3	INHIBITORS	NNPS	O	INHIBITORS	prep_by	1	SENT_136	[p8l929t712r1253b752],
4	OF	IN	O	of	_	0	SENT_136	[p8l1287t712r1359b752],
5	PGP	NNP	O	PGP	prep_of	3	SENT_136	[p8l1388t712r1493b752],
6	(	CD	NUMBER	(	num	5	SENT_136	[p8l1525t712r1896b761],
7	VERAPAMIL	NNP	O	VERAPAMIL	dep	1	SENT_136	[p8l1525t712r1896b761],
8	)	CD	NUMBER	)	num	7	SENT_136	[p8l1525t712r1896b761],

1	AND	CC	O	and	_	0	SENT_137	[p8l707t776r848b816],
2	/	:	O	/	punct	1	SENT_137	[p8l707t776r848b816],
3	OR	NN	O	or	nn	4	SENT_137	[p8l850t776r928b816],
4	GST	NN	O	gst	dep	1	SENT_137	[p8l959t776r1065b816],
5	(	CD	NUMBER	(	num	6	SENT_137	[p8l1098t776r1443b825],
6	CURCUMIN	NN	O	curcumin	dep	4	SENT_137	[p8l1098t776r1443b825],
7	)	CD	NUMBER	)	dep	1	SENT_137	[p8l1098t776r1443b825],

1	HEp2	NN	O	hep2	nn	2	SENT_138	[p8l1171t921r1304b973],
2	cells	NNS	O	cell	nsubj	3	SENT_138	[p8l1326t921r1429b961],
3	p.M	VBP	O	p.m	_	0	SENT_138	[p8l1454t922r1539b972],
4	HEp2A	NN	O	hep2a	nn	5	SENT_138	[p8l1653t921r1828b973],
5	cells	NNS	O	cell	nsubj	6	SENT_138	[p8l1849t921r1952b961],
6	p.M	VBP	O	p.m	ccomp	3	SENT_138	[p8l1978t922r2062b972],
7	(	CD	NUMBER	(	num	8	SENT_138	[p8l1195t978r1337b1028],
8	mean	NN	O	mean	dobj	6	SENT_138	[p8l1195t978r1337b1028],
9	:	:	O	:	_	0	SENT_138	[p8l1363t981r1398b1016],
10	SD	NN	O	sd	dep	8	SENT_138	[p8l1426t978r1515b1027],
11	)	CD	NUMBER	)	number	12	SENT_138	[p8l1426t978r1515b1027],
12	(	CD	NUMBER	(	num	13	SENT_138	[p8l1698t978r1839b1028],
13	mean	NN	O	mean	dep	10	SENT_138	[p8l1698t978r1839b1028],
14	i	FW	O	i	tmod	6	SENT_138	[p8l1866t981r1901b1016],
15	SD	NN	O	sd	nn	16	SENT_138	[p8l1929t978r2017b1027],
16	)	NN	O	)	dep	14	SENT_138	[p8l1929t978r2017b1027],

1	Doxorubicin	NN	O	doxorubicin	_	0	SENT_139	[p8l88t1131r469b1184],
2	alone	RB	O	alone	advmod	4	SENT_139	[p8l498t1132r658b1184],
3	7.29	CD	NUMBER	7.29	pobj	2	SENT_139	[p8l1174t1132r1302b1185],
4	i	FW	O	i	dep	1	SENT_139	[p8l1332t1136r1378b1181],
5	0.3	CD	NUMBER	0.3	number	6	SENT_139	[p8l1407t1132r1495b1184],
6	>	JJR	O	>	amod	4	SENT_139	[p8l1776t1132r1944b1184],
7	100	CD	NUMBER	100	num	8	SENT_139	[p8l1776t1132r1944b1184],
8	Doxorubicin	NN	O	doxorubicin	dep	4	SENT_139	[p8l88t1205r469b1258],
9	+	CC	O	+	_	0	SENT_139	[p8l504t1210r549b1255],
10	verapamil	NN	O	verapamil	conj_+	4	SENT_139	[p8l585t1205r885b1273],
11	2.79	CD	NUMBER	2.79	num	10	SENT_139	[p8l1174t1206r1302b1259],
12	:	:	O	:	_	0	SENT_139	[p8l1332t1210r1378b1255],
13	0.2	CD	NUMBER	0.2	number	14	SENT_139	[p8l1407t1206r1498b1258],
14	5.28	CD	NUMBER	5.28	dep	10	SENT_139	[p8l1696t1205r1822b1258],
15	i	FW	O	i	dep	21	SENT_139	[p8l1854t1210r1899b1255],
16	0.82	CD	NUMBER	0.82	num	17	SENT_139	[p8l1928t1206r2057b1258],
17	Doxorubicin	NN	O	doxorubicin	dep	15	SENT_139	[p8l88t1279r469b1331],
18	+	CC	O	+	_	0	SENT_139	[p8l504t1284r549b1329],
19	curcumin	NN	O	curcumin	conj_+	17	SENT_139	[p8l585t1279r868b1331],
20	2.46	CD	NUMBER	2.46	dep	21	SENT_139	[p8l1174t1279r1302b1332],
21	i	FW	O	i	dep	26	SENT_139	[p8l1332t1284r1378b1329],
22	1.11	CD	NUMBER	1.11	number	23	SENT_139	[p8l1414t1280r1530b1332],
23	36.22	CD	NUMBER	36.22	dep	21	SENT_139	[p8l1659t1279r1824b1332],
24	i	FW	O	i	dep	23	SENT_139	[p8l1854t1284r1899b1329],
25	0.88	CD	NUMBER	0.88	num	26	SENT_139	[p8l1928t1280r2055b1332],
26	Doxorubicin	NN	O	doxorubicin	dep	10	SENT_139	[p8l88t1353r469b1429],
27	+	CC	O	+	_	0	SENT_139	[p8l504t1357r549b1403],
28	Verapamil	NN	O	verapamil	conj_+	10	SENT_139	[p8l585t1353r885b1421],
29	+	CC	O	+	_	0	SENT_139	[p8l920t1357r965b1403],
30	1.52	CD	NUMBER	1.52	conj_+	10	SENT_139	[p8l1181t1353r1303b1406],
31	i	FW	O	i	dep	30	SENT_139	[p8l1332t1357r1378b1403],
32	0.10	CD	NUMBER	0.10	dep	30	SENT_139	[p8l1407t1353r1536b1406],
33	3.54	CD	NUMBER	3.54	num	35	SENT_139	[p8l1697t1353r1824b1406],
34	:	:	O	:	_	0	SENT_139	[p8l1854t1357r1899b1403],
35	0.45	CD	NUMBER	0.45	dep	1	SENT_139	[p8l1928t1353r2055b1406],

1	C1lI	NN	O	c1lus	_	0	SENT_140	[p8l165t1438r448b1473],
2	'	''	O	'	_	0	SENT_140	[p8l165t1438r448b1473],
3	C11II11Il	NN	O	c11ii11il	dep	1	SENT_140	[p8l165t1438r448b1473],

1	Doxorubicin	NN	O	doxorubicin	_	0	SENT_141	[p8l88t1496r469b1548],
2	+	CC	O	+	_	0	SENT_141	[p8l504t1500r549b1545],
3	ethacrynic	JJ	O	ethacrynic	amod	4	SENT_141	[p8l585t1496r896b1564],
4	acid	NN	O	acid	conj_+	1	SENT_141	[p8l926t1496r1050b1548],
5	0.79	CD	NUMBER	0.79	num	7	SENT_141	[p8l1174t1496r1302b1549],
6	:	:	O	:	_	0	SENT_141	[p8l1332t1500r1378b1545],
7	0.40	CD	NUMBER	0.40	dep	1	SENT_141	[p8l1407t1496r1536b1548],
8	20.23	CD	NUMBER	20.23	num	10	SENT_141	[p8l1657t1496r1821b1548],
9	:	:	O	:	_	0	SENT_141	[p8l1854t1500r1899b1545],
10	0.73	CD	NUMBER	0.73	dep	7	SENT_141	[p8l1928t1496r2054b1548],

1	Verapamil	NNP	O	Verapamil	nn	2	SENT_142	[p8l84t1675r401b1743],
2	concentration	NN	O	concentration	nsubj	5	SENT_142	[p8l460t1675r870b1727],
3	was	VBD	O	be	cop	5	SENT_142	[p8l928t1691r1041b1727],
4	5	CD	NUMBER	5	num	5	SENT_142	[p8l1103t1675r1134b1727],
5	ptM	NN	O	ptm	_	0	SENT_142	[p8l1200t1676r1327b1742],
6	,	,	O	,	_	0	SENT_142	[p8l1200t1676r1327b1742],
7	curcumin	NN	O	curcumin	nn	9	SENT_142	[p8l1389t1675r1672b1727],
8	25	CD	NUMBER	25	num	9	SENT_142	[p8l1731t1675r1801b1727],
9	p.M	NN	O	p.m	conj_and	5	SENT_142	[p8l1867t1676r1977b1742],
10	and	CC	O	and	_	0	SENT_142	[p8l2037t1675r2144b1727],
11	ethacrynic	JJ	O	ethacrynic	amod	12	SENT_142	[p8l9t1748r320b1817],
12	acid	NN	O	acid	conj_and	5	SENT_142	[p8l350t1749r474b1801],
13	25	CD	NUMBER	25	num	14	SENT_142	[p8l501t1748r570b1801],
14	p.M.	NN	O	p.m.	dep	12	SENT_142	[p8l606t1750r731b1816],

1	Construction	NN	O	construction	_	0	SENT_143	[p8l12t1978r424b2034],
2	of	IN	O	of	_	0	SENT_143	[p8l454t1977r527b2049],
3	GSTP1	NN	O	gstp1	nn	5	SENT_143	[p8l545t1977r766b2034],
4	expression	NN	O	expression	nn	5	SENT_143	[p8l802t1979r1140b2049],
5	vector	NN	O	vector	prep_of	1	SENT_143	[p8l1171t1988r1371b2033],

1	A	DT	O	a	det	3	SENT_144	[p8l88t2077r144b2132],
2	635	CD	NUMBER	635	num	3	SENT_144	[p8l175t2077r284b2133],
3	bp	NN	O	bp	nsubj	8	SENT_144	[p8l316t2077r392b2150],
4	human	JJ	O	human	amod	6	SENT_144	[p8l421t2077r632b2133],
5	GSTP1	NN	O	gstp1	nn	6	SENT_144	[p8l662t2077r881b2133],
6	CDNA	NN	ORGANIZATION	cdna	dep	3	SENT_144	[p8l918t2077r1119b2133],
7	(	CD	NUMBER	(	dep	3	SENT_144	[p8l1150t2077r1432b2150],
8	supplied	VBN	O	supply	partmod	21	SENT_144	[p8l1150t2077r1432b2150],
9	by	IN	O	by	_	0	SENT_144	[p8l1459t2077r1536b2150],
10	Dr.	NNP	O	Dr.	nn	12	SENT_144	[p8l1565t2078r1661b2133],
11	C.	NNP	PERSON	C.	nn	12	SENT_144	[p8l1695t2077r1759b2133],
12	Henderson	NNP	PERSON	Henderson	agent	8	SENT_144	[p8l1792t2077r2140b2143],
13	,	,	O	,	_	0	SENT_144	[p8l1792t2077r2140b2143],
14	University	NNP	ORGANIZATION	University	appos	12	SENT_144	[p8l8t2162r330b2235],
15	of	IN	ORGANIZATION	of	_	0	SENT_144	[p8l360t2162r428b2218],
16	Dundee	NNP	ORGANIZATION	Dundee	prep_of	14	SENT_144	[p8l451t2162r706b2229],
17	,	,	O	,	_	0	SENT_144	[p8l451t2162r706b2229],
18	Scotland	NNP	LOCATION	Scotland	nn	19	SENT_144	[p8l739t2162r1027b2231],
19	)	NNP	O	)	nsubjpass	21	SENT_144	[p8l739t2162r1027b2231],
20	was	VBD	O	be	auxpass	21	SENT_144	[p8l1059t2180r1176b2218],
21	inserted	VBN	O	insert	_	0	SENT_144	[p8l1206t2162r1447b2218],
22	into	IN	O	into	_	0	SENT_144	[p8l1475t2162r1592b2218],
23	pcDNA3	NN	O	pcdna3	nn	25	SENT_144	[p8l1621t2162r2135b2235],
24	.1	CD	NUMBER	.1	num	25	SENT_144	[p8l1621t2162r2135b2235],
25	Zeo	NN	O	zeo	prep_into	21	SENT_144	[p8l1621t2162r2135b2235],
26	+	CC	O	+	_	0	SENT_144	[p8l1621t2162r2135b2235],
27	(	CD	NUMBER	(	num	30	SENT_144	[p8l11t2246r366b2319],
28	Invitrogen	NNP	ORGANIZATION	Invitrogen	nn	30	SENT_144	[p8l11t2246r366b2319],
29	,	,	O	,	_	0	SENT_144	[p8l11t2246r366b2319],
30	Groningen	NNP	ORGANIZATION	Groningen	prep_into	21	SENT_144	[p8l409t2246r751b2319],
31	,	,	O	,	_	0	SENT_144	[p8l409t2246r751b2319],
32	the	DT	O	the	det	34	SENT_144	[p8l792t2246r884b2302],
33	Netherlands	NNP	LOCATION	Netherlands	nn	34	SENT_144	[p8l922t2246r1315b2315],
34	)	NN	O	)	appos	25	SENT_144	[p8l922t2246r1315b2315],
35	at	IN	O	at	_	0	SENT_144	[p8l1356t2254r1410b2302],
36	the	DT	O	the	det	38	SENT_144	[p8l1447t2246r1539b2302],
37	EcoRI	NN	O	ecorus	nn	38	SENT_144	[p8l1576t2248r1774b2302],
38	site	NN	O	site	prep_at	34	SENT_144	[p8l1814t2246r1916b2302],
39	in	IN	O	in	_	0	SENT_144	[p8l1954t2246r2013b2302],
40	the	DT	O	the	det	43	SENT_144	[p8l2051t2246r2143b2302],
41	multiple	JJ	O	multiple	amod	43	SENT_144	[p8l8t2331r262b2404],
42	cloning	NN	O	cloning	nn	43	SENT_144	[p8l305t2331r532b2404],
43	site	NN	O	site	prep_in	38	SENT_144	[p8l578t2331r694b2387],
44	.	.	O	.	_	0	SENT_144	[p8l578t2331r694b2387],

1	Orientation	NN	O	orientation	nsubjpass	6	SENT_145	[p8l741t2331r1087b2388],
2	of	IN	O	of	_	0	SENT_145	[p8l1130t2331r1197b2387],
3	the	DT	O	the	det	4	SENT_145	[p8l1234t2331r1326b2387],
4	cDNA	NN	O	cdna	prep_of	1	SENT_145	[p8l1369t2332r1571b2387],
5	was	VBD	O	be	auxpass	6	SENT_145	[p8l1613t2349r1730b2388],
6	checked	VBN	O	check	_	0	SENT_145	[p8l1775t2331r2025b2387],
7	by	IN	O	by	_	0	SENT_145	[p8l2065t2331r2142b2404],
8	sequencing	NN	O	sequencing	agent	6	SENT_145	[p8l11t2416r367b2489],
9	.	.	O	.	_	0	SENT_145	[p8l11t2416r367b2489],

1	Stable	JJ	O	stable	amod	2	SENT_146	[p8l9t2574r206b2631],
2	transfection	NN	O	transfection	_	0	SENT_146	[p8l237t2575r615b2646],
3	of	IN	O	of	_	0	SENT_146	[p8l646t2575r718b2646],
4	HEp2	NN	O	hep2	prep_of	2	SENT_146	[p8l732t2575r916b2646],

1	Cells	NNS	O	cell	nsubjpass	3	SENT_147	[p8l89t2674r249b2730],
2	were	VBD	O	be	auxpass	3	SENT_147	[p8l291t2692r444b2730],
3	grown	VBN	O	grow	_	0	SENT_147	[p8l485t2692r688b2746],
4	in	IN	O	in	_	0	SENT_147	[p8l727t2674r788b2729],
5	25	CD	NUMBER	25	num	9	SENT_147	[p8l828t2674r901b2730],
6	cm2	NN	O	cm2	nn	9	SENT_147	[p8l946t2662r1072b2730],
7	tissue	NN	O	tissue	nn	9	SENT_147	[p8l1112t2674r1292b2730],
8	culture	NN	O	culture	nn	9	SENT_147	[p8l1334t2674r1553b2730],
9	ﬂasks	NNS	O	ﬂasks	prep_in	3	SENT_147	[p8l1594t2674r1772b2730],
10	until	IN	O	until	_	0	SENT_147	[p8l1813t2674r1958b2730],
11	60	CD	PERCENT	60	number	12	SENT_147	[p8l2000t2674r2139b2730],
12	%	NN	PERCENT	%	amod	13	SENT_147	[p8l2000t2674r2139b2730],
13	conﬂuent	NN	O	conﬂuent	prep_until	9	SENT_147	[p8l9t2758r320b2814],
14	.	.	O	.	_	0	SENT_147	[p8l9t2758r320b2814],

1	An	DT	O	a	det	2	SENT_148	[p8l358t2758r455b2813],
2	amount	NN	O	amount	nsubj	21	SENT_148	[p8l490t2766r727b2814],
3	of	IN	O	of	_	0	SENT_148	[p8l761t2758r830b2814],
4	3	CD	NUMBER	3	num	5	SENT_148	[p8l861t2758r893b2814],
5	ug	NN	O	ug	prep_of	2	SENT_148	[p8l936t2775r1021b2831],
6	of	IN	O	of	_	0	SENT_148	[p8l1057t2758r1126b2814],
7	pcDNA3	NN	O	pcdna3	nn	9	SENT_148	[p8l1153t2758r1979b2831],
8	.1	CD	NUMBER	.1	num	9	SENT_148	[p8l1153t2758r1979b2831],
9	Zeo	NN	O	zeo	prep_of	5	SENT_148	[p8l1153t2758r1979b2831],
10	+	CC	O	+	_	0	SENT_148	[p8l1153t2758r1979b2831],
11	HGSTP1	NN	O	hgstp1	prep_of	5	SENT_148	[p8l1153t2758r1979b2831],
12	was	VBD	O	be	aux	14	SENT_148	[p8l2021t2775r2141b2814],
13	then	RB	O	then	advmod	14	SENT_148	[p8l8t2842r145b2898],
14	transfected	VBN	O	transfect	_	0	SENT_148	[p8l192t2842r542b2898],
15	into	IN	O	into	_	0	SENT_148	[p8l589t2842r711b2898],
16	cells	NNS	O	cell	prep_into	14	SENT_148	[p8l761t2842r902b2898],
17	using	VBG	O	use	partmod	16	SENT_148	[p8l952t2842r1123b2915],
18	lipofectin	NN	O	lipofectin	nn	19	SENT_148	[p8l1172t2842r1477b2915],
19	reagent	NN	O	reagent	dobj	17	SENT_148	[p8l1524t2850r1759b2915],
20	as	IN	O	as	_	0	SENT_148	[p8l1808t2860r1869b2898],
21	recommended	VBN	O	recommend	conj_as	14	SENT_148	[p8l1918t2860r2141b2898, p8l8t2925r260b2981],
22	by	IN	O	by	_	0	SENT_148	[p8l305t2925r383b2998],
23	the	DT	O	the	det	24	SENT_148	[p8l430t2925r525b2981],
24	supplier	NN	O	supplier	prep_by	21	SENT_148	[p8l574t2925r829b2998],
25	(	CD	NUMBER	(	num	24	SENT_148	[p8l876t2925r1031b2995],
26	Life	NNP	ORGANIZATION	Life	nn	28	SENT_148	[p8l876t2925r1031b2995],
27	Technologies	NNPS	ORGANIZATION	Technologies	nn	28	SENT_148	[p8l1077t2925r1549b2998],
28	)	NN	O	)	dobj	14	SENT_148	[p8l1077t2925r1549b2998],
29	.	.	O	.	_	0	SENT_148	[p8l1077t2925r1549b2998],

1	Cells	NNS	O	cell	nsubjpass	4	SENT_149	[p8l1601t2925r1760b2982],
2	were	VBD	O	be	auxpass	4	SENT_149	[p8l1808t2943r1961b2981],
3	then	RB	O	then	advmod	4	SENT_149	[p8l2007t2925r2144b2981],
4	grown	VBN	O	grow	_	0	SENT_149	[p8l9t3027r211b3082],
5	under	IN	O	under	_	0	SENT_149	[p8l234t3009r417b3065],
6	normal	JJ	O	normal	amod	8	SENT_149	[p8l439t3009r663b3066],
7	growth	NN	O	growth	nn	8	SENT_149	[p8l688t3009r913b3082],
8	conditions	NNS	O	condition	prep_under	4	SENT_149	[p8l937t3009r1266b3065],
9	for	IN	O	for	_	0	SENT_149	[p8l1292t3009r1384b3065],
10	48	CD	DURATION	48	num	11	SENT_149	[p8l1406t3010r1482b3066],
11	hr	NN	DURATION	hr	prep_for	4	SENT_149	[p8l1508t3009r1590b3076],
12	,	,	O	,	_	0	SENT_149	[p8l1508t3009r1590b3076],
13	after	IN	O	after	_	0	SENT_149	[p8l1619t3009r1763b3065],
14	which	WDT	O	which	rel	18	SENT_149	[p8l1786t3009r1979b3066],
15	time	NN	O	time	nn	16	SENT_149	[p8l2003t3009r2143b3065],
16	cells	NNS	O	cell	nsubjpass	20	SENT_149	[p8l9t3093r151b3149],
17	were	VBD	O	be	auxpass	18	SENT_149	[p8l179t3111r332b3150],
18	trypsinised	VBN	O	trypsinise	rcmod	11	SENT_149	[p8l357t3093r707b3166],
19	and	CC	O	and	_	0	SENT_149	[p8l734t3093r846b3150],
20	seeded	VBN	O	seed	conj_and	18	SENT_149	[p8l874t3093r1087b3149],
21	onto	IN	O	onto	_	0	SENT_149	[p8l1113t3102r1252b3149],
22	a	DT	O	a	det	27	SENT_149	[p8l1279t3111r1312b3149],
23	120	CD	NUMBER	120	num	27	SENT_149	[p8l1344t3094r1454b3150],
24	mm	NN	O	mm	nn	27	SENT_149	[p8l1480t3111r1603b3149],
25	cell	NN	O	cell	nn	27	SENT_149	[p8l1628t3093r1741b3149],
26	culture	NN	O	culture	nn	27	SENT_149	[p8l1767t3093r1986b3149],
27	dish	NN	O	dish	prep_onto	18	SENT_149	[p8l2013t3093r2144b3149],
28	and	CC	O	and	_	0	SENT_149	[p8l10t3177r122b3234],
29	grown	VBN	O	grow	conj_and	18	SENT_149	[p8l150t3195r352b3250],
30	in	IN	O	in	_	0	SENT_149	[p8l379t3177r440b3233],
31	normal	JJ	O	normal	amod	33	SENT_149	[p8l467t3178r692b3234],
32	growth	NN	O	growth	nn	33	SENT_149	[p8l720t3178r944b3250],
33	medium	NN	O	medium	prep_in	29	SENT_149	[p8l971t3177r1233b3234],
34	containing	VBG	O	contain	partmod	33	SENT_149	[p8l1260t3177r1595b3250],
35	400	CD	NUMBER	400	num	37	SENT_149	[p8l1622t3178r1740b3234],
36	ug/ml	NN	O	ug/ml	nn	37	SENT_149	[p8l1774t3177r1966b3250],
37	Zeocin	NN	O	zeocin	dobj	34	SENT_149	[p8l1993t3179r2140b3234, p8l9t3262r104b3318],
38	(	CD	NUMBER	(	num	40	SENT_149	[p8l137t3262r517b3335],
39	Invitrogen	NNP	ORGANIZATION	Invitrogen	nn	40	SENT_149	[p8l137t3262r517b3335],
40	)	NN	O	)	dobj	18	SENT_149	[p8l137t3262r517b3335],
41	for	IN	O	for	_	0	SENT_149	[p8l550t3262r643b3318],
42	selection	NN	O	selection	prep_for	18	SENT_149	[p8l674t3262r970b3318],
43	.	.	O	.	_	0	SENT_149	[p8l674t3262r970b3318],

1	Colonies	NNS	O	colony	nsubjpass	3	SENT_150	[p8l1006t3262r1286b3318],
2	were	VBD	O	be	auxpass	3	SENT_150	[p8l1319t3279r1471b3318],
3	grown	VBN	O	grow	_	0	SENT_150	[p8l1503t3279r1705b3335],
4	for	IN	O	for	_	0	SENT_150	[p8l1735t3262r1828b3318],
5	2	CD	DURATION	2	num	6	SENT_150	[p8l1858t3262r1894b3317],
6	weeks	NNS	NUMBER	week	prep_for	3	SENT_150	[p8l1925t3262r2140b3328],
7	,	,	O	,	_	0	SENT_150	[p8l1925t3262r2140b3328],
8	replacing	VBG	O	replace	xcomp	3	SENT_150	[p8l8t3346r303b3419],
9	the	DT	O	the	det	11	SENT_150	[p8l343t3346r439b3402],
10	selective	JJ	O	selective	amod	11	SENT_150	[p8l480t3346r755b3402],
11	medium	NN	O	medium	dobj	8	SENT_150	[p8l794t3346r1056b3402],
12	every	DT	SET	every	det	14	SENT_150	[p8l1094t3364r1268b3419],
13	3	CD	SET	3	num	14	SENT_150	[p8l1310t3346r1341b3402],
14	days	NNS	NUMBER	day	tmod	8	SENT_150	[p8l1385t3346r1546b3419],
15	,	,	O	,	_	0	SENT_150	[p8l1385t3346r1546b3419],
16	after	IN	O	after	_	0	SENT_150	[p8l1589t3346r1734b3402],
17	which	WDT	O	which	det	18	SENT_150	[p8l1771t3346r1965b3402],
18	time	NN	O	time	prep_after	3	SENT_150	[p8l2003t3346r2143b3402],

1	TABLE	NN	O	table	nn	4	SENT_151	[p8l67t3444r260b3484],
2	II	CD	NUMBER	ii	num	4	SENT_151	[p8l291t3445r335b3484],
3	—	NN	O	—	nn	4	SENT_151	[p8l350t3469r379b3473],
4	EFFECT	NN	O	effect	_	0	SENT_151	[p8l393t3445r601b3485],
5	OF	IN	O	of	_	0	SENT_151	[p8l633t3445r705b3485],
6	CURCUMIN	NNP	O	CURCUMIN	nn	7	SENT_151	[p8l735t3445r1045b3485],
7	ON	NNP	O	ON	prep_of	4	SENT_151	[p8l1076t3445r1158b3485],
8	GST	NN	O	gst	nn	9	SENT_151	[p8l1188t3445r1295b3485],
9	ACTIVITY	NN	O	activity	dep	4	SENT_151	[p8l1326t3445r1598b3485],
10	IN	IN	O	in	_	0	SENT_151	[p8l1627t3446r1688b3485],
11	HEp2	NN	O	hep2	prep_in	9	SENT_151	[p8l1718t3445r1864b3497],
12	,	,	O	,	_	0	SENT_151	[p8l1718t3445r1864b3497],
13	HEp2A	NN	O	hep2a	appos	11	SENT_151	[p8l1896t3445r2084b3497],
14	,	,	O	,	_	0	SENT_151	[p8l1896t3445r2084b3497],

1	RAT	NN	O	rat	_	0	SENT_152	[p8l426t3528r540b3568],
2	LIVER	NN	O	liver	nn	3	SENT_152	[p8l570t3529r740b3569],
3	CYTOSOL	NN	O	cytosol	dep	1	SENT_152	[p8l770t3528r1035b3569],
4	AND	CC	O	and	_	0	SENT_152	[p8l1065t3528r1188b3568],
5	PURIFIED	JJ	O	purified	amod	6	SENT_152	[p8l1219t3529r1477b3569],
6	GSTP1-1	NN	O	gstp1-1	dep	1	SENT_152	[p8l1510t3528r1721b3569],

1	GST	NN	O	gst	nn	2	SENT_153	[p8l1036t3641r1143b3682],
2	activity	NN	O	activity	dep	8	SENT_153	[p8l1165t3641r1335b3693],
3	(	CD	NUMBER	(	num	4	SENT_153	[p8l1358t3641r1705b3693],
4	mmol/min/mg	NN	O	mmol/min/mg	dep	2	SENT_153	[p8l1358t3641r1705b3693],
5	protein	NN	O	protein	dep	8	SENT_153	[p8l1725t3641r1906b3693],
6	)	CD	NUMBER	)	num	5	SENT_153	[p8l1725t3641r1906b3693],
7	Control	NN	O	control	nn	8	SENT_153	[p8l1017t3737r1191b3777],
8	Curcumin	NN	O	curcumin	_	0	SENT_153	[p8l1604t3737r1834b3777],
9	(	CD	NUMBER	(	number	10	SENT_153	[p8l1856t3737r1928b3786],
10	25	CD	NUMBER	25	dep	8	SENT_153	[p8l1856t3737r1928b3786],
11	p.	NN	O	p.	nn	13	SENT_153	[p8l1954t3737r2057b3788],
12	M	NN	O	m	nn	13	SENT_153	[p8l1954t3737r2057b3788],
13	)	NN	O	)	dep	10	SENT_153	[p8l1954t3737r2057b3788],

1	Rat	NN	O	rat	nn	3	SENT_154	[p9l88t47r193b98],
2	liver	NN	O	liver	nn	3	SENT_154	[p9l219t45r357b98],
3	cytosol	NN	O	cytosol	dep	28	SENT_154	[p9l383t45r599b113],
4	0.163	CD	NUMBER	0.163	dep	3	SENT_154	[p9l885t45r1049b98],
5	:	:	O	:	_	0	SENT_154	[p9l1081t50r1127b95],
6	0.059	CD	NUMBER	0.059	number	7	SENT_154	[p9l1156t45r1322b99],
7	0.089	CD	NUMBER	0.089	dep	4	SENT_154	[p9l1612t46r1778b99],
8	:	:	O	:	_	0	SENT_154	[p9l1808t50r1854b95],
9	0.049	CD	NUMBER	0.049	num	10	SENT_154	[p9l1883t46r2049b99],
10	HEp2	NN	O	hep2	dep	4	SENT_154	[p9l89t121r262b188],
11	0.010	CD	NUMBER	0.010	dep	10	SENT_154	[p9l885t121r1052b173],
12	:	:	O	:	_	0	SENT_154	[p9l1081t125r1127b170],
13	0.004	CD	NUMBER	0.004	number	14	SENT_154	[p9l1156t121r1323b173],
14	0.003	CD	NUMBER	0.003	dep	4	SENT_154	[p9l1612t121r1776b173],
15	:	:	O	:	_	0	SENT_154	[p9l1808t125r1854b170],
16	0.006	CD	NUMBER	0.006	num	17	SENT_154	[p9l1883t120r2050b173],
17	HEp2A	NN	O	hep2a	dep	14	SENT_154	[p9l89t207r318b274],
18	0.016	CD	NUMBER	0.016	dep	17	SENT_154	[p9l885t206r1051b259],
19	:	:	O	:	_	0	SENT_154	[p9l1081t211r1127b256],
20	0.003	CD	NUMBER	0.003	number	21	SENT_154	[p9l1156t207r1320b259],
21	0.008	CD	NUMBER	0.008	dep	4	SENT_154	[p9l1612t206r1777b259],
22	:	:	O	:	_	0	SENT_154	[p9l1809t211r1854b256],
23	0.003	CD	NUMBER	0.003	num	25	SENT_154	[p9l1883t206r2047b259],
24	GSTPl	NN	O	gstpl	nn	25	SENT_154	[p9l90t292r366b345],
25	—	NN	O	—	dep	21	SENT_154	[p9l90t292r366b345],
26	l	NN	O	l	tmod	25	SENT_154	[p9l90t292r366b345],
27	85.1	CD	NUMBER	85.1	dep	28	SENT_154	[p9l925t292r1046b345],
28	i	FW	O	i	dep	33	SENT_154	[p9l1081t296r1127b342],
29	14.1	CD	NUMBER	14.1	number	30	SENT_154	[p9l1163t292r1279b344],
30	14.6	CD	NUMBER	14.6	dep	28	SENT_154	[p9l1656t292r1778b345],
31	1	CD	NUMBER	1	num	32	SENT_154	[p9l1809t296r1854b342],
32	‘	NN	O	‘	dep	30	SENT_154	[p9l1809t296r1854b342],
33	2.1	CD	NUMBER	2.1	_	0	SENT_154	[p9l1884t292r1968b344],

1	GST	NN	O	gst	nn	2	SENT_155	[p9l85t479r225b532],
2	activity	NN	O	activity	nsubjpass	4	SENT_155	[p9l249t479r472b547],
3	was	VBD	O	be	auxpass	4	SENT_155	[p9l495t496r609b531],
4	measured	VBN	O	measure	_	0	SENT_155	[p9l633t479r922b531],
5	with	IN	O	with	_	0	SENT_155	[p9l944t479r1076b532],
6	CDNB	NN	O	cdnb	prep_with	4	SENT_155	[p9l1100t479r1322b532],
7	.	.	O	.	_	0	SENT_155	[p9l1100t479r1322b532],

1	GSTPl	NN	O	gstpl	nsubjpass	5	SENT_156	[p9l1349t479r1625b532],
2	—	CD	NUMBER	—	num	3	SENT_156	[p9l1349t479r1625b532],
3	l	NN	O	l	tmod	5	SENT_156	[p9l1349t479r1625b532],
4	was	VBD	O	be	auxpass	5	SENT_156	[p9l1655t496r1769b531],
5	supplied	VBN	O	supply	_	0	SENT_156	[p9l1795t479r2048b547],
6	by	IN	O	by	prep	5	SENT_156	[p9l2068t479r2143b547],

1	Calbiochem	NNP	O	Calbiochem	nn	3	SENT_157	[p9l9t553r373b605],
2	(	NNP	O	(	nn	3	SENT_157	[p9l402t553r800b621],
3	Nottingham	NNP	O	Nottingham	_	0	SENT_157	[p9l402t553r800b621],
4	,	,	O	,	_	0	SENT_157	[p9l402t553r800b621],
5	UK	NNP	LOCATION	UK	nn	6	SENT_157	[p9l830t553r978b618],
6	)	NNP	O	)	appos	3	SENT_157	[p9l830t553r978b618],
7	.	.	O	.	_	0	SENT_157	[p9l830t553r978b618],

1	E	NN	O	e	nn	3	SENT_158	[p9l716t851r718b877],
2	I	CD	NUMBER	i	num	3	SENT_158	[p9l750t808r788b845],
3	um	NN	O	um	_	0	SENT_158	[p9l798t785r1058b851],
4	...	:	O	...	_	0	SENT_158	[p9l798t785r1058b851],
5	iiii	NN	O	iiii	dep	3	SENT_158	[p9l1059t785r1074b786],
6	.9	CD	NUMBER	.9	num	5	SENT_158	[p9l1072t813r1099b851],
7	ii	LS	O	ii	prep	5	SENT_158	[p9l1075t785r1082b786],
8	8	CD	NUMBER	8	number	9	SENT_158	[p9l1083t785r1086b786],
9	5	CD	NUMBER	5	dep	7	SENT_158	[p9l1087t785r1189b851],
10	.	.	O	.	_	0	SENT_158	[p9l1087t785r1189b851],

1	.	.	O	.	_	0	SENT_159	[p9l1087t785r1189b851],

1	iiii	NN	O	iiii	nn	3	SENT_160	[p9l1139t785r1170b786],
2	8	CD	NUMBER	8	num	3	SENT_160	[p9l1171t785r1198b845],
3	iiiiiiiiiiiiiiiiiiiiiiiiiiiii	NN	O	iiiiiiiiiiiiiiiiiiiiiiiiiiiii	_	0	SENT_160	[p9l1199t784r1422b786],
4	88	CD	NUMBER	88	num	7	SENT_160	[p9l1423t785r1430b786],
5	jjﬂgﬂl	NN	O	jjﬂgﬂl	nn	7	SENT_160	[p9l156t898r291b936],
6	‘	NN	O	‘	nn	7	SENT_160	[p9l717t893r718b898],
7	U	NN	O	u	dep	3	SENT_160	[p9l750t887r1056b931],
8	+	CC	O	+	_	0	SENT_160	[p9l1067t893r1093b925],
9	Cyuhlpnrh	NN	O	cyuhlpnrh	nn	10	SENT_160	[p9l1109t888r1361b942],
10	A	NN	O	a	dep	3	SENT_160	[p9l1372t888r1410b926],

1	«	NN	O	«	nn	2	SENT_161	[p9l152t1197r291b1235],
2	mm	NN	O	mm	_	0	SENT_161	[p9l152t1197r291b1235],
3	1	CD	NUMBER	1	dep	2	SENT_161	[p9l326t1176r328b1180],

1	Elna-n	NN	O	elna-n	_	0	SENT_162	[p9l17t1655r61b1944],
2	'	''	O	'	_	0	SENT_162	[p9l17t1655r61b1944],
3	;	:	O	;	_	0	SENT_162	[p9l17t1655r61b1944],
4	|	CD	NUMBER	|	dep	1	SENT_162	[p9l17t1655r61b1944],
5	:	:	O	:	_	0	SENT_162	[p9l17t1655r61b1944],
6	rI1	NN	O	ri1	dep	4	SENT_162	[p9l17t1655r61b1944],
7	.	.	O	.	_	0	SENT_162	[p9l17t1655r61b1944],

1	l	NN	O	l	_	0	SENT_163	[p9l17t1655r61b1944],
2	:	:	O	:	_	0	SENT_163	[p9l17t1655r61b1944],
3	it	PRP	O	it	dep	1	SENT_163	[p9l17t1655r61b1944],
4	:	:	O	:	_	0	SENT_163	[p9l17t1655r61b1944],
5	in	IN	O	in	_	0	SENT_163	[p9l17t1655r61b1944],
6	Hwmuemn	NNP	LOCATION	Hwmuemn	prep_in	9	SENT_163	[p9l17t1373r65b1645],
7	-	:	O	-	_	0	SENT_163	[p9l17t1155r71b1363],
8	I	PRP	O	I	nsubj	9	SENT_163	[p9l17t1155r71b1363],
9	[	VBP	O	[	rcmod	3	SENT_163	[p9l17t1155r71b1363],
10	J5	NN	O	j5	nsubj	22	SENT_163	[p9l17t1155r71b1363],
11	:	:	O	:	_	0	SENT_163	[p9l17t1155r71b1363],
12	I	PRP	O	I	dep	10	SENT_163	[p9l17t1155r71b1363],
13	'	''	O	'	_	0	SENT_163	[p9l17t1155r71b1363],
14	I	PRP	O	I	dep	10	SENT_163	[p9l17t1155r71b1363],
15	:	:	O	:	_	0	SENT_163	[p9l17t1155r71b1363],
16	ilm	NN	O	ilm	dep	14	SENT_163	[p9l17t1155r71b1363],
17	'	''	O	'	_	0	SENT_163	[p9l17t1155r71b1363],
18	§	CD	NUMBER	§	num	19	SENT_163	[p9l17t1155r71b1363],
19	p	NN	O	p	dep	16	SENT_163	[p9l17t1155r71b1363],
20	'	''	O	'	_	0	SENT_163	[p9l17t1155r71b1363],
21	‘	JJ	O	‘	amod	22	SENT_163	[p9l17t989r71b1144],
22	ifalrueél	NN	O	ifalrueél	xcomp	9	SENT_163	[p9l17t989r71b1144],

1	E	NN	O	e	_	0	SENT_164	[p9l156t1495r237b1533],

1	ﬂm	NN	O	ﬂm	_	0	SENT_165	[p9l156t1794r291b1832],

1	I-mp	NN	O	i-mp	_	0	SENT_166	[p9l355t2019r473b2072],
2	:	:	O	:	_	0	SENT_166	[p9l355t2019r473b2072],
3	11259	CD	NUMBER	11259	dep	1	SENT_166	[p9l885t2018r1141b2072],
4	:	:	O	:	_	0	SENT_166	[p9l885t2018r1141b2072],
5	-	:	O	-	_	0	SENT_166	[p9l885t2018r1141b2072],
6	.	.	O	.	_	0	SENT_166	[p9l885t2018r1141b2072],

1	mn	NN	O	mn	_	0	SENT_167	[p9l885t2018r1141b2072],
2	.	.	O	.	_	0	SENT_167	[p9l885t2018r1141b2072],

1	lﬂplik	NN	O	lﬂplik	_	0	SENT_168	[p9l1393t2018r1554b2072],
2	.	.	O	.	_	0	SENT_168	[p9l1393t2018r1554b2072],

1	@c	NN	O	@c	_	0	SENT_169	[p9l1778t2018r2068b2067],
2	*	CD	NUMBER	*	num	3	SENT_169	[p9l1778t2018r2068b2067],
3	^	NN	O	^	dep	1	SENT_169	[p9l1778t2018r2068b2067],
4	+	CC	O	+	rcmod	3	SENT_169	[p9l1778t2018r2068b2067],

1	FIGURE	NN	O	figure	_	0	SENT_170	[p9l79t2244r299b2296],
2	2	CD	NUMBER	2	number	3	SENT_170	[p9l324t2243r359b2295],
3	—	CD	NUMBER	—	num	5	SENT_170	[p9l379t2276r417b2280],
4	Doxorubicin	NN	O	doxorubicin	nn	5	SENT_170	[p9l437t2243r818b2296],
5	efﬂux	NN	O	efﬂux	dep	1	SENT_170	[p9l843t2243r1017b2296],
6	in	IN	O	in	_	0	SENT_170	[p9l1041t2243r1099b2295],
7	HEp2	NN	O	hep2	nn	10	SENT_170	[p9l1123t2244r1297b2312],
8	and	CC	O	and	_	0	SENT_170	[p9l1324t2244r1430b2296],
9	HEp2A	NN	O	hep2a	nn	10	SENT_170	[p9l1454t2244r1684b2312],
10	cells	NNS	O	cell	prep_in	5	SENT_170	[p9l1709t2243r1860b2296],
11	.	.	O	.	_	0	SENT_170	[p9l1709t2243r1860b2296],

1	Doxorubicin	NN	O	doxorubicin	nn	2	SENT_171	[p9l1888t2245r2141b2296, p9l7t2317r158b2370],
2	accumulation	NN	O	accumulation	nsubjpass	24	SENT_171	[p9l181t2317r601b2380],
3	,	,	O	,	_	0	SENT_171	[p9l181t2317r601b2380],
4	efﬂux	NN	O	efﬂux	npadvmod	24	SENT_171	[p9l626t2317r800b2370],
5	after	IN	O	after	_	0	SENT_171	[p9l823t2317r959b2370],
6	1	CD	DURATION	1	num	7	SENT_171	[p9l987t2318r1009b2369],
7	hr	NN	DURATION	hr	prep_after	24	SENT_171	[p9l1036t2317r1114b2380],
8	,	,	O	,	_	0	SENT_171	[p9l1036t2317r1114b2380],
9	effects	NNS	O	effect	nsubjpass	24	SENT_171	[p9l1139t2317r1336b2370],
10	of	IN	O	of	_	0	SENT_171	[p9l1360t2317r1426b2370],
11	cyclosporine	NN	O	cyclosporine	prep_of	9	SENT_171	[p9l1442t2317r1826b2385],
12	(	CD	NUMBER	(	number	13	SENT_171	[p9l1850t2318r1905b2382],
13	3	CD	NUMBER	3	num	15	SENT_171	[p9l1850t2318r1905b2382],
14	pug/ml	NN	O	pug/ml	nn	15	SENT_171	[p9l1935t2317r2141b2385],
15	)	NN	O	)	dep	11	SENT_171	[p9l1935t2317r2141b2385],
16	and	CC	O	and	_	0	SENT_171	[p9l10t2391r116b2444],
17	verapamil	NN	O	verapamil	conj_and	11	SENT_171	[p9l137t2391r437b2459],
18	(	CD	NUMBER	(	num	17	SENT_171	[p9l461t2391r516b2456],
19	5	CD	NUMBER	5	num	22	SENT_171	[p9l461t2391r516b2456],
20	p.	NN	O	p.	nn	22	SENT_171	[p9l545t2392r679b2459],
21	M	NN	O	m	nn	22	SENT_171	[p9l545t2392r679b2459],
22	)	NN	O	)	dep	17	SENT_171	[p9l545t2392r679b2459],
23	are	VBP	O	be	auxpass	24	SENT_171	[p9l703t2408r792b2444],
24	shown	VBN	O	show	_	0	SENT_171	[p9l815t2391r1024b2444],
25	.	.	O	.	_	0	SENT_171	[p9l815t2391r1024b2444],

1	Measurements	NNS	O	measurement	nsubjpass	3	SENT_172	[p9l1048t2392r1486b2444],
2	are	VBP	O	be	auxpass	3	SENT_172	[p9l1510t2408r1599b2444],
3	given	VBN	O	give	_	0	SENT_172	[p9l1621t2391r1786b2459],
4	in	IN	O	in	_	0	SENT_172	[p9l1807t2391r1864b2443],
5	arbitrary	JJ	O	arbitrary	amod	6	SENT_172	[p9l1886t2391r2143b2459],
6	units	NNS	O	unit	prep_in	3	SENT_172	[p9l8t2465r152b2517],
7	of	IN	O	of	_	0	SENT_172	[p9l193t2465r258b2517],
8	ﬂuorescence	NN	O	ﬂuorescence	prep_of	6	SENT_172	[p9l292t2465r682b2517],
9	.	.	O	.	_	0	SENT_172	[p9l292t2465r682b2517],

1	Each	DT	O	each	det	2	SENT_173	[p9l724t2465r875b2517],
2	point	NN	O	point	nsubj	3	SENT_173	[p9l911t2465r1067b2533],
3	represents	VBZ	O	represent	_	0	SENT_173	[p9l1104t2472r1407b2533],
4	the	DT	O	the	det	5	SENT_173	[p9l1447t2465r1538b2517],
5	mean	NN	O	mean	dobj	3	SENT_173	[p9l1576t2482r1739b2517],
6	of	IN	O	of	_	0	SENT_173	[p9l1777t2465r1842b2517],
7	triplicate	NN	O	triplicate	nn	8	SENT_173	[p9l1875t2465r2142b2533],
8	determinations	NNS	O	determination	prep_of	5	SENT_173	[p9l9t2539r471b2591],
9	.	.	O	.	_	0	SENT_173	[p9l9t2539r471b2591],

1	colonies	NNS	O	colony	nsubj	3	SENT_174	[p9l9t2751r271b2808],
2	were	VBD	O	be	cop	3	SENT_174	[p9l307t2769r459b2808],
3	large	JJ	O	large	_	0	SENT_174	[p9l493t2751r650b2824],
4	enough	RB	O	enough	advmod	3	SENT_174	[p9l684t2752r917b2824],
5	to	TO	O	to	_	0	SENT_174	[p9l950t2760r1009b2808],
6	trypsinise	NN	O	trypsinise	prep_to	3	SENT_174	[p9l1043t2751r1352b2824],
7	and	CC	O	and	_	0	SENT_174	[p9l1387t2751r1500b2808],
8	transfer	NN	O	transfer	prep_to	3	SENT_174	[p9l1532t2751r1776b2808],
9	to	TO	O	to	_	0	SENT_174	[p9l1807t2760r1867b2808],
10	48-well	JJ	O	48-well	amod	12	SENT_174	[p9l1900t2752r2143b2808],
11	culture	NN	O	culture	nn	12	SENT_174	[p9l9t2836r228b2892],
12	plates	NNS	O	plate	prep_to	3	SENT_174	[p9l261t2836r462b2909],
13	.	.	O	.	_	0	SENT_174	[p9l261t2836r462b2909],

1	Cells	NNS	O	cell	nsubj	2	SENT_175	[p9l501t2836r661b2892],
2	continued	VBD	O	continue	_	0	SENT_175	[p9l696t2836r1010b2892],
3	to	TO	O	to	aux	5	SENT_175	[p9l1042t2844r1102b2892],
4	be	VB	O	be	auxpass	5	SENT_175	[p9l1135t2836r1209b2892],
5	grown	VBN	O	grow	xcomp	2	SENT_175	[p9l1243t2853r1445b2909],
6	in	IN	O	in	_	0	SENT_175	[p9l1478t2836r1539b2891],
7	selective	JJ	O	selective	amod	8	SENT_175	[p9l1574t2836r1849b2892],
8	medium	NN	O	medium	prep_in	5	SENT_175	[p9l1883t2836r2144b2892],
9	and	CC	O	and	_	0	SENT_175	[p9l10t2920r123b2976],
10	expanded	VBN	O	expand	xcomp	2	SENT_175	[p9l148t2920r453b2993],
11	until	IN	O	until	mark	15	SENT_175	[p9l477t2920r622b2976],
12	stable	JJ	O	stable	amod	13	SENT_175	[p9l651t2920r832b2976],
13	cultures	NNS	O	culture	nsubj	15	SENT_175	[p9l858t2920r1108b2976],
14	were	VBD	O	be	cop	15	SENT_175	[p9l1135t2937r1288b2976],
15	large	JJ	O	large	advcl	10	SENT_175	[p9l1314t2920r1472b2993],
16	enough	RB	O	enough	advmod	15	SENT_175	[p9l1498t2920r1731b2993],
17	to	TO	O	to	aux	19	SENT_175	[p9l1756t2928r1816b2976],
18	be	VB	O	be	auxpass	19	SENT_175	[p9l1841t2920r1915b2976],
19	grown	VBN	O	grow	xcomp	15	SENT_175	[p9l1941t2937r2143b2993],
20	in	IN	O	in	_	0	SENT_175	[p9l8t3004r69b3060],
21	75	CD	NUMBER	75	num	23	SENT_175	[p9l98t3004r172b3061],
22	cm2	NN	O	cm2	nn	23	SENT_175	[p9l206t2992r332b3060],
23	ﬂasks	NNS	O	ﬂasks	prep_in	19	SENT_175	[p9l363t3004r557b3060],
24	.	.	O	.	_	0	SENT_175	[p9l363t3004r557b3060],

1	At	IN	O	at	_	0	SENT_176	[p9l591t3005r670b3060],
2	this	DT	O	this	det	3	SENT_176	[p9l698t3004r810b3060],
3	point	NN	O	point	prep_at	7	SENT_176	[p9l840t3004r1021b3077],
4	,	,	O	,	_	0	SENT_176	[p9l840t3004r1021b3077],
5	cells	NNS	O	cell	nsubjpass	7	SENT_176	[p9l1054t3004r1196b3060],
6	were	VBD	O	be	auxpass	7	SENT_176	[p9l1228t3022r1380b3060],
7	maintained	VBN	O	maintain	_	0	SENT_176	[p9l1410t3004r1765b3060],
8	in	IN	O	in	_	0	SENT_176	[p9l1793t3004r1854b3060],
9	medium	NN	O	medium	prep_in	7	SENT_176	[p9l1883t3004r2145b3060],
10	containing	VBG	O	contain	xcomp	7	SENT_176	[p9l9t3088r344b3161],
11	200	CD	NUMBER	200	num	13	SENT_176	[p9l393t3088r509b3145],
12	ug/ml	JJ	O	ug/ml	amod	13	SENT_176	[p9l562t3088r755b3161],
13	zeocin	NN	O	zeocin	dobj	10	SENT_176	[p9l804t3088r1010b3144],
14	and	CC	O	and	_	0	SENT_176	[p9l1058t3088r1171b3144],
15	expression	NN	O	expression	conj_and	13	SENT_176	[p9l1218t3088r1558b3161],
16	and	CC	O	and	_	0	SENT_176	[p9l1607t3088r1720b3144],
17	function	NN	O	function	conj_and	13	SENT_176	[p9l1766t3088r2031b3144],
18	of	IN	O	of	_	0	SENT_176	[p9l2079t3088r2149b3144],
19	GSTP1	NN	O	gstp1	prep_of	15	SENT_176	[p9l10t3173r235b3229],
20	assessed	VBN	O	assess	partmod	19	SENT_176	[p9l273t3172r556b3229],
21	.	.	O	.	_	0	SENT_176	[p9l273t3172r556b3229],

1	Data	NN	O	datum	nn	2	SENT_177	[p9l7t3307r166b3362],
2	analysis	NN	O	analysis	_	0	SENT_177	[p9l195t3305r455b3377],

1	Differences	NNS	O	difference	nsubjpass	11	SENT_178	[p9l88t3405r458b3462],
2	in	IN	O	in	_	0	SENT_178	[p9l499t3405r560b3461],
3	ﬂuorescence	NN	O	ﬂuorescence	nn	4	SENT_178	[p9l600t3405r996b3462],
4	values	NNS	O	value	prep_in	1	SENT_178	[p9l1036t3405r1237b3462],
5	in	IN	O	in	_	0	SENT_178	[p9l1278t3405r1338b3461],
6	efﬂux	NN	O	efﬂux	nn	7	SENT_178	[p9l1377t3405r1561b3462],
7	experiments	NNS	O	experiment	prep_in	4	SENT_178	[p9l1602t3405r1989b3478],
8	and	CC	O	and	_	0	SENT_178	[p9l2031t3405r2144b3462],
9	cytotoxicity	NN	O	cytotoxicity	prep_in	4	SENT_178	[p9l9t3489r388b3562],
10	were	VBD	O	be	auxpass	11	SENT_178	[p9l421t3507r574b3546],
11	assessed	VBN	O	assess	_	0	SENT_178	[p9l607t3489r876b3546],
12	by	IN	O	by	_	0	SENT_178	[p9l906t3489r984b3562],
13	the	DT	O	the	det	15	SENT_178	[p9l1016t3490r1112b3546],
14	2-sample	JJ	O	2-sample	amod	15	SENT_178	[p9l1145t3490r1435b3562],
15	t-test	NN	O	t-test	agent	11	SENT_178	[p9l1469t3498r1626b3546],
16	and	CC	O	and	_	0	SENT_178	[p9l1658t3489r1771b3546],
17	by	IN	O	by	_	0	SENT_178	[p9l1801t3489r1880b3562],
18	Anova	NNP	ORGANIZATION	Anova	agent	11	SENT_178	[p9l1911t3490r2139b3546],
19	.	.	O	.	_	0	SENT_178	[p9l1911t3490r2139b3546],

1	Results	NNS	O	result	nsubjpass	3	SENT_179	[p9l8t3574r240b3630],
2	were	VBD	O	be	auxpass	3	SENT_179	[p9l269t3591r421b3630],
3	considered	VBN	O	consider	_	0	SENT_179	[p9l448t3574r793b3630],
4	to	TO	O	to	aux	7	SENT_179	[p9l818t3582r877b3630],
5	be	VB	O	be	cop	7	SENT_179	[p9l903t3574r977b3630],
6	statistically	RB	O	statistically	advmod	7	SENT_179	[p9l1006t3574r1366b3647],
7	signiﬁcant	JJ	O	signiﬁcant	xcomp	3	SENT_179	[p9l1395t3574r1725b3647],
8	at	IN	O	at	_	0	SENT_179	[p9l1751t3582r1806b3630],
9	p	NN	O	p	prep_at	7	SENT_179	[p9l1824t3593r1868b3646],
10	<	JJR	O	<	dep	7	SENT_179	[p9l1900t3579r1954b3626],
11	0.05	CD	NUMBER	0.05	advmod	7	SENT_179	[p9l1985t3573r2139b3630],
12	.	.	O	.	_	0	SENT_179	[p9l1985t3573r2139b3630],

1	RESULTS	NNS	O	result	_	0	SENT_180	[p10l932t73r1216b119],

1	Drug	NN	O	drug	nn	2	SENT_181	[p10l7t166r175b235],
2	sensitivity	NN	O	sensitivity	_	0	SENT_181	[p10l204t166r522b235],

1	Using	VBG	O	use	partmod	30	SENT_182	[p10l88t263r277b336],
2	the	DT	O	the	det	4	SENT_182	[p10l298t263r394b319],
3	MTT	NNP	O	MTT	nn	4	SENT_182	[p10l415t264r582b318],
4	test	NN	O	test	dobj	1	SENT_182	[p10l603t271r729b329],
5	,	,	O	,	_	0	SENT_182	[p10l603t271r729b329],
6	the	DT	O	the	det	7	SENT_182	[p10l752t263r848b319],
7	sensitivity	NN	O	sensitivity	nsubjpass	30	SENT_182	[p10l871t263r1196b336],
8	of	IN	O	of	_	0	SENT_182	[p10l1218t263r1287b319],
9	the	DT	O	the	det	13	SENT_182	[p10l1302t263r1398b319],
10	wild-type	JJ	O	wild-type	amod	13	SENT_182	[p10l1419t263r1723b336],
11	and	CC	O	and	_	0	SENT_182	[p10l1746t263r1858b319],
12	resistant	JJ	O	resistant	conj_and	10	SENT_182	[p10l1877t263r2144b319],
13	cells	NNS	O	cell	prep_of	7	SENT_182	[p10l9t346r151b402],
14	to	TO	O	to	_	0	SENT_182	[p10l179t355r238b402],
15	doxorubicin	NN	O	doxorubicin	prep_to	13	SENT_182	[p10l266t346r650b402],
16	and	CC	O	and	_	0	SENT_182	[p10l677t346r790b402],
17	the	DT	O	the	det	18	SENT_182	[p10l815t346r910b402],
18	effects	NNS	O	effect	prep_of	7	SENT_182	[p10l937t346r1146b402],
19	of	IN	O	of	_	0	SENT_182	[p10l1174t346r1243b402],
20	inhibitors	NNS	O	inhibitor	prep_of	18	SENT_182	[p10l1263t346r1567b402],
21	of	IN	O	of	_	0	SENT_182	[p10l1595t346r1664b402],
22	GST	NN	O	gst	nn	25	SENT_182	[p10l1686t346r1834b403],
23	and	CC	O	and	_	0	SENT_182	[p10l1861t346r1974b402],
24	drug	NN	O	drug	nn	25	SENT_182	[p10l1999t346r2142b419],
25	transporters	NNS	O	transporter	prep_of	20	SENT_182	[p10l8t438r383b503],
26	on	IN	O	on	_	0	SENT_182	[p10l427t448r504b486],
27	this	DT	O	this	det	28	SENT_182	[p10l545t430r657b486],
28	sensitivity	NN	O	sensitivity	prep_on	25	SENT_182	[p10l702t430r1026b503],
29	was	VBD	O	be	auxpass	30	SENT_182	[p10l1069t448r1189b486],
30	compared	VBN	O	compare	_	0	SENT_182	[p10l1232t430r1546b503],
31	to	TO	O	to	aux	32	SENT_182	[p10l1587t439r1646b486],
32	determine	VB	O	determine	xcomp	30	SENT_182	[p10l1689t430r2006b486],
33	the	DT	O	the	det	34	SENT_182	[p10l2047t430r2143b486],
34	contribution	NN	O	contribution	dobj	32	SENT_182	[p10l9t514r398b570],
35	of	IN	O	of	_	0	SENT_182	[p10l443t514r511b570],
36	metabolism	NN	O	metabolism	nn	39	SENT_182	[p10l550t514r923b571],
37	and	CC	O	and	_	0	SENT_182	[p10l967t514r1080b570],
38	drug	NN	O	drug	nn	39	SENT_182	[p10l1123t514r1266b587],
39	efﬂux	NN	O	efﬂux	prep_of	34	SENT_182	[p10l1312t514r1495b570],
40	to	TO	O	to	_	0	SENT_182	[p10l1539t523r1599b570],
41	resistance	NN	O	resistance	prep_to	32	SENT_182	[p10l1642t514r1973b571],
42	.	.	O	.	_	0	SENT_182	[p10l1642t514r1973b571],

1	The	DT	O	the	det	3	SENT_183	[p10l2021t514r2143b571],
2	highest	JJS	O	highest	amod	3	SENT_183	[p10l8t598r239b671],
3	concentration	NN	O	concentration	nsubj	6	SENT_183	[p10l279t598r713b655],
4	of	IN	O	of	_	0	SENT_183	[p10l755t598r824b655],
5	doxorubicin	NN	O	doxorubicin	prep_of	3	SENT_183	[p10l860t598r1245b655],
6	used	VBD	O	use	_	0	SENT_183	[p10l1285t599r1431b655],
7	(	CD	NUMBER	(	number	8	SENT_183	[p10l1473t599r1615b668],
8	100	CD	NUMBER	100	num	9	SENT_183	[p10l1473t599r1615b668],
9	p.	NN	O	p.	dobj	6	SENT_183	[p10l1662t599r1804b671],
10	M	NN	O	m	nn	11	SENT_183	[p10l1662t599r1804b671],
11	)	NN	O	)	nsubj	12	SENT_183	[p10l1662t599r1804b671],
12	produced	VBD	O	produce	rcmod	9	SENT_183	[p10l1846t598r2144b671],
13	30	CD	PERCENT	30	number	14	SENT_183	[p10l11t683r150b739],
14	%	NN	PERCENT	%	amod	16	SENT_183	[p10l11t683r150b739],
15	cell	NN	O	cell	nn	16	SENT_183	[p10l197t683r310b739],
16	death	NN	O	death	dobj	12	SENT_183	[p10l354t683r525b739],
17	in	IN	O	in	_	0	SENT_183	[p10l568t683r628b738],
18	untreated	JJ	O	untreated	amod	19	SENT_183	[p10l670t683r967b739],
19	drug-resistant	JJ	O	drug-resistant	amod	21	SENT_183	[p10l1011t683r1449b756],
20	HEp2A	NN	O	hep2a	nn	21	SENT_183	[p10l1492t683r1734b755],
21	cells	NNS	O	cell	prep_in	12	SENT_183	[p10l1778t683r1938b739],
22	.	.	O	.	_	0	SENT_183	[p10l1778t683r1938b739],

1	IC50	NN	O	ic50	nn	2	SENT_184	[p10l1985t683r2143b739],
2	value	NN	O	value	nsubjpass	5	SENT_184	[p10l9t767r179b823],
3	was	VBD	O	be	auxpass	5	SENT_184	[p10l215t785r335b823],
4	therefore	RB	O	therefore	advmod	5	SENT_184	[p10l371t767r658b823],
5	deﬁned	VBN	O	deﬁned	_	0	SENT_184	[p10l694t767r927b823],
6	as	IN	O	as	_	0	SENT_184	[p10l963t785r1024b823],
7	>	JJR	O	>	prep_as	5	SENT_184	[p10l1066t767r1245b823],
8	100	CD	NUMBER	100	num	9	SENT_184	[p10l1066t767r1245b823],
9	p.M	NN	O	p.m	dep	7	SENT_184	[p10l1285t768r1402b839],
10	(	CD	NUMBER	(	num	11	SENT_184	[p10l1439t767r1584b840],
11	Fig	NN	O	fig	dep	9	SENT_184	[p10l1439t767r1584b840],
12	.	.	O	.	_	0	SENT_184	[p10l1439t767r1584b840],

1	la	DT	O	la	_	0	SENT_185	[p10l1631t767r1720b833],
2	;	:	O	;	_	0	SENT_185	[p10l1631t767r1720b833],
3	Table	NNP	O	Table	dep	1	SENT_185	[p10l1758t767r1938b823],
4	I	PRP	O	I	nsubj	5	SENT_185	[p10l1972t768r2040b836],
5	)	VBP	O	)	rcmod	3	SENT_185	[p10l1972t768r2040b836],
6	.	.	O	.	_	0	SENT_185	[p10l1972t768r2040b836],

1	In	IN	O	in	_	0	SENT_186	[p10l2078t768r2143b822],
2	HEp2	NN	O	hep2	nn	3	SENT_186	[p10l9t851r192b923],
3	cells	NNS	O	cell	prep_in	11	SENT_186	[p10l228t850r389b917],
4	,	,	O	,	_	0	SENT_186	[p10l228t850r389b917],
5	the	DT	O	the	det	8	SENT_186	[p10l426t850r521b906],
6	doxorubicin	NN	O	doxorubicin	nn	8	SENT_186	[p10l557t850r941b906],
7	IC50	NN	O	ic50	nn	8	SENT_186	[p10l975t850r1132b907],
8	value	NN	O	value	nsubj	11	SENT_186	[p10l1167t850r1338b906],
9	was	VBD	O	be	cop	11	SENT_186	[p10l1373t868r1493b906],
10	7.29	CD	NUMBER	7.29	num	11	SENT_186	[p10l1529t851r1665b907],
11	p.M	NN	O	p.m	_	0	SENT_186	[p10l1706t852r1823b922],
12	(	CD	NUMBER	(	num	13	SENT_186	[p10l1860t850r2005b923],
13	Fig	NN	O	fig	dep	11	SENT_186	[p10l1860t850r2005b923],
14	.	.	O	.	_	0	SENT_186	[p10l1860t850r2005b923],

1	119	CD	NUMBER	119	_	0	SENT_187	[p10l2050t850r2139b917],
2	;	:	O	;	_	0	SENT_187	[p10l2050t850r2139b917],
3	Table	NNP	O	Table	dep	1	SENT_187	[p10l9t934r188b990],
4	I	PRP	O	I	nsubj	5	SENT_187	[p10l236t935r303b1004],
5	)	VBP	O	)	rcmod	3	SENT_187	[p10l236t935r303b1004],
6	.	.	O	.	_	0	SENT_187	[p10l236t935r303b1004],

1	HEp2A	NN	O	hep2a	nn	2	SENT_188	[p10l354t935r597b1007],
2	cells	NNS	O	cell	nsubj	5	SENT_188	[p10l644t934r787b991],
3	were	VBD	O	be	cop	5	SENT_188	[p10l836t952r989b991],
4	thus	RB	O	thus	advmod	5	SENT_188	[p10l1036t934r1165b991],
5	>	JJR	O	>	_	0	SENT_188	[p10l1219t934r1515b991],
6	13-fold	RB	O	13-fold	advmod	8	SENT_188	[p10l1219t934r1515b991],
7	more	RBR	O	more	advmod	8	SENT_188	[p10l1562t952r1724b990],
8	resistant	JJ	O	resistant	dep	5	SENT_188	[p10l1770t934r2037b991],
9	to	TO	O	to	_	0	SENT_188	[p10l2083t943r2142b990],
10	doxorubicin	NN	O	doxorubicin	prep_to	5	SENT_188	[p10l9t1018r394b1075],
11	than	IN	O	than	_	0	SENT_188	[p10l421t1018r556b1075],
12	HEp2	NN	O	hep2	nn	13	SENT_188	[p10l584t1019r768b1091],
13	cells	NNS	O	cell	prep_than	5	SENT_188	[p10l796t1018r956b1075],
14	.	.	O	.	_	0	SENT_188	[p10l796t1018r956b1075],

1	Treatment	NN	O	treatment	nsubj	7	SENT_189	[p10l987t1020r1316b1074],
2	of	IN	O	of	_	0	SENT_189	[p10l1343t1018r1412b1074],
3	HEp2A	NN	O	hep2a	nn	4	SENT_189	[p10l1434t1019r1677b1091],
4	cells	NNS	O	cell	prep_of	1	SENT_189	[p10l1704t1018r1846b1074],
5	by	IN	O	by	_	0	SENT_189	[p10l1874t1018r1953b1091],
6	verapamil	NN	O	verapamil	prep_by	4	SENT_189	[p10l1981t1036r2141b1074, p10l7t1102r189b1175],
7	reduced	VBD	O	reduce	_	0	SENT_189	[p10l216t1103r469b1159],
8	the	DT	O	the	det	10	SENT_189	[p10l497t1103r592b1159],
9	doxorubicin	NN	O	doxorubicin	nn	10	SENT_189	[p10l622t1102r1006b1159],
10	IC50	NN	O	ic50	dobj	7	SENT_189	[p10l1034t1102r1192b1159],
11	from	IN	O	from	_	0	SENT_189	[p10l1220t1102r1375b1159],
12	>	JJR	O	>	prep_from	7	SENT_189	[p10l1407t1103r1586b1159],
13	100	CD	NUMBER	100	num	14	SENT_189	[p10l1407t1103r1586b1159],
14	p.M	NN	O	p.m	dep	20	SENT_189	[p10l1620t1104r1737b1175],
15	to	TO	O	to	_	0	SENT_189	[p10l1766t1111r1825b1159],
16	5.28	CD	NUMBER	5.28	num	17	SENT_189	[p10l1855t1102r1989b1159],
17	ptM	NN	O	ptm	prep_to	14	SENT_189	[p10l2026t1104r2142b1175],
18	(	CD	NUMBER	(	num	19	SENT_189	[p10l11t1187r72b1259],
19	p	NN	O	p	dep	20	SENT_189	[p10l11t1187r72b1259],
20	<	JJR	O	<	dep	12	SENT_189	[p10l100t1192r154b1239],
21	0.001	CD	NUMBER	0.001	num	22	SENT_189	[p10l181t1187r401b1256],
22	)	NN	O	)	dep	20	SENT_189	[p10l181t1187r401b1256],
23	.	.	O	.	_	0	SENT_189	[p10l181t1187r401b1256],

1	Inhibition	NN	O	inhibition	nsubj	47	SENT_190	[p10l427t1187r741b1243],
2	of	IN	O	of	_	0	SENT_190	[p10l763t1187r832b1243],
3	GST	NN	O	gst	prep_of	1	SENT_190	[p10l849t1187r997b1243],
4	alone	RB	O	alone	advmod	3	SENT_190	[p10l1020t1187r1190b1243],
5	by	IN	O	by	_	0	SENT_190	[p10l1211t1187r1289b1260],
6	curcumin	NN	O	curcumin	prep_by	3	SENT_190	[p10l1311t1187r1628b1253],
7	,	,	O	,	_	0	SENT_190	[p10l1311t1187r1628b1253],
8	which	WDT	O	which	nsubjpass	12	SENT_190	[p10l1653t1187r1847b1243],
9	has	VBZ	O	have	aux	12	SENT_190	[p10l1867t1187r1970b1243],
10	been	VBN	O	be	auxpass	12	SENT_190	[p10l1993t1187r2143b1243],
11	previously	RB	DATE	previously	advmod	12	SENT_190	[p10l8t1271r344b1344],
12	shown	VBN	O	show	rcmod	6	SENT_190	[p10l382t1271r586b1327],
13	to	TO	O	to	aux	17	SENT_190	[p10l621t1279r680b1327],
14	be	VB	O	be	cop	17	SENT_190	[p10l715t1271r789b1327],
15	a	DT	O	a	det	17	SENT_190	[p10l826t1289r859b1327],
16	GST	NN	O	gst	nn	17	SENT_190	[p10l894t1271r1042b1327],
17	inhibitor	NN	O	inhibitor	xcomp	12	SENT_190	[p10l1077t1271r1352b1327],
18	with	IN	O	with	_	0	SENT_190	[p10l1386t1271r1526b1327],
19	selectivity	NN	O	selectivity	prep_with	17	SENT_190	[p10l1563t1271r1887b1344],
20	toward	IN	O	toward	_	0	SENT_190	[p10l1923t1271r2144b1327],
21	GSTP125	CD	NUMBER	gstp125	number	22	SENT_190	[p10l10t1343r382b1412],
22	’26	CD	NUMBER	’26	prep_toward	19	SENT_190	[p10l10t1343r382b1412],
23	and	CC	O	and	_	0	SENT_190	[p10l413t1355r525b1411],
24	was	VBD	O	be	cop	27	SENT_190	[p10l554t1373r674b1411],
25	a	DT	O	a	det	27	SENT_190	[p10l706t1373r739b1411],
26	potent	JJ	O	potent	amod	27	SENT_190	[p10l765t1364r966b1428],
27	inhibitor	NN	O	inhibitor	conj_and	12	SENT_190	[p10l993t1355r1269b1411],
28	of	IN	O	of	_	0	SENT_190	[p10l1297t1355r1366b1411],
29	both	DT	O	both	det	32	SENT_190	[p10l1388t1355r1530b1411],
30	total	JJ	O	total	amod	32	SENT_190	[p10l1558t1355r1698b1411],
31	GST	NN	O	gst	nn	32	SENT_190	[p10l1728t1356r1876b1412],
32	activity	NN	O	activity	prep_of	27	SENT_190	[p10l1907t1355r2142b1428],
33	in	IN	O	in	_	0	SENT_190	[p10l8t1439r69b1495],
34	the	DT	O	the	det	36	SENT_190	[p10l90t1439r185b1495],
35	cell	NN	O	cell	nn	36	SENT_190	[p10l208t1439r320b1495],
36	lines	NNS	O	line	prep_in	32	SENT_190	[p10l342t1439r489b1495],
37	and	CC	O	and	_	0	SENT_190	[p10l514t1439r626b1495],
38	puriﬁed	JJ	O	puriﬁed	amod	40	SENT_190	[p10l646t1439r895b1512],
39	GSTP1	NN	O	gstp1	nn	40	SENT_190	[p10l916t1439r1142b1496],
40	activity	NN	O	activity	prep_in	32	SENT_190	[p10l1172t1439r1408b1512],
41	at	IN	O	at	_	0	SENT_190	[p10l1431t1447r1487b1495],
42	the	DT	O	the	det	43	SENT_190	[p10l1507t1439r1602b1495],
43	concentration	NN	O	concentration	prep_at	27	SENT_190	[p10l1624t1439r2058b1495],
44	of	IN	O	of	_	0	SENT_190	[p10l2080t1439r2149b1495],
45	25	CD	NUMBER	25	num	46	SENT_190	[p10l10t1523r83b1580],
46	p.M	NN	O	p.m	prep_of	43	SENT_190	[p10l115t1525r231b1596],
47	used	VBD	O	use	ccomp	53	SENT_190	[p10l254t1523r400b1579],
48	(	CD	NUMBER	(	dobj	47	SENT_190	[p10l425t1523r629b1593],
49	Table	NNP	O	Table	nn	51	SENT_190	[p10l425t1523r629b1593],
50	II	NNP	O	II	nn	51	SENT_190	[p10l652t1524r747b1593],
51	)	NNP	O	)	dep	48	SENT_190	[p10l652t1524r747b1593],
52	,	,	O	,	_	0	SENT_190	[p10l652t1524r747b1593],
53	reduced	VBD	O	reduce	_	0	SENT_190	[p10l772t1523r1025b1580],
54	doxorubicin	NN	O	doxorubicin	nn	55	SENT_190	[p10l1048t1523r1432b1579],
55	IC50	NN	O	ic50	dobj	53	SENT_190	[p10l1455t1523r1613b1580],
56	from	IN	O	from	_	0	SENT_190	[p10l1637t1523r1791b1579],
57	>	JJR	O	>	prep_from	53	SENT_190	[p10l1818t1529r1872b1576],
58	100	CD	NUMBER	100	num	59	SENT_190	[p10l1887t1524r1997b1580],
59	p.M	NN	O	p.m	nsubj	68	SENT_190	[p10l2026t1525r2142b1595],
60	to	TO	O	to	_	0	SENT_190	[p10l8t1616r68b1664],
61	36.22	CD	NUMBER	36.22	num	62	SENT_190	[p10l102t1607r278b1664],
62	p.	NN	O	p.	prep_to	59	SENT_190	[p10l315t1609r432b1680],
63	,	,	O	,	_	0	SENT_190	[p10l315t1609r432b1680],
64	M	NN	O	m	appos	62	SENT_190	[p10l315t1609r432b1680],
65	in	IN	O	in	_	0	SENT_190	[p10l464t1607r524b1663],
66	HEp2A	NN	O	hep2a	nn	67	SENT_190	[p10l556t1608r798b1680],
67	cells	NNS	O	cell	prep_in	64	SENT_190	[p10l830t1608r973b1664],
68	(	VBP	O	(	rcmod	57	SENT_190	[p10l1009t1608r1069b1679],
69	p	NN	O	p	dep	70	SENT_190	[p10l1009t1608r1069b1679],
70	<	JJR	O	<	dobj	68	SENT_190	[p10l1107t1613r1161b1660],
71	0.001	CD	NUMBER	0.001	num	72	SENT_190	[p10l1199t1608r1419b1677],
72	)	NN	O	)	nsubj	53	SENT_190	[p10l1199t1608r1419b1677],
73	.	.	O	.	_	0	SENT_190	[p10l1199t1608r1419b1677],

1	Curcumin	NN	O	curcumin	npadvmod	2	SENT_191	[p10l1455t1607r1773b1664],
2	alone	RB	O	alone	advmod	3	SENT_191	[p10l1806t1608r1976b1664],
3	chemosensitised	VBD	O	chemosensitise	_	0	SENT_191	[p10l2008t1608r2141b1664, p10l8t1692r421b1748],
4	drug-sensitive	JJ	O	drug-sensitive	amod	6	SENT_191	[p10l453t1692r903b1765],
5	HEp2	NN	O	hep2	nn	6	SENT_191	[p10l936t1692r1120b1765],
6	cells	NNS	O	cell	nsubj	19	SENT_191	[p10l1153t1692r1295b1748],
7	and	CC	O	and	_	0	SENT_191	[p10l1331t1692r1443b1748],
8	reduced	VBN	O	reduce	amod	10	SENT_191	[p10l1474t1692r1727b1748],
9	doxorubicin	NN	O	doxorubicin	nn	10	SENT_191	[p10l1759t1692r2144b1748],
10	IC50	NN	O	ic50	nsubj	19	SENT_191	[p10l9t1776r166b1832],
11	from	IN	O	from	_	0	SENT_191	[p10l198t1776r352b1832],
12	7.29	CD	NUMBER	7.29	num	13	SENT_191	[p10l383t1776r519b1833],
13	p.M	NN	O	p.m	prep_from	6	SENT_191	[p10l557t1777r674b1848],
14	to	TO	O	to	_	0	SENT_191	[p10l705t1784r764b1832],
15	2.46	CD	NUMBER	2.46	num	16	SENT_191	[p10l797t1776r933b1832],
16	p.M	NN	O	p.m	prep_to	13	SENT_191	[p10l971t1777r1087b1848],
17	(	CD	NUMBER	(	num	18	SENT_191	[p10l1122t1777r1183b1848],
18	p	NN	O	p	npadvmod	19	SENT_191	[p10l1122t1777r1183b1848],
19	<	JJR	O	<	xcomp	3	SENT_191	[p10l1220t1782r1274b1828],
20	0.001	CD	NUMBER	0.001	num	23	SENT_191	[p10l1311t1776r1513b1845],
21	)	NN	O	)	nn	23	SENT_191	[p10l1311t1776r1513b1845],
22	(	CD	NUMBER	(	num	23	SENT_191	[p10l1549t1776r1694b1849],
23	Fig	NN	O	fig	nsubj	3	SENT_191	[p10l1549t1776r1694b1849],
24	.	.	O	.	_	0	SENT_191	[p10l1549t1776r1694b1849],

1	119	CD	NUMBER	119	_	0	SENT_192	[p10l1736t1776r1826b1842],
2	;	:	O	;	_	0	SENT_192	[p10l1736t1776r1826b1842],
3	Table	NNP	O	Table	dep	1	SENT_192	[p10l1860t1776r2040b1832],
4	I	PRP	O	I	nsubj	5	SENT_192	[p10l2072t1777r2139b1845],
5	)	VBP	O	)	rcmod	3	SENT_192	[p10l2072t1777r2139b1845],
6	.	.	O	.	_	0	SENT_192	[p10l2072t1777r2139b1845],

1	-	:	O	-	_	0	SENT_193	[p11l1678t141r1705b173],
2	rr	NN	O	rr	_	0	SENT_193	[p11l1678t141r1705b173],
3	5	CD	NUMBER	5	num	4	SENT_193	[p11l1786t114r1877b195],
4	’	NN	O	’	dep	2	SENT_193	[p11l1786t114r1877b195],
5	?	.	O	?	_	0	SENT_193	[p11l1786t114r1877b195],

1	.	.	O	.	_	0	SENT_194	[p11l1104t356r1276b372],

1	EE	NN	O	ee	_	0	SENT_195	[p11l1104t356r1276b372],
2	'	''	O	'	_	0	SENT_195	[p11l1104t356r1276b372],
3	?	.	O	?	_	0	SENT_195	[p11l1104t356r1276b372],

1	-	:	O	-	_	0	SENT_196	[p11l1104t356r1276b372],
2	,	,	O	,	_	0	SENT_196	[p11l1104t356r1276b372],
3	_	NN	O	_	advmod	5	SENT_196	[p11l1104t356r1276b372],
4	'	''	O	'	_	0	SENT_196	[p11l1104t356r1276b372],
5	‘	NN	O	‘	_	0	SENT_196	[p11l1104t356r1276b372],
6	'	''	O	'	_	0	SENT_196	[p11l1104t356r1276b372],
7	?	.	O	?	_	0	SENT_196	[p11l1104t356r1276b372],
8	'	''	O	'	_	0	SENT_196	[p11l1104t356r1276b372],

1	’	NN	O	’	_	0	SENT_197	[p11l1104t356r1276b372],
2	'	''	O	'	_	0	SENT_197	[p11l1297t356r1303b358],

1	FIGURE	NN	O	figure	nn	4	SENT_198	[p11l79t507r299b561],
2	3	CD	NUMBER	3	num	4	SENT_198	[p11l337t506r372b561],
3	—	NN	O	—	nn	4	SENT_198	[p11l393t540r432b544],
4	Immunoblot	NN	O	immunoblot	_	0	SENT_198	[p11l451t507r826b560],
5	for	IN	O	for	_	0	SENT_198	[p11l864t507r952b560],
6	P-glycoprotein	NN	O	p-glycoprotein	prep_for	4	SENT_198	[p11l988t507r1438b576],
7	(	CD	NUMBER	(	dep	4	SENT_198	[p11l1479t508r1641b576],
8	Pgp	NNP	O	Pgp	dep	9	SENT_198	[p11l1479t508r1641b576],
9	)	CD	NUMBER	)	dep	7	SENT_198	[p11l1479t508r1641b576],
10	in	IN	O	in	_	0	SENT_198	[p11l1681t507r1739b560],
11	HEp2A	NN	O	hep2a	prep_in	9	SENT_198	[p11l1777t507r2007b576],
12	and	CC	O	and	cc	9	SENT_198	[p11l2046t507r2153b560],

1	HEp2	NN	O	hep2	nn	2	SENT_199	[p11l8t582r182b651],
2	cells	NNS	O	cell	_	0	SENT_199	[p11l211t582r362b635],
3	.	.	O	.	_	0	SENT_199	[p11l211t582r362b635],

1	The	DT	O	the	det	2	SENT_200	[p11l394t582r510b635],
2	position	NN	O	position	nsubjpass	6	SENT_200	[p11l536t582r781b651],
3	of	IN	O	of	_	0	SENT_200	[p11l809t582r874b635],
4	Pgp	NNP	ORGANIZATION	Pgp	prep_of	2	SENT_200	[p11l897t583r1012b651],
5	is	VBZ	O	be	auxpass	6	SENT_200	[p11l1040t582r1087b635],
6	indicated	VBN	O	indicate	_	0	SENT_200	[p11l1116t582r1408b635],
7	.	.	O	.	_	0	SENT_200	[p11l1116t582r1408b635],

1	There	EX	O	there	expl	2	SENT_201	[p11l7t812r193b868],
2	was	VBD	O	be	_	0	SENT_201	[p11l224t830r345b868],
3	no	DT	O	no	det	4	SENT_201	[p11l377t830r455b868],
4	effect	NN	O	effect	nsubj	2	SENT_201	[p11l487t812r669b868],
5	on	IN	O	on	_	0	SENT_201	[p11l699t830r777b868],
6	levels	NNS	O	level	prep_on	2	SENT_201	[p11l808t812r991b868],
7	of	IN	O	of	_	0	SENT_201	[p11l1025t812r1094b868],
8	GSTP1	NN	O	gstp1	nn	9	SENT_201	[p11l1121t812r1347b868],
9	protein	NN	O	protein	prep_of	6	SENT_201	[p11l1384t812r1611b885],
10	in	IN	O	in	_	0	SENT_201	[p11l1642t812r1702b867],
11	HEp2A	NN	O	hep2a	nn	12	SENT_201	[p11l1733t812r1977b885],
12	cells	NNS	O	cell	prep_in	9	SENT_201	[p11l2008t812r2151b868],
13	treated	VBN	O	treat	partmod	12	SENT_201	[p11l7t895r225b951],
14	with	IN	O	with	_	0	SENT_201	[p11l258t895r399b951],
15	25	CD	NUMBER	25	num	17	SENT_201	[p11l433t895r507b952],
16	p.M	NN	O	p.m	nn	17	SENT_201	[p11l549t897r666b967],
17	curcumin	NN	O	curcumin	prep_with	13	SENT_201	[p11l701t895r1019b962],
18	,	,	O	,	_	0	SENT_201	[p11l701t895r1019b962],
19	suggesting	VBG	O	suggest	dep	2	SENT_201	[p11l1058t895r1397b968],
20	that	IN	O	that	complm	25	SENT_201	[p11l1431t895r1551b951],
21	the	DT	O	the	det	22	SENT_201	[p11l1583t895r1679b951],
22	effect	NN	O	effect	nsubj	25	SENT_201	[p11l1714t895r1895b951],
23	of	IN	O	of	_	0	SENT_201	[p11l1928t895r1997b951],
24	curcumin	NN	O	curcumin	prep_of	22	SENT_201	[p11l2026t913r2151b951, p11l8t979r207b1035],
25	was	VBD	O	be	ccomp	19	SENT_201	[p11l231t997r352b1036],
26	to	TO	O	to	aux	27	SENT_201	[p11l378t988r438b1035],
27	inhibit	VB	O	inhibit	xcomp	25	SENT_201	[p11l463t979r672b1036],
28	enzyme	NN	O	enzyme	nn	29	SENT_201	[p11l696t997r943b1052],
29	activity	NN	O	activity	dobj	27	SENT_201	[p11l969t979r1206b1052],
30	and	CC	O	and	_	0	SENT_201	[p11l1233t979r1346b1035],
31	was	VBD	O	be	conj_and	19	SENT_201	[p11l1369t997r1490b1036],
32	not	RB	O	not	neg	31	SENT_201	[p11l1516t988r1618b1035],
33	on	IN	O	on	_	0	SENT_201	[p11l1642t997r1719b1035],
34	gene	NN	O	gene	nn	35	SENT_201	[p11l1745t997r1893b1052],
35	expression	NN	O	expression	prep_on	31	SENT_201	[p11l1918t997r2150b1052, p11l10t1063r155b1120],
36	.	.	O	.	_	0	SENT_201	[p11l1918t997r2150b1052, p11l10t1063r155b1120],

1	Another	DT	O	another	det	3	SENT_202	[p11l194t1064r457b1120],
2	GST	NN	O	gst	nn	3	SENT_202	[p11l491t1064r640b1120],
3	inhibitor	NN	O	inhibitor	nsubj	10	SENT_202	[p11l674t1063r967b1130],
4	,	,	O	,	_	0	SENT_202	[p11l674t1063r967b1130],
5	ethacrynic	JJ	O	ethacrynic	amod	6	SENT_202	[p11l1005t1063r1336b1136],
6	acid	NN	O	acid	appos	3	SENT_202	[p11l1373t1063r1521b1130],
7	,	,	O	,	_	0	SENT_202	[p11l1373t1063r1521b1130],
8	was	VBD	O	be	cop	10	SENT_202	[p11l1559t1081r1679b1120],
9	slightly	RB	O	slightly	advmod	10	SENT_202	[p11l1718t1063r1954b1136],
10	cytotoxic	JJ	O	cytotoxic	_	0	SENT_202	[p11l1990t1072r2150b1136, p11l7t1148r165b1204],
11	to	TO	O	to	_	0	SENT_202	[p11l209t1156r268b1204],
12	cells	NNS	O	cell	prep_to	10	SENT_202	[p11l313t1148r455b1204],
13	in	IN	O	in	_	0	SENT_202	[p11l500t1148r560b1203],
14	the	DT	O	the	det	15	SENT_202	[p11l603t1148r699b1204],
15	absence	NN	O	absence	prep_in	10	SENT_202	[p11l743t1148r994b1204],
16	of	IN	O	of	_	0	SENT_202	[p11l1037t1148r1107b1204],
17	doxorubicin	NN	O	doxorubicin	prep_of	15	SENT_202	[p11l1145t1148r1531b1204],
18	but	CC	O	but	_	0	SENT_202	[p11l1572t1148r1675b1204],
19	gave	VBD	O	give	conj_but	10	SENT_202	[p11l1718t1165r1866b1221],
20	broadly	RB	O	broadly	advmod	21	SENT_202	[p11l1908t1148r2152b1220],
21	similar	JJ	O	similar	amod	23	SENT_202	[p11l10t1232r231b1288],
22	IC50	NN	O	ic50	nn	23	SENT_202	[p11l254t1232r412b1288],
23	values	NNS	O	value	dobj	19	SENT_202	[p11l438t1232r640b1288],
24	when	WRB	O	when	advmod	25	SENT_202	[p11l667t1232r839b1288],
25	combined	VBN	O	combine	dep	23	SENT_202	[p11l865t1232r1180b1288],
26	with	IN	O	with	_	0	SENT_202	[p11l1205t1232r1346b1288],
27	doxorubicin	NN	O	doxorubicin	prep_with	25	SENT_202	[p11l1371t1232r1758b1288],
28	to	TO	O	to	_	0	SENT_202	[p11l1782t1241r1842b1288],
29	those	DT	O	those	prep_to	25	SENT_202	[p11l1868t1232r2035b1288],
30	for	IN	O	for	_	0	SENT_202	[p11l2061t1232r2154b1288],
31	curcumin	NN	O	curcumin	prep_for	29	SENT_202	[p11l8t1316r310b1372],
32	combined	VBN	O	combine	partmod	31	SENT_202	[p11l341t1316r657b1372],
33	with	IN	O	with	_	0	SENT_202	[p11l688t1316r829b1372],
34	doxorubicin	NN	O	doxorubicin	prep_with	32	SENT_202	[p11l860t1316r1247b1372],
35	of	IN	O	of	_	0	SENT_202	[p11l1279t1316r1348b1372],
36	0.79	CD	NUMBER	0.79	num	37	SENT_202	[p11l1375t1316r1511b1373],
37	p.M	NN	O	p.m	prep_of	34	SENT_202	[p11l1549t1317r1667b1388],
38	for	IN	O	for	_	0	SENT_202	[p11l1699t1316r1791b1372],
39	HEp2	NN	O	hep2	prep_for	37	SENT_202	[p11l1821t1316r2006b1389],
40	and	CC	O	and	_	0	SENT_202	[p11l2040t1316r2153b1372],
41	20.23	CD	NUMBER	20.23	num	42	SENT_202	[p11l9t1399r182b1456],
42	p.M	NN	O	p.m	conj_and	37	SENT_202	[p11l218t1401r336b1471],
43	for	IN	O	for	_	0	SENT_202	[p11l363t1399r456b1455],
44	Hep2A	NN	O	hep2a	prep_for	42	SENT_202	[p11l482t1400r729b1472],
45	,	,	O	,	_	0	SENT_202	[p11l482t1400r729b1472],
46	conﬁrming	VBG	O	conﬁrming	dep	25	SENT_202	[p11l760t1399r1109b1472],
47	the	DT	O	the	det	48	SENT_202	[p11l1137t1399r1233b1455],
48	effect	NN	O	effect	dobj	46	SENT_202	[p11l1261t1399r1442b1455],
49	of	IN	O	of	_	0	SENT_202	[p11l1469t1399r1538b1455],
50	GST	NN	O	gst	nn	51	SENT_202	[p11l1561t1399r1710b1456],
51	inhibition	NN	O	inhibition	prep_of	48	SENT_202	[p11l1736t1399r2048b1455],
52	on	IN	O	on	_	0	SENT_202	[p11l2075t1417r2153b1455],
53	resistance	NN	O	resistance	nn	55	SENT_202	[p11l7t1483r322b1540],
54	(	CD	NUMBER	(	num	55	SENT_202	[p11l368t1483r573b1553],
55	Table	NNP	O	Table	prep_on	46	SENT_202	[p11l368t1483r573b1553],
56	I	PRP	O	I	nsubj	57	SENT_202	[p11l615t1484r683b1553],
57	)	VBP	O	)	rcmod	55	SENT_202	[p11l615t1484r683b1553],
58	.	.	O	.	_	0	SENT_202	[p11l615t1484r683b1553],

1	Verapamil	NNP	O	Verapamil	nsubj	4	SENT_203	[p11l729t1483r1067b1556],
2	and	CC	O	and	_	0	SENT_203	[p11l1111t1483r1224b1539],
3	curcumin	NN	O	curcumin	conj_and	1	SENT_203	[p11l1266t1483r1567b1539],
4	administered	VBN	O	administer	_	0	SENT_203	[p11l1611t1483r2024b1540],
5	together	RB	O	together	dep	6	SENT_203	[p11l2066t1492r2151b1539, p11l8t1568r208b1640],
6	had	VBD	O	have	dep	4	SENT_203	[p11l235t1568r350b1624],
7	an	DT	O	a	det	10	SENT_203	[p11l381t1585r453b1624],
8	additive	JJ	O	additive	amod	10	SENT_203	[p11l483t1567r739b1624],
9	chemosensitising	NN	O	chemosensitising	nn	10	SENT_203	[p11l769t1567r1320b1640],
10	effect	NN	O	effect	dobj	6	SENT_203	[p11l1350t1567r1532b1624],
11	in	IN	O	in	_	0	SENT_203	[p11l1560t1567r1621b1623],
12	HEp2A	NN	O	hep2a	nn	13	SENT_203	[p11l1649t1568r1893b1640],
13	cells	NNS	O	cell	prep_in	10	SENT_203	[p11l1923t1568r2066b1624],
14	at	IN	O	at	_	0	SENT_203	[p11l2098t1576r2154b1624],
15	doxorubicin	NN	O	doxorubicin	nn	16	SENT_203	[p11l8t1652r395b1708],
16	concentrations	NNS	O	concentration	prep_at	6	SENT_203	[p11l420t1652r885b1708],
17	between	IN	O	between	_	0	SENT_203	[p11l911t1652r1179b1708],
18	5	CD	TIME	5	num	19	SENT_203	[p11l1205t1652r1238b1708],
19	p.M	NN	TIME	p.m	prep_between	16	SENT_203	[p11l1272t1653r1390b1724],
20	and	CC	O	and	_	0	SENT_203	[p11l1417t1652r1530b1708],
21	10	CD	TIME	10	num	22	SENT_203	[p11l1562t1652r1632b1708],
22	p.M	NN	TIME	p.m	prep_at	6	SENT_203	[p11l1663t1653r1781b1724],
23	(	CD	NUMBER	(	num	24	SENT_203	[p11l1809t1652r1871b1724],
24	p	NN	O	p	npadvmod	25	SENT_203	[p11l1809t1652r1871b1724],
25	<	JJR	O	<	amod	22	SENT_203	[p11l1902t1658r1956b1704],
26	0.05	CD	NUMBER	0.05	num	29	SENT_203	[p11l1987t1651r2150b1721],
27	)	NN	O	)	nn	29	SENT_203	[p11l1987t1651r2150b1721],
28	(	CD	NUMBER	(	num	29	SENT_203	[p11l10t1736r155b1809],
29	Fig	NN	O	fig	nsubj	6	SENT_203	[p11l10t1736r155b1809],
30	.	.	O	.	_	0	SENT_203	[p11l10t1736r155b1809],

1	la	DT	O	la	det	2	SENT_204	[p11l196t1736r310b1805],
2	)	NN	O	)	_	0	SENT_204	[p11l196t1736r310b1805],
3	.	.	O	.	_	0	SENT_204	[p11l196t1736r310b1805],

1	Doxorubicin	NN	O	doxorubicin	nn	2	SENT_205	[p11l6t1891r411b1948],
2	eﬁlux	NN	O	eﬁlux	_	0	SENT_205	[p11l442t1891r615b1963],

1	Doxorubicin	NN	O	doxorubicin	nn	2	SENT_206	[p11l88t1991r493b2048],
2	accumulation	NN	O	accumulation	nsubjpass	12	SENT_206	[p11l520t1991r950b2048],
3	and	CC	O	and	_	0	SENT_206	[p11l977t1991r1090b2048],
4	efﬂux	NN	O	efﬂux	nsubjpass	12	SENT_206	[p11l1116t1991r1301b2048],
5	in	IN	O	in	_	0	SENT_206	[p11l1327t1991r1388b2047],
6	the	DT	O	the	det	10	SENT_206	[p11l1413t1991r1509b2048],
7	sensitive	JJ	O	sensitive	amod	10	SENT_206	[p11l1538t1991r1815b2048],
8	and	CC	O	and	_	0	SENT_206	[p11l1842t1991r1956b2048],
9	resistant	JJ	O	resistant	amod	10	SENT_206	[p11l1980t1991r2151b2048, p11l7t2084r127b2132],
10	cells	NNS	O	cell	prep_in	2	SENT_206	[p11l153t2075r296b2132],
11	were	VBD	O	be	auxpass	12	SENT_206	[p11l325t2093r479b2132],
12	assessed	VBN	O	assess	_	0	SENT_206	[p11l507t2076r777b2132],
13	by	IN	O	by	_	0	SENT_206	[p11l801t2076r881b2148],
14	ﬂow	NN	O	ﬂow	nn	15	SENT_206	[p11l909t2075r1048b2132],
15	cytometry	NN	O	cytometry	agent	12	SENT_206	[p11l1076t2084r1416b2148],
16	.	.	O	.	_	0	SENT_206	[p11l1076t2084r1416b2148],

1	Doxorubicin	NN	O	doxorubicin	nn	2	SENT_207	[p11l1446t2075r1851b2132],
2	accumulation	NN	O	accumulation	nsubj	4	SENT_207	[p11l1879t2093r2150b2132, p11l8t2160r189b2216],
3	was	VBD	O	be	cop	4	SENT_207	[p11l232t2177r353b2216],
4	greater	JJR	O	greater	_	0	SENT_207	[p11l399t2168r621b2233],
5	in	IN	O	in	_	0	SENT_207	[p11l663t2160r723b2215],
6	HEp2	NN	O	hep2	nn	7	SENT_207	[p11l766t2160r951b2233],
7	(	NN	O	(	prep_in	4	SENT_207	[p11l998t2159r1133b2229],
8	501	CD	NUMBER	501	advmod	4	SENT_207	[p11l998t2159r1133b2229],
9	:	:	O	:	_	0	SENT_207	[p11l1192t2165r1240b2213],
10	12.5	CD	NUMBER	12.5	number	11	SENT_207	[p11l1299t2159r1426b2216],
11	arbitrary	JJ	O	arbitrary	amod	12	SENT_207	[p11l1475t2160r1748b2233],
12	units	NNS	O	unit	nsubj	17	SENT_207	[p11l1791t2160r1971b2229],
13	)	RB	O	)	amod	12	SENT_207	[p11l1791t2160r1971b2229],
14	than	IN	O	than	_	0	SENT_207	[p11l2016t2160r2153b2216],
15	HEp2A	NN	O	hep2a	nn	16	SENT_207	[p11l8t2244r252b2317],
16	cells	NNS	O	cell	prep_than	13	SENT_207	[p11l274t2244r417b2300],
17	(	VBP	O	(	parataxis	4	SENT_207	[p11l445t2244r580b2313],
18	441	CD	NUMBER	441	dobj	17	SENT_207	[p11l445t2244r580b2313],
19	:	:	O	:	_	0	SENT_207	[p11l619t2249r667b2297],
20	6.8	CD	NUMBER	6.8	num	21	SENT_207	[p11l699t2244r793b2300],
21	units	NNS	O	unit	nn	22	SENT_207	[p11l819t2244r971b2300],
22	p	NN	O	p	dep	18	SENT_207	[p11l989t2263r1033b2316],
23	<	JJR	O	<	dep	22	SENT_207	[p11l1062t2250r1117b2296],
24	0.001	CD	NUMBER	0.001	num	25	SENT_207	[p11l1145t2244r1366b2313],
25	)	NN	O	)	dep	22	SENT_207	[p11l1145t2244r1366b2313],
26	.	.	O	.	_	0	SENT_207	[p11l1145t2244r1366b2313],

1	After	IN	O	after	_	0	SENT_208	[p11l1393t2244r1563b2300],
2	1	CD	DURATION	1	num	3	SENT_208	[p11l1591t2244r1615b2299],
3	hr	NN	DURATION	hr	prep_after	6	SENT_208	[p11l1644t2244r1727b2311],
4	,	,	O	,	_	0	SENT_208	[p11l1644t2244r1727b2311],
5	ﬂuorescence	NN	O	ﬂuorescence	nsubj	6	SENT_208	[p11l1753t2244r2152b2300],
6	declined	VBD	O	decline	_	0	SENT_208	[p11l8t2328r279b2384],
7	in	IN	O	in	_	0	SENT_208	[p11l314t2328r375b2383],
8	HEp2A	NN	O	hep2a	nn	9	SENT_208	[p11l411t2328r654b2401],
9	cells	NNS	O	cell	prep_in	6	SENT_208	[p11l691t2328r834b2384],
10	to	TO	O	to	_	0	SENT_208	[p11l871t2336r931b2384],
11	331	CD	NUMBER	331	prep_to	6	SENT_208	[p11l970t2328r1080b2384],
12	:	:	O	:	_	0	SENT_208	[p11l1131t2333r1179b2381],
13	8.9	CD	NUMBER	8.9	num	14	SENT_208	[p11l1226t2328r1320b2385],
14	units	NNS	O	unit	nsubj	15	SENT_208	[p11l1357t2328r1510b2384],
15	(	VBP	O	(	parataxis	6	SENT_208	[p11l1551t2328r1717b2397],
16	25	CD	PERCENT	25	number	17	SENT_208	[p11l1551t2328r1717b2397],
17	%	NN	PERCENT	%	amod	19	SENT_208	[p11l1551t2328r1717b2397],
18	loss	NN	O	loss	nn	19	SENT_208	[p11l1757t2328r1904b2397],
19	)	NN	O	)	dobj	15	SENT_208	[p11l1757t2328r1904b2397],
20	due	JJ	O	due	_	0	SENT_208	[p11l1943t2328r2056b2384],
21	to	TO	O	to	_	0	SENT_208	[p11l2092t2336r2152b2384],
22	efﬂux	NN	O	efﬂux	prep_due_to	19	SENT_208	[p11l8t2411r209b2467],
23	.	.	O	.	_	0	SENT_208	[p11l8t2411r209b2467],

1	At	IN	O	at	_	0	SENT_209	[p11l239t2412r319b2467],
2	this	DT	O	this	det	3	SENT_209	[p11l344t2411r456b2467],
3	interval	NN	O	interval	prep_at	10	SENT_209	[p11l484t2411r745b2478],
4	,	,	O	,	_	0	SENT_209	[p11l484t2411r745b2478],
5	ﬂuorescence	NN	O	ﬂuorescence	nsubj	10	SENT_209	[p11l775t2411r1174b2467],
6	in	IN	O	in	_	0	SENT_209	[p11l1200t2411r1261b2467],
7	HEp2	NN	O	hep2	nn	8	SENT_209	[p11l1286t2411r1472b2484],
8	cells	NNS	O	cell	prep_in	5	SENT_209	[p11l1499t2411r1642b2467],
9	was	VBD	O	be	cop	10	SENT_209	[p11l1670t2429r1791b2467],
10	453	CD	NUMBER	453	_	0	SENT_209	[p11l1818t2411r1933b2468],
11	:	:	O	:	_	0	SENT_209	[p11l1971t2416r2020b2464],
12	9.4	CD	NUMBER	9.4	num	13	SENT_209	[p11l2055t2411r2152b2468],
13	units	NNS	O	unit	dep	10	SENT_209	[p11l7t2495r160b2551],
14	(	CD	NUMBER	(	num	15	SENT_209	[p11l207t2496r268b2567],
15	p	NN	O	p	npadvmod	16	SENT_209	[p11l207t2496r268b2567],
16	<	JJR	O	<	amod	13	SENT_209	[p11l317t2501r371b2548],
17	0.001	CD	NUMBER	0.001	num	18	SENT_209	[p11l420t2496r622b2565],
18	)	NN	O	)	dep	13	SENT_209	[p11l420t2496r622b2565],
19	representing	VBG	O	represent	partmod	10	SENT_209	[p11l667t2495r1062b2568],
20	10	CD	PERCENT	10	number	21	SENT_209	[p11l1114t2496r1248b2552],
21	%	NN	PERCENT	%	amod	22	SENT_209	[p11l1114t2496r1248b2552],
22	loss	NN	O	loss	dobj	19	SENT_209	[p11l1294t2495r1433b2552],
23	.	.	O	.	_	0	SENT_209	[p11l1294t2495r1433b2552],

1	Both	DT	O	both	det	2	SENT_210	[p11l1480t2495r1634b2551],
2	Verapamil	NNP	O	Verapamil	nsubj	5	SENT_210	[p11l1676t2495r1996b2568],
3	and	CC	O	and	_	0	SENT_210	[p11l2040t2495r2153b2551],
4	cyclosporine	NN	O	cyclosporine	nsubj	5	SENT_210	[p11l8t2579r416b2652],
5	inhibited	VBD	O	inhibit	_	0	SENT_210	[p11l441t2579r726b2636],
6	efﬂux	NN	O	efﬂux	dobj	5	SENT_210	[p11l750t2579r935b2636],
7	in	IN	O	in	_	0	SENT_210	[p11l959t2579r1020b2635],
8	HEp2A	NN	O	hep2a	nn	9	SENT_210	[p11l1044t2580r1288b2652],
9	cells	NNS	O	cell	prep_in	5	SENT_210	[p11l1313t2579r1474b2636],
10	.	.	O	.	_	0	SENT_210	[p11l1313t2579r1474b2636],

1	Fluorescence	NN	O	fluorescence	nn	2	SENT_211	[p11l1502t2580r1924b2636],
2	values	NNS	O	value	_	0	SENT_211	[p11l1949t2579r2151b2636],
3	after	IN	O	after	mark	7	SENT_211	[p11l9t2664r154b2720],
4	1	CD	DURATION	1	num	5	SENT_211	[p11l182t2664r206b2719],
5	hr	NN	DURATION	hr	nsubj	7	SENT_211	[p11l233t2664r301b2719],
6	were	VBD	O	be	cop	7	SENT_211	[p11l321t2681r474b2720],
7	408.9	CD	NUMBER	408.9	dep	2	SENT_211	[p11l496t2664r674b2721],
8	:	:	O	:	_	0	SENT_211	[p11l706t2669r754b2717],
9	2.5	CD	PERCENT	2.5	num	13	SENT_211	[p11l785t2663r879b2720],
10	(	CD	PERCENT	(	number	11	SENT_211	[p11l906t2664r1093b2733],
11	7.5	CD	PERCENT	7.5	dep	12	SENT_211	[p11l906t2664r1093b2733],
12	%	NN	PERCENT	%	dep	13	SENT_211	[p11l906t2664r1093b2733],
13	loss	NN	O	loss	dep	2	SENT_211	[p11l1118t2664r1239b2720],
14	Verapamil	NNP	O	Verapamil	dep	13	SENT_211	[p11l1263t2664r1607b2737],
15	)	CD	NUMBER	)	num	14	SENT_211	[p11l1263t2664r1607b2737],
16	and	CC	O	and	_	0	SENT_211	[p11l1633t2664r1746b2720],
17	425.2	CD	NUMBER	425.2	conj_and	14	SENT_211	[p11l1766t2663r1945b2720],
18	:	:	O	:	_	0	SENT_211	[p11l1976t2669r2024b2717],
19	6.1	CD	PERCENT	6.1	number	20	SENT_211	[p11l2055t2664r2145b2720],
20	(	CD	PERCENT	(	dep	14	SENT_211	[p11l10t2748r136b2817],
21	4	CD	PERCENT	4	num	22	SENT_211	[p11l10t2748r136b2817],
22	%	NN	PERCENT	%	dep	31	SENT_211	[p11l10t2748r136b2817],
23	loss	NN	O	loss	nn	24	SENT_211	[p11l162t2748r282b2804],
24	cyclosporine	NN	O	cyclosporine	dep	22	SENT_211	[p11l307t2748r740b2821],
25	)	CD	NUMBER	)	num	26	SENT_211	[p11l307t2748r740b2821],
26	units	NNS	O	unit	dep	24	SENT_211	[p11l764t2748r936b2815],
27	,	,	O	,	_	0	SENT_211	[p11l764t2748r936b2815],
28	respectively	RB	O	respectively	advmod	24	SENT_211	[p11l960t2748r1347b2821],
29	(	CD	NUMBER	(	num	30	SENT_211	[p11l1372t2749r1433b2820],
30	p	NN	O	p	dep	31	SENT_211	[p11l1372t2749r1433b2820],
31	<	JJR	O	<	dep	37	SENT_211	[p11l1462t2754r1516b2800],
32	0.001	CD	NUMBER	0.001	dep	31	SENT_211	[p11l1543t2748r1715b2804],
33	vs.	CC	O	vs.	prep	32	SENT_211	[p11l1744t2766r1829b2804],
34	untreated	JJ	O	untreated	amod	36	SENT_211	[p11l1855t2748r2153b2804],
35	HEp2A	NN	O	hep2a	nn	36	SENT_211	[p11l8t2832r252b2905],
36	cells	NNS	O	cell	dep	33	SENT_211	[p11l279t2832r466b2901],
37	)	CD	NUMBER	)	dep	14	SENT_211	[p11l279t2832r466b2901],
38	.	.	O	.	_	0	SENT_211	[p11l279t2832r466b2901],

1	Efﬂux	NNP	O	Efﬂux	nsubjpass	8	SENT_212	[p11l497t2832r696b2888],
2	in	IN	O	in	_	0	SENT_212	[p11l723t2832r784b2887],
3	HEp2	NN	O	hep2	nn	4	SENT_212	[p11l811t2832r996b2905],
4	cells	NNS	O	cell	prep_in	1	SENT_212	[p11l1024t2832r1167b2888],
5	was	VBD	O	be	auxpass	8	SENT_212	[p11l1196t2850r1317b2888],
6	not	RB	O	not	neg	8	SENT_212	[p11l1345t2840r1447b2888],
7	signiﬁcantly	RB	O	signiﬁcantly	advmod	8	SENT_212	[p11l1475t2832r1868b2905],
8	affected	VBN	O	affect	_	0	SENT_212	[p11l1897t2832r2153b2888],
9	by	IN	O	by	_	0	SENT_212	[p11l6t2915r85b2988],
10	Verapamil	NNP	O	Verapamil	agent	8	SENT_212	[p11l115t2915r434b2988],
11	or	CC	O	or	_	0	SENT_212	[p11l464t2933r530b2971],
12	cyclosporine	NN	O	cyclosporine	nn	14	SENT_212	[p11l558t2915r966b2988],
13	(	CD	NUMBER	(	num	14	SENT_212	[p11l998t2915r1144b2988],
14	Fig	NN	O	fig	conj_or	10	SENT_212	[p11l998t2915r1144b2988],
15	.	.	O	.	_	0	SENT_212	[p11l998t2915r1144b2988],

1	2	CD	NUMBER	2	num	2	SENT_213	[p11l1178t2916r1258b2985],
2	)	CD	NUMBER	)	_	0	SENT_213	[p11l1178t2916r1258b2985],
3	.	.	O	.	_	0	SENT_213	[p11l1178t2916r1258b2985],

1	P-glycoprotein	NN	O	p-glycoprotein	_	0	SENT_214	[p11l6t3071r487b3143],
2	and	CC	O	and	_	0	SENT_214	[p11l517t3071r639b3127],
3	MRPI	NN	O	mrpus	nn	4	SENT_214	[p11l662t3071r862b3126],
4	expression	NN	O	expression	conj_and	1	SENT_214	[p11l899t3073r1239b3143],

1	To	TO	O	to	aux	2	SENT_215	[p12l88t22r174b77],
2	determine	VB	O	determine	purpcl	35	SENT_215	[p12l214t21r532b77],
3	whether	IN	O	whether	complm	20	SENT_215	[p12l571t21r829b77],
4	the	DT	O	the	det	5	SENT_215	[p12l865t21r961b77],
5	differences	NNS	O	difference	nsubj	20	SENT_215	[p12l999t21r1352b77],
6	between	IN	O	between	_	0	SENT_215	[p12l1391t21r1658b77],
7	the	DT	O	the	det	11	SENT_215	[p12l1695t21r1791b77],
8	Hep2	NN	O	hep2	nn	11	SENT_215	[p12l1829t21r2000b94],
9	and	CC	O	and	_	0	SENT_215	[p12l2040t21r2153b77],
10	Hep2A	NN	O	hep2a	nn	11	SENT_215	[p12l8t105r238b178],
11	cells	NNS	O	cell	prep_between	5	SENT_215	[p12l273t105r415b161],
12	with	IN	O	with	_	0	SENT_215	[p12l452t105r593b161],
13	respect	NN	O	respect	_	0	SENT_215	[p12l626t113r853b178],
14	to	TO	O	to	_	0	SENT_215	[p12l886t113r946b161],
15	doxorubicin	NN	O	doxorubicin	nn	16	SENT_215	[p12l982t105r1368b161],
16	cytotoxicity	NN	O	cytotoxicity	prep_with_respect_to	11	SENT_215	[p12l1403t105r1784b177],
17	and	CC	O	and	_	0	SENT_215	[p12l1820t105r1934b161],
18	efﬂux	NN	O	efﬂux	conj_and	16	SENT_215	[p12l1968t105r2152b161],
19	were	VBD	O	be	cop	20	SENT_215	[p12l8t207r161b245],
20	due	JJ	O	due	ccomp	2	SENT_215	[p12l195t189r308b245],
21	to	TO	O	to	_	0	SENT_215	[p12l341t197r401b245],
22	Pgp	NNP	O	Pgp	nn	25	SENT_215	[p12l434t190r557b262],
23	and/or	NNP	O	and/or	nn	25	SENT_215	[p12l592t189r795b245],
24	MRPl	NNP	O	MRPl	nn	25	SENT_215	[p12l827t189r1028b244],
25	overexpression	NN	O	overexpression	prep_to	20	SENT_215	[p12l1069t189r1570b262],
26	,	,	O	,	_	0	SENT_215	[p12l1069t189r1570b262],
27	levels	NNS	O	level	nsubjpass	35	SENT_215	[p12l1606t189r1789b245],
28	of	IN	O	of	_	0	SENT_215	[p12l1825t189r1894b245],
29	mRNA	NN	O	mrna	prep_of	27	SENT_215	[p12l1922t189r2153b245],
30	and	CC	O	and	_	0	SENT_215	[p12l9t272r122b328],
31	protein	NN	O	protein	prep_of	27	SENT_215	[p12l154t272r381b345],
32	for	IN	O	for	_	0	SENT_215	[p12l415t272r508b328],
33	both	DT	O	both	prep_for	29	SENT_215	[p12l539t272r681b328],
34	were	VBD	O	be	auxpass	35	SENT_215	[p12l715t290r868b329],
35	analysed	VBN	O	analyse	_	0	SENT_215	[p12l904t272r1182b345],
36	by	IN	O	by	_	0	SENT_215	[p12l1214t272r1293b345],
37	immunoblotting	NN	O	immunoblotting	agent	35	SENT_215	[p12l1327t272r1843b345],
38	and	CC	O	and	_	0	SENT_215	[p12l1879t272r1992b328],
39	RTPCR	NN	O	rtpcr	agent	35	SENT_215	[p12l2025t273r2150b328, p12l7t357r174b413],
40	.	.	O	.	_	0	SENT_215	[p12l2025t273r2150b328, p12l7t357r174b413],

1	Both	DT	O	both	preconj	3	SENT_216	[p12l217t356r371b412],
2	Pgp	NN	O	pgp	nn	3	SENT_216	[p12l410t358r532b429],
3	protein	NN	O	protein	nsubjpass	7	SENT_216	[p12l572t356r799b429],
4	and	CC	O	and	_	0	SENT_216	[p12l840t356r953b412],
5	mRNA	NN	O	mrna	conj_and	3	SENT_216	[p12l991t357r1222b413],
6	were	VBD	O	be	auxpass	7	SENT_216	[p12l1262t374r1415b413],
7	expressed	VBN	O	express	_	0	SENT_216	[p12l1455t356r1770b429],
8	in	IN	O	in	_	0	SENT_216	[p12l1809t356r1870b412],
9	HEp2A	NN	O	hep2a	nn	10	SENT_216	[p12l1909t357r2153b429],
10	cells	NNS	O	cell	prep_in	7	SENT_216	[p12l8t441r169b497],
11	.	.	O	.	_	0	SENT_216	[p12l8t441r169b497],

1	Pgp	NN	O	pgp	nn	2	SENT_217	[p12l197t442r319b513],
2	protein	NN	O	protein	nsubj	4	SENT_217	[p12l343t440r570b513],
3	was	VBD	O	be	cop	4	SENT_217	[p12l594t458r715b497],
4	undetectable	JJ	O	undetectable	_	0	SENT_217	[p12l740t440r1145b497],
5	in	IN	O	in	_	0	SENT_217	[p12l1169t440r1230b496],
6	HEp2	NN	O	hep2	nn	7	SENT_217	[p12l1253t441r1438b513],
7	cells	NNS	O	cell	prep_in	4	SENT_217	[p12l1464t440r1606b497],
8	by	IN	O	by	_	0	SENT_217	[p12l1631t440r1710b513],
9	immunoblotting	NN	O	immunoblotting	prep_by	4	SENT_217	[p12l1734t440r2150b497, p12l7t525r148b598],
10	,	,	O	,	_	0	SENT_217	[p12l1734t440r2150b497, p12l7t525r148b598],
11	although	IN	O	although	mark	15	SENT_217	[p12l177t525r456b598],
12	the	DT	O	the	det	13	SENT_217	[p12l480t525r576b581],
13	transcript	NN	O	transcript	nsubjpass	15	SENT_217	[p12l601t525r904b597],
14	was	VBD	O	be	auxpass	15	SENT_217	[p12l928t542r1049b581],
15	detected	VBN	O	detect	advcl	4	SENT_217	[p12l1076t525r1342b581],
16	at	IN	O	at	_	0	SENT_217	[p12l1368t533r1423b581],
17	low	JJ	O	low	amod	18	SENT_217	[p12l1447t525r1565b581],
18	level	NN	O	level	prep_at	15	SENT_217	[p12l1591t525r1745b581],
19	by	IN	O	by	_	0	SENT_217	[p12l1768t525r1847b598],
20	RT	NN	O	rt	agent	15	SENT_217	[p12l1873t526r1974b580],
21	-	:	O	-	_	0	SENT_217	[p12l1978t525r2153b581],
22	PCR	NN	O	pcr	dep	20	SENT_217	[p12l1978t525r2153b581],
23	(	CD	NUMBER	(	num	24	SENT_217	[p12l10t609r187b682],
24	Figs	NNS	O	fig	dep	22	SENT_217	[p12l10t609r187b682],
25	.	.	O	.	_	0	SENT_217	[p12l10t609r187b682],

1	3	CD	NUMBER	3	_	0	SENT_218	[p12l232t609r285b675],
2	,	,	O	,	_	0	SENT_218	[p12l232t609r285b675],
3	4a	CD	NUMBER	4a	num	4	SENT_218	[p12l327t609r448b678],
4	)	NN	O	)	appos	1	SENT_218	[p12l327t609r448b678],
5	.	.	O	.	_	0	SENT_218	[p12l327t609r448b678],

1	Pgp	NN	O	pgp	nn	3	SENT_219	[p12l491t610r614b682],
2	transcript	NN	O	transcript	nn	3	SENT_219	[p12l654t609r957b682],
3	expression	NN	O	expression	nsubj	6	SENT_219	[p12l995t609r1337b682],
4	was	VBD	O	be	cop	6	SENT_219	[p12l1376t627r1497b665],
5	2.9-fold	RB	O	2.9-fold	advmod	6	SENT_219	[p12l1539t609r1793b666],
6	greater	JJR	O	greater	_	0	SENT_219	[p12l1833t617r2055b682],
7	in	IN	O	in	_	0	SENT_219	[p12l2092t609r2153b664],
8	HEp2A	NN	O	hep2a	prep_in	6	SENT_219	[p12l8t693r251b766],
9	than	IN	O	than	mark	13	SENT_219	[p12l286t693r423b749],
10	in	IN	O	in	_	0	SENT_219	[p12l457t693r517b748],
11	HEp2	NN	O	hep2	prep_in	13	SENT_219	[p12l551t693r736b766],
12	cells	NNS	O	cell	nsubj	13	SENT_219	[p12l772t693r915b749],
13	(	VBP	O	(	advcl	6	SENT_219	[p12l954t693r1099b766],
14	Fig	NN	O	fig	dobj	13	SENT_219	[p12l954t693r1099b766],
15	.	.	O	.	_	0	SENT_219	[p12l954t693r1099b766],

1	4a	NN	O	4a	_	0	SENT_220	[p12l1137t693r1259b762],
2	)	NN	O	)	dep	1	SENT_220	[p12l1137t693r1259b762],
3	.	.	O	.	_	0	SENT_220	[p12l1137t693r1259b762],

1	Expression	NN	O	expression	nsubj	4	SENT_221	[p12l1297t693r1654b766],
2	of	IN	O	of	_	0	SENT_221	[p12l1689t693r1758b749],
3	MRPl	NN	O	mrpl	prep_of	1	SENT_221	[p12l1787t693r1988b748],
4	was	VBD	O	be	_	0	SENT_221	[p12l2030t711r2151b749],

1	HARBOTTLE	NNP	PERSON	HARBOTTLE	nn	3	SENT_222	[p12l128t788r441b824],
2	ET	NNP	O	ET	nn	3	SENT_222	[p12l459t789r525b824],
3	AL.	NNP	O	AL.	_	0	SENT_222	[p12l535t788r607b824],
4	.	.	O	.	_	0	SENT_222	[p12l535t788r607b824],

1	3	CD	NUMBER	3	num	4	SENT_223	[p12l420t912r456b957],
2	«	NN	O	«	nn	4	SENT_223	[p12l1058t917r1117b975],
3	ac	NN	O	ac	nn	4	SENT_223	[p12l1058t917r1117b975],
4	«	NN	O	«	nn	13	SENT_223	[p12l1429t916r1483b975],
5	=	JJ	O	=	amod	4	SENT_223	[p12l1429t916r1483b975],
6	1	CD	NUMBER	1	tmod	5	SENT_223	[p12l1429t916r1483b975],
7	:	:	O	:	_	0	SENT_223	[p12l1429t916r1483b975],
8	ﬁl	NN	O	ﬁl	dep	4	SENT_223	[p12l881t984r940b1021],
9	IN	IN	O	in	_	0	SENT_223	[p12l1058t984r1117b1026],
10	Ell	NN	PERSON	ell	nn	12	SENT_223	[p12l1243t980r1302b1021],
11	N	NN	O	n	nn	12	SENT_223	[p12l1425t980r1484b1021],
12	‘	NN	O	‘	prep_in	8	SENT_223	[p12l899t1030r963b1075],
13	D	NN	O	d	nsubj	29	SENT_223	[p12l899t1030r963b1075],
14	:	:	O	:	_	0	SENT_223	[p12l899t1030r963b1075],
15	in	IN	O	in	prep	13	SENT_223	[p12l1076t1030r1139b1075],
16	in	IN	O	in	pcomp	15	SENT_223	[p12l1261t1026r1321b1075],
17	E.	NNP	O	E.	pobj	16	SENT_223	[p12l1443t1026r1506b1071],
18	F1	SYM	O	f1	dep	17	SENT_223	[p12l885t1105r940b1155],
19	-	:	O	-	_	0	SENT_223	[p12l885t1105r940b1155],
20	'	''	O	'	_	0	SENT_223	[p12l885t1105r940b1155],
21	-	:	O	-	_	0	SENT_223	[p12l885t1105r940b1155],
22	I	PRP	O	I	nsubj	23	SENT_223	[p12l885t1105r940b1155],
23	LEI	VBP	O	lei	parataxis	29	SENT_223	[p12l1062t1109r1121b1155],
24	:	:	O	:	_	0	SENT_223	[p12l1062t1109r1121b1155],
25	LT	NN	O	lt	dobj	23	SENT_223	[p12l1243t1105r1302b1151],
26	-	:	O	-	_	0	SENT_223	[p12l1243t1105r1302b1151],
27	‘	NN	O	‘	nsubj	29	SENT_223	[p12l1243t1105r1302b1151],
28	I	PRP	O	I	advmod	27	SENT_223	[p12l1243t1105r1302b1151],
29	I11	VBP	O	i11	_	0	SENT_223	[p12l1429t1105r1488b1151],
30	I	PRP	O	I	nsubj	31	SENT_223	[p12l886t1160r944b1223],
31	I	PRP	O	I	xcomp	29	SENT_223	[p12l1062t1160r1121b1223],
32	E	NN	O	e	nn	33	SENT_223	[p12l1243t1160r1302b1223],
33	E	NN	O	e	dep	31	SENT_223	[p12l1429t1160r1488b1223],
34	"	''	O	"	punct	29	SENT_223	[p12l51t1395r83b1398],

1	11	CD	NUMBER	11	dep	4	SENT_224	[p12l1732t1394r1868b1430],
2	'	''	O	'	_	0	SENT_224	[p12l1732t1394r1868b1430],
3	˙Pm	NN	O	˙pm	nsubj	4	SENT_224	[p12l2014t1431r2080b1434],
4	+	CC	O	+	_	0	SENT_224	[p12l2014t1431r2080b1434],
5	.	.	O	.	_	0	SENT_224	[p12l2130t1432r2135b1434],

1	i333	NN	O	i333	nn	2	SENT_225	[p12l1981t1294r2153b1434],
2	km	NN	O	km	_	0	SENT_225	[p12l6t1395r148b1462],
3	----	CD	NUMBER	----	num	4	SENT_225	[p12l1732t1466r1868b1498],
4	F	NN	O	f	dep	2	SENT_225	[p12l1732t1466r1868b1498],
5	392	CD	NUMBER	392	dep	2	SENT_225	[p12l1981t1452r2112b1512],

1	I	PRP	O	I	nsubj	2	SENT_226	[p12l11t1615r119b1679],
2	---	VBP	O	---_VBP	_	0	SENT_226	[p12l1741t1593r1868b1620],
3	II	CD	NUMBER	ii	num	5	SENT_226	[p12l1741t1593r1868b1620],
4	i603	JJ	O	i603	amod	5	SENT_226	[p12l1895t1575r2112b1715],
5	GAPDH	NN	O	gapdh	dobj	2	SENT_226	[p12l424t1751r741b1810],
6	.	.	O	.	_	0	SENT_226	[p12l1764t1806r1768b1810],

1	‘	NN	O	‘	nn	2	SENT_227	[p12l1895t1733r2113b1792],
2	H310	NN	O	h310	_	0	SENT_227	[p12l1895t1733r2113b1792],
3	MJJRI	NNP	O	MJJRI	dep	2	SENT_227	[p12l510t1833r746b1895],
4	__	CD	NUMBER	__	num	3	SENT_227	[p12l1822t1886r1845b1895],
5	"	``	O	"	punct	6	SENT_227	[p12l1895t1806r2112b1932],
6	“	NN	O	“	dep	3	SENT_227	[p12l1895t1806r2112b1932],
7	2	CD	NUMBER	2	num	6	SENT_227	[p12l1895t1806r2112b1932],
8	?	.	O	?	_	0	SENT_227	[p12l1895t1806r2112b1932],

1	}	NN	O	}	nn	2	SENT_228	[p12l1895t1806r2112b1932],
2	mg	NN	O	mg	_	0	SENT_228	[p12l15t1977r119b2040],
3	234	CD	NUMBER	234	dep	2	SENT_228	[p12l1986t1954r2117b2013],

1	‘	NN	O	‘	nn	2	SENT_229	[p12l10t2202r92b2270],
2	T6	NN	O	t6	_	0	SENT_229	[p12l10t2202r92b2270],

1	In	IN	O	in	dep	5	SENT_230	[p12l420t2298r460b2358],
2	I	PRP	O	I	pobj	1	SENT_230	[p12l1004t2298r1026b2362],
3	2	CD	NUMBER	2	dep	2	SENT_230	[p12l1234t2294r1275b2362],
4	3	CD	NUMBER	3	num	5	SENT_230	[p12l1447t2294r1483b2362],
5	4	CD	NUMBER	4	_	0	SENT_230	[p12l1668t2294r1710b2358],

1	1353	CD	DATE	1353	_	0	SENT_231	[p12l64t2606r251b2687],
2	IWE	NNP	O	IWE	dep	1	SENT_231	[p12l58t2719r246b2800],
3	W2	NN	O	w2	dep	1	SENT_231	[p12l101t2837r246b2918],

1	3	CD	NUMBER	3	_	0	SENT_232	[p12l101t3367r257b3447],
2	"	``	O	"	punct	4	SENT_232	[p12l101t3367r257b3447],
3	}	CD	NUMBER	}	num	4	SENT_232	[p12l101t3367r257b3447],
4	GAPDH	NN	O	gapdh	dep	1	SENT_232	[p12l1789t3340r2149b3415],
5	23	CD	NUMBER	23	num	6	SENT_232	[p12l107t3469r246b3549],
6	]	NN	O	]	dep	4	SENT_232	[p12l107t3469r246b3549],
7	5	CD	NUMBER	5	num	8	SENT_232	[p12l305t3511r307b3587],
8	MRPI	NN	O	mrpus	dep	1	SENT_232	[p12l1789t3447r2052b3522],

1	FIGURE	NN	O	figure	_	0	SENT_233	[p13l78t61r298b115],
2	4	CD	NUMBER	4	number	3	SENT_233	[p13l321t61r356b114],
3	—	CD	NUMBER	—	num	4	SENT_233	[p13l377t94r415b99],
4	Pgp	NN	O	pgp	dep	1	SENT_233	[p13l435t62r550b130],
5	and	CC	O	and	_	0	SENT_233	[p13l575t61r682b114],
6	MRP1	NN	O	mrp1	nn	8	SENT_233	[p13l704t62r894b114],
7	mRNA	NN	O	mrna	nn	8	SENT_233	[p13l924t62r1141b115],
8	expression	NN	O	expression	conj_and	4	SENT_233	[p13l1165t61r1487b130],
9	in	IN	O	in	_	0	SENT_233	[p13l1510t61r1567b114],
10	HEp2A	NN	O	hep2a	nn	13	SENT_233	[p13l1590t62r1820b130],
11	and	CC	O	and	_	0	SENT_233	[p13l1844t61r1951b114],
12	HEp2	NN	O	hep2	conj_and	10	SENT_233	[p13l1973t62r2148b130],
13	cells	NNS	O	cell	prep_in	8	SENT_233	[p13l7t137r158b190],
14	.	.	O	.	_	0	SENT_233	[p13l7t137r158b190],

1	Ethidium	NN	O	ethidium	_	0	SENT_234	[p13l202t137r484b190],
2	bromide-stained	JJ	O	bromide-stained	amod	5	SENT_234	[p13l523t137r1016b190],
3	agarose	NN	O	agarose	nn	5	SENT_234	[p13l1057t154r1286b206],
4	gel	NN	O	gel	nn	5	SENT_234	[p13l1327t137r1417b206],
5	electrophoresis	NN	O	electrophoresis	dep	1	SENT_234	[p13l1458t137r1913b206],
6	of	IN	O	of	_	0	SENT_234	[p13l1957t137r2022b190],
7	the	DT	O	the	det	8	SENT_234	[p13l2057t137r2148b190],
8	products	NNS	O	product	prep_of	5	SENT_234	[p13l6t213r264b282],
9	of	IN	O	of	_	0	SENT_234	[p13l302t213r367b266],
10	RT-PCR	NN	O	rt-pcr	nn	11	SENT_234	[p13l397t213r662b267],
11	analysis	NN	O	analysis	prep_of	8	SENT_234	[p13l697t213r937b282],
12	for	IN	O	for	_	0	SENT_234	[p13l974t213r1062b266],
13	(	CD	NUMBER	(	prep_for	11	SENT_234	[p13l1097t214r1180b279],
14	a	DT	O	a	det	16	SENT_234	[p13l1097t214r1180b279],
15	)	NN	O	)	nn	16	SENT_234	[p13l1097t214r1180b279],
16	Pgp	NN	O	pgp	dep	1	SENT_234	[p13l1217t214r1332b282],
17	and	CC	O	and	_	0	SENT_234	[p13l1369t213r1476b266],
18	(	NN	O	(	nn	19	SENT_234	[p13l1513t213r1595b279],
19	b	NN	O	b	conj_and	16	SENT_234	[p13l1513t213r1595b279],
20	)	CD	NUMBER	)	num	23	SENT_234	[p13l1513t213r1595b279],
21	MRP1	NN	O	mrp1	nn	23	SENT_234	[p13l1632t213r1822b266],
22	transcript	NN	O	transcript	nn	23	SENT_234	[p13l1863t213r2149b282],
23	expression	NN	O	expression	dep	16	SENT_234	[p13l7t290r344b359],
24	.	.	O	.	_	0	SENT_234	[p13l7t290r344b359],

1	GAPDH	NN	O	gapdh	nsubj	4	SENT_235	[p13l372t290r631b343],
2	is	VBZ	O	be	cop	4	SENT_235	[p13l654t290r701b343],
3	internal	JJ	O	internal	amod	4	SENT_235	[p13l725t290r955b343],
4	control	NN	O	control	_	0	SENT_235	[p13l979t290r1207b343],
5	.	.	O	.	_	0	SENT_235	[p13l979t290r1207b343],

1	In	IN	O	in	_	0	SENT_236	[p13l1233t291r1295b342],
2	(	CD	NUMBER	(	prep_in	10	SENT_236	[p13l1320t291r1420b356],
3	a	DT	O	a	det	4	SENT_236	[p13l1320t291r1420b356],
4	)	NN	O	)	nsubj	10	SENT_236	[p13l1320t291r1420b356],
5	,	,	O	,	_	0	SENT_236	[p13l1320t291r1420b356],
6	lanes	NNS	O	lane	appos	4	SENT_236	[p13l1446t290r1599b343],
7	1	CD	NUMBER	1	num	6	SENT_236	[p13l1631t290r1653b342],
8	and	CC	O	and	_	0	SENT_236	[p13l1684t290r1791b343],
9	2	CD	NUMBER	2	appos	4	SENT_236	[p13l1814t290r1848b342],
10	represent	VBP	O	represent	_	0	SENT_236	[p13l1871t297r2150b359],
11	3	CD	NUMBER	3	num	13	SENT_236	[p13l8t365r38b418],
12	ul	NN	O	ul	nn	13	SENT_236	[p13l78t365r142b433],
13	samples	NNS	O	sample	nsubj	14	SENT_236	[p13l175t365r414b434],
14	(	VBP	O	(	ccomp	10	SENT_236	[p13l448t364r567b430],
15	6	CD	PERCENT	6	number	16	SENT_236	[p13l448t364r567b430],
16	%	NN	PERCENT	%	amod	19	SENT_236	[p13l448t364r567b430],
17	total	JJ	O	total	amod	19	SENT_236	[p13l601t365r734b418],
18	CDNA	JJ	ORGANIZATION	cdna	amod	19	SENT_236	[p13l765t365r984b430],
19	)	NN	O	)	dobj	14	SENT_236	[p13l765t365r984b430],
20	reverse	JJ	O	reverse	nsubj	35	SENT_236	[p13l1015t381r1233b418],
21	transcribed	VBN	O	transcribe	partmod	20	SENT_236	[p13l1264t364r1600b418],
22	CDNA	NN	ORGANIZATION	cdna	nn	23	SENT_236	[p13l1631t365r1826b418],
23	mix	NN	O	mix	dobj	21	SENT_236	[p13l1856t365r1972b417],
24	from	IN	O	from	_	0	SENT_236	[p13l2003t364r2150b418],
25	HEp2	NN	O	hep2	nn	28	SENT_236	[p13l7t441r181b509],
26	and	CC	O	and	_	0	SENT_236	[p13l206t440r312b494],
27	HEp2A	NN	O	hep2a	nn	28	SENT_236	[p13l335t441r564b509],
28	cells	NNS	O	cell	prep_from	21	SENT_236	[p13l588t440r740b503],
29	,	,	O	,	_	0	SENT_236	[p13l588t440r740b503],
30	while	IN	O	while	_	0	SENT_236	[p13l767t440r932b494],
31	lanes	NNS	O	lane	prep_while	21	SENT_236	[p13l956t440r1108b494],
32	3	CD	NUMBER	3	num	31	SENT_236	[p13l1134t441r1164b494],
33	and	CC	O	and	_	0	SENT_236	[p13l1192t440r1299b494],
34	4	CD	NUMBER	4	conj_and	31	SENT_236	[p13l1321t441r1356b493],
35	represent	VBP	O	represent	rcmod	19	SENT_236	[p13l1379t448r1657b509],
36	5	CD	NUMBER	5	num	37	SENT_236	[p13l1680t440r1711b494],
37	pl	NN	O	pl	nsubj	44	SENT_236	[p13l1742t440r1807b509],
38	(	CD	PERCENT	(	number	39	SENT_236	[p13l1832t441r1989b506],
39	10	CD	PERCENT	10	dep	40	SENT_236	[p13l1832t441r1989b506],
40	%	NN	PERCENT	%	dep	44	SENT_236	[p13l1832t441r1989b506],
41	total	JJ	O	total	amod	44	SENT_236	[p13l2015t440r2148b494],
42	cDNA	NN	O	cdna	nn	44	SENT_236	[p13l7t517r225b582],
43	)	NN	O	)	nn	44	SENT_236	[p13l7t517r225b582],
44	samples	NNS	O	sample	xcomp	35	SENT_236	[p13l262t516r517b585],
45	.	.	O	.	_	0	SENT_236	[p13l262t516r517b585],

1	In	IN	O	in	_	0	SENT_237	[p13l553t517r614b569],
2	(	CD	NUMBER	(	num	4	SENT_237	[p13l648t516r748b582],
3	b	NN	O	b	nn	4	SENT_237	[p13l648t516r748b582],
4	)	NN	O	)	prep_in	23	SENT_237	[p13l648t516r748b582],
5	,	,	O	,	_	0	SENT_237	[p13l648t516r748b582],
6	lanes	NNS	O	lane	nsubj	23	SENT_237	[p13l783t516r935b569],
7	1	CD	NUMBER	1	num	6	SENT_237	[p13l976t517r998b569],
8	and	CC	O	and	_	0	SENT_237	[p13l1038t516r1144b569],
9	2	CD	NUMBER	2	nsubj	23	SENT_237	[p13l1176t517r1211b569],
10	represent	VBP	O	represent	rcmod	6	SENT_237	[p13l1243t524r1521b585],
11	HEp2A	NN	O	hep2a	nn	12	SENT_237	[p13l1551t517r1781b585],
12	MRP1	NN	O	mrp1	dobj	10	SENT_237	[p13l1812t517r2002b569],
13	and	CC	O	and	_	0	SENT_237	[p13l2042t516r2149b569],
14	GAPDH	NN	O	gapdh	conj_and	12	SENT_237	[p13l7t592r282b655],
15	,	,	O	,	_	0	SENT_237	[p13l7t592r282b655],
16	respectively	RB	O	respectively	advmod	12	SENT_237	[p13l312t592r694b661],
17	,	,	O	,	_	0	SENT_237	[p13l312t592r694b661],
18	and	CC	O	and	_	0	SENT_237	[p13l727t592r834b645],
19	lanes	NNS	O	lane	dobj	10	SENT_237	[p13l861t592r1014b645],
20	3	CD	NUMBER	3	num	19	SENT_237	[p13l1046t592r1076b646],
21	and	CC	O	and	_	0	SENT_237	[p13l1109t592r1216b645],
22	4	CD	NUMBER	4	conj_and	12	SENT_237	[p13l1243t592r1279b645],
23	represent	VBP	O	represent	_	0	SENT_237	[p13l1307t600r1585b661],
24	HEp2	NN	O	hep2	nn	25	SENT_237	[p13l1613t592r1787b661],
25	MRP1	NN	O	mrp1	dobj	23	SENT_237	[p13l1816t593r2005b645],
26	and	CC	O	and	_	0	SENT_237	[p13l2042t592r2149b645],
27	GAPDH	NN	O	gapdh	conj_and	25	SENT_237	[p13l7t668r282b731],
28	,	,	O	,	_	0	SENT_237	[p13l7t668r282b731],
29	respectively	RB	O	respectively	advmod	23	SENT_237	[p13l311t668r692b737],
30	.	.	O	.	_	0	SENT_237	[p13l311t668r692b737],

1	Molecular	JJ	O	molecular	amod	3	SENT_238	[p13l723t668r1035b721],
2	weight	NN	O	weight	nn	3	SENT_238	[p13l1061t668r1266b737],
3	markers	NNS	O	marker	nsubjpass	6	SENT_238	[p13l1292t668r1533b721],
4	are	VBP	O	be	auxpass	6	SENT_238	[p13l1564t685r1653b721],
5	also	RB	O	also	advmod	6	SENT_238	[p13l1682t668r1799b721],
6	shown	VBN	O	show	_	0	SENT_238	[p13l1830t668r2039b721],
7	.	.	O	.	_	0	SENT_238	[p13l1830t668r2039b721],

1	also	RB	O	also	advmod	2	SENT_239	[p13l8t898r133b954],
2	greater	JJR	O	greater	_	0	SENT_239	[p13l171t906r393b971],
3	in	IN	O	in	_	0	SENT_239	[p13l428t898r488b954],
4	HEp2A	NN	O	hep2a	nn	5	SENT_239	[p13l525t899r768b971],
5	cells	NNS	O	cell	prep_in	2	SENT_239	[p13l806t898r966b954],
6	.	.	O	.	_	0	SENT_239	[p13l806t898r966b954],

1	RT-PCR	NN	O	rt-pcr	nn	2	SENT_240	[p13l1007t898r1287b955],
2	experiments	NNS	O	experiment	nsubj	3	SENT_240	[p13l1323t898r1711b971],
3	showed	VBD	O	show	_	0	SENT_240	[p13l1753t898r1994b955],
4	that	IN	O	that	complm	7	SENT_240	[p13l2030t898r2149b954],
5	HEp2A	NN	O	hep2a	nn	6	SENT_240	[p13l7t983r250b1055],
6	cells	NNS	O	cell	nsubj	7	SENT_240	[p13l278t982r421b1039],
7	expressed	VBD	O	express	ccomp	3	SENT_240	[p13l451t982r766b1055],
8	3.2-fold	RB	O	3.2-fold	advmod	9	SENT_240	[p13l795t982r1048b1039],
9	higher	JJR	O	higher	amod	10	SENT_240	[p13l1075t982r1280b1055],
10	levels	NNS	O	level	dobj	7	SENT_240	[p13l1306t982r1490b1039],
11	of	IN	O	of	_	0	SENT_240	[p13l1520t982r1589b1038],
12	MRP1	NN	O	mrp1	nn	13	SENT_240	[p13l1611t983r1812b1038],
13	transcript	NN	O	transcript	prep_of	10	SENT_240	[p13l1847t982r2150b1055],
14	than	IN	O	than	mark	17	SENT_240	[p13l6t1066r143b1123],
15	HEp2	NN	O	hep2	nn	16	SENT_240	[p13l172t1067r356b1139],
16	cells	NNS	O	cell	nsubj	17	SENT_240	[p13l386t1067r529b1123],
17	(	VBP	O	(	advcl	7	SENT_240	[p13l562t1066r708b1139],
18	Fig	NN	O	fig	dobj	17	SENT_240	[p13l562t1066r708b1139],
19	.	.	O	.	_	0	SENT_240	[p13l562t1066r708b1139],

1	419	CD	NUMBER	419	_	0	SENT_241	[p13l740t1066r862b1136],
2	)	NN	O	)	dep	1	SENT_241	[p13l740t1066r862b1136],
3	.	.	O	.	_	0	SENT_241	[p13l740t1066r862b1136],

1	Glutathione	NN	O	glutathione	nn	2	SENT_242	[p13l9t1212r387b1269],
2	S	NN	O	s	_	0	SENT_242	[p13l420t1212r847b1284],
3	—	CD	NUMBER	—	num	5	SENT_242	[p13l420t1212r847b1284],
4	transferase	NN	O	transferase	nn	5	SENT_242	[p13l420t1212r847b1284],
5	expression	NN	O	expression	dep	2	SENT_242	[p13l878t1214r1218b1284],
6	and	CC	O	and	_	0	SENT_242	[p13l1248t1212r1370b1268],
7	activity	NN	O	activity	conj_and	5	SENT_242	[p13l1395t1214r1630b1284],

1	To	TO	O	to	aux	2	SENT_243	[p13l87t1314r173b1369],
2	determine	VB	O	determine	purpcl	19	SENT_243	[p13l209t1313r527b1369],
3	whether	IN	O	whether	complm	8	SENT_243	[p13l562t1313r820b1369],
4	GST	NN	O	gst	nn	5	SENT_243	[p13l854t1313r1002b1369],
5	isoforms	NNS	O	isoform	nsubj	8	SENT_243	[p13l1036t1313r1313b1369],
6	might	MD	O	might	aux	8	SENT_243	[p13l1349t1313r1536b1386],
7	also	RB	O	also	advmod	8	SENT_243	[p13l1571t1313r1695b1369],
8	contribute	VB	O	contribute	ccomp	2	SENT_243	[p13l1731t1313r2054b1369],
9	to	TO	O	to	_	0	SENT_243	[p13l2088t1321r2148b1369],
10	doxorubicin	NN	O	doxorubicin	nn	11	SENT_243	[p13l7t1396r393b1452],
11	resistance	NN	O	resistance	prep_to	8	SENT_243	[p13l432t1396r748b1452],
12	in	IN	O	in	_	0	SENT_243	[p13l789t1396r850b1452],
13	Hep2A	NN	O	hep2a	nn	14	SENT_243	[p13l890t1397r1120b1469],
14	cells	NNS	O	cell	prep_in	11	SENT_243	[p13l1161t1396r1323b1463],
15	,	,	O	,	_	0	SENT_243	[p13l1161t1396r1323b1463],
16	immunoblotting	NN	O	immunoblotting	nn	17	SENT_243	[p13l1366t1396r1881b1469],
17	experiments	NNS	O	experiment	nsubjpass	19	SENT_243	[p13l1923t1396r2146b1469, p13l7t1488r195b1536],
18	were	VBD	O	be	auxpass	19	SENT_243	[p13l225t1498r379b1537],
19	performed	VBN	O	perform	_	0	SENT_243	[p13l407t1480r741b1553],
20	using	VBG	O	use	xcomp	19	SENT_243	[p13l768t1480r940b1553],
21	a	DT	O	a	det	22	SENT_243	[p13l971t1498r1004b1536],
22	range	NN	O	range	dobj	20	SENT_243	[p13l1031t1498r1208b1553],
23	of	IN	O	of	_	0	SENT_243	[p13l1238t1480r1307b1536],
24	antisera	NNS	O	antisera	nn	25	SENT_243	[p13l1332t1480r1579b1536],
25	speciﬁc	NN	O	speciﬁc	prep_of	22	SENT_243	[p13l1609t1480r1849b1553],
26	for	IN	O	for	_	0	SENT_243	[p13l1879t1480r1972b1536],
27	individual	JJ	O	individual	amod	29	SENT_243	[p13l1999t1480r2146b1537, p13l7t1564r205b1621],
28	GST	NN	O	gst	nn	29	SENT_243	[p13l251t1565r399b1621],
29	classes	NNS	O	class	prep_for	25	SENT_243	[p13l444t1565r680b1621],
30	.	.	O	.	_	0	SENT_243	[p13l444t1565r680b1621],

1	Total	JJ	O	total	amod	3	SENT_244	[p13l728t1565r896b1621],
2	GST	NN	O	gst	nn	3	SENT_244	[p13l942t1565r1090b1621],
3	activity	NN	O	activity	nsubjpass	6	SENT_244	[p13l1136t1564r1373b1637],
4	was	VBD	O	be	auxpass	6	SENT_244	[p13l1418t1582r1538b1621],
5	also	RB	O	also	advmod	6	SENT_244	[p13l1586t1565r1710b1621],
6	assessed	VBN	O	assess	_	0	SENT_244	[p13l1757t1564r2027b1621],
7	by	IN	O	by	_	0	SENT_244	[p13l2069t1564r2148b1637],
8	enzyme	NN	O	enzyme	nn	9	SENT_244	[p13l7t1666r254b1721],
9	assay	NN	O	assay	agent	6	SENT_244	[p13l303t1666r489b1721],
10	.	.	O	.	_	0	SENT_244	[p13l303t1666r489b1721],

1	Densitometry	NN	O	densitometry	nn	2	SENT_245	[p13l539t1648r974b1721],
2	analysis	NN	O	analysis	nsubj	5	SENT_245	[p13l1023t1648r1276b1721],
3	of	IN	O	of	_	0	SENT_245	[p13l1326t1648r1395b1705],
4	immunoblots	NNS	O	immunoblot	prep_of	2	SENT_245	[p13l1436t1648r1856b1705],
5	demonstrated	VBD	O	demonstrate	_	0	SENT_245	[p13l1906t1649r2146b1705, p13l9t1733r219b1789],
6	5.7	CD	NUMBER	5.7	number	7	SENT_245	[p13l245t1732r499b1789],
7	—	CD	NUMBER	—	nsubj	8	SENT_245	[p13l245t1732r499b1789],
8	fold	JJ	O	fold	ccomp	5	SENT_245	[p13l245t1732r499b1789],
9	greater	JJR	O	greater	amod	10	SENT_245	[p13l525t1741r747b1806],
10	expression	NN	O	expression	dobj	8	SENT_245	[p13l771t1733r1112b1806],
11	of	IN	O	of	_	0	SENT_245	[p13l1138t1733r1207b1789],
12	GSTPI	NNP	O	GSTPI	prep_of	10	SENT_245	[p13l1229t1733r1455b1789],
13	in	IN	O	in	_	0	SENT_245	[p13l1487t1733r1548b1788],
14	HEp2A	NN	O	hep2a	nn	15	SENT_245	[p13l1573t1733r1816b1805],
15	cells	NNS	O	cell	prep_in	12	SENT_245	[p13l1842t1733r1985b1789],
16	than	IN	O	than	prep	8	SENT_245	[p13l2012t1733r2149b1789],
17	in	IN	O	in	pcomp	16	SENT_245	[p13l6t1817r67b1872],
18	the	DT	O	the	det	22	SENT_245	[p13l97t1817r193b1873],
19	HEp2	NN	O	hep2	nn	22	SENT_245	[p13l222t1817r407b1890],
20	line	NN	O	line	nn	22	SENT_245	[p13l438t1817r556b1873],
21	(	NN	O	(	nn	22	SENT_245	[p13l588t1817r734b1890],
22	Fig	NN	O	fig	pobj	17	SENT_245	[p13l588t1817r734b1890],
23	.	.	O	.	_	0	SENT_245	[p13l588t1817r734b1890],

1	5a	NN	O	5a	_	0	SENT_246	[p13l769t1817r888b1886],
2	)	NN	O	)	dep	1	SENT_246	[p13l769t1817r888b1886],
3	.	.	O	.	_	0	SENT_246	[p13l769t1817r888b1886],

1	GSTM	NNP	O	GSTM	nn	3	SENT_247	[p13l924t1817r1143b1873],
2	class	NN	O	class	nn	3	SENT_247	[p13l1174t1817r1326b1873],
3	levels	NNS	O	level	nsubj	5	SENT_247	[p13l1358t1817r1541b1873],
4	were	VBD	O	be	cop	5	SENT_247	[p13l1573t1835r1727b1873],
5	similar	JJ	O	similar	_	0	SENT_247	[p13l1759t1817r1979b1873],
6	with	IN	O	with	_	0	SENT_247	[p13l2008t1817r2149b1873],
7	densitometry	NN	O	densitometry	nn	8	SENT_247	[p13l7t1900r423b1973],
8	ratios	NNS	O	ratio	prep_with	5	SENT_247	[p13l455t1900r631b1956],
9	of	IN	O	of	_	0	SENT_247	[p13l666t1900r735b1956],
10	121.1	CD	NUMBER	121.1	number	11	SENT_247	[p13l770t1901r916b1956],
11	(	CD	NUMBER	(	num	12	SENT_247	[p13l958t1900r1103b1973],
12	Fig	NN	O	fig	prep_of	8	SENT_247	[p13l958t1900r1103b1973],
13	.	.	O	.	_	0	SENT_247	[p13l958t1900r1103b1973],

1	519	CD	NUMBER	519	_	0	SENT_248	[p13l1141t1900r1260b1969],
2	)	NN	O	)	dep	1	SENT_248	[p13l1141t1900r1260b1969],
3	.	.	O	.	_	0	SENT_248	[p13l1141t1900r1260b1969],

1	GST	NN	O	gst	nn	2	SENT_249	[p13l1298t1900r1446b1957],
2	alpha	NN	O	alpha	nsubj	13	SENT_249	[p13l1481t1900r1652b1973],
3	class	NN	O	class	nn	4	SENT_249	[p13l1683t1900r1835b1956],
4	enzymes	NNS	O	enzyme	nsubj	6	SENT_249	[p13l1870t1918r2147b1973],
5	were	VBD	O	be	cop	6	SENT_249	[p13l7t2002r160b2041],
6	undetectable	JJ	O	undetectable	rcmod	2	SENT_249	[p13l209t1984r614b2040],
7	in	IN	O	in	_	0	SENT_249	[p13l664t1984r724b2040],
8	either	CC	O	either	preconj	9	SENT_249	[p13l774t1984r956b2040],
9	HEp2A	NN	O	hep2a	prep_in	6	SENT_249	[p13l1004t1985r1247b2057],
10	or	CC	O	or	_	0	SENT_249	[p13l1297t2002r1363b2040],
11	HEp2	NN	O	hep2	nn	12	SENT_249	[p13l1411t1985r1595b2057],
12	cells	NNS	O	cell	prep_in	6	SENT_249	[p13l1646t1984r1789b2041],
13	(	VBP	O	(	_	0	SENT_249	[p13l1842t1984r2000b2054],
14	data	NNS	O	datum	dobj	13	SENT_249	[p13l1842t1984r2000b2054],
15	not	RB	O	not	neg	16	SENT_249	[p13l2048t1993r2150b2040],
16	shown	VBN	O	show	rcmod	14	SENT_249	[p13l9t2069r257b2138],
17	)	NN	O	)	dobj	16	SENT_249	[p13l9t2069r257b2138],
18	.	.	O	.	_	0	SENT_249	[p13l9t2069r257b2138],

1	Total	JJ	O	total	amod	6	SENT_250	[p13l315t2069r482b2125],
2	glutathione	NN	O	glutathione	nn	6	SENT_250	[p13l538t2068r896b2141],
3	S	NN	O	s	nn	6	SENT_250	[p13l950t2068r1363b2125],
4	—	CD	NUMBER	—	num	6	SENT_250	[p13l950t2068r1363b2125],
5	transferase	NN	O	transferase	nn	6	SENT_250	[p13l950t2068r1363b2125],
6	activity	NN	O	activity	nsubj	13	SENT_250	[p13l1419t2068r1656b2141],
7	measured	VBN	O	measure	partmod	6	SENT_250	[p13l1710t2069r2017b2125],
8	by	IN	O	by	_	0	SENT_250	[p13l2069t2069r2148b2141],
9	CDNB	NN	O	cdnb	nn	10	SENT_250	[p13l7t2153r223b2209],
10	assay	NN	O	assay	agent	7	SENT_250	[p13l258t2170r428b2225],
11	was	VBD	O	be	cop	13	SENT_250	[p13l458t2170r578b2209],
12	1.7-fold	RB	O	1.7-fold	advmod	13	SENT_250	[p13l617t2153r865b2209],
13	greater	JJR	O	greater	_	0	SENT_250	[p13l893t2161r1115b2226],
14	in	IN	O	in	_	0	SENT_250	[p13l1142t2153r1203b2208],
15	HEp2A	NN	O	hep2a	prep_in	13	SENT_250	[p13l1232t2153r1475b2226],
16	than	IN	O	than	_	0	SENT_250	[p13l1504t2153r1641b2209],
17	HEp2	NN	O	hep2	nn	18	SENT_250	[p13l1669t2153r1854b2226],
18	cells	NNS	O	cell	prep_than	13	SENT_250	[p13l1884t2153r2045b2209],
19	.	.	O	.	_	0	SENT_250	[p13l1884t2153r2045b2209],

1	Stable	JJ	O	stable	amod	2	SENT_251	[p13l7t2298r204b2355],
2	transfection	NN	O	transfection	_	0	SENT_251	[p13l236t2298r615b2370],
3	of	IN	O	of	_	0	SENT_251	[p13l646t2298r718b2370],
4	glutathione	NN	O	glutathione	nn	5	SENT_251	[p13l734t2298r1097b2370],
5	S	NN	O	s	prep_of	2	SENT_251	[p13l1129t2298r1557b2370],
6	—	CD	NUMBER	—	num	8	SENT_251	[p13l1129t2298r1557b2370],
7	transferase	NN	O	transferase	nn	8	SENT_251	[p13l1129t2298r1557b2370],
8	PI	NN	O	pi	dep	2	SENT_251	[p13l1586t2299r1669b2354],

1	To	TO	O	to	aux	3	SENT_252	[p13l87t2400r174b2454],
2	further	RB	O	further	advmod	3	SENT_252	[p13l212t2398r439b2454],
3	analyse	VB	O	analyse	purpcl	16	SENT_252	[p13l474t2398r721b2471],
4	the	DT	O	the	det	5	SENT_252	[p13l757t2398r856b2454],
5	role	NN	O	role	dobj	3	SENT_252	[p13l891t2398r1019b2454],
6	of	IN	O	of	_	0	SENT_252	[p13l1056t2398r1126b2454],
7	GSTPI	NNP	ORGANIZATION	GSTPI	prep_of	5	SENT_252	[p13l1158t2398r1390b2455],
8	in	IN	O	in	_	0	SENT_252	[p13l1433t2398r1495b2454],
9	doxorubicin	NN	O	doxorubicin	nn	10	SENT_252	[p13l1531t2398r1933b2454],
10	resistance	NN	O	resistance	prep_in	7	SENT_252	[p13l1967t2398r2146b2454, p13l6t2491r199b2549],
11	,	,	O	,	_	0	SENT_252	[p13l1967t2398r2146b2454, p13l6t2491r199b2549],
12	HEp2	NN	O	hep2	nn	13	SENT_252	[p13l246t2483r435b2555],
13	cells	NNS	O	cell	nsubjpass	16	SENT_252	[p13l480t2482r629b2539],
14	were	VBD	O	be	auxpass	16	SENT_252	[p13l675t2500r833b2539],
15	stably	RB	O	stably	advmod	16	SENT_252	[p13l880t2482r1075b2555],
16	transfected	VBN	O	transfect	_	0	SENT_252	[p13l1119t2482r1486b2538],
17	with	IN	O	with	_	0	SENT_252	[p13l1529t2482r1675b2539],
18	a	DT	O	a	det	21	SENT_252	[p13l1720t2500r1753b2538],
19	full-length	JJ	O	full-length	amod	21	SENT_252	[p13l1796t2482r2149b2555],
20	cDNA	NN	O	cdna	nn	21	SENT_252	[p13l7t2567r219b2623],
21	clone	NN	O	clone	prep_with	16	SENT_252	[p13l260t2567r437b2623],
22	for	IN	O	for	_	0	SENT_252	[p13l479t2566r574b2623],
23	GSTPI	NNP	O	GSTPI	prep_for	21	SENT_252	[p13l615t2567r872b2623],
24	.	.	O	.	_	0	SENT_252	[p13l615t2567r872b2623],

1	Immunoblot	NN	O	immunoblot	nn	4	SENT_253	[p13l917t2567r1328b2623],
2	and	CC	O	and	_	0	SENT_253	[p13l1369t2567r1485b2623],
3	CDNB	NN	O	cdnb	nn	4	SENT_253	[p13l1526t2567r1746b2623],
4	activity	NN	O	activity	nsubjpass	14	SENT_253	[p13l1793t2566r2041b2639],
5	of	IN	O	of	_	0	SENT_253	[p13l2083t2566r2154b2623],
6	clones	NNS	O	clone	prep_of	4	SENT_253	[p13l7t2651r216b2707],
7	produced	VBN	O	produce	partmod	6	SENT_253	[p13l252t2651r562b2724],
8	by	IN	O	by	_	0	SENT_253	[p13l596t2651r677b2724],
9	stable	JJ	O	stable	amod	10	SENT_253	[p13l716t2651r906b2707],
10	transfection	NN	O	transfection	agent	7	SENT_253	[p13l942t2651r1337b2707],
11	of	IN	O	of	_	0	SENT_253	[p13l1374t2651r1445b2707],
12	HEp2	NN	O	hep2	prep_of	10	SENT_253	[p13l1476t2651r1664b2724],
13	are	VBP	O	be	auxpass	14	SENT_253	[p13l1703t2668r1800b2707],
14	shown	VBN	O	show	_	0	SENT_253	[p13l1839t2651r2051b2707],
15	in	IN	O	in	_	0	SENT_253	[p13l2086t2651r2149b2706],
16	Figure	NNP	O	Figure	prep_in	14	SENT_253	[p13l6t2735r222b2808],
17	6	CD	NUMBER	6	num	16	SENT_253	[p13l252t2735r307b2791],
18	.	.	O	.	_	0	SENT_253	[p13l252t2735r307b2791],

1	Clone	NN	O	clone	nn	2	SENT_254	[p13l340t2735r536b2791],
2	G3	NN	O	g3	nsubjpass	16	SENT_254	[p13l566t2735r681b2801],
3	,	,	O	,	_	0	SENT_254	[p13l566t2735r681b2801],
4	which	WDT	O	which	nsubj	5	SENT_254	[p13l714t2735r915b2791],
5	showed	VBD	O	show	rcmod	2	SENT_254	[p13l946t2735r1195b2791],
6	1.5-fold	RB	O	1.5-fold	advmod	7	SENT_254	[p13l1231t2735r1490b2791],
7	greater	JJR	O	greater	amod	9	SENT_254	[p13l1519t2743r1750b2808],
8	GST	NN	O	gst	nn	9	SENT_254	[p13l1779t2735r1930b2791],
9	activity	NN	O	activity	dobj	5	SENT_254	[p13l1961t2735r2146b2791, p13l6t2818r92b2891],
10	than	IN	O	than	_	0	SENT_254	[p13l115t2818r257b2874],
11	the	DT	O	the	det	13	SENT_254	[p13l279t2818r379b2874],
12	control	NN	O	control	nn	13	SENT_254	[p13l403t2818r637b2874],
13	clone	NN	O	clone	prep_than	5	SENT_254	[p13l661t2818r857b2885],
14	,	,	O	,	_	0	SENT_254	[p13l661t2818r857b2885],
15	was	VBD	O	be	auxpass	16	SENT_254	[p13l884t2836r1008b2875],
16	chosen	VBN	O	choose	_	0	SENT_254	[p13l1034t2818r1262b2874],
17	for	IN	O	for	_	0	SENT_254	[p13l1286t2818r1381b2874],
18	cytotoxicity	NN	O	cytotoxicity	nn	19	SENT_254	[p13l1404t2818r1802b2891],
19	assays	NNS	O	assay	prep_for	16	SENT_254	[p13l1828t2836r2055b2891],
20	.	.	O	.	_	0	SENT_254	[p13l1828t2836r2055b2891],

1	In	IN	O	in	_	0	SENT_255	[p13l2082t2820r2149b2874],

1	GLUTATHIONE	NN	O	glutathione	nsubj	2	SENT_256	[p13l244t2972r450b2992],
2	S	NN	O	s	_	0	SENT_256	[p13l460t2972r703b2992],
3	.	.	O	.	_	0	SENT_256	[p13l460t2972r703b2992],

1	—	NN	O	—	_	0	SENT_257	[p13l460t2972r703b2992],
2	.	.	O	.	_	0	SENT_257	[p13l460t2972r703b2992],

1	TRANSFERASES	NNPS	O	TRANSFERASES	_	0	SENT_258	[p13l460t2972r703b2992],
2	AND	CC	O	and	_	0	SENT_258	[p13l715t2972r777b2992],
3	DRUG	NN	O	drug	nn	4	SENT_258	[p13l788t2972r870b2992],
4	TRANSPORTERS	NN	O	transporter	conj_and	1	SENT_258	[p13l880t2972r1102b2992],
5	IN	IN	O	in	_	0	SENT_258	[p13l1114t2972r1144b2992],
6	DOXORUBICIN	NNP	O	DOXORUBICIN	prep_in	4	SENT_258	[p13l1154t2972r1358b2992],
7	RESISTANCE	NN	O	resistance	dep	1	SENT_258	[p13l1368t2972r1544b2992],
8	781	CD	NUMBER	781	num	7	SENT_258	[p13l1863t2966r1915b2992],

1	E	NN	O	e	_	0	SENT_259	[p13l803t3131r890b3265],
2	-1	CD	NUMBER	-1	num	1	SENT_259	[p13l1030t3173r1116b3260],
3	:	:	O	:	_	0	SENT_259	[p13l1030t3173r1116b3260],
4	,	,	O	,	_	0	SENT_259	[p13l804t3265r890b3335],
5	_	NN	O	_	dep	1	SENT_259	[p13l804t3265r890b3335],
6	:	:	O	:	_	0	SENT_259	[p13l804t3265r890b3335],
7	q	VB	O	q	dep	1	SENT_259	[p13l804t3265r890b3335],
8	mgtm	NN	O	mgtm	nn	9	SENT_259	[p13l1030t3265r1325b3355],
9	E	NN	O	e	nsubj	10	SENT_259	[p13l814t3362r890b3447],
10	El	NNP	O	El	xcomp	7	SENT_259	[p13l1057t3318r1138b3373],
11	.	.	O	.	_	0	SENT_259	[p13l1057t3318r1138b3373],

1	ﬂ	NN	O	ﬂ	_	0	SENT_260	[p13l804t3447r890b3527],
2	EL	NN	O	el	nn	3	SENT_260	[p13l1266t3318r1347b3372],
3	E	NN	O	e	dep	1	SENT_260	[p13l1244t3372r1326b3522],

1	kDa	NN	O	kda	_	0	SENT_261	[p13l1680t3437r1878b3522],
2	we	PRP	O	we	dep	1	SENT_261	[p14l739t195r921b248],
3	.	.	O	.	_	0	SENT_261	[p14l1095t284r1100b285],

1	—	NN	O	—	_	0	SENT_262	[p14l1604t231r1621b247],
2	29.0	CD	NUMBER	29.0	num	1	SENT_262	[p14l1685t200r1889b285],

1	GSTPL	NN	O	gstpl	_	0	SENT_263	[p14l256t333r643b420],

1	I	PRP	O	I	_	0	SENT_264	[p14l739t371r938b484],

1	I	PRP	O	I	_	0	SENT_265	[p14l943t296r1222b436],

1	KR	NN	O	kr	_	0	SENT_266	[p14l787t1395r970b1487],
2	*	CD	NUMBER	*	num	4	SENT_266	[p14l787t1395r970b1487],
3	Rat	NN	O	rat	nn	4	SENT_266	[p14l846t1176r933b1342],
4	Liver	NN	O	liver	dep	1	SENT_266	[p14l846t892r933b1149],

1	Irﬂpl-EL	JJ	O	irﬂpl-el	amod	2	SENT_267	[p14l1100t978r1213b1342],
2	HEp2	NN	O	hep2	_	0	SENT_267	[p14l1357t1069r1465b1342],

1	E	NN	O	e	_	0	SENT_268	[p14l1701t1203r1905b1288],

1	GSTML	NN	O	gstml	nn	2	SENT_269	[p14l261t1808r707b1900],
2	L	NN	O	l	_	0	SENT_269	[p14l764t1827r782b1939],

1	FIGURE	NN	O	figure	_	0	SENT_270	[p14l79t2404r299b2457],
2	5	CD	NUMBER	5	dep	1	SENT_270	[p14l330t2404r365b2457],
3	.	.	O	.	_	0	SENT_270	[p14l386t2404r819b2457],

1	—	NN	O	—	_	0	SENT_271	[p14l386t2404r819b2457],
2	.	.	O	.	_	0	SENT_271	[p14l386t2404r819b2457],

1	Immunob1ot	NN	O	immunob1ot	_	0	SENT_272	[p14l386t2404r819b2457],
2	for	IN	O	for	_	0	SENT_272	[p14l848t2404r936b2457],
3	GST	NN	O	gst	nn	4	SENT_272	[p14l966t2404r1107b2457],
4	expression	NN	O	expression	prep_for	1	SENT_272	[p14l1138t2404r1461b2473],
5	in	IN	O	in	_	0	SENT_272	[p14l1491t2404r1548b2456],
6	HEp2A	NN	O	hep2a	nn	9	SENT_272	[p14l1578t2404r1809b2473],
7	and	CC	O	and	_	0	SENT_272	[p14l1841t2404r1947b2457],
8	HEp2	NN	O	hep2	nn	9	SENT_272	[p14l1978t2404r2152b2473],
9	cells	NNS	O	cell	prep_in	1	SENT_272	[p14l8t2480r160b2533],
10	.	.	O	.	_	0	SENT_272	[p14l8t2480r160b2533],

1	(	NN	O	(	nsubj	19	SENT_273	[p14l186t2481r269b2546],
2	a	DT	O	a	det	3	SENT_273	[p14l186t2481r269b2546],
3	)	NN	O	)	nsubj	7	SENT_273	[p14l186t2481r269b2546],
4	Shown	VBN	O	show	partmod	3	SENT_273	[p14l294t2480r501b2533],
5	is	VBZ	O	be	cop	7	SENT_273	[p14l522t2480r569b2533],
6	a	DT	O	a	det	7	SENT_273	[p14l593t2496r624b2533],
7	blot	NN	O	blot	rcmod	1	SENT_273	[p14l643t2480r761b2533],
8	incubated	VBN	O	incubate	partmod	7	SENT_273	[p14l781t2480r1075b2533],
9	with	IN	O	with	_	0	SENT_273	[p14l1096t2480r1229b2533],
10	anti-GSTP	JJ	O	anti-gstp	amod	12	SENT_273	[p14l1251t2480r1573b2533],
11	class	NN	O	class	nn	12	SENT_273	[p14l1594t2480r1738b2533],
12	antibody	NN	O	antibody	prep_with	8	SENT_273	[p14l1762t2480r2023b2549],
13	and	CC	O	and	_	0	SENT_273	[p14l2047t2480r2153b2533],
14	(	NN	O	(	conj_and	12	SENT_273	[p14l9t2554r92b2621],
15	19	CD	NUMBER	19	number	16	SENT_273	[p14l9t2554r92b2621],
16	)	CD	NUMBER	)	num	18	SENT_273	[p14l9t2554r92b2621],
17	a	DT	O	a	det	18	SENT_273	[p14l135t2571r166b2608],
18	blot	NN	O	blot	dep	14	SENT_273	[p14l204t2555r322b2608],
19	incubated	VBN	O	incubate	_	0	SENT_273	[p14l361t2554r655b2608],
20	with	IN	O	with	_	0	SENT_273	[p14l694t2555r827b2608],
21	anti	JJ	O	anti	prep_with	19	SENT_273	[p14l868t2555r1215b2608],
22	.	.	O	.	_	0	SENT_273	[p14l868t2555r1215b2608],

1	—	NN	O	—	_	0	SENT_274	[p14l868t2555r1215b2608],
2	.	.	O	.	_	0	SENT_274	[p14l868t2555r1215b2608],

1	GSTM	NNP	O	GSTM	_	0	SENT_275	[p14l868t2555r1215b2608],
2	class	NN	O	class	dep	1	SENT_275	[p14l1255t2555r1416b2608],
3	.	.	O	.	_	0	SENT_275	[p14l1255t2555r1416b2608],

1	Rat	NN	O	rat	nn	3	SENT_276	[p14l1459t2556r1564b2608],
2	liver	NN	O	liver	nn	3	SENT_276	[p14l1603t2555r1741b2608],
3	cytosol	NN	O	cytosol	nsubjpass	5	SENT_276	[p14l1780t2555r1996b2624],
4	was	VBD	O	be	auxpass	5	SENT_276	[p14l2037t2571r2151b2608],
5	included	VBN	O	include	_	0	SENT_276	[p14l7t2630r268b2684],
6	as	IN	O	as	_	0	SENT_276	[p14l301t2647r359b2684],
7	a	DT	O	a	det	9	SENT_276	[p14l395t2647r427b2684],
8	positive	JJ	O	positive	amod	9	SENT_276	[p14l457t2630r696b2699],
9	control	NN	O	control	prep_as	5	SENT_276	[p14l729t2630r942b2684],
10	and	CC	O	and	_	0	SENT_276	[p14l976t2630r1083b2684],
11	the	DT	O	the	det	12	SENT_276	[p14l1115t2630r1205b2684],
12	positions	NNS	O	position	nsubjpass	17	SENT_276	[p14l1238t2630r1509b2699],
13	of	IN	O	of	_	0	SENT_276	[p14l1545t2630r1610b2684],
14	size	NN	O	size	nn	15	SENT_276	[p14l1640t2630r1753b2684],
15	markers	NNS	O	marker	prep_of	12	SENT_276	[p14l1786t2630r2027b2684],
16	are	VBP	O	be	auxpass	17	SENT_276	[p14l2063t2647r2152b2684],
17	indicated	VBN	O	indicate	conj_and	5	SENT_276	[p14l7t2706r299b2759],
18	.	.	O	.	_	0	SENT_276	[p14l7t2706r299b2759],

1	the	DT	O	the	det	2	SENT_277	[p14l7t2921r106b2977],
2	case	NN	O	case	nsubj	14	SENT_277	[p14l134t2939r274b2977],
3	of	IN	O	of	_	0	SENT_277	[p14l301t2921r372b2977],
4	clone	NN	O	clone	nn	5	SENT_277	[p14l394t2921r572b2977],
5	G3	NN	O	g3	prep_of	2	SENT_277	[p14l599t2921r715b2988],
6	,	,	O	,	_	0	SENT_277	[p14l599t2921r715b2988],
7	the	DT	O	the	det	9	SENT_277	[p14l744t2921r843b2977],
8	IC50	NN	O	ic50	nn	9	SENT_277	[p14l870t2921r1032b2978],
9	value	NN	O	value	appos	5	SENT_277	[p14l1060t2921r1238b2978],
10	for	IN	O	for	_	0	SENT_277	[p14l1265t2921r1361b2977],
11	doxorubicin	NN	O	doxorubicin	prep_for	9	SENT_277	[p14l1386t2921r1789b2977],
12	was	VBD	O	be	cop	14	SENT_277	[p14l1815t2939r1939b2978],
13	15.47	CD	NUMBER	15.47	num	14	SENT_277	[p14l1975t2921r2150b2978],
14	p.M	NN	O	p.m	_	0	SENT_277	[p14l13t3010r132b3081],
15	as	IN	O	as	mark	24	SENT_277	[p14l160t3026r223b3065],
16	compared	VBN	O	compare	_	0	SENT_277	[p14l253t3009r579b3081],
17	with	IN	O	with	prepc_compared_with	24	SENT_277	[p14l605t3008r751b3065],
18	6.94	CD	NUMBER	6.94	num	19	SENT_277	[p14l779t3008r920b3065],
19	p.M	NN	O	p.m	pobj	24	SENT_277	[p14l953t3010r1071b3081],
20	in	IN	O	in	_	0	SENT_277	[p14l1099t3008r1161b3064],
21	the	DT	O	the	det	22	SENT_277	[p14l1188t3009r1287b3065],
22	control	NN	O	control	prep_in	19	SENT_277	[p14l1314t3008r1549b3065],
23	cells	NNS	O	cell	nsubj	24	SENT_277	[p14l1576t3008r1726b3065],
24	(	VBP	O	(	advcl	14	SENT_277	[p14l1757t3009r1819b3080],
25	p	NN	O	p	nsubj	26	SENT_277	[p14l1757t3009r1819b3080],
26	=	JJ	O	=	ccomp	24	SENT_277	[p14l1855t3028r1904b3047],
27	0.046	CD	NUMBER	0.046	num	28	SENT_277	[p14l1939t3008r2150b3078],
28	)	CD	NUMBER	)	iobj	26	SENT_277	[p14l1939t3008r2150b3078],
29	(	CD	NUMBER	(	num	30	SENT_277	[p14l10t3096r162b3169],
30	Fig	NN	O	fig	dobj	26	SENT_277	[p14l10t3096r162b3169],
31	.	.	O	.	_	0	SENT_277	[p14l10t3096r162b3169],

1	7	CD	NUMBER	7	_	0	SENT_278	[p14l196t3096r280b3165],
2	)	NN	O	)	dep	1	SENT_278	[p14l196t3096r280b3165],
3	.	.	O	.	_	0	SENT_278	[p14l196t3096r280b3165],

1	Treatment	NN	O	treatment	nsubj	8	SENT_279	[p14l313t3097r656b3152],
2	of	IN	O	of	_	0	SENT_279	[p14l685t3096r756b3152],
3	the	DT	O	the	det	5	SENT_279	[p14l781t3096r880b3152],
4	HEp2	NN	O	hep2	nn	5	SENT_279	[p14l910t3096r1099b3168],
5	clones	NNS	O	clone	prep_of	1	SENT_279	[p14l1131t3096r1339b3152],
6	with	IN	O	with	_	0	SENT_279	[p14l1371t3096r1517b3152],
7	curcumin	NN	O	curcumin	prep_with	5	SENT_279	[p14l1547t3096r1860b3152],
8	resulted	VBD	O	result	_	0	SENT_279	[p14l1888t3096r2153b3152],
9	in	IN	O	in	_	0	SENT_279	[p14l7t3182r70b3238],
10	a	DT	O	a	det	11	SENT_279	[p14l118t3200r151b3238],
11	increase	NN	O	increase	prep_in	8	SENT_279	[p14l196t3182r469b3238],
12	in	IN	O	in	_	0	SENT_279	[p14l516t3182r578b3238],
13	doxorubicin	NN	O	doxorubicin	nn	14	SENT_279	[p14l625t3182r1027b3238],
14	cytotoxicity	NN	O	cytotoxicity	prep_in	8	SENT_279	[p14l1074t3182r1492b3255],
15	,	,	O	,	_	0	SENT_279	[p14l1074t3182r1492b3255],
16	with	IN	O	with	_	0	SENT_279	[p14l1543t3182r1688b3238],
17	the	DT	O	the	det	18	SENT_279	[p14l1734t3182r1833b3238],
18	IC50	NN	O	ic50	prep_with	8	SENT_279	[p14l1880t3182r2044b3239],
19	in	IN	O	in	_	0	SENT_279	[p14l2091t3182r2153b3238],
20	control	NN	O	control	nn	21	SENT_279	[p14l8t3270r242b3326],
21	cells	NNS	O	cell	prep_in	18	SENT_279	[p14l282t3270r431b3326],
22	being	VBG	O	be	auxpass	23	SENT_279	[p14l471t3269r654b3342],
23	reduced	VBN	O	reduce	partmod	21	SENT_279	[p14l693t3270r956b3326],
24	from	IN	O	from	_	0	SENT_279	[p14l994t3269r1154b3326],
25	6.94	CD	NUMBER	6.94	num	26	SENT_279	[p14l1193t3269r1334b3327],
26	ptM	NN	O	ptm	prep_from	23	SENT_279	[p14l1379t3271r1498b3342],
27	to	TO	O	to	_	0	SENT_279	[p14l1537t3278r1598b3326],
28	3.24	CD	NUMBER	3.24	num	31	SENT_279	[p14l1640t3270r1780b3326],
29	p.M	NN	O	p.m	nn	31	SENT_279	[p14l1825t3271r1944b3342],
30	(	NN	O	(	nn	31	SENT_279	[p14l1985t3270r2048b3341],
31	p	NN	O	p	prep_to	23	SENT_279	[p14l1985t3270r2048b3341],
32	=	JJ	O	=	dep	47	SENT_279	[p14l2096t3289r2144b3308],
33	0.03	CD	NUMBER	0.03	num	34	SENT_279	[p14l8t3357r198b3426],
34	)	NN	O	)	dep	32	SENT_279	[p14l8t3357r198b3426],
35	,	,	O	,	_	0	SENT_279	[p14l8t3357r198b3426],
36	while	IN	O	while	mark	47	SENT_279	[p14l233t3357r416b3413],
37	in	IN	O	in	_	0	SENT_279	[p14l448t3357r510b3412],
38	the	DT	O	the	det	39	SENT_279	[p14l542t3357r641b3413],
39	GSTPI	NNP	MISC	GSTPI	nsubj	40	SENT_279	[p14l674t3357r907b3413],
40	expressing	VBG	O	express	prepc_in	47	SENT_279	[p14l946t3357r1302b3429],
41	G3	NN	O	g3	nn	42	SENT_279	[p14l1336t3357r1428b3413],
42	cells	NNS	O	cell	dobj	40	SENT_279	[p14l1465t3357r1613b3413],
43	the	DT	O	the	det	45	SENT_279	[p14l1647t3357r1746b3413],
44	IC50	NN	O	ic50	nn	45	SENT_279	[p14l1778t3357r1942b3413],
45	value	NN	O	value	nsubjpass	47	SENT_279	[p14l1974t3357r2152b3413],
46	was	VBD	O	be	auxpass	47	SENT_279	[p14l8t3461r132b3499],
47	reduced	VBN	O	reduce	parataxis	23	SENT_279	[p14l172t3443r436b3499],
48	from	IN	O	from	_	0	SENT_279	[p14l475t3443r634b3499],
49	15.47	CD	NUMBER	15.47	num	50	SENT_279	[p14l680t3443r855b3500],
50	p.M	NN	O	p.m	prep_from	47	SENT_279	[p14l902t3445r1021b3515],
51	to	TO	O	to	_	0	SENT_279	[p14l1061t3451r1122b3499],
52	3.99	CD	NUMBER	3.99	num	55	SENT_279	[p14l1164t3444r1304b3500],
53	MM	NN	O	mm	nn	55	SENT_279	[p14l1350t3445r1469b3515],
54	(	NN	O	(	nn	55	SENT_279	[p14l1511t3444r1574b3515],
55	p	NN	O	p	prep_to	23	SENT_279	[p14l1511t3444r1574b3515],
56	=	JJ	O	=	amod	55	SENT_279	[p14l1623t3463r1671b3482],
57	0.01	CD	NUMBER	0.01	num	58	SENT_279	[p14l1719t3444r1909b3512],
58	)	NN	O	)	dep	56	SENT_279	[p14l1719t3444r1909b3512],
59	,	,	O	,	_	0	SENT_279	[p14l1719t3444r1909b3512],
60	which	WDT	O	which	nsubj	63	SENT_279	[p14l1952t3443r2153b3499],
61	would	MD	O	would	aux	63	SENT_279	[p14l8t3530r213b3587],
62	be	VB	O	be	cop	63	SENT_279	[p14l252t3530r328b3586],
63	consistent	JJ	O	consistent	rcmod	55	SENT_279	[p14l370t3530r705b3586],
64	with	IN	O	with	_	0	SENT_279	[p14l744t3530r890b3587],
65	the	DT	O	the	det	66	SENT_279	[p14l930t3530r1029b3586],
66	effect	NN	O	effect	prep_with	63	SENT_279	[p14l1071t3530r1260b3586],
67	of	IN	O	of	_	0	SENT_279	[p14l1300t3530r1371b3586],
68	curcumin	NN	O	curcumin	prep_of	66	SENT_279	[p14l1407t3530r1719b3586],
69	already	RB	O	already	advmod	70	SENT_279	[p14l1761t3530r2004b3603],
70	observed	VBN	O	observe	partmod	68	SENT_279	[p14l2045t3530r2150b3586, p14l10t3618r224b3674],
71	in	IN	O	in	_	0	SENT_279	[p14l248t3618r311b3673],
72	HEp2	NN	O	hep2	nn	75	SENT_279	[p14l336t3618r526b3690],
73	and	CC	O	and	_	0	SENT_279	[p14l553t3618r670b3674],
74	HEp2A	NN	O	hep2a	conj_and	72	SENT_279	[p14l695t3618r945b3690],
75	cells	NNS	O	cell	prep_in	70	SENT_279	[p14l971t3618r1140b3674],
76	.	.	O	.	_	0	SENT_279	[p14l971t3618r1140b3674],

1	Similar	JJ	O	similar	amod	2	SENT_280	[p14l1171t3618r1415b3674],
2	results	NNS	O	result	nsubjpass	4	SENT_280	[p14l1438t3618r1655b3674],
3	were	VBD	O	be	auxpass	4	SENT_280	[p14l1683t3635r1841b3674],
4	obtained	VBN	O	obtain	_	0	SENT_280	[p14l1867t3618r2153b3674],
5	for	IN	O	for	_	0	SENT_280	[p14l8t3705r104b3761],
6	another	DT	O	another	det	8	SENT_280	[p14l136t3705r385b3761],
7	clone	NN	O	clone	nn	8	SENT_280	[p14l416t3705r594b3761],
8	G4	NN	O	g4	prep_for	4	SENT_280	[p14l627t3705r742b3761],
9	.	.	O	.	_	0	SENT_280	[p14l627t3705r742b3761],

1	Eﬁﬁﬁﬁnﬂvly	RB	O	eﬁﬁﬁﬁnﬂvly	advmod	3	SENT_281	[p15l465t167r926b257],
2	*	CD	NUMBER	*	number	3	SENT_281	[p15l1011t130r1065b258],
3	5	CD	NUMBER	5	_	0	SENT_281	[p15l1122t172r1172b258],
4	an	DT	O	a	det	5	SENT_281	[p15l1219t172r1273b221],
5	9	CD	NUMBER	9	dep	3	SENT_281	[p15l1310t172r1364b221],
6	-	:	O	-	_	0	SENT_281	[p15l1310t172r1364b221],
7	;	:	O	;	_	0	SENT_281	[p15l1401t130r1455b221],
8	''	''	O	''	_	0	SENT_281	[p15l1401t130r1455b221],
9	=	JJ	O	=	amod	13	SENT_281	[p15l1401t130r1455b221],
10	7	CD	NUMBER	7	num	13	SENT_281	[p15l1401t130r1455b221],
11	p	NN	O	p	amod	13	SENT_281	[p15l465t252r883b323],
12	*	CD	NUMBER	*	number	11	SENT_281	[p15l465t252r883b323],
13	E	NN	O	e	dep	3	SENT_281	[p15l1011t263r1065b333],
14	3	CD	NUMBER	3	dep	13	SENT_281	[p15l1123t258r1176b333],
15	.	.	O	.	_	0	SENT_281	[p15l1123t258r1176b333],

1	_	NN	O	_	_	0	SENT_282	[p15l1241t226r1364b333],
2	.	.	O	.	_	0	SENT_282	[p15l1241t226r1364b333],

1	E	NN	O	e	_	0	SENT_283	[p15l1241t226r1364b333],
2	§	SYM	O	§	dep	1	SENT_283	[p15l1401t226r1455b333],

1	ii	LS	O	ii	dep	2	SENT_284	[p15l1198t397r1203b401],
2	I	PRP	O	I	_	0	SENT_284	[p15l1316t392r1317b396],
3	I	PRP	O	I	dobj	2	SENT_284	[p15l1466t398r1467b401],
4	Shell	NNP	O	Shell	dobj	2	SENT_284	[p15l1552t428r1782b482],
5	:	:	O	:	_	0	SENT_284	[p15l1552t428r1782b482],

1	5H	NN	O	5h	_	0	SENT_285	[p15l1552t648r1750b713],
2	_	NN	O	_	dep	1	SENT_285	[p15l1552t648r1750b713],
3	.	.	O	.	_	0	SENT_285	[p15l1552t648r1750b713],

1	,	,	O	,	_	0	SENT_286	[p15l1552t648r1750b713],
2	.	.	O	.	_	0	SENT_286	[p15l1552t648r1750b713],

1	iIW	NN	O	iiw	_	0	SENT_287	[p15l1552t648r1750b713],
2	33.300	CD	NUMBER	33.300	num	1	SENT_287	[p15l1551t755r1750b820],

1	1:511	CD	NUMBER	1:511	num	2	SENT_288	[p15l384t964r615b1013],
2	-.1	CD	NUMBER	-.1	_	0	SENT_288	[p15l384t964r615b1013],
3	1	CD	NUMBER	1	num	4	SENT_288	[p15l647t932r829b1018],
4	Em	NN	O	em	dep	2	SENT_288	[p15l1557t894r1750b959],
5	10,105	CD	NUMBER	10,105	dep	2	SENT_288	[p15l1557t1066r1750b1131],

1	FIGURE	NN	O	figure	nn	4	SENT_289	[p15l78t2250r298b2304],
2	6	CD	NUMBER	6	num	4	SENT_289	[p15l326t2250r361b2303],
3	—	NN	O	—	nn	4	SENT_289	[p15l381t2283r419b2287],
4	Immunoblot	NN	O	immunoblot	_	0	SENT_289	[p15l439t2250r813b2303],
5	analysis	NN	O	analysis	nn	8	SENT_289	[p15l841t2250r1080b2319],
6	and	CC	O	and	_	0	SENT_289	[p15l1111t2250r1217b2303],
7	GST	NN	O	gst	conj_and	5	SENT_289	[p15l1245t2250r1386b2304],
8	activity	NN	O	activity	dep	4	SENT_289	[p15l1414t2250r1638b2319],
9	of	IN	O	of	_	0	SENT_289	[p15l1666t2250r1732b2303],
10	HEp2	NN	O	hep2	nn	11	SENT_289	[p15l1754t2250r1928b2319],
11	clones	NNS	O	clone	prep_of	8	SENT_289	[p15l1957t2250r2147b2303],
12	stably	RB	O	stably	advmod	13	SENT_289	[p15l9t2325r185b2394],
13	expressing	VBG	O	express	partmod	4	SENT_289	[p15l206t2325r528b2394],
14	GSTP1	NN	O	gstp1	dobj	13	SENT_289	[p15l549t2325r785b2378],
15	.	.	O	.	_	0	SENT_289	[p15l549t2325r785b2378],

1	Clones	NNS	O	clone	nsubj	2	SENT_290	[p15l810t2325r1016b2378],
2	marked	VBD	O	mark	_	0	SENT_290	[p15l1038t2325r1264b2378],
3	*	CD	NUMBER	*	nsubjpass	5	SENT_290	[p15l1287t2325r1315b2357],
4	were	VBD	O	be	auxpass	5	SENT_290	[p15l1340t2341r1484b2378],
5	selected	VBN	O	select	ccomp	2	SENT_290	[p15l1507t2325r1748b2378],
6	to	TO	O	to	aux	8	SENT_290	[p15l1767t2333r1823b2378],
7	be	VB	O	be	auxpass	8	SENT_290	[p15l1843t2325r1914b2378],
8	used	VBN	O	use	xcomp	5	SENT_290	[p15l1933t2325r2072b2378],
9	in	IN	O	in	_	0	SENT_290	[p15l2091t2325r2149b2377],
10	doxorubicin	NN	O	doxorubicin	nn	12	SENT_290	[p15l7t2399r372b2453],
11	cytotoxicity	NN	O	cytotoxicity	nn	12	SENT_290	[p15l399t2399r759b2469],
12	assays	NNS	O	assay	prep_in	8	SENT_290	[p15l788t2416r993b2469],
13	.	.	O	.	_	0	SENT_290	[p15l788t2416r993b2469],

1	DISCUSSION	NN	O	discussion	_	0	SENT_291	[p15l880t2630r1274b2676],

1	Acquired	VBN	O	acquire	amod	3	SENT_292	[p15l86t2754r385b2827],
2	drug	NN	O	drug	nn	3	SENT_292	[p15l408t2754r552b2827],
3	resistance	NN	O	resistance	nsubj	4	SENT_292	[p15l575t2754r891b2810],
4	follows	VBZ	O	follow	_	0	SENT_292	[p15l915t2754r1151b2810],
5	selection	NN	O	selection	dobj	4	SENT_292	[p15l1179t2754r1461b2810],
6	or	CC	O	or	_	0	SENT_292	[p15l1485t2772r1550b2810],
7	induction	NN	O	induction	conj_or	5	SENT_292	[p15l1572t2754r1874b2810],
8	by	IN	O	by	_	0	SENT_292	[p15l1896t2754r1975b2827],
9	therapy	NN	O	therapy	prep_by	4	SENT_292	[p15l1998t2754r2146b2810, p15l8t2855r120b2910],
10	of	IN	O	of	_	0	SENT_292	[p15l141t2837r211b2893],
11	diverse	JJ	O	diverse	amod	13	SENT_292	[p15l226t2837r455b2893],
12	molecular	JJ	O	molecular	amod	13	SENT_292	[p15l475t2837r796b2893],
13	events	NNS	O	event	prep_of	9	SENT_292	[p15l816t2845r1016b2893],
14	and	CC	O	and	_	0	SENT_292	[p15l1040t2837r1153b2893],
15	is	VBZ	O	be	cop	19	SENT_292	[p15l1172t2837r1222b2893],
16	a	DT	O	a	det	19	SENT_292	[p15l1246t2855r1279b2893],
17	principal	JJ	O	principal	amod	19	SENT_292	[p15l1296t2837r1581b2910],
18	unresolved	JJ	O	unresolved	amod	19	SENT_292	[p15l1601t2837r1953b2893],
19	cause	NN	O	cause	conj_and	4	SENT_292	[p15l1973t2855r2148b2893],
20	of	IN	O	of	_	0	SENT_292	[p15l7t2921r77b2977],
21	cancer	NN	O	cancer	nn	23	SENT_292	[p15l96t2939r304b2978],
22	treatment	NN	O	treatment	nn	23	SENT_292	[p15l326t2929r629b2978],
23	failure	NN	O	failure	prep_of	19	SENT_292	[p15l652t2921r875b2978],
24	.	.	O	.	_	0	SENT_292	[p15l652t2921r875b2978],

1	The	DT	O	the	det	2	SENT_293	[p15l903t2921r1026b2978],
2	relationship	NN	O	relationship	nsubjpass	11	SENT_293	[p15l1049t2921r1426b2994],
3	between	IN	O	between	_	0	SENT_293	[p15l1450t2921r1717b2978],
4	efﬂux	NN	O	efﬂux	nn	5	SENT_293	[p15l1741t2921r1926b2978],
5	mechanisms	NNS	O	mechanism	prep_between	2	SENT_293	[p15l1950t2921r2146b2978, p15l8t3005r226b3062],
6	and	CC	O	and	_	0	SENT_293	[p15l269t3005r382b3062],
7	drug	NN	O	drug	nn	8	SENT_293	[p15l423t3005r566b3078],
8	resistance	NN	O	resistance	prep_between	2	SENT_293	[p15l606t3005r922b3062],
9	is	VBZ	O	be	auxpass	11	SENT_293	[p15l962t3005r1012b3062],
10	well	RB	O	well	advmod	11	SENT_293	[p15l1054t3005r1190b3062],
11	established	VBN	O	establish	_	0	SENT_293	[p15l1231t3005r1662b3062],
12	.	.	O	.	_	0	SENT_293	[p15l1231t3005r1662b3062],

1	”	NN	O	”	nn	3	SENT_294	[p15l1231t3005r1662b3062],
2	Pgp-mediated	JJ	O	pgp-mediated	amod	3	SENT_294	[p15l1704t3005r2149b3078],
3	efﬂux	NN	O	efﬂux	nsubj	8	SENT_294	[p15l7t3089r192b3146],
4	of	IN	O	of	_	0	SENT_294	[p15l237t3089r307b3146],
5	unconjugated	JJ	O	unconjugated	amod	6	SENT_294	[p15l345t3089r778b3162],
6	doxorubicin	NN	O	doxorubicin	prep_of	3	SENT_294	[p15l822t3089r1208b3146],
7	is	VBZ	O	be	cop	8	SENT_294	[p15l1252t3089r1302b3146],
8	proﬁcient	JJ	O	proﬁcient	_	0	SENT_294	[p15l1348t3089r1672b3162],
9	,	,	O	,	_	0	SENT_294	[p15l1348t3089r1672b3162],
10	while	IN	O	while	mark	12	SENT_294	[p15l1720t3089r1896b3146],
11	MRPl	NN	ORGANIZATION	mrpl	nsubj	12	SENT_294	[p15l1940t3090r2141b3145],
12	supports	VBZ	O	support	advcl	8	SENT_294	[p15l9t3182r275b3247],
13	energy-dependent	JJ	O	energy-dependent	amod	14	SENT_294	[p15l339t3174r914b3247],
14	efﬂux	NN	O	efﬂux	dobj	12	SENT_294	[p15l975t3174r1160b3230],
15	of	IN	O	of	_	0	SENT_294	[p15l1223t3174r1292b3230],
16	glutathione-drug	NN	O	glutathione-drug	nn	17	SENT_294	[p15l1350t3174r1882b3247],
17	conjugates	NNS	O	conjugate	prep_of	14	SENT_294	[p15l1946t3174r2146b3247, p15l7t3258r243b3331],
18	.	.	O	.	_	0	SENT_294	[p15l1946t3174r2146b3247, p15l7t3258r243b3331],

1	“	NN	O	“	npadvmod	19	SENT_295	[p15l1946t3174r2146b3247, p15l7t3258r243b3331],
2	In	IN	O	in	_	0	SENT_295	[p15l274t3259r340b3313],
3	our	PRP$	O	we	poss	4	SENT_295	[p15l366t3276r472b3314],
4	study	NN	O	study	prep_in	19	SENT_295	[p15l500t3258r686b3331],
5	,	,	O	,	_	0	SENT_295	[p15l500t3258r686b3331],
6	verapamil	NN	O	verapamil	nsubj	19	SENT_295	[p15l716t3258r1052b3331],
7	,	,	O	,	_	0	SENT_295	[p15l716t3258r1052b3331],
8	which	WDT	O	which	nsubj	9	SENT_295	[p15l1082t3258r1276b3314],
9	inhibits	VBZ	O	inhibit	rcmod	6	SENT_295	[p15l1303t3258r1540b3314],
10	both	CC	O	both	prep	9	SENT_295	[p15l1567t3258r1709b3314],
11	the	DT	O	the	det	12	SENT_295	[p15l1736t3258r1832b3314],
12	Pgp	NNP	O	Pgp	dep	10	SENT_295	[p15l1858t3259r2005b3331],
13	-	:	O	-	_	0	SENT_295	[p15l1858t3259r2005b3331],
14	and	CC	O	and	_	0	SENT_295	[p15l2036t3258r2149b3314],
15	MRP1-mediated	JJ	O	mrp1-mediated	amod	17	SENT_295	[p15l6t3341r537b3397],
16	efﬂux	NN	O	efﬂux	nn	17	SENT_295	[p15l558t3341r743b3397],
17	pathways	NNS	O	pathway	conj_and	12	SENT_295	[p15l764t3341r1083b3414],
18	,	,	O	,	_	0	SENT_295	[p15l764t3341r1083b3414],
19	chemosensitised	VBN	O	chemosensitise	_	0	SENT_295	[p15l1109t3341r1634b3397],
20	HEp2A	NN	O	hep2a	nn	21	SENT_295	[p15l1655t3342r1899b3414],
21	cells	NNS	O	cell	dobj	19	SENT_295	[p15l1921t3341r2064b3397],
22	to	TO	O	to	_	0	SENT_295	[p15l2088t3349r2148b3397],
23	doxorubicin	NN	O	doxorubicin	prep_to	19	SENT_295	[p15l7t3425r410b3492],
24	,	,	O	,	_	0	SENT_295	[p15l7t3425r410b3492],
25	possibly	RB	O	possibly	advmod	19	SENT_295	[p15l455t3425r721b3498],
26	through	IN	O	through	_	0	SENT_295	[p15l766t3425r1014b3498],
27	effects	NNS	O	effect	prep_through	19	SENT_295	[p15l1057t3425r1267b3482],
28	on	IN	O	on	_	0	SENT_295	[p15l1313t3443r1391b3482],
29	both	DT	O	both	det	31	SENT_295	[p15l1433t3425r1575b3482],
30	efﬂux	NN	O	efﬂux	nn	31	SENT_295	[p15l1619t3425r1803b3482],
31	pathways	NNS	O	pathway	prep_on	27	SENT_295	[p15l1846t3425r2147b3498],
32	since	IN	O	since	mark	37	SENT_295	[p15l9t3509r169b3566],
33	Pgp	NNP	ORGANIZATION	Pgp	nsubjpass	37	SENT_295	[p15l194t3511r316b3582],
34	and	CC	O	and	_	0	SENT_295	[p15l343t3509r456b3566],
35	MRPI	NNP	O	MRPI	nsubjpass	37	SENT_295	[p15l480t3510r681b3565],
36	were	VBD	O	be	auxpass	37	SENT_295	[p15l713t3527r867b3566],
37	overexpressed	VBN	O	overexpress	advcl	19	SENT_295	[p15l893t3509r1350b3582],
38	in	IN	O	in	_	0	SENT_295	[p15l1375t3509r1435b3565],
39	the	DT	O	the	det	42	SENT_295	[p15l1460t3509r1555b3566],
40	resistant	JJ	O	resistant	amod	42	SENT_295	[p15l1579t3509r1848b3566],
41	cell	NN	O	cell	nn	42	SENT_295	[p15l1872t3509r1985b3566],
42	line	NN	O	line	prep_in	37	SENT_295	[p15l2010t3509r2144b3566],
43	.	.	O	.	_	0	SENT_295	[p15l2010t3509r2144b3566],

1	By	IN	O	by	_	0	SENT_296	[p15l6t3595r97b3666],
2	verapamil	NN	O	verapamil	nn	3	SENT_296	[p15l118t3593r437b3666],
3	treatment	NN	O	treatment	agent	8	SENT_296	[p15l457t3602r776b3660],
4	,	,	O	,	_	0	SENT_296	[p15l457t3602r776b3660],
5	doxorubicin	NN	O	doxorubicin	nn	6	SENT_296	[p15l799t3593r1185b3650],
6	ICSO	NN	O	icso	nsubjpass	8	SENT_296	[p15l1205t3593r1363b3650],
7	was	VBD	O	be	auxpass	8	SENT_296	[p15l1383t3611r1504b3650],
8	reduced	VBN	O	reduce	_	0	SENT_296	[p15l1525t3593r1779b3650],
9	to	TO	O	to	_	0	SENT_296	[p15l1798t3602r1857b3650],
10	levels	NNS	O	level	prep_to	8	SENT_296	[p15l1878t3594r2062b3650],
11	of	IN	O	of	_	0	SENT_296	[p15l2084t3593r2154b3650],
12	<	JJR	O	<	prep_of	10	SENT_296	[p15l12t3678r108b3734],
13	5	CD	NUMBER	5	number	15	SENT_296	[p15l12t3678r108b3734],
14	p.	NN	O	p.	dep	15	SENT_296	[p15l157t3679r292b3750],
15	M	NN	O	m	amod	12	SENT_296	[p15l157t3679r292b3750],
16	,	,	O	,	_	0	SENT_296	[p15l157t3679r292b3750],
17	which	WDT	O	which	nsubj	18	SENT_296	[p15l336t3678r531b3734],
18	is	VBZ	O	be	rcmod	12	SENT_296	[p15l571t3678r621b3734],
19	within	IN	O	within	_	0	SENT_296	[p15l664t3678r867b3734],
20	the	DT	O	the	det	22	SENT_296	[p15l908t3678r1004b3734],
21	concentration	NN	O	concentration	nn	22	SENT_296	[p15l1045t3678r1480b3734],
22	range	NN	O	range	prep_within	18	SENT_296	[p15l1520t3695r1697b3751],
23	that	WDT	O	that	nsubjpass	26	SENT_296	[p15l1738t3678r1858b3734],
24	may	MD	O	may	aux	26	SENT_296	[p15l1898t3695r2033b3751],
25	be	VB	O	be	auxpass	26	SENT_296	[p15l2073t3678r2148b3734],
26	achieved	VBN	O	achieve	rcmod	22	SENT_296	[p16l8t12r290b68],
27	during	IN	O	during	_	0	SENT_296	[p16l320t12r526b85],
28	clinical	JJ	O	clinical	amod	29	SENT_296	[p16l556t12r790b68],
29	therapy	NN	O	therapy	prep_during	26	SENT_296	[p16l819t12r1134b85],
30	.28	CD	NUMBER	.28	tmod	26	SENT_296	[p16l819t12r1134b85],

1	In	IN	O	in	_	0	SENT_297	[p16l87t113r152b167],
2	addition	NN	O	addition	_	0	SENT_297	[p16l194t112r454b168],
3	to	TO	O	to	_	0	SENT_297	[p16l495t120r554b168],
4	the	DT	O	the	det	6	SENT_297	[p16l596t112r692b168],
5	well-established	JJ	O	well-established	amod	6	SENT_297	[p16l734t112r1254b168],
6	roles	NNS	O	role	prep_in_addition_to	15	SENT_297	[p16l1293t112r1447b168],
7	for	IN	O	for	_	0	SENT_297	[p16l1489t112r1583b168],
8	Pgp	NNP	O	Pgp	prep_for	6	SENT_297	[p16l1622t113r1744b185],
9	and	CC	O	and	_	0	SENT_297	[p16l1787t112r1900b168],
10	MRP1	NN	O	mrp1	nn	11	SENT_297	[p16l1940t112r2141b167],
11	overexpression	NN	O	overexpression	prep_for	6	SENT_297	[p16l7t196r508b269],
12	,	,	O	,	_	0	SENT_297	[p16l7t196r508b269],
13	our	PRP$	O	we	poss	14	SENT_297	[p16l539t214r644b252],
14	study	NN	O	study	nsubj	15	SENT_297	[p16l672t196r840b269],
15	indicates	VBZ	O	indicate	_	0	SENT_297	[p16l868t196r1150b252],
16	a	DT	O	a	det	17	SENT_297	[p16l1180t214r1213b252],
17	role	NN	O	role	dobj	15	SENT_297	[p16l1237t196r1361b252],
18	for	IN	O	for	_	0	SENT_297	[p16l1387t196r1481b252],
19	GSTP1	NN	O	gstp1	prep_for	17	SENT_297	[p16l1507t196r1733b252],
20	in	IN	O	in	_	0	SENT_297	[p16l1767t196r1827b251],
21	the	DT	O	the	det	22	SENT_297	[p16l1854t196r1949b252],
22	resistance	NN	O	resistance	prep_in	19	SENT_297	[p16l1975t196r2146b252, p16l6t287r173b335],
23	of	IN	O	of	_	0	SENT_297	[p16l202t279r271b335],
24	HEp2A	NN	O	hep2a	nn	25	SENT_297	[p16l292t280r536b352],
25	cells	NNS	O	cell	prep_of	22	SENT_297	[p16l563t279r706b335],
26	to	TO	O	to	_	0	SENT_297	[p16l734t288r794b335],
27	doxorubicin	NN	O	doxorubicin	prep_to	15	SENT_297	[p16l823t279r1224b335],
28	.	.	O	.	_	0	SENT_297	[p16l823t279r1224b335],

1	The	DT	O	the	det	2	SENT_298	[p16l1255t279r1377b335],
2	contribution	NN	O	contribution	nsubjpass	8	SENT_298	[p16l1405t279r1795b335],
3	of	IN	O	of	_	0	SENT_298	[p16l1824t279r1893b335],
4	GSTP1	NN	O	gstp1	prep_of	2	SENT_298	[p16l1915t279r2141b336],
5	to	TO	O	to	_	0	SENT_298	[p16l6t372r66b419],
6	resistance	NN	O	resistance	prep_to	4	SENT_298	[p16l104t363r420b419],
7	is	VBZ	O	be	auxpass	8	SENT_298	[p16l458t363r508b419],
8	suggested	VBN	O	suggest	_	0	SENT_298	[p16l551t363r864b436],
9	both	CC	O	both	preconj	8	SENT_298	[p16l900t363r1042b419],
10	by	IN	O	by	_	0	SENT_298	[p16l1079t363r1158b436],
11	the	DT	O	the	det	12	SENT_298	[p16l1197t363r1292b419],
12	loss	NN	O	loss	agent	8	SENT_298	[p16l1332t363r1452b419],
13	of	IN	O	of	_	0	SENT_298	[p16l1494t363r1563b419],
14	resistance	NN	O	resistance	prep_of	12	SENT_298	[p16l1595t363r1910b419],
15	of	IN	O	of	_	0	SENT_298	[p16l1950t363r2019b419],
16	the	DT	O	the	det	18	SENT_298	[p16l2052t363r2148b419],
17	HEp2A	NN	O	hep2a	nn	18	SENT_298	[p16l7t448r250b520],
18	cells	NNS	O	cell	prep_of	14	SENT_298	[p16l284t448r426b504],
19	in	IN	O	in	_	0	SENT_298	[p16l462t447r523b503],
20	the	DT	O	the	det	21	SENT_298	[p16l556t448r652b504],
21	presence	NN	O	presence	prep_in	18	SENT_298	[p16l684t465r964b520],
22	of	IN	O	of	_	0	SENT_298	[p16l999t447r1068b504],
23	GSTP1	NN	O	gstp1	nn	24	SENT_298	[p16l1097t448r1323b504],
24	inhibitors	NNS	O	inhibitor	prep_of	21	SENT_298	[p16l1364t447r1669b504],
25	and	CC	O	and	_	0	SENT_298	[p16l1706t448r1818b504],
26	by	IN	O	by	_	0	SENT_298	[p16l1850t448r1929b520],
27	stable	JJ	O	stable	amod	28	SENT_298	[p16l1965t448r2148b504],
28	expression	NN	O	expression	conj_and	12	SENT_298	[p16l7t531r348b604],
29	of	IN	O	of	_	0	SENT_298	[p16l388t531r457b588],
30	GSTP1	NN	O	gstp1	prep_of	28	SENT_298	[p16l492t532r718b588],
31	in	IN	O	in	_	0	SENT_298	[p16l764t531r824b587],
32	the	DT	O	the	det	35	SENT_298	[p16l863t532r959b588],
33	parental	JJ	O	parental	amod	35	SENT_298	[p16l997t532r1255b604],
34	cell	NN	O	cell	nn	35	SENT_298	[p16l1294t532r1407b588],
35	line	NN	O	line	prep_in	8	SENT_298	[p16l1447t531r1565b588],
36	also	RB	O	also	advmod	37	SENT_298	[p16l1605t532r1730b588],
37	resulting	VBG	O	result	partmod	35	SENT_298	[p16l1769t531r2048b604],
38	in	IN	O	in	_	0	SENT_298	[p16l2088t531r2149b587],
39	decreased	VBN	O	decrease	amod	40	SENT_298	[p16l7t616r322b672],
40	cytotoxicity	NN	O	cytotoxicity	prep_in	37	SENT_298	[p16l346t616r744b688],
41	,	,	O	,	_	0	SENT_298	[p16l346t616r744b688],
42	which	WDT	O	which	nsubj	44	SENT_298	[p16l771t616r965b672],
43	is	VBZ	O	be	cop	44	SENT_298	[p16l988t616r1037b672],
44	curcumin-sensitive	JJ	O	curcumin-sensitive	rcmod	40	SENT_298	[p16l1064t616r1689b672],
45	.	.	O	.	_	0	SENT_298	[p16l1064t616r1689b672],

1	However	RB	O	however	advmod	13	SENT_299	[p16l1716t617r2026b682],
2	,	,	O	,	_	0	SENT_299	[p16l1716t617r2026b682],
3	the	DT	O	the	det	4	SENT_299	[p16l2052t616r2148b672],
4	role	NN	O	role	nsubj	13	SENT_299	[p16l6t700r129b756],
5	of	IN	O	of	_	0	SENT_299	[p16l160t700r229b756],
6	GSTP1	NN	O	gstp1	prep_of	4	SENT_299	[p16l254t700r481b756],
7	in	IN	O	in	_	0	SENT_299	[p16l517t700r578b755],
8	cellular	JJ	O	cellular	amod	9	SENT_299	[p16l608t700r848b756],
9	resistance	NN	O	resistance	prep_in	6	SENT_299	[p16l875t700r1190b756],
10	to	TO	O	to	_	0	SENT_299	[p16l1220t708r1279b756],
11	doxorubicin	NN	O	doxorubicin	prep_to	9	SENT_299	[p16l1311t700r1697b756],
12	remains	VBZ	O	remain	cop	13	SENT_299	[p16l1725t700r1976b756],
13	controversial	JJ	O	controversial	_	0	SENT_299	[p16l2008t718r2146b756, p16l6t783r323b839],
14	.	.	O	.	_	0	SENT_299	[p16l2008t718r2146b756, p16l6t783r323b839],

1	In	IN	O	in	dep	184	SENT_300	[p16l357t785r422b839],
2	a	DT	O	a	dep	184	SENT_300	[p16l453t801r485b839],
3	number	NN	O	number	dep	184	SENT_300	[p16l514t783r759b839],
4	of	IN	O	of	dep	184	SENT_300	[p16l787t783r856b839],
5	studies	NNS	O	study	dep	184	SENT_300	[p16l883t783r1118b850],
6	,	,	O	,	_	0	SENT_300	[p16l883t783r1118b850],
7	overexpression	NN	O	overexpression	dep	184	SENT_300	[p16l1151t783r1635b856],
8	of	IN	O	of	dep	184	SENT_300	[p16l1665t783r1734b839],
9	this	DT	O	this	dep	184	SENT_300	[p16l1757t783r1870b839],
10	isoform	NN	O	isoform	dep	184	SENT_300	[p16l1901t783r2150b839],
11	correlates	VBZ	O	correlate	dep	184	SENT_300	[p16l7t867r315b923],
12	with	IN	O	with	dep	184	SENT_300	[p16l347t867r488b923],
13	resistance	NN	O	resistance	dep	184	SENT_300	[p16l517t867r832b923],
14	to	TO	O	to	dep	184	SENT_300	[p16l863t876r923b923],
15	doxorubicin	NN	O	doxorubicin	dep	184	SENT_300	[p16l955t867r1461b933],
16	,8	CD	NUMBER	,8	dep	184	SENT_300	[p16l955t867r1461b933],
17	a29	NN	O	a29	dep	184	SENT_300	[p16l955t867r1461b933],
18	but	CC	O	but	dep	184	SENT_300	[p16l1491t867r1594b923],
19	in	IN	O	in	dep	184	SENT_300	[p16l1623t867r1684b922],
20	other	JJ	O	other	dep	184	SENT_300	[p16l1715t867r1878b923],
21	studies	NNS	O	study	dep	184	SENT_300	[p16l1910t867r2145b933],
22	,	,	O	,	_	0	SENT_300	[p16l1910t867r2145b933],
23	which	WDT	O	which	dep	184	SENT_300	[p16l7t950r201b1007],
24	generally	RB	O	generally	dep	184	SENT_300	[p16l231t951r527b1023],
25	involved	VBD	O	involve	dep	184	SENT_300	[p16l557t950r837b1007],
26	other	JJ	O	other	dep	184	SENT_300	[p16l867t951r1031b1007],
27	cell	NN	O	cell	dep	184	SENT_300	[p16l1059t951r1172b1007],
28	types	NNS	O	type	dep	184	SENT_300	[p16l1202t959r1387b1023],
29	,	,	O	,	_	0	SENT_300	[p16l1202t959r1387b1023],
30	no	DT	O	no	dep	184	SENT_300	[p16l1420t968r1497b1007],
31	evidence	NN	O	evidence	dep	184	SENT_300	[p16l1529t950r1811b1007],
32	for	IN	O	for	dep	184	SENT_300	[p16l1841t950r1934b1007],
33	a	DT	O	a	dep	184	SENT_300	[p16l1964t968r1997b1007],
34	role	NN	O	role	dep	184	SENT_300	[p16l2025t951r2148b1007],
35	for	IN	O	for	dep	184	SENT_300	[p16l7t1034r99b1091],
36	GSTP1	NN	O	gstp1	dep	184	SENT_300	[p16l121t1035r347b1091],
37	in	IN	O	in	dep	184	SENT_300	[p16l376t1034r436b1090],
38	resistance	NN	O	resistance	dep	184	SENT_300	[p16l456t1034r772b1091],
39	was	VBD	O	be	dep	184	SENT_300	[p16l794t1052r914b1091],
40	obtained	VBN	O	obtain	dep	184	SENT_300	[p16l938t1034r1363b1091],
41	.16	CD	NUMBER	.16	dep	184	SENT_300	[p16l938t1034r1363b1091],
42	a3	NN	O	a3	dep	184	SENT_300	[p16l938t1034r1363b1091],
43	°	CD	NUMBER	°	dep	184	SENT_300	[p16l938t1034r1363b1091],
44	In	IN	O	in	dep	184	SENT_300	[p16l1384t1036r1449b1090],
45	particular	JJ	O	particular	dep	184	SENT_300	[p16l1469t1034r1793b1107],
46	,	,	O	,	_	0	SENT_300	[p16l1469t1034r1793b1107],
47	there	EX	O	there	dep	184	SENT_300	[p16l1817t1035r1976b1091],
48	is	VBZ	O	be	dep	184	SENT_300	[p16l1997t1034r2047b1091],
49	no	DT	O	no	dep	184	SENT_300	[p16l2070t1052r2148b1091],
50	clear	JJ	O	clear	dep	184	SENT_300	[p16l7t1119r162b1175],
51	evidence	NN	O	evidence	dep	184	SENT_300	[p16l185t1119r467b1175],
52	for	IN	O	for	dep	184	SENT_300	[p16l491t1119r584b1175],
53	the	DT	O	the	dep	184	SENT_300	[p16l606t1119r702b1175],
54	production	NN	O	production	dep	184	SENT_300	[p16l725t1119r1072b1191],
55	of	IN	O	of	dep	184	SENT_300	[p16l1096t1119r1166b1175],
56	a	DT	O	a	dep	184	SENT_300	[p16l1185t1136r1218b1175],
57	doxorubicin-GSH	JJ	O	doxorubicin-gsh	dep	184	SENT_300	[p16l1242t1119r1814b1175],
58	conjugate	NN	O	conjugate	dep	184	SENT_300	[p16l1839t1119r2148b1191],
59	in	FW	O	in	dep	184	SENT_300	[p16l9t1205r66b1259],
60	vivo	FW	O	vivo	dep	184	SENT_300	[p16l89t1205r219b1260],
61	though	IN	O	though	dep	184	SENT_300	[p16l241t1203r463b1276],
62	in	FW	O	in	dep	184	SENT_300	[p16l487t1205r543b1259],
63	vitro	FW	O	vitro	dep	184	SENT_300	[p16l566t1205r714b1260],
64	synthetic	JJ	O	synthetic	dep	184	SENT_300	[p16l740t1203r1023b1276],
65	experiments	NNS	O	experiment	dep	184	SENT_300	[p16l1047t1203r1435b1276],
66	suggest	VBP	O	suggest	dep	184	SENT_300	[p16l1461t1211r1699b1276],
67	this	DT	O	this	dep	184	SENT_300	[p16l1719t1203r1831b1259],
68	would	MD	O	would	dep	184	SENT_300	[p16l1855t1203r2054b1259],
69	be	VB	O	be	dep	184	SENT_300	[p16l2073t1203r2148b1259],
70	possible	JJ	O	possible	dep	184	SENT_300	[p16l6t1286r340b1359],
71	,31	CD	NUMBER	,31	dep	184	SENT_300	[p16l6t1286r340b1359],
72	and	CC	O	and	dep	184	SENT_300	[p16l375t1286r488b1342],
73	the	DT	O	the	dep	184	SENT_300	[p16l515t1286r611b1342],
74	synthetic	JJ	O	synthetic	dep	184	SENT_300	[p16l641t1286r925b1359],
75	conjugate	NN	O	conjugate	dep	184	SENT_300	[p16l955t1286r1264b1359],
76	is	VBZ	O	be	dep	184	SENT_300	[p16l1292t1286r1342b1342],
77	a	DT	O	a	dep	184	SENT_300	[p16l1373t1304r1406b1342],
78	substrate	NN	O	substrate	dep	184	SENT_300	[p16l1435t1286r1715b1342],
79	for	IN	O	for	dep	184	SENT_300	[p16l1743t1286r1837b1342],
80	MRPl	NNP	O	MRPl	dep	184	SENT_300	[p16l1862t1286r2148b1342],
81	.12	CD	NUMBER	.12	dep	184	SENT_300	[p16l1862t1286r2148b1342],
82	It	PRP	O	it	dep	184	SENT_300	[p16l7t1372r54b1426],
83	has	VBZ	O	have	dep	184	SENT_300	[p16l78t1370r181b1426],
84	been	VBN	O	be	dep	184	SENT_300	[p16l206t1370r357b1426],
85	suggested	VBN	O	suggest	dep	184	SENT_300	[p16l384t1370r697b1443],
86	that	IN	O	that	dep	184	SENT_300	[p16l721t1370r841b1426],
87	since	IN	O	since	dep	184	SENT_300	[p16l867t1370r1027b1426],
88	anthracyclines	NNS	O	anthracycline	dep	184	SENT_300	[p16l1053t1370r1512b1443],
89	exert	VBP	O	exert	dep	184	SENT_300	[p16l1540t1379r1698b1426],
90	some	DT	O	some	dep	184	SENT_300	[p16l1725t1388r1889b1426],
91	of	IN	O	of	dep	184	SENT_300	[p16l1915t1370r1984b1426],
92	their	PRP$	O	they	dep	184	SENT_300	[p16l2003t1370r2150b1426],
93	toxicity	NN	O	toxicity	dep	184	SENT_300	[p16l6t1454r249b1527],
94	through	IN	O	through	dep	184	SENT_300	[p16l283t1454r531b1527],
95	production	NN	O	production	dep	184	SENT_300	[p16l563t1454r910b1527],
96	of	IN	O	of	dep	184	SENT_300	[p16l944t1454r1013b1511],
97	reactive	JJ	O	reactive	dep	184	SENT_300	[p16l1040t1455r1292b1511],
98	oxygen	NN	O	oxygen	dep	184	SENT_300	[p16l1327t1472r1560b1527],
99	species	NNS	O	species	dep	184	SENT_300	[p16l1596t1454r1821b1527],
100	and	CC	O	and	dep	184	SENT_300	[p16l1858t1455r1971b1511],
101	lipid	NN	O	lipid	dep	184	SENT_300	[p16l2003t1454r2149b1527],
102	peroxidation	NN	O	peroxidation	dep	184	SENT_300	[p16l6t1538r428b1611],
103	,	,	O	,	_	0	SENT_300	[p16l6t1538r428b1611],
104	GST	NN	O	gst	dep	184	SENT_300	[p16l466t1539r614b1595],
105	overexpression	NN	O	overexpression	dep	184	SENT_300	[p16l649t1538r1133b1611],
106	might	MD	O	might	dep	184	SENT_300	[p16l1167t1538r1353b1611],
107	protect	VB	O	protect	dep	184	SENT_300	[p16l1385t1547r1608b1611],
108	by	IN	O	by	dep	184	SENT_300	[p16l1640t1539r1719b1611],
109	detoxicating	VBG	O	detoxicate	dep	184	SENT_300	[p16l1754t1538r2148b1611],
110	products	NNS	O	product	dep	184	SENT_300	[p16l6t1623r279b1696],
111	of	IN	O	of	dep	184	SENT_300	[p16l309t1623r379b1679],
112	oxidative	JJ	O	oxidative	dep	184	SENT_300	[p16l401t1623r697b1679],
113	stress	NN	O	stress	dep	184	SENT_300	[p16l728t1631r900b1679],
114	rather	RB	O	rather	dep	184	SENT_300	[p16l928t1623r1116b1679],
115	than	IN	O	than	dep	184	SENT_300	[p16l1142t1623r1278b1679],
116	direct	JJ	O	direct	dep	184	SENT_300	[p16l1306t1623r1487b1679],
117	conjugation	NN	O	conjugation	dep	184	SENT_300	[p16l1514t1623r1938b1696],
118	.3	NN	NUMBER	.3	dep	184	SENT_300	[p16l1514t1623r1938b1696],
119	However	RB	O	however	dep	184	SENT_300	[p16l1967t1624r2146b1679, p16l7t1725r159b1773],
120	,	,	O	,	_	0	SENT_300	[p16l1967t1624r2146b1679, p16l7t1725r159b1773],
121	it	PRP	O	it	dep	184	SENT_300	[p16l193t1707r237b1763],
122	is	VBZ	O	be	dep	184	SENT_300	[p16l266t1707r316b1763],
123	also	RB	O	also	dep	184	SENT_300	[p16l350t1707r475b1763],
124	clear	JJ	O	clear	dep	184	SENT_300	[p16l507t1707r662b1763],
125	that	IN	O	that	dep	184	SENT_300	[p16l691t1707r811b1763],
126	MRPl	NN	O	mrpl	dep	184	SENT_300	[p16l840t1707r1041b1762],
127	overexpression	NN	O	overexpression	dep	184	SENT_300	[p16l1080t1707r1563b1780],
128	can	MD	O	can	dep	184	SENT_300	[p16l1594t1725r1703b1763],
129	contribute	VB	O	contribute	dep	184	SENT_300	[p16l1734t1707r2057b1763],
130	to	TO	O	to	dep	184	SENT_300	[p16l2088t1715r2148b1763],
131	doxorubicin	NN	O	doxorubicin	dep	184	SENT_300	[p16l7t1790r393b1846],
132	resistance	NN	O	resistance	dep	184	SENT_300	[p16l427t1790r742b1846],
133	probably	RB	O	probably	dep	184	SENT_300	[p16l776t1790r1060b1863],
134	through	IN	O	through	dep	184	SENT_300	[p16l1095t1790r1344b1863],
135	increased	VBN	O	increase	dep	184	SENT_300	[p16l1378t1790r1680b1846],
136	efﬂux	NN	O	efﬂux	dep	184	SENT_300	[p16l1714t1790r1916b1857],
137	,	,	O	,	_	0	SENT_300	[p16l1714t1790r1916b1857],
138	which	WDT	O	which	dep	184	SENT_300	[p16l1954t1790r2149b1846],
139	would	MD	O	would	dep	184	SENT_300	[p16l7t1874r206b1930],
140	involve	VB	O	involve	dep	184	SENT_300	[p16l226t1874r464b1931],
141	either	CC	O	either	dep	184	SENT_300	[p16l485t1874r667b1930],
142	formation	NN	O	formation	dep	184	SENT_300	[p16l686t1874r1000b1930],
143	of	IN	O	of	dep	184	SENT_300	[p16l1022t1874r1091b1930],
144	a	DT	O	a	dep	184	SENT_300	[p16l1107t1892r1140b1930],
145	doxorubicin-GSH	JJ	O	doxorubicin-gsh	dep	184	SENT_300	[p16l1160t1874r1733b1931],
146	conjugate	NN	O	conjugate	dep	184	SENT_300	[p16l1754t1874r2063b1947],
147	or	CC	O	or	dep	184	SENT_300	[p16l2085t1892r2150b1930],
148	a	DT	O	a	dep	184	SENT_300	[p16l8t1976r41b2015],
149	cotransport	NN	O	cotransport	dep	184	SENT_300	[p16l71t1967r431b2031],
150	mechanism	NN	O	mechanism	dep	184	SENT_300	[p16l460t1958r825b2015],
151	with	IN	O	with	dep	184	SENT_300	[p16l855t1958r995b2015],
152	GSH1132	NN	O	gsh1132	dep	184	SENT_300	[p16l1026t1959r1334b2015],
153	A	NN	O	a	dep	184	SENT_300	[p16l1365t1959r1421b2014],
154	study	NN	O	study	dep	184	SENT_300	[p16l1454t1959r1622b2031],
155	on	IN	O	on	dep	184	SENT_300	[p16l1654t1976r1732b2015],
156	doxorubicin	NN	O	doxorubicin	dep	184	SENT_300	[p16l1763t1958r2149b2015],
157	resistance	NN	O	resistance	dep	184	SENT_300	[p16l6t2042r321b2099],
158	using	VBG	O	use	dep	184	SENT_300	[p16l351t2042r522b2115],
159	3T3	NN	O	3t3	dep	184	SENT_300	[p16l555t2042r1040b2099],
160	—	NN	O	—	dep	184	SENT_300	[p16l555t2042r1040b2099],
161	ﬁbroblasts	NNS	O	ﬁbroblasts	dep	184	SENT_300	[p16l555t2042r1040b2099],
162	transfected	VBN	O	transfect	dep	184	SENT_300	[p16l1072t2042r1423b2099],
163	with	IN	O	with	dep	184	SENT_300	[p16l1453t2042r1593b2099],
164	combinations	NNS	O	combination	dep	184	SENT_300	[p16l1623t2042r2052b2099],
165	of	IN	O	of	dep	184	SENT_300	[p16l2085t2042r2154b2099],
166	MRP1	NN	O	mrp1	dep	184	SENT_300	[p16l6t2127r231b2193],
167	,	,	O	,	_	0	SENT_300	[p16l6t2127r231b2193],
168	y-glutamylcysteine	NN	O	y-glutamylcysteine	dep	184	SENT_300	[p16l282t2127r900b2199],
169	synthetase	NN	O	synthetase	dep	184	SENT_300	[p16l950t2127r1280b2199],
170	and	CC	O	and	dep	184	SENT_300	[p16l1329t2127r1442b2183],
171	GSTP1	NN	O	gstp1	dep	184	SENT_300	[p16l1490t2127r1716b2183],
172	found	VBD	O	find	dep	184	SENT_300	[p16l1771t2127r1956b2183],
173	little	JJ	O	little	dep	184	SENT_300	[p16l2003t2127r2148b2183],
174	effect	NN	O	effect	dep	184	SENT_300	[p16l7t2211r188b2267],
175	by	IN	O	by	dep	184	SENT_300	[p16l216t2211r294b2284],
176	GSTP1	NN	O	gstp1	dep	184	SENT_300	[p16l326t2211r553b2267],
177	transfection	NN	O	transfection	dep	184	SENT_300	[p16l589t2211r967b2267],
178	alone	RB	O	alone	dep	184	SENT_300	[p16l998t2211r1185b2277],
179	,	,	O	,	_	0	SENT_300	[p16l998t2211r1185b2277],
180	but	CC	O	but	dep	184	SENT_300	[p16l1217t2211r1320b2267],
181	cotransfection	NN	O	cotransfection	dep	184	SENT_300	[p16l1350t2211r1802b2267],
182	with	IN	O	with	dep	184	SENT_300	[p16l1832t2211r1973b2267],
183	all	DT	O	all	dep	184	SENT_300	[p16l2004t2211r2080b2267],
184	3	CD	NUMBER	3	_	0	SENT_300	[p16l2113t2211r2144b2267],

1	782	CD	NUMBER	782	_	0	SENT_301	[p16l56t2359r111b2385],
2	HARBOTTLE	NNP	O	HARBOTTLE	nn	4	SENT_301	[p16l947t2365r1119b2385],
3	ET	NNP	O	ET	nn	4	SENT_301	[p16l1129t2365r1166b2385],
4	AL.	NNP	O	AL.	dep	1	SENT_301	[p16l1171t2365r1211b2385],
5	.	.	O	.	_	0	SENT_301	[p16l1171t2365r1211b2385],

1	1	CD	NUMBER	1	nsubj	2	SENT_302	[p16l94t2434r103b2451],
2	oo	NN	O	oo	_	0	SENT_302	[p16l107t2434r131b2451],
3	-	:	O	-	_	0	SENT_302	[p16l754t2451r834b2470],
4	.	.	O	.	_	0	SENT_302	[p16l754t2451r834b2470],

1	—	NN	O	—	_	0	SENT_303	[p16l754t2451r834b2470],
2	.	.	O	.	_	0	SENT_303	[p16l754t2451r834b2470],

1	i	LS	O	i	_	0	SENT_304	[p16l754t2451r834b2470],
2	.	.	O	.	_	0	SENT_304	[p16l754t2451r834b2470],

1	—	NN	O	—	_	0	SENT_305	[p16l754t2451r834b2470],
2	.	.	O	.	_	0	SENT_305	[p16l754t2451r834b2470],

1	~	NN	O	~	nn	2	SENT_306	[p16l754t2451r834b2470],
2	I-IEp2	NN	O	i-iep2	_	0	SENT_306	[p16l839t2450r896b2473],
3	Zeo	NNP	O	Zeo	nn	4	SENT_306	[p16l901t2450r940b2468],
4	Control	NNP	O	Control	dep	2	SENT_306	[p16l949t2450r1025b2468],
5	.	.	O	.	_	0	SENT_306	[p16l753t2481r896b2503],

1	—	NN	O	—	_	0	SENT_307	[p16l753t2481r896b2503],
2	.	.	O	.	_	0	SENT_307	[p16l753t2481r896b2503],

1	-	:	O	-	_	0	SENT_308	[p16l753t2481r896b2503],
2	O	NN	O	o	_	0	SENT_308	[p16l753t2481r896b2503],
3	-	:	O	-	_	0	SENT_308	[p16l753t2481r896b2503],
4	.	.	O	.	_	0	SENT_308	[p16l753t2481r896b2503],

1	—	NN	O	—	_	0	SENT_309	[p16l753t2481r896b2503],
2	.	.	O	.	_	0	SENT_309	[p16l753t2481r896b2503],

1	HEp2	NN	O	hep2	_	0	SENT_310	[p16l753t2481r896b2503],
2	GSTP1	NN	O	gstp1	nn	3	SENT_310	[p16l901t2481r968b2498],
3	Clone	NN	O	clone	rcmod	1	SENT_310	[p16l978t2481r1036b2499],
4	3	CD	NUMBER	3	dep	3	SENT_310	[p16l1043t2481r1053b2498],
5	—	SYM	O	—	dep	3	SENT_310	[p16l754t2520r762b2521],
6	-	:	O	-	_	0	SENT_310	[p16l768t2520r775b2522],
7	A	NN	O	a	nn	8	SENT_310	[p16l781t2511r803b2529],
8	~	NN	O	~	dep	1	SENT_310	[p16l809t2520r817b2522],
9	—	CD	NUMBER	—	number	10	SENT_310	[p16l823t2520r831b2521],
10	}	CD	NUMBER	}	dep	8	SENT_310	[p16l839t2510r896b2533],
11	IEp2	NN	O	iep2	nn	13	SENT_310	[p16l839t2510r896b2533],
12	Zeo	NN	O	zeo	nn	13	SENT_310	[p16l901t2510r940b2527],
13	Conto1	NN	O	conto1	dep	8	SENT_310	[p16l949t2509r1036b2527],
14	+	CC	O	+	_	0	SENT_310	[p16l949t2509r1036b2527],
15	Curcumin	NN	O	curcumin	nn	18	SENT_310	[p16l1043t2509r1139b2527],
16	—	CD	NUMBER	—	num	18	SENT_310	[p16l754t2551r762b2552],
17	~	NN	O	~	nn	18	SENT_310	[p16l768t2550r775b2552],
18	o	NN	O	o	conj_+	13	SENT_310	[p16l782t2542r803b2559],
19	-	:	O	-	_	0	SENT_310	[p16l809t2550r817b2552],
20	~	NN	O	~	nn	21	SENT_310	[p16l823t2550r831b2552],
21	HEp2	NN	O	hep2	dep	1	SENT_310	[p16l839t2541r896b2563],
22	GSTP1	NN	O	gstp1	nn	23	SENT_310	[p16l901t2541r968b2558],
23	Clone	NN	O	clone	dep	21	SENT_310	[p16l978t2540r1036b2558],
24	3	CD	NUMBER	3	dep	1	SENT_310	[p16l1043t2541r1053b2558],
25	+	CC	O	+	_	0	SENT_310	[p16l1060t2543r1073b2555],
26	Curcumin	NN	O	curcumin	dep	1	SENT_310	[p16l1080t2540r1176b2558],

1	80	CD	NUMBER	80	num	2	SENT_311	[p16l107t2544r132b2561],
2	r	NN	O	r	_	0	SENT_311	[p16l172t2569r220b2572],
3	_	CD	NUMBER	_	number	4	SENT_311	[p16l172t2569r220b2572],
4	“	CD	NUMBER	“	dep	2	SENT_311	[p16l172t2569r220b2572],
5	i	FW	O	i	dep	4	SENT_311	[p16l240t2571r247b2572],
6	Q	NNP	O	Q	dep	2	SENT_311	[p16l481t2551r503b2606],

1	40	CD	NUMBER	40	_	0	SENT_312	[p16l107t2760r147b2778],
2	-	:	O	-	_	0	SENT_312	[p16l107t2760r147b2778],
3	QT	NN	O	qt	dep	1	SENT_312	[p16l680t2745r717b2776],
4	+	CC	O	+	_	0	SENT_312	[p16l680t2745r717b2776],
5	@g	NN	O	@g	nn	6	SENT_312	[p16l746t2760r785b2785],
6	T	NN	O	t	dep	1	SENT_312	[p16l746t2760r785b2785],
7	+	CC	O	+	_	0	SENT_312	[p16l746t2760r785b2785],
8	__	NN	O	__	conj_+	3	SENT_312	[p16l933t2782r952b2788],
9	....	CD	NUMBER	....	num	8	SENT_312	[p16l978t2774r1024b2780],
10	.	.	O	.	_	0	SENT_312	[p16l1031t2771r1051b2775],

1	.	.	O	.	_	0	SENT_313	[p16l1031t2771r1051b2775],

1	QT	NN	O	qt	_	0	SENT_314	[p16l1074t2773r1117b2787],
2	+	CC	O	+	cc	1	SENT_314	[p16l1074t2773r1117b2787],

1	Percenlnge	NNP	O	Percenlnge	nn	3	SENT_315	[p16l56t2725r78b2844],
2	Cell	NNP	O	Cell	nn	3	SENT_315	[p16l55t2677r73b2719],
3	Survival	NNP	O	Survival	_	0	SENT_315	[p16l56t2584r73b2667],
4	20	CD	NUMBER	20	dep	3	SENT_315	[p16l107t2867r132b2885],

1	FIGURE	NN	O	figure	nn	4	SENT_316	[p16l1268t2904r1371b2928],
2	7	CD	NUMBER	7	num	4	SENT_316	[p16l1381t2904r1398b2928],
3	—	NN	O	—	nn	4	SENT_316	[p16l1407t2919r1425b2921],
4	Effect	NN	O	effect	_	0	SENT_316	[p16l1434t2903r1520b2928],
5	of	IN	O	of	_	0	SENT_316	[p16l1531t2903r1561b2928],
6	stable	JJ	O	stable	amod	7	SENT_316	[p16l1570t2903r1651b2928],
7	transfection	NN	O	transfection	prep_of	4	SENT_316	[p16l1661t2903r1827b2928],
8	of	IN	O	of	_	0	SENT_316	[p16l1838t2903r1869b2928],
9	HEp2	NN	O	hep2	nn	10	SENT_316	[p16l1876t2904r1958b2936],
10	cells	NNS	O	cell	prep_of	7	SENT_316	[p16l1969t2903r2032b2928],
11	with	IN	O	with	_	0	SENT_316	[p16l2043t2903r2105b2928],
12	human	JJ	O	human	amod	13	SENT_316	[p16l1235t2939r1330b2964],
13	GSTP1	NN	O	gstp1	prep_with	10	SENT_316	[p16l1344t2939r1444b2964],
14	and	CC	O	and	_	0	SENT_316	[p16l1462t2939r1511b2964],
15	the	DT	O	the	det	18	SENT_316	[p16l1525t2939r1567b2964],
16	GSTP1	NN	O	gstp1	nn	18	SENT_316	[p16l1581t2939r1681b2964],
17	inhibitor	NN	O	inhibitor	nn	18	SENT_316	[p16l1698t2939r1820b2964],
18	curcumin	NN	O	curcumin	conj_and	10	SENT_316	[p16l1833t2939r1965b2964],
19	(	CD	NUMBER	(	number	20	SENT_316	[p16l1980t2939r2024b2969],
20	25	CD	NUMBER	25	num	24	SENT_316	[p16l1980t2939r2024b2969],
21	pLM	NN	O	plm	nn	24	SENT_316	[p16l2041t2939r2104b2971],
22	)	NN	O	)	nn	24	SENT_316	[p16l2041t2939r2104b2971],
23	o	NN	O	o	nn	24	SENT_316	[p16l120t2976r131b2994],
24	T	NN	O	t	dep	18	SENT_316	[p16l487t2984r498b2994],
25	‘	SYM	O	‘	dep	4	SENT_316	[p16l721t2982r1167b2993],
26	-	:	O	-	_	0	SENT_316	[p16l721t2982r1167b2993],
27	*	NN	O	*	dep	4	SENT_316	[p16l721t2982r1167b2993],
28	.	.	O	.	_	0	SENT_316	[p16l721t2982r1167b2993],

1	—	NN	O	—	_	0	SENT_317	[p16l721t2982r1167b2993],
2	.	.	O	.	_	0	SENT_317	[p16l721t2982r1167b2993],

1	r	NN	O	r	_	0	SENT_318	[p16l721t2982r1167b2993],
2	“‘	CD	NUMBER	“‘	num	1	SENT_318	[p16l721t2982r1167b2993],
3	:	:	O	:	_	0	SENT_318	[p16l721t2982r1167b2993],
4	.	.	O	.	_	0	SENT_318	[p16l721t2982r1167b2993],

1	—	NN	O	—	_	0	SENT_319	[p16l721t2982r1167b2993],
2	.	.	O	.	_	0	SENT_319	[p16l721t2982r1167b2993],

1	:	:	O	:	_	0	SENT_320	[p16l721t2982r1167b2993],
2	'	''	O	'	_	0	SENT_320	[p16l721t2982r1167b2993],
3	.	.	O	.	_	0	SENT_320	[p16l721t2982r1167b2993],

1	—	NN	O	—	_	0	SENT_321	[p16l721t2982r1167b2993],
2	.	.	O	.	_	0	SENT_321	[p16l721t2982r1167b2993],

1	.	.	O	.	_	0	SENT_322	[p16l721t2982r1167b2993],

1	—	NN	O	—	_	0	SENT_323	[p16l721t2982r1167b2993],
2	.	.	O	.	_	0	SENT_323	[p16l721t2982r1167b2993],

1	*	NN	O	*	nn	2	SENT_324	[p16l721t2982r1167b2993],
2	m	NN	O	m	_	0	SENT_324	[p16l721t2982r1167b2993],
3	on	IN	O	on	_	0	SENT_324	[p16l1235t2982r1269b2999],
4	doxorubicin-induced	JJ	O	doxorubicin-induced	amod	5	SENT_324	[p16l1281t2974r1575b2999],
5	cytotoxicity	NN	O	cytotoxicity	prep_on	2	SENT_324	[p16l1587t2974r1762b3007],
6	.	.	O	.	_	0	SENT_324	[p16l1587t2974r1762b3007],

1	Each	DT	O	each	det	2	SENT_325	[p16l1775t2974r1846b2999],
2	point	NN	O	point	nsubj	7	SENT_325	[p16l1857t2974r1930b3007],
3	is	VBZ	O	be	cop	7	SENT_325	[p16l1941t2974r1962b2999],
4	the	DT	O	the	det	7	SENT_325	[p16l1975t2974r2017b2999],
5	mean	JJ	O	mean	amod	7	SENT_325	[p16l2029t2982r2105b2999],
6	0.1	CD	NUMBER	0.1	number	7	SENT_325	[p16l138t3012r167b3029],
7	1	CD	NUMBER	1	_	0	SENT_325	[p16l486t3012r495b3029],
8	10	CD	NUMBER	10	number	9	SENT_325	[p16l816t3011r841b3029],
9	100	CD	NUMBER	100	num	7	SENT_325	[p16l1148t3011r1185b3028],
10	of	IN	O	of	_	0	SENT_325	[p16l1235t3008r1266b3033],
11	triplicate	NN	O	triplicate	nn	12	SENT_325	[p16l1275t3008r1400b3040],
12	determinations	NNS	O	determination	prep_of	7	SENT_325	[p16l1413t3008r1629b3033],
13	.	.	O	.	_	0	SENT_325	[p16l1413t3008r1629b3033],

1	The	DT	O	the	det	2	SENT_326	[p16l1643t3008r1697b3033],
2	experiment	NN	O	experiment	nsubj	5	SENT_326	[p16l1709t3008r1868b3040],
3	shown	VBN	O	show	partmod	2	SENT_326	[p16l1880t3008r1971b3033],
4	was	VBD	O	be	cop	5	SENT_326	[p16l1983t3016r2036b3033],
5	perDvmruﬁdn	NNP	O	perDvmruﬁdn	_	0	SENT_326	[p16l2048t3016r2104b3040, p16l487t3047r617b3065],

1	C	NN	O	c	nsubj	8	SENT_327	[p16l622t3047r834b3072],
2	°	CD	NUMBER	°	num	3	SENT_327	[p16l622t3047r834b3072],
3	n	NN	O	n	dep	1	SENT_327	[p16l622t3047r834b3072],
4	°	CD	NUMBER	°	num	5	SENT_327	[p16l622t3047r834b3072],
5	°	NN	O	°	dep	1	SENT_327	[p16l622t3047r834b3072],
6	n	NN	O	n	dep	5	SENT_327	[p16l622t3047r834b3072],
7	'	''	O	'	_	0	SENT_327	[p16l622t3047r834b3072],
8	=	JJ	O	=	_	0	SENT_327	[p16l622t3047r834b3072],
9	’	NN	O	’	dobj	8	SENT_327	[p16l622t3047r834b3072],
10	=	JJ	O	=	amod	9	SENT_327	[p16l622t3047r834b3072],
11	'	''	O	'	_	0	SENT_327	[p16l622t3047r834b3072],
12	i	FW	O	i	nsubj	16	SENT_327	[p16l622t3047r834b3072],
13	°	FW	O	°	dep	12	SENT_327	[p16l622t3047r834b3072],
14	'	''	O	'	_	0	SENT_327	[p16l622t3047r834b3072],
15	I	PRP	O	I	advmod	16	SENT_327	[p16l622t3047r834b3072],
16	(	VBP	O	(	rcmod	9	SENT_327	[p16l622t3047r834b3072],
17	uM	NN	O	um	nn	18	SENT_327	[p16l622t3047r834b3072],
18	)	NN	O	)	dobj	16	SENT_327	[p16l622t3047r834b3072],
19	formed	VBN	O	form	partmod	18	SENT_327	[p16l1235t3048r1336b3074],
20	with	IN	O	with	_	0	SENT_327	[p16l1349t3048r1411b3074],
21	clone	NN	O	clone	nn	22	SENT_327	[p16l1424t3049r1499b3074],
22	G3	NN	O	g3	prep_with	19	SENT_327	[p16l1513t3049r1562b3074],
23	.	.	O	.	_	0	SENT_327	[p16l1513t3049r1562b3074],

1	cDNAs	NNS	O	cdna	nsubj	2	SENT_328	[p16l9t3236r245b3292],
2	resulted	VBD	O	result	_	0	SENT_328	[p16l284t3235r538b3292],
3	in	IN	O	in	_	0	SENT_328	[p16l575t3235r635b3291],
4	the	DT	O	the	det	6	SENT_328	[p16l674t3235r769b3291],
5	largest	JJS	O	largest	amod	6	SENT_328	[p16l808t3235r1020b3308],
6	resistance	NN	O	resistance	prep_in	54	SENT_328	[p16l1057t3235r1371b3292],
7	to	TO	O	to	_	0	SENT_328	[p16l1410t3244r1469b3291],
8	doxorubicin	NN	O	doxorubicin	prep_to	6	SENT_328	[p16l1509t3235r1911b3302],
9	,	,	O	,	_	0	SENT_328	[p16l1509t3235r1911b3302],
10	which	WDT	O	which	nsubj	13	SENT_328	[p16l1953t3235r2147b3292],
11	would	MD	O	would	aux	13	SENT_328	[p16l9t3319r207b3376],
12	be	VB	O	be	cop	13	SENT_328	[p16l231t3320r305b3376],
13	consistent	JJ	O	consistent	rcmod	8	SENT_328	[p16l331t3319r650b3376],
14	with	IN	O	with	_	0	SENT_328	[p16l674t3319r815b3376],
15	a	DT	O	a	det	16	SENT_328	[p16l841t3337r874b3376],
16	role	NN	O	role	prep_with	13	SENT_328	[p16l897t3320r1020b3376],
17	for	IN	O	for	_	0	SENT_328	[p16l1046t3319r1138b3376],
18	both	DT	O	both	det	19	SENT_328	[p16l1160t3319r1303b3376],
19	GSTP1	NN	O	gstp1	prep_for	16	SENT_328	[p16l1328t3320r1554b3376],
20	and	CC	O	and	_	0	SENT_328	[p16l1588t3320r1700b3376],
21	cellular	JJ	O	cellular	amod	23	SENT_328	[p16l1725t3319r1965b3376],
22	GSH	NN	O	gsh	nn	23	SENT_328	[p16l1989t3320r2146b3376],
23	levels	NNS	O	level	conj_and	19	SENT_328	[p16l9t3404r191b3460],
24	in	IN	O	in	_	0	SENT_328	[p16l234t3404r295b3459],
25	doxorubicin	NN	O	doxorubicin	nn	26	SENT_328	[p16l335t3404r721b3460],
26	detoxication	NN	O	detoxication	prep_in	13	SENT_328	[p16l761t3404r1155b3460],
27	in	IN	O	in	_	0	SENT_328	[p16l1195t3404r1256b3459],
28	addition	NN	O	addition	prep_in	26	SENT_328	[p16l1298t3404r1557b3460],
29	to	TO	O	to	_	0	SENT_328	[p16l1597t3412r1657b3460],
30	MRP1	NN	O	mrp1	prep_to	13	SENT_328	[p16l1697t3404r1981b3460],
31	.33	CD	NUMBER	.33	num	30	SENT_328	[p16l1697t3404r1981b3460],
32	The	DT	O	the	det	33	SENT_328	[p16l2023t3404r2146b3460],
33	failure	NN	O	failure	nsubj	54	SENT_328	[p17l9t21r215b77],
34	to	TO	O	to	aux	35	SENT_328	[p17l237t29r296b77],
35	see	VB	O	see	infmod	33	SENT_328	[p17l321t39r418b77],
36	an	DT	O	a	det	37	SENT_328	[p17l441t39r513b77],
37	effect	NN	O	effect	dobj	35	SENT_328	[p17l535t21r716b77],
38	in	IN	O	in	_	0	SENT_328	[p17l735t21r796b76],
39	3T3	NN	O	3t3	nn	40	SENT_328	[p17l819t21r940b77],
40	cells	NNS	O	cell	prep_in	35	SENT_328	[p17l966t21r1108b77],
41	and	CC	O	and	_	0	SENT_328	[p17l1133t21r1246b77],
42	in	IN	O	in	_	0	SENT_328	[p17l1266t21r1327b76],
43	earlier	JJR	O	earlier	amod	44	SENT_328	[p17l1348t21r1552b77],
44	studies	NNS	O	study	conj_and	40	SENT_328	[p17l1574t21r1790b77],
45	on	IN	O	on	_	0	SENT_328	[p17l1814t39r1891b77],
46	MCF-7	NN	O	mcf-7	nn	47	SENT_328	[p17l1912t21r2144b77],
47	cells34	NNS	O	cells34	prep_on	44	SENT_328	[p17l9t92r216b160],
48	when	WRB	O	when	advmod	52	SENT_328	[p17l246t104r418b160],
49	GSTP1	NN	O	gstp1	nsubjpass	52	SENT_328	[p17l450t104r675b161],
50	only	RB	O	only	advmod	52	SENT_328	[p17l714t104r852b177],
51	was	VBD	O	be	auxpass	52	SENT_328	[p17l884t122r1004b160],
52	transfected	VBN	O	transfect	advcl	35	SENT_328	[p17l1036t104r1387b160],
53	may	MD	O	may	aux	54	SENT_328	[p17l1416t122r1552b177],
54	reﬂect	VB	O	reﬂect	ccomp	2	SENT_328	[p17l1582t104r1782b160],
55	a	DT	O	a	det	56	SENT_328	[p17l1813t122r1846b160],
56	need	NN	O	need	dobj	54	SENT_328	[p17l1875t104r2025b160],
57	for	IN	O	for	_	0	SENT_328	[p17l2055t104r2148b160],
58	some	DT	O	some	det	60	SENT_328	[p17l11t206r175b244],
59	MRPI	NN	O	mrpus	nn	60	SENT_328	[p17l202t189r403b244],
60	expression	NN	O	expression	prep_for	56	SENT_328	[p17l437t188r777b261],
61	in	IN	O	in	_	0	SENT_328	[p17l804t188r864b244],
62	the	DT	O	the	det	65	SENT_328	[p17l890t188r986b244],
63	parental	JJ	O	parental	amod	65	SENT_328	[p17l1012t188r1269b261],
64	cell	NN	O	cell	nn	65	SENT_328	[p17l1296t188r1409b244],
65	line	NN	O	line	prep_in	60	SENT_328	[p17l1436t188r1554b244],
66	to	TO	O	to	aux	67	SENT_328	[p17l1581t197r1640b244],
67	allow	VB	O	allow	xcomp	54	SENT_328	[p17l1669t188r1843b245],
68	efﬂux	NN	O	efﬂux	dobj	67	SENT_328	[p17l1871t188r2055b244],
69	of	IN	O	of	_	0	SENT_328	[p17l2082t188r2152b244],
70	doxorubicin	NN	O	doxorubicin	prep_of	68	SENT_328	[p17l9t272r410b329],
71	.	.	O	.	_	0	SENT_328	[p17l9t272r410b329],

1	Though	IN	O	though	_	0	SENT_329	[p17l453t272r700b345],
2	MRPl	NN	O	mrpl	nn	3	SENT_329	[p17l738t273r939b328],
3	levels	NNS	O	level	prep_though	7	SENT_329	[p17l985t272r1168b329],
4	in	IN	O	in	_	0	SENT_329	[p17l1208t272r1268b328],
5	HEp2	NN	O	hep2	prep_in	3	SENT_329	[p17l1307t273r1491b345],
6	cells	NNS	O	cell	nsubj	7	SENT_329	[p17l1531t272r1673b329],
7	were	VBD	O	be	_	0	SENT_329	[p17l1714t290r1867b329],
8	approx	RB	O	approx	advmod	7	SENT_329	[p17l1907t290r2142b345],
9	.	.	O	.	_	0	SENT_329	[p17l1907t290r2142b345],

1	3-fold	RB	O	3-fold	advmod	2	SENT_330	[p17l11t356r203b413],
2	lower	JJR	O	lower	ccomp	15	SENT_330	[p17l244t357r426b413],
3	than	IN	O	than	prep	2	SENT_330	[p17l466t356r602b413],
4	in	IN	O	in	pcomp	3	SENT_330	[p17l642t356r703b412],
5	HEp2A	NN	O	hep2a	nn	6	SENT_330	[p17l744t357r987b429],
6	cells	NNS	O	cell	pobj	4	SENT_330	[p17l1029t356r1190b423],
7	,	,	O	,	_	0	SENT_330	[p17l1029t356r1190b423],
8	a	DT	O	a	det	9	SENT_330	[p17l1236t374r1269b413],
9	signal	NN	O	signal	nsubj	15	SENT_330	[p17l1312t356r1498b429],
10	was	VBD	O	be	cop	15	SENT_330	[p17l1540t374r1661b413],
11	detectable	JJ	O	detectable	acomp	15	SENT_330	[p17l1705t356r2027b413],
12	by	IN	O	by	_	0	SENT_330	[p17l2067t357r2146b429],
13	RT-PCR	NN	O	rt-pcr	prep_by	15	SENT_330	[p17l8t441r304b507],
14	,	,	O	,	_	0	SENT_330	[p17l8t441r304b507],
15	indicating	VBG	O	indicate	_	0	SENT_330	[p17l339t441r657b514],
16	a	DT	O	a	det	18	SENT_330	[p17l692t458r725b497],
17	low	JJ	O	low	amod	18	SENT_330	[p17l756t441r873b497],
18	level	NN	O	level	dobj	15	SENT_330	[p17l906t441r1060b497],
19	of	IN	O	of	_	0	SENT_330	[p17l1093t441r1162b497],
20	expression	NN	O	expression	prep_of	18	SENT_330	[p17l1189t441r1530b514],
21	of	IN	O	of	_	0	SENT_330	[p17l1563t441r1632b497],
22	this	DT	O	this	det	23	SENT_330	[p17l1659t441r1770b497],
23	protein	NN	O	protein	prep_of	20	SENT_330	[p17l1803t441r2045b513],
24	.	.	O	.	_	0	SENT_330	[p17l1803t441r2045b513],

1	In	IN	O	in	_	0	SENT_331	[p17l2082t442r2147b496],
2	our	PRP$	O	we	poss	3	SENT_331	[p17l9t543r115b581],
3	study	NN	O	study	prep_in	7	SENT_331	[p17l140t525r326b598],
4	,	,	O	,	_	0	SENT_331	[p17l140t525r326b598],
5	curcumin	NN	O	curcumin	nsubj	7	SENT_331	[p17l354t525r655b581],
6	alone	RB	O	alone	advmod	7	SENT_331	[p17l681t525r850b581],
7	had	VBD	O	have	_	0	SENT_331	[p17l874t525r989b581],
8	a	DT	O	a	det	10	SENT_331	[p17l1015t543r1048b581],
9	small	JJ	O	small	amod	10	SENT_331	[p17l1073t525r1242b581],
10	effect	NN	O	effect	dobj	7	SENT_331	[p17l1267t525r1448b581],
11	in	IN	O	in	_	0	SENT_331	[p17l1471t525r1532b580],
12	potentiating	VBG	O	potentiate	prepc_in	10	SENT_331	[p17l1555t525r1936b598],
13	doxorubicin	NN	O	doxorubicin	nn	14	SENT_331	[p17l1962t525r2144b581, p17l8t608r234b664],
14	cytotoxicity	NN	O	cytotoxicity	dobj	12	SENT_331	[p17l274t608r654b681],
15	in	IN	O	in	_	0	SENT_331	[p17l695t608r755b664],
16	the	DT	O	the	det	19	SENT_331	[p17l795t608r890b664],
17	parent	NN	O	parent	nn	19	SENT_331	[p17l929t617r1130b681],
18	HEp2	NN	O	hep2	nn	19	SENT_331	[p17l1169t609r1353b681],
19	cells	NNS	O	cell	prep_in	12	SENT_331	[p17l1394t608r1555b675],
20	,	,	O	,	_	0	SENT_331	[p17l1394t608r1555b675],
21	which	WDT	O	which	nsubj	22	SENT_331	[p17l1599t608r1793b664],
22	expressed	VBD	O	express	rcmod	19	SENT_331	[p17l1833t608r2147b681],
23	GSTP1	NN	O	gstp1	dobj	22	SENT_331	[p17l10t693r235b749],
24	at	IN	O	at	_	0	SENT_331	[p17l269t700r324b748],
25	a	DT	O	a	det	27	SENT_331	[p17l348t710r382b748],
26	low	JJ	O	low	amod	27	SENT_331	[p17l405t692r522b749],
27	level	NN	O	level	prep_at	22	SENT_331	[p17l547t692r701b749],
28	but	CC	O	but	_	0	SENT_331	[p17l724t692r827b748],
29	had	VBD	O	have	conj_but	22	SENT_331	[p17l850t692r964b749],
30	little	JJ	O	little	amod	31	SENT_331	[p17l988t692r1133b748],
31	Pgp	NNP	O	Pgp	dobj	29	SENT_331	[p17l1157t694r1279b765],
32	and	CC	O	and	_	0	SENT_331	[p17l1306t692r1418b748],
33	MRP1	NN	O	mrp1	conj_and	31	SENT_331	[p17l1442t693r1665b749],
34	.	.	O	.	_	0	SENT_331	[p17l1442t693r1665b749],

1	In	IN	O	in	_	0	SENT_332	[p17l1694t694r1759b748],
2	the	DT	O	the	det	4	SENT_332	[p17l1783t692r1878b749],
3	HEp2A	NN	O	hep2a	nn	4	SENT_332	[p17l1904t693r2146b765],
4	subclone	NN	O	subclone	prep_in	7	SENT_332	[p17l11t777r309b843],
5	,	,	O	,	_	0	SENT_332	[p17l11t777r309b843],
6	it	PRP	O	it	nsubj	7	SENT_332	[p17l339t776r383b833],
7	had	VBD	O	have	_	0	SENT_332	[p17l408t776r523b833],
8	a	DT	O	a	det	11	SENT_332	[p17l551t794r584b833],
9	greater	JJR	O	greater	amod	11	SENT_332	[p17l611t785r832b849],
10	chemosensitising	NN	O	chemosensitising	nn	11	SENT_332	[p17l859t776r1408b849],
11	effect	NN	O	effect	dobj	7	SENT_332	[p17l1437t776r1618b833],
12	at	IN	O	at	_	0	SENT_332	[p17l1646t785r1701b833],
13	high	JJ	O	high	amod	17	SENT_332	[p17l1726t776r1868b849],
14	doxoru	NN	O	doxoru	nn	17	SENT_332	[p17l1895t777r2144b833],
15	—	NN	O	—	nn	17	SENT_332	[p17l1895t777r2144b833],
16	bicin	NN	O	bicin	nn	17	SENT_332	[p17l7t860r167b917],
17	concentrations	NNS	O	concentration	prep_at	11	SENT_332	[p17l189t860r671b927],
18	,	,	O	,	_	0	SENT_332	[p17l189t860r671b927],
19	which	WDT	O	which	nsubj	22	SENT_332	[p17l696t860r890b917],
20	would	MD	O	would	aux	22	SENT_332	[p17l911t861r1110b917],
21	be	VB	O	be	cop	22	SENT_332	[p17l1129t861r1203b917],
22	consistent	JJ	O	consistent	rcmod	17	SENT_332	[p17l1226t860r1545b917],
23	with	IN	O	with	_	0	SENT_332	[p17l1566t860r1706b917],
24	a	DT	O	a	det	26	SENT_332	[p17l1729t878r1762b917],
25	greater	JJR	O	greater	amod	26	SENT_332	[p17l1783t869r2004b933],
26	role	NN	O	role	prep_with	22	SENT_332	[p17l2023t861r2146b917],
27	for	IN	O	for	_	0	SENT_332	[p17l9t945r101b1001],
28	GSTP1	NN	O	gstp1	prep_for	26	SENT_332	[p17l135t945r361b1001],
29	in	IN	O	in	_	0	SENT_332	[p17l403t945r464b1000],
30	resistance	NN	O	resistance	prep_in	22	SENT_332	[p17l497t945r812b1001],
31	when	WRB	O	when	advmod	33	SENT_332	[p17l847t945r1018b1001],
32	there	EX	O	there	expl	33	SENT_332	[p17l1052t945r1210b1001],
33	was	VBD	O	be	advcl	22	SENT_332	[p17l1246t962r1366b1001],
34	also	RB	O	also	advmod	33	SENT_332	[p17l1404t945r1528b1001],
35	overexpression	NN	O	overexpression	nsubj	33	SENT_332	[p17l1565t945r2047b1018],
36	of	IN	O	of	_	0	SENT_332	[p17l2083t945r2152b1001],
37	MRP1	NN	O	mrp1	prep_of	35	SENT_332	[p17l8t1029r232b1085],
38	.	.	O	.	_	0	SENT_332	[p17l8t1029r232b1085],

1	It	PRP	O	it	nsubjpass	4	SENT_333	[p17l89t1130r137b1185],
2	has	VBZ	O	have	aux	4	SENT_333	[p17l169t1129r272b1185],
3	been	VBN	O	be	auxpass	4	SENT_333	[p17l307t1129r458b1185],
4	suggested	VBN	O	suggest	_	0	SENT_333	[p17l495t1129r806b1202],
5	that	IN	O	that	complm	12	SENT_333	[p17l840t1129r959b1185],
6	alterations	NNS	O	alteration	nsubj	12	SENT_333	[p17l994t1129r1322b1185],
7	in	IN	O	in	_	0	SENT_333	[p17l1358t1129r1419b1184],
8	glutathione	NN	O	glutathione	nn	10	SENT_333	[p17l1454t1129r1811b1202],
9	reductase	NN	O	reductase	nn	10	SENT_333	[p17l1845t1129r2146b1185],
10	activity	NN	O	activity	prep_in	6	SENT_333	[p17l10t1213r247b1286],
11	could	MD	O	could	aux	12	SENT_333	[p17l293t1213r469b1269],
12	contribute	VB	O	contribute	ccomp	4	SENT_333	[p17l514t1213r836b1269],
13	to	TO	O	to	_	0	SENT_333	[p17l881t1221r940b1269],
14	doxorubicin	NN	O	doxorubicin	nn	15	SENT_333	[p17l987t1213r1372b1269],
15	resistance	NN	O	resistance	prep_to	12	SENT_333	[p17l1416t1213r1731b1269],
16	in	IN	O	in	_	0	SENT_333	[p17l1776t1213r1837b1268],
17	resistant	JJ	O	resistant	amod	21	SENT_333	[p17l1880t1213r2148b1269],
18	HL-60	NN	O	hl-60	nn	21	SENT_333	[p17l9t1296r220b1353],
19	human	JJ	O	human	amod	21	SENT_333	[p17l253t1296r470b1352],
20	leukemia	NN	O	leukemia	nn	21	SENT_333	[p17l503t1296r797b1352],
21	cells	NNS	O	cell	prep_in	15	SENT_333	[p17l830t1296r972b1352],
22	by	IN	O	by	_	0	SENT_333	[p17l1006t1296r1085b1369],
23	raising	VBG	O	raise	prepc_by	12	SENT_333	[p17l1118t1296r1334b1369],
24	intracellular	JJ	O	intracellular	amod	26	SENT_333	[p17l1369t1296r1756b1352],
25	glutathione	NN	O	glutathione	nn	26	SENT_333	[p17l1788t1296r2146b1369],
26	levels	NNS	O	level	iobj	23	SENT_333	[p17l9t1380r269b1447],
27	,35	CD	NUMBER	,35	dobj	23	SENT_333	[p17l9t1380r269b1447],
28	but	CC	O	but	_	0	SENT_333	[p17l291t1380r394b1436],
29	we	PRP	O	we	nsubj	30	SENT_333	[p17l413t1398r504b1437],
30	found	VBD	O	find	conj_but	4	SENT_333	[p17l525t1380r711b1436],
31	no	DT	O	no	det	32	SENT_333	[p17l731t1398r808b1437],
32	evidence	NN	O	evidence	nsubj	41	SENT_333	[p17l830t1380r1112b1437],
33	that	IN	O	that	complm	37	SENT_333	[p17l1133t1380r1252b1436],
34	this	DT	O	this	nsubj	37	SENT_333	[p17l1272t1380r1384b1436],
35	was	VBD	O	be	cop	37	SENT_333	[p17l1406t1398r1527b1437],
36	the	DT	O	the	det	37	SENT_333	[p17l1549t1380r1645b1436],
37	case	NN	O	case	dep	32	SENT_333	[p17l1666t1398r1801b1436],
38	in	IN	O	in	_	0	SENT_333	[p17l1823t1380r1883b1436],
39	HEp2A	NN	O	hep2a	nn	40	SENT_333	[p17l1904t1381r2146b1453],
40	cells	NNS	O	cell	prep_in	37	SENT_333	[p17l9t1464r151b1520],
41	(	VBP	O	(	ccomp	30	SENT_333	[p17l201t1464r358b1534],
42	data	NNS	O	datum	dobj	41	SENT_333	[p17l201t1464r358b1534],
43	not	RB	O	not	neg	44	SENT_333	[p17l403t1473r504b1520],
44	shown	VBN	O	show	rcmod	42	SENT_333	[p17l551t1464r800b1534],
45	)	NN	O	)	dobj	44	SENT_333	[p17l551t1464r800b1534],
46	,	,	O	,	_	0	SENT_333	[p17l551t1464r800b1534],
47	suggesting	VBG	O	suggest	partmod	44	SENT_333	[p17l851t1464r1188b1537],
48	again	RB	O	again	advmod	47	SENT_333	[p17l1236t1464r1406b1537],
49	that	IN	O	that	complm	54	SENT_333	[p17l1451t1464r1571b1520],
50	mechanisms	NNS	O	mechanism	nsubj	54	SENT_333	[p17l1615t1464r2008b1521],
51	for	IN	O	for	_	0	SENT_333	[p17l2055t1464r2148b1520],
52	doxorubicin	NN	O	doxorubicin	nn	53	SENT_333	[p17l9t1548r394b1605],
53	resistance	NN	O	resistance	prep_for	50	SENT_333	[p17l422t1548r737b1605],
54	depend	VBP	O	depend	ccomp	47	SENT_333	[p17l767t1549r996b1621],
55	on	IN	O	on	_	0	SENT_333	[p17l1025t1566r1103b1605],
56	the	DT	O	the	det	57	SENT_333	[p17l1131t1549r1227b1605],
57	type	NN	O	type	prep_on	54	SENT_333	[p17l1256t1557r1392b1621],
58	of	IN	O	of	_	0	SENT_333	[p17l1422t1548r1491b1605],
59	cell	NN	O	cell	nn	60	SENT_333	[p17l1515t1549r1628b1605],
60	line	NN	O	line	prep_of	57	SENT_333	[p17l1657t1548r1775b1605],
61	involved	VBN	O	involve	partmod	60	SENT_333	[p17l1804t1548r2099b1605],
62	.	.	O	.	_	0	SENT_333	[p17l1804t1548r2099b1605],

1	Clinical	JJ	O	clinical	amod	2	SENT_334	[p17l89t1648r340b1705],
2	responsiveness	NN	O	responsiveness	nsubj	7	SENT_334	[p17l378t1648r857b1721],
3	to	TO	O	to	_	0	SENT_334	[p17l897t1657r956b1704],
4	cancer	NN	O	cancer	nn	5	SENT_334	[p17l997t1666r1205b1704],
5	chemotherapy	NN	O	chemotherapy	prep_to	2	SENT_334	[p17l1243t1648r1694b1721],
6	may	MD	O	may	aux	7	SENT_334	[p17l1733t1666r1869b1721],
7	involve	VB	O	involve	_	0	SENT_334	[p17l1908t1648r2146b1705],
8	factors	NNS	O	factor	dobj	7	SENT_334	[p17l9t1732r222b1789],
9	of	IN	O	of	_	0	SENT_334	[p17l254t1732r323b1789],
10	tumor	NN	O	tumor	nn	11	SENT_334	[p17l345t1741r536b1789],
11	burden	NN	O	burden	prep_of	8	SENT_334	[p17l561t1732r800b1799],
12	,	,	O	,	_	0	SENT_334	[p17l561t1732r800b1799],
13	tumor	NN	O	tumor	nn	14	SENT_334	[p17l831t1741r1022b1789],
14	heterogeneity	NN	O	heterogeneity	conj_in	8	SENT_334	[p17l1048t1732r1482b1805],
15	and	CC	O	and	_	0	SENT_334	[p17l1513t1733r1626b1789],
16	drug	NN	O	drug	nn	17	SENT_334	[p17l1653t1733r1797b1805],
17	clearance	NN	O	clearance	conj_in	8	SENT_334	[p17l1827t1732r2143b1799],
18	,	,	O	,	_	0	SENT_334	[p17l1827t1732r2143b1799],
19	in	IN	O	in	_	0	SENT_334	[p17l8t1817r69b1872],
20	addition	NN	O	addition	_	0	SENT_334	[p17l117t1817r377b1873],
21	to	TO	O	to	_	0	SENT_334	[p17l424t1825r483b1873],
22	mechanisms	NNS	O	mechanism	conj_in	8	SENT_334	[p17l531t1817r924b1873],
23	of	IN	O	of	_	0	SENT_334	[p17l974t1817r1043b1873],
24	drug	NN	O	drug	nn	25	SENT_334	[p17l1085t1817r1229b1890],
25	resistance	NN	O	resistance	prep_of	22	SENT_334	[p17l1276t1817r1607b1873],
26	.	.	O	.	_	0	SENT_334	[p17l1276t1817r1607b1873],

1	Assessment	NNP	O	Assessment	nsubjpass	14	SENT_335	[p17l1658t1817r2036b1873],
2	of	IN	O	of	_	0	SENT_335	[p17l2083t1817r2152b1873],
3	resistance	NN	O	resistance	nn	4	SENT_335	[p17l8t1901r322b1957],
4	markers	NNS	O	marker	prep_of	1	SENT_335	[p17l360t1901r614b1957],
5	against	IN	O	against	_	0	SENT_335	[p17l654t1901r879b1974],
6	response	NN	O	response	prep_against	4	SENT_335	[p17l914t1919r1193b1974],
7	to	TO	O	to	_	0	SENT_335	[p17l1230t1910r1289b1957],
8	individual	JJ	O	individual	amod	9	SENT_335	[p17l1327t1901r1650b1957],
9	drugs	NNS	O	drug	prep_to	6	SENT_335	[p17l1688t1901r1861b1974],
10	such	JJ	O	such	_	0	SENT_335	[p17l1903t1901r2045b1957],
11	as	IN	O	as	_	0	SENT_335	[p17l2083t1919r2145b1957],
12	doxorubicin	NN	O	doxorubicin	prep_such_as	9	SENT_335	[p17l9t1984r394b2040],
13	is	VBZ	O	be	auxpass	14	SENT_335	[p17l419t1984r469b2040],
14	complicated	VBN	O	complicate	_	0	SENT_335	[p17l497t1984r886b2057],
15	by	IN	O	by	_	0	SENT_335	[p17l910t1984r988b2057],
16	the	DT	O	the	det	18	SENT_335	[p17l1014t1984r1109b2040],
17	clinical	JJ	O	clinical	amod	18	SENT_335	[p17l1136t1984r1369b2040],
18	requirement	NN	O	requirement	agent	14	SENT_335	[p17l1393t1984r1781b2057],
19	for	IN	O	for	_	0	SENT_335	[p17l1805t1984r1898b2040],
20	combination	NN	O	combination	nn	21	SENT_335	[p17l1922t1984r2144b2040, p17l9t2068r207b2125],
21	chemotherapy	NN	O	chemotherapy	prep_for	18	SENT_335	[p17l239t2068r706b2141],
22	.	.	O	.	_	0	SENT_335	[p17l239t2068r706b2141],

1	Studies	NNS	O	study	nsubj	5	SENT_336	[p17l743t2068r973b2125],
2	of	IN	O	of	_	0	SENT_336	[p17l1007t2068r1076b2124],
3	leukemias	NNS	O	leukemia	prep_of	1	SENT_336	[p17l1102t2068r1423b2125],
4	have	VBP	O	have	aux	5	SENT_336	[p17l1455t2068r1605b2125],
5	shown	VBN	O	show	ccomp	31	SENT_336	[p17l1639t2068r1844b2125],
6	that	IN	O	that	complm	9	SENT_336	[p17l1875t2068r1994b2124],
7	Pgp	NN	ORGANIZATION	pgp	nn	8	SENT_336	[p17l2023t2070r2145b2141],
8	expression	NN	O	expression	nsubj	9	SENT_336	[p17l8t2152r350b2225],
9	correlates	VBZ	O	correlate	ccomp	5	SENT_336	[p17l378t2153r687b2209],
10	with	IN	O	with	_	0	SENT_336	[p17l717t2152r857b2209],
11	a	DT	O	a	det	13	SENT_336	[p17l887t2170r920b2209],
12	poor	JJ	O	poor	amod	13	SENT_336	[p17l946t2170r1094b2225],
13	response	NN	O	response	prep_with	9	SENT_336	[p17l1119t2170r1400b2225],
14	to	TO	O	to	_	0	SENT_336	[p17l1428t2161r1487b2209],
15	multimodal	JJ	O	multimodal	amod	16	SENT_336	[p17l1516t2152r1885b2209],
16	chemotherapy	NN	O	chemotherapy	prep_to	13	SENT_336	[p17l1914t2152r2150b2209, p17l7t2237r246b2309],
17	involving	VBG	O	involve	partmod	16	SENT_336	[p17l286t2236r592b2309],
18	the	DT	O	the	det	20	SENT_336	[p17l633t2236r729b2293],
19	anthracyclines	NNS	O	anthracycline	nn	20	SENT_336	[p17l770t2236r1229b2309],
20	doxorubicin	NN	O	doxorubicin	dobj	17	SENT_336	[p17l1272t2236r1658b2293],
21	or	CC	O	or	_	0	SENT_336	[p17l1698t2254r1764b2293],
22	daunorubicin	NN	O	daunorubicin	dobj	17	SENT_336	[p17l1803t2236r2150b2293, p17l8t2320r181b2377],
23	.36	CD	NUMBER	.36	num	22	SENT_336	[p17l1803t2236r2150b2293, p17l8t2320r181b2377],
24	Similarly	RB	O	similarly	advmod	17	SENT_336	[p17l207t2321r519b2394],
25	,	,	O	,	_	0	SENT_336	[p17l207t2321r519b2394],
26	an	DT	O	a	det	28	SENT_336	[p17l547t2338r620b2377],
27	inverse	JJ	O	inverse	amod	28	SENT_336	[p17l642t2321r872b2377],
28	relationship	NN	O	relationship	nsubjpass	31	SENT_336	[p17l895t2321r1273b2394],
29	has	VBZ	O	have	aux	31	SENT_336	[p17l1296t2321r1400b2377],
30	been	VBN	O	be	auxpass	31	SENT_336	[p17l1424t2321r1575b2377],
31	reported	VBN	O	report	_	0	SENT_336	[p17l1597t2321r1864b2393],
32	between	IN	O	between	_	0	SENT_336	[p17l1886t2321r2153b2377],
33	GSTP1	NN	O	gstp1	nn	34	SENT_336	[p17l9t2405r235b2461],
34	expression	NN	O	expression	prep_between	31	SENT_336	[p17l286t2405r628b2478],
35	and	CC	O	and	_	0	SENT_336	[p17l673t2405r786b2461],
36	response	NN	O	response	prep_between	31	SENT_336	[p17l827t2423r1108b2478],
37	to	TO	O	to	_	0	SENT_336	[p17l1151t2413r1211b2461],
38	combination	NN	O	combination	nn	39	SENT_336	[p17l1256t2405r1656b2461],
39	chemotherapy	NN	O	chemotherapy	prep_to	31	SENT_336	[p17l1700t2405r2152b2478],
40	with	IN	O	with	_	0	SENT_336	[p17l8t2488r149b2544],
41	doxorubicin	NN	O	doxorubicin	prep_with	31	SENT_336	[p17l172t2488r559b2544],
42	in	IN	O	in	_	0	SENT_336	[p17l582t2488r643b2544],
43	ovarian	JJ	O	ovarian	amod	44	SENT_336	[p17l667t2488r906b2544],
44	cancer	NN	O	cancer	prep_in	41	SENT_336	[p17l929t2488r1213b2544],
45	.37	CD	NUMBER	.37	num	46	SENT_336	[p17l929t2488r1213b2544],
46	Modulators	NNS	O	modulator	nsubj	53	SENT_336	[p17l1238t2488r1605b2544],
47	of	IN	O	of	_	0	SENT_336	[p17l1631t2488r1701b2544],
48	Pgp	NNP	ORGANIZATION	Pgp	prep_of	46	SENT_336	[p17l1719t2490r1841b2561],
49	and	CC	O	and	_	0	SENT_336	[p17l1867t2488r1980b2544],
50	GST	NN	O	gst	prep_of	46	SENT_336	[p17l2004t2488r2152b2545],
51	are	VBP	O	be	aux	53	SENT_336	[p17l9t2590r103b2628],
52	currently	RB	DATE	currently	advmod	53	SENT_336	[p17l142t2572r429b2645],
53	undergoing	VBG	O	undergo	rcmod	44	SENT_336	[p17l467t2572r831b2645],
54	clinical	JJ	O	clinical	amod	55	SENT_336	[p17l871t2572r1104b2628],
55	evaluation	NN	O	evaluation	dobj	53	SENT_336	[p17l1143t2572r1493b2639],
56	,	,	O	,	_	0	SENT_336	[p17l1143t2572r1493b2639],
57	although	IN	O	although	mark	72	SENT_336	[p17l1535t2572r1814b2645],
58	questions	NNS	O	question	nsubjpass	72	SENT_336	[p17l1851t2572r2151b2645],
59	relating	VBG	O	relate	partmod	58	SENT_336	[p17l7t2656r250b2729],
60	to	TO	O	to	_	0	SENT_336	[p17l295t2665r354b2712],
61	altered	JJ	O	altered	amod	62	SENT_336	[p17l401t2656r617b2712],
62	pharmacokinetics	NNS	O	pharmacokinetic	prep_to	59	SENT_336	[p17l659t2656r1223b2729],
63	and	CC	O	and	_	0	SENT_336	[p17l1271t2656r1384b2712],
64	effects	NNS	O	effect	prep_to	59	SENT_336	[p17l1427t2656r1637b2713],
65	of	IN	O	of	_	0	SENT_336	[p17l1684t2656r1753b2713],
66	therapy	NN	O	therapy	prep_of	62	SENT_336	[p17l1791t2656r2030b2729],
67	on	IN	O	on	_	0	SENT_336	[p17l2075t2674r2153b2713],
68	normal	JJ	O	normal	amod	69	SENT_336	[p17l7t2740r233b2797],
69	tissues	NNS	O	tissue	prep_on	59	SENT_336	[p17l274t2740r485b2797],
70	have	VBP	O	have	aux	72	SENT_336	[p17l527t2741r677b2797],
71	been	VBN	O	be	auxpass	72	SENT_336	[p17l717t2741r869b2797],
72	raised	VBN	O	raise	advcl	31	SENT_336	[p17l909t2740r1176b2797],
73	.38	CD	NUMBER	.38	num	75	SENT_336	[p17l909t2740r1176b2797],
74	Preliminary	JJ	O	preliminary	amod	75	SENT_336	[p17l1219t2740r1596b2813],
75	reports	NNS	O	report	nsubj	76	SENT_336	[p17l1637t2749r1857b2813],
76	indicate	VBP	O	indicate	ccomp	72	SENT_336	[p17l1900t2740r2152b2797],
77	mixed	JJ	O	mixed	amod	78	SENT_336	[p17l7t2825r207b2881],
78	success	NN	O	success	dobj	76	SENT_336	[p17l233t2842r485b2881],
79	.	.	O	.	_	0	SENT_336	[p17l233t2842r485b2881],

1	The	DT	O	the	det	2	SENT_337	[p17l513t2825r635b2881],
2	use	NN	O	use	nsubjpass	10	SENT_337	[p17l659t2842r764b2881],
3	of	IN	O	of	_	0	SENT_337	[p17l789t2825r858b2881],
4	the	DT	O	the	det	7	SENT_337	[p17l876t2825r972b2881],
5	Pgp	NNP	O	Pgp	nn	7	SENT_337	[p17l996t2826r1118b2898],
6	inhibitor	NN	O	inhibitor	nn	7	SENT_337	[p17l1143t2825r1420b2881],
7	cyclosporine	NN	O	cyclosporine	prep_of	2	SENT_337	[p17l1442t2825r1850b2898],
8	has	VBZ	O	have	aux	10	SENT_337	[p17l1874t2825r1977b2881],
9	been	VBN	O	be	auxpass	10	SENT_337	[p17l2002t2825r2153b2881],
10	associated	VBN	O	associate	_	0	SENT_337	[p17l9t2909r337b2965],
11	with	IN	O	with	_	0	SENT_337	[p17l364t2909r505b2965],
12	clinical	JJ	O	clinical	amod	13	SENT_337	[p17l532t2909r766b2965],
13	responses	NNS	O	response	prep_with	10	SENT_337	[p17l793t2927r1102b2982],
14	to	TO	O	to	_	0	SENT_337	[p17l1132t2917r1191b2965],
15	drug	NN	O	drug	nn	16	SENT_337	[p17l1220t2909r1364b2982],
16	combinations	NNS	O	combination	prep_to	10	SENT_337	[p17l1393t2909r1822b2965],
17	including	VBG	O	include	_	0	SENT_337	[p17l1850t2909r2152b2982],
18	doxorubicin	NN	O	doxorubicin	prep_including	16	SENT_337	[p17l8t2992r412b3059],
19	,	,	O	,	_	0	SENT_337	[p17l8t2992r412b3059],
20	to	TO	O	to	_	0	SENT_337	[p17l444t3001r503b3048],
21	which	WDT	O	which	rel	27	SENT_337	[p17l534t2992r729b3048],
22	the	DT	O	the	det	23	SENT_337	[p17l757t2992r853b3048],
23	disease	NN	O	disease	nsubj	27	SENT_337	[p17l884t2992r1113b3048],
24	had	VBD	O	have	aux	27	SENT_337	[p17l1143t2992r1258b3048],
25	previously	RB	DATE	previously	advmod	27	SENT_337	[p17l1285t2992r1624b3065],
26	been	VBN	O	be	cop	27	SENT_337	[p17l1653t2992r1803b3048],
27	unresponsive	JJ	O	unresponsive	rcmod	18	SENT_337	[p17l1832t3010r2150b3065, p17l10t3076r212b3133],
28	.39	CD	NUMBER	.39	num	30	SENT_337	[p17l1832t3010r2150b3065, p17l10t3076r212b3133],
29	GST	NN	O	gst	nn	30	SENT_337	[p17l248t3077r397b3133],
30	inhibitors	NNS	O	inhibitor	nsubjpass	36	SENT_337	[p17l430t3076r734b3132],
31	such	JJ	O	such	_	0	SENT_337	[p17l772t3076r915b3132],
32	as	IN	O	as	_	0	SENT_337	[p17l950t3094r1011b3133],
33	sulphasalazine	NN	O	sulphasalazine	prep_such_as	30	SENT_337	[p17l1049t3076r1513b3149],
34	have	VBP	O	have	aux	36	SENT_337	[p17l1547t3076r1697b3133],
35	been	VBN	O	be	auxpass	36	SENT_337	[p17l1729t3076r1880b3132],
36	used	VBN	O	use	ccomp	27	SENT_337	[p17l1913t3076r2060b3132],
37	in	IN	O	in	_	0	SENT_337	[p17l2092t3076r2153b3132],
38	combination	NN	O	combination	prep_in	36	SENT_337	[p17l8t3160r408b3217],
39	with	IN	O	with	_	0	SENT_337	[p17l446t3160r587b3217],
40	melphalan	NN	O	melphalan	prep_with	36	SENT_337	[p17l625t3160r958b3233],
41	in	IN	O	in	_	0	SENT_337	[p17l996t3160r1057b3216],
42	patients	NNS	O	patient	prep_in	40	SENT_337	[p17l1093t3160r1341b3233],
43	with	IN	O	with	_	0	SENT_337	[p17l1381t3160r1522b3217],
44	previously	RB	DATE	previously	advmod	45	SENT_337	[p17l1559t3160r1898b3233],
45	treated	VBN	O	treat	amod	47	SENT_337	[p17l1936t3160r2153b3217],
46	advanced	JJ	O	advanced	amod	47	SENT_337	[p17l9t3245r310b3301],
47	cancers	NNS	O	cancer	prep_with	42	SENT_337	[p17l355t3262r591b3301],
48	of	IN	O	of	_	0	SENT_337	[p17l640t3244r709b3301],
49	different	JJ	O	different	amod	50	SENT_337	[p17l750t3244r1025b3301],
50	origins	NNS	O	origin	prep_of	47	SENT_337	[p17l1070t3244r1306b3317],
51	.	.	O	.	_	0	SENT_337	[p17l1070t3244r1306b3317],

1	A	DT	O	a	det	3	SENT_338	[p17l1355t3245r1411b3300],
2	partial	JJ	O	partial	amod	3	SENT_338	[p17l1455t3244r1660b3317],
3	response	NN	O	response	nsubjpass	5	SENT_338	[p17l1704t3262r1985b3317],
4	was	VBD	O	be	auxpass	5	SENT_338	[p17l2030t3262r2151b3301],
5	observed	VBN	O	observe	_	0	SENT_338	[p17l8t3329r297b3385],
6	in	IN	O	in	_	0	SENT_338	[p17l325t3329r386b3384],
7	2	CD	NUMBER	2	num	10	SENT_338	[p17l415t3329r452b3384],
8	outof	NN	O	outof	nn	10	SENT_338	[p17l482t3329r655b3385],
9	4	CD	NUMBER	4	num	10	SENT_338	[p17l678t3329r716b3384],
10	patients	NNS	O	patient	prep_in	5	SENT_338	[p17l744t3329r992b3402],
11	with	IN	O	with	_	0	SENT_338	[p17l1023t3329r1164b3385],
12	ovarian	JJ	O	ovarian	amod	15	SENT_338	[p17l1193t3329r1432b3385],
13	cancer	NN	O	cancer	nn	15	SENT_338	[p17l1461t3329r1746b3385],
14	.4	CD	NUMBER	.4	num	15	SENT_338	[p17l1461t3329r1746b3385],
15	°	NN	O	°	prep_with	10	SENT_338	[p17l1461t3329r1746b3385],

1	Our	PRP$	O	we	poss	2	SENT_339	[p18l89t21r212b77],
2	study	NN	O	study	nsubj	3	SENT_339	[p18l256t21r425b93],
3	supports	VBZ	O	support	_	0	SENT_339	[p18l470t29r736b93],
4	a	DT	O	a	det	5	SENT_339	[p18l781t38r815b77],
5	role	NN	O	role	dobj	3	SENT_339	[p18l854t21r978b77],
6	for	IN	O	for	_	0	SENT_339	[p18l1020t20r1113b77],
7	GSTP1	NN	O	gstp1	nn	8	SENT_339	[p18l1155t21r1381b77],
8	metabolism	NN	O	metabolism	prep_for	5	SENT_339	[p18l1431t20r1805b77],
9	alongside	IN	O	alongside	_	0	SENT_339	[p18l1848t20r2152b93],
10	MRPl	NN	O	mrpl	prep_alongside	3	SENT_339	[p18l7t105r240b160],
11	-	:	O	-	_	0	SENT_339	[p18l7t105r240b160],
12	and	CC	O	and	_	0	SENT_339	[p18l283t105r396b161],
13	Pgp	NNP	O	Pgp	nn	14	SENT_339	[p18l434t105r880b178],
14	—	NNP	O	—	nsubj	15	SENT_339	[p18l434t105r880b178],
15	mediated	VBD	O	mediate	conj_and	3	SENT_339	[p18l434t105r880b178],
16	efﬂux	NN	O	efﬂux	dobj	15	SENT_339	[p18l918t105r1103b161],
17	in	IN	O	in	_	0	SENT_339	[p18l1142t105r1203b160],
18	acquired	VBN	O	acquire	amod	20	SENT_339	[p18l1243t105r1517b178],
19	doxorubicin	NN	O	doxorubicin	nn	20	SENT_339	[p18l1556t105r1942b161],
20	resistance	NN	O	resistance	prep_in	16	SENT_339	[p18l1980t105r2150b161, p18l7t197r191b245],
21	.	.	O	.	_	0	SENT_339	[p18l1980t105r2150b161, p18l7t197r191b245],

1	Further	JJ	O	further	amod	2	SENT_340	[p18l228t189r465b245],
2	work	NN	O	work	nsubj	4	SENT_340	[p18l497t189r662b245],
3	may	MD	O	may	aux	4	SENT_340	[p18l693t207r829b262],
4	promote	VB	O	promote	_	0	SENT_340	[p18l862t197r1129b262],
5	development	NN	O	development	dobj	4	SENT_340	[p18l1164t189r1578b262],
6	of	IN	O	of	_	0	SENT_340	[p18l1611t189r1680b245],
7	rational	JJ	O	rational	amod	9	SENT_340	[p18l1707t189r1951b245],
8	treatment	NN	O	treatment	nn	9	SENT_340	[p18l1985t197r2151b245, p18l7t280r167b328],
9	strategies	NNS	O	strategy	prep_of	5	SENT_340	[p18l215t272r513b345],
10	of	IN	O	of	_	0	SENT_340	[p18l562t272r631b328],
11	cytotoxic	JJ	O	cytotoxic	amod	12	SENT_340	[p18l673t272r969b345],
12	agents	NNS	O	agent	prep_of	9	SENT_340	[p18l1018t280r1218b345],
13	and	CC	O	and	_	0	SENT_340	[p18l1268t272r1381b328],
14	appropriate	JJ	O	appropriate	amod	16	SENT_340	[p18l1428t272r1790b345],
15	resistance	NN	O	resistance	nn	16	SENT_340	[p18l1837t272r2152b328],
16	modulators	NNS	O	modulator	prep_of	5	SENT_340	[p18l7t356r366b412],
17	aimed	VBN	O	aim	partmod	16	SENT_340	[p18l407t356r600b413],
18	at	IN	O	at	_	0	SENT_340	[p18l639t365r694b413],
19	improved	VBN	O	improve	amod	20	SENT_340	[p18l731t356r1038b429],
20	outcome	NN	O	outcome	prep_at	17	SENT_340	[p18l1075t365r1349b413],
21	in	IN	O	in	_	0	SENT_340	[p18l1387t356r1448b412],
22	acquired	VBN	O	acquire	amod	24	SENT_340	[p18l1487t356r1761b429],
23	drug	NN	O	drug	nn	24	SENT_340	[p18l1799t356r1942b429],
24	resistance	NN	O	resistance	prep_in	20	SENT_340	[p18l1980t356r2150b413, p18l7t434r191b482],
25	.	.	O	.	_	0	SENT_340	[p18l1980t356r2150b413, p18l7t434r191b482],

1	ACKNOWLEDGEMENTS	NNS	O	acknowledgement	_	0	SENT_341	[p18l706t643r1450b689],

1	We	PRP	O	we	nsubj	2	SENT_342	[p18l87t768r197b823],
2	thank	VBP	O	thank	_	0	SENT_342	[p18l224t767r402b823],
3	Prof.	NNP	O	Prof.	nn	5	SENT_342	[p18l426t767r578b823],
4	John	NNP	PERSON	John	nn	5	SENT_342	[p18l608t767r759b823],
5	Hayes	NNP	PERSON	Hayes	dobj	2	SENT_342	[p18l784t768r981b840],
6	and	CC	O	and	_	0	SENT_342	[p18l1011t767r1124b823],
7	Dr.	NNP	O	Dr.	nn	9	SENT_342	[p18l1149t768r1248b823],
8	Colin	NNP	PERSON	Colin	nn	9	SENT_342	[p18l1279t767r1455b823],
9	Henderson	NNP	PERSON	Henderson	conj_and	5	SENT_342	[p18l1481t767r1844b833],
10	,	,	O	,	_	0	SENT_342	[p18l1481t767r1844b833],
11	Biomedical	NNP	ORGANIZATION	Biomedical	nn	14	SENT_342	[p18l1873t767r2150b823, p18l7t851r121b907],
12	Research	NNP	ORGANIZATION	Research	nn	14	SENT_342	[p18l143t851r437b907],
13	Centre	NNP	ORGANIZATION	Centre	nn	14	SENT_342	[p18l459t851r671b907],
14	Dundee	NNP	ORGANIZATION	Dundee	appos	5	SENT_342	[p18l693t851r958b917],
15	,	,	O	,	_	0	SENT_342	[p18l693t851r958b917],
16	for	IN	O	for	_	0	SENT_342	[p18l983t851r1076b907],
17	MAbs	NNS	MISC	mab	prep_for	5	SENT_342	[p18l1096t851r1294b907],
18	against	IN	O	against	_	0	SENT_342	[p18l1319t851r1545b924],
19	GST	NN	O	gst	nn	20	SENT_342	[p18l1567t851r1715b907],
20	isoforms	NNS	O	isoform	prep_against	17	SENT_342	[p18l1737t851r2015b907],
21	and	CC	O	and	_	0	SENT_342	[p18l2040t851r2153b907],
22	the	DT	O	the	det	24	SENT_342	[p18l7t935r103b991],
23	GSTP1	NN	O	gstp1	nn	24	SENT_342	[p18l127t935r353b992],
24	clone	NN	O	clone	conj_and	20	SENT_342	[p18l383t935r554b991],
25	and	CC	O	and	_	0	SENT_342	[p18l578t935r691b991],
26	Prof.	NNP	O	Prof.	nn	28	SENT_342	[p18l712t935r865b991],
27	Martin	NNP	PERSON	Martin	nn	28	SENT_342	[p18l890t935r1108b991],
28	Clynes	NNP	PERSON	Clynes	prep_for	5	SENT_342	[p18l1130t935r1368b1008],
29	,	,	O	,	_	0	SENT_342	[p18l1130t935r1368b1008],
30	Dublin	NNP	ORGANIZATION	Dublin	nn	32	SENT_342	[p18l1393t935r1615b991],
31	City	NNP	ORGANIZATION	City	nn	32	SENT_342	[p18l1637t935r1772b1008],
32	University	NNP	ORGANIZATION	University	appos	28	SENT_342	[p18l1794t935r2150b1008],
33	,	,	O	,	_	0	SENT_342	[p18l1794t935r2150b1008],
34	Dublin	NNP	LOCATION	Dublin	appos	28	SENT_342	[p18l7t1019r246b1086],
35	,	,	O	,	_	0	SENT_342	[p18l7t1019r246b1086],
36	for	IN	O	for	_	0	SENT_342	[p18l278t1019r371b1075],
37	HEp2	NN	O	hep2	nn	41	SENT_342	[p18l399t1020r584b1092],
38	and	CC	O	and	_	0	SENT_342	[p18l615t1019r728b1075],
39	HEp2A	NN	O	hep2a	conj_and	37	SENT_342	[p18l756t1020r1000b1092],
40	cell	NN	O	cell	nn	41	SENT_342	[p18l1030t1019r1143b1075],
41	lines	NNS	O	line	prep_for	28	SENT_342	[p18l1173t1019r1338b1076],
42	.	.	O	.	_	0	SENT_342	[p18l1173t1019r1338b1076],

1	REFERENCES	NNS	O	reference	_	0	SENT_343	[p18l983t1154r1177b1176],

1	l.	NNP	O	l.	nn	3	SENT_344	[p18l13t1260r54b1309],
2	Tewey	NNP	O	Tewey	nn	3	SENT_344	[p18l150t1260r342b1323],
3	KM	NNP	O	KM	_	0	SENT_344	[p18l371t1260r498b1318],
4	,	,	O	,	_	0	SENT_344	[p18l371t1260r498b1318],
5	Rowe	NNP	ORGANIZATION	Rowe	nn	6	SENT_344	[p18l528t1260r692b1309],
6	TC	NNP	ORGANIZATION	TC	appos	3	SENT_344	[p18l720t1260r825b1318],
7	,	,	O	,	_	0	SENT_344	[p18l720t1260r825b1318],
8	Yang	NNP	PERSON	Yang	nn	9	SENT_344	[p18l855t1260r1007b1324],
9	L	NNP	PERSON	L	appos	3	SENT_344	[p18l1034t1260r1092b1318],
10	,	,	O	,	_	0	SENT_344	[p18l1034t1260r1092b1318],
11	Halligan	NNP	O	Halligan	nn	12	SENT_344	[p18l1122t1259r1367b1324],
12	BD	NNP	O	BD	appos	3	SENT_344	[p18l1394t1260r1506b1318],
13	,	,	O	,	_	0	SENT_344	[p18l1394t1260r1506b1318],
14	Liu	NNP	PERSON	Liu	nn	15	SENT_344	[p18l1536t1259r1633b1309],
15	LF	NNP	O	LF	appos	3	SENT_344	[p18l1660t1260r1757b1309],
16	.	.	O	.	_	0	SENT_344	[p18l1660t1260r1757b1309],

1	Adriamycin	NNP	MISC	Adriamycin	nn	2	SENT_345	[p18l1788t1259r2150b1323],
2	—	NN	O	—	nsubj	3	SENT_345	[p18l1788t1259r2150b1323],
3	induced	VBD	O	induce	_	0	SENT_345	[p18l150t1334r375b1383],
4	DNA	NN	O	dna	nn	5	SENT_345	[p18l395t1335r549b1384],
5	damage	NN	O	damage	dobj	3	SENT_345	[p18l571t1334r790b1398],
6	mediated	VBN	O	mediate	partmod	5	SENT_345	[p18l812t1334r1073b1383],
7	by	IN	O	by	_	0	SENT_345	[p18l1092t1334r1163b1398],
8	mammalian	JJ	O	mammalian	amod	10	SENT_345	[p18l1185t1334r1521b1383],
9	DNA	NN	O	dna	nn	10	SENT_345	[p18l1542t1334r1695b1383],
10	topoisomeraseII	NN	O	topoisomeraseius	agent	6	SENT_345	[p18l1716t1334r2150b1398, p18l150t1410r209b1459],
11	.	.	O	.	_	0	SENT_345	[p18l1716t1334r2150b1398, p18l150t1410r209b1459],

1	Science	NNP	O	Science	nn	2	SENT_346	[p18l241t1409r459b1459],
2	l984	NN	O	l984	_	0	SENT_346	[p18l492t1409r984b1468],
3	;	:	O	;	_	0	SENT_346	[p18l492t1409r984b1468],
4	226:466	CD	NUMBER	226:466	number	5	SENT_346	[p18l492t1409r984b1468],
5	—	CD	NUMBER	—	dep	2	SENT_346	[p18l492t1409r984b1468],
6	8	CD	NUMBER	8	dep	5	SENT_346	[p18l492t1409r984b1468],
7	.	.	O	.	_	0	SENT_346	[p18l492t1409r984b1468],

1	2	LS	NUMBER	2	_	0	SENT_347	[p18l7t1485r54b1534],
2	.	.	O	.	_	0	SENT_347	[p18l7t1485r54b1534],

1	Tritton	NNP	ORGANIZATION	Tritton	nn	2	SENT_348	[p18l150t1484r347b1534],
2	TR	NN	ORGANIZATION	tr	nsubj	13	SENT_348	[p18l372t1486r476b1543],
3	,	,	O	,	_	0	SENT_348	[p18l372t1486r476b1543],
4	Yee	NNP	PERSON	Yee	nn	6	SENT_348	[p18l505t1486r617b1534],
5	G.	NNP	O	G.	nn	6	SENT_348	[p18l645t1485r707b1534],
6	The	NNP	O	The	appos	2	SENT_348	[p18l737t1484r845b1534],
7	anticancer	JJ	O	anticancer	amod	9	SENT_348	[p18l873t1484r1165b1534],
8	agent	NN	O	agent	nn	9	SENT_348	[p18l1190t1492r1343b1549],
9	adriamycin	NN	O	adriamycin	dep	6	SENT_348	[p18l1369t1484r1688b1549],
10	can	MD	O	can	aux	13	SENT_348	[p18l1714t1500r1811b1534],
11	be	VB	O	be	cop	13	SENT_348	[p18l1835t1484r1901b1534],
12	actively	RB	O	actively	advmod	13	SENT_348	[p18l1928t1484r2151b1549],
13	cytotoxic	JJ	O	cytotoxic	_	0	SENT_348	[p18l150t1559r413b1623],
14	without	IN	O	without	_	0	SENT_348	[p18l440t1559r658b1609],
15	entering	VBG	O	enter	prepc_without	13	SENT_348	[p18l683t1559r914b1624],
16	cells	NNS	O	cell	dobj	15	SENT_348	[p18l941t1559r1084b1609],
17	.	.	O	.	_	0	SENT_348	[p18l941t1559r1084b1609],

1	Science	NNP	O	Science	_	0	SENT_349	[p18l1115t1559r1334b1609],
2	1982	CD	DATE	1982	num	1	SENT_349	[p18l1367t1560r1753b1618],
3	;	:	O	;	_	0	SENT_349	[p18l1367t1560r1753b1618],
4	217:248	CD	NUMBER	217:248	number	5	SENT_349	[p18l1367t1560r1753b1618],
5	-50	CD	NUMBER	-50	dep	1	SENT_349	[p18l1765t1559r1886b1609],
6	.	.	O	.	_	0	SENT_349	[p18l1765t1559r1886b1609],

1	3	LS	NUMBER	3	_	0	SENT_350	[p18l8t1634r54b1684],
2	.	.	O	.	_	0	SENT_350	[p18l8t1634r54b1684],

1	Awasthi	NNP	PERSON	Awasthi	_	0	SENT_351	[p18l150t1634r385b1684],
2	S	NN	O	s	nn	1	SENT_351	[p18l430t1634r481b1693],
3	,	,	O	,	_	0	SENT_351	[p18l430t1634r481b1693],
4	Sharma	FW	PERSON	sharma	dep	1	SENT_351	[p18l528t1634r744b1684],
5	R	NN	PERSON	r	dep	1	SENT_351	[p18l784t1635r845b1693],
6	,	,	O	,	_	0	SENT_351	[p18l784t1635r845b1693],
7	Awasthi	NNP	PERSON	Awasthi	nn	8	SENT_351	[p18l890t1634r1126b1684],
8	YC	NNP	O	YC	appos	5	SENT_351	[p18l1169t1634r1281b1693],
9	,	,	O	,	_	0	SENT_351	[p18l1169t1634r1281b1693],
10	Belli	NNP	PERSON	Belli	nn	11	SENT_351	[p18l1325t1634r1462b1684],
11	JA	NNP	O	JA	appos	5	SENT_351	[p18l1504t1634r1598b1693],
12	,	,	O	,	_	0	SENT_351	[p18l1504t1634r1598b1693],
13	Frenkel	NNP	PERSON	Frenkel	nn	14	SENT_351	[p18l1642t1634r1859b1684],
14	EP	NNP	O	EP	appos	5	SENT_351	[p18l1901t1635r1997b1684],
15	.	.	O	.	_	0	SENT_351	[p18l1901t1635r1997b1684],

1	The	DT	O	the	det	2	SENT_352	[p18l2042t1634r2151b1684],
2	relationship	NN	O	relationship	_	0	SENT_352	[p18l149t1709r485b1774],
3	of	IN	O	of	_	0	SENT_352	[p18l519t1709r581b1759],
4	doxorubicin	NN	O	doxorubicin	nn	5	SENT_352	[p18l610t1710r954b1759],
5	binding	NN	O	binding	prep_of	2	SENT_352	[p18l986t1709r1203b1774],
6	to	TO	O	to	_	0	SENT_352	[p18l1236t1717r1289b1759],
7	membrane	NN	O	membrane	nn	9	SENT_352	[p18l1323t1710r1805b1774],
8	—	NN	O	—	nn	9	SENT_352	[p18l1323t1710r1805b1774],
9	lipids	NNS	O	lipid	prep_to	2	SENT_352	[p18l1323t1710r1805b1774],
10	with	IN	O	with	_	0	SENT_352	[p18l1840t1710r1965b1759],
11	drugresistance	NN	O	drugresistance	prep_with	2	SENT_352	[p18l1999t1710r2149b1774, p18l149t1784r444b1835],
12	.	.	O	.	_	0	SENT_352	[p18l1999t1710r2149b1774, p18l149t1784r444b1835],

1	Cancer	NNP	O	Cancer	nn	3	SENT_353	[p18l474t1785r675b1835],
2	Letts	NNP	O	Letts	nn	3	SENT_353	[p18l699t1786r839b1834],
3	l992	NN	O	l992	_	0	SENT_353	[p18l874t1784r1357b1843],
4	;	:	O	;	_	0	SENT_353	[p18l874t1784r1357b1843],
5	63:109	CD	NUMBER	63:109	number	6	SENT_353	[p18l874t1784r1357b1843],
6	—	CD	NUMBER	—	dep	3	SENT_353	[p18l874t1784r1357b1843],
7	16	CD	NUMBER	16	dep	6	SENT_353	[p18l874t1784r1357b1843],
8	.	.	O	.	_	0	SENT_353	[p18l874t1784r1357b1843],

1	4	LS	NUMBER	4	_	0	SENT_354	[p18l6t1860r54b1909],
2	.	.	O	.	_	0	SENT_354	[p18l6t1860r54b1909],

1	Fojo	NNP	MISC	Fojo	nn	2	SENT_355	[p18l149t1859r278b1924],
2	A	NNP	MISC	A	_	0	SENT_355	[p18l307t1860r372b1918],
3	,	,	O	,	_	0	SENT_355	[p18l307t1860r372b1918],
4	Akiyama	NNP	PERSON	Akiyama	nn	5	SENT_355	[p18l403t1859r664b1924],
5	S	NNP	O	S	appos	2	SENT_355	[p18l693t1859r745b1918],
6	,	,	O	,	_	0	SENT_355	[p18l693t1859r745b1918],
7	Gottesman	NNP	PERSON	Gottesman	nn	8	SENT_355	[p18l777t1860r1084b1909],
8	MM	NN	O	mm	appos	2	SENT_355	[p18l1111t1860r1252b1918],
9	,	,	O	,	_	0	SENT_355	[p18l1111t1860r1252b1918],
10	Pastan	NNP	PERSON	Pastan	appos	2	SENT_355	[p18l1283t1860r1468b1909],
11	1	CD	NUMBER	1	num	10	SENT_355	[p18l1496t1860r1533b1909],
12	.	.	O	.	_	0	SENT_355	[p18l1496t1860r1533b1909],

1	Reduced	VBN	O	reduce	amod	3	SENT_356	[p18l1564t1859r1814b1909],
2	drug	NN	O	drug	nn	3	SENT_356	[p18l1842t1859r1970b1924],
3	accumulation	NN	O	accumulation	_	0	SENT_356	[p18l2000t1875r2150b1909, p18l150t1934r402b1983],
4	in	IN	O	in	_	0	SENT_356	[p18l431t1934r485b1983],
5	multiple	JJ	O	multiple	amod	9	SENT_356	[p18l515t1934r751b1998],
6	drug-resistant	JJ	O	drug-resistant	amod	9	SENT_356	[p18l782t1934r1174b1998],
7	human-KB	JJ	O	human-kb	amod	9	SENT_356	[p18l1202t1934r1514b1983],
8	carcinoma	NN	O	carcinoma	nn	9	SENT_356	[p18l1548t1934r1845b1983],
9	cell-lines	NNS	O	cell-line	prep_in	3	SENT_356	[p18l1874t1934r2148b1983],
10	.	.	O	.	_	0	SENT_356	[p18l1874t1934r2148b1983],

1	Cancer	NNP	O	Cancer	nn	3	SENT_357	[p18l150t2010r352b2060],
2	Res	NNP	O	Res	nn	3	SENT_357	[p18l376t2011r480b2060],
3	l985	NN	O	l985	_	0	SENT_357	[p18l514t2009r988b2068],
4	;	:	O	;	_	0	SENT_357	[p18l514t2009r988b2068],
5	45:3002	CD	NUMBER	45:3002	num	6	SENT_357	[p18l514t2009r988b2068],
6	—	NN	O	—	dep	3	SENT_357	[p18l514t2009r988b2068],
7	7	CD	NUMBER	7	dep	6	SENT_357	[p18l514t2009r988b2068],
8	.	.	O	.	_	0	SENT_357	[p18l514t2009r988b2068],

1	5	CD	NUMBER	5	_	0	SENT_358	[p18l7t2084r54b2134],
2	.	.	O	.	_	0	SENT_358	[p18l7t2084r54b2134],

1	Cole	NNP	O	Cole	nn	2	SENT_359	[p18l150t2084r282b2134],
2	SPC	NNP	O	SPC	_	0	SENT_359	[p18l312t2085r451b2143],
3	,	,	O	,	_	0	SENT_359	[p18l312t2085r451b2143],
4	Bhardwaj	NNP	PERSON	Bhardwaj	nn	5	SENT_359	[p18l480t2084r752b2149],
5	G	NNP	PERSON	G	appos	2	SENT_359	[p18l785t2085r849b2143],
6	,	,	O	,	_	0	SENT_359	[p18l785t2085r849b2143],
7	Gerlach	NNP	PERSON	Gerlach	nn	8	SENT_359	[p18l880t2084r1104b2134],
8	JH	NNP	O	JH	appos	5	SENT_359	[p18l1130t2086r1223b2143],
9	,	,	O	,	_	0	SENT_359	[p18l1130t2086r1223b2143],
10	Mackie	NNP	PERSON	Mackie	nn	11	SENT_359	[p18l1253t2084r1466b2134],
11	J	NNP	PERSON	J	appos	5	SENT_359	[p18l1493t2086r1534b2143],
12	,	,	O	,	_	0	SENT_359	[p18l1493t2086r1534b2143],
13	Grant	NNP	PERSON	Grant	nn	14	SENT_359	[p18l1565t2085r1726b2134],
14	CE	NNP	O	CE	appos	5	SENT_359	[p18l1753t2085r1857b2143],
15	,	,	O	,	_	0	SENT_359	[p18l1753t2085r1857b2143],
16	Almquist	NNP	PERSON	Almquist	nn	17	SENT_359	[p18l1887t2084r2153b2149],
17	KC	NNP	O	KC	appos	5	SENT_359	[p18l151t2160r262b2218],
18	,	,	O	,	_	0	SENT_359	[p18l151t2160r262b2218],
19	et	FW	O	et	nn	20	SENT_359	[p18l306t2167r356b2209],
20	al.	FW	O	al.	appos	5	SENT_359	[p18l397t2159r459b2209],
21	.	.	O	.	_	0	SENT_359	[p18l397t2159r459b2209],

1	Overexpression	NN	O	overexpression	_	0	SENT_360	[p18l505t2159r951b2223],
2	of	IN	O	of	_	0	SENT_360	[p18l992t2159r1054b2209],
3	a	DT	O	a	det	5	SENT_360	[p18l1091t2175r1121b2209],
4	transporter	NN	O	transporter	nn	5	SENT_360	[p18l1160t2166r1470b2223],
5	gene	NN	O	gene	prep_of	1	SENT_360	[p18l1510t2175r1642b2224],
6	in	IN	O	in	_	0	SENT_360	[p18l1683t2159r1737b2208],
7	a	DT	O	a	det	15	SENT_360	[p18l1778t2175r1808b2209],
8	multidrug	JJ	O	multidrug	amod	15	SENT_360	[p18l1847t2159r2150b2224],
9	—	NN	O	—	npadvmod	10	SENT_360	[p18l1847t2159r2150b2224],
10	resistant	JJ	O	resistant	amod	15	SENT_360	[p18l149t2234r387b2283],
11	human	JJ	O	human	amod	15	SENT_360	[p18l411t2234r605b2283],
12	lung-cancer	NN	O	lung-cancer	nn	15	SENT_360	[p18l631t2234r968b2298],
13	cell	NN	O	cell	nn	15	SENT_360	[p18l992t2234r1239b2283],
14	—	NN	O	—	nn	15	SENT_360	[p18l992t2234r1239b2283],
15	line	NN	O	line	prep_in	1	SENT_360	[p18l992t2234r1239b2283],
16	.	.	O	.	_	0	SENT_360	[p18l992t2234r1239b2283],

1	Science	NNP	O	Science	nn	2	SENT_361	[p18l1270t2234r1489b2284],
2	l992	NN	O	l992	_	0	SENT_361	[p18l1522t2234r2049b2292],
3	;	:	O	;	_	0	SENT_361	[p18l1522t2234r2049b2292],
4	258	CD	NUMBER	258	num	6	SENT_361	[p18l1522t2234r2049b2292],
5	:	:	O	:	_	0	SENT_361	[p18l1522t2234r2049b2292],
6	l650	CD	NUMBER	l650	dep	2	SENT_361	[p18l1522t2234r2049b2292],
7	—	CD	NUMBER	—	number	8	SENT_361	[p18l1522t2234r2049b2292],
8	4	CD	NUMBER	4	dep	6	SENT_361	[p18l1522t2234r2049b2292],
9	.	.	O	.	_	0	SENT_361	[p18l1522t2234r2049b2292],

1	6	CD	NUMBER	6	_	0	SENT_362	[p18l7t2309r54b2359],
2	.	.	O	.	_	0	SENT_362	[p18l7t2309r54b2359],

1	Hayes	NNP	PERSON	Hayes	nn	2	SENT_363	[p18l150t2311r325b2374],
2	JD	NNP	O	JD	_	0	SENT_363	[p18l351t2311r444b2368],
3	,	,	O	,	_	0	SENT_363	[p18l351t2311r444b2368],
4	Pulford	NNP	PERSON	Pulford	nn	5	SENT_363	[p18l471t2309r685b2359],
5	DJ	NNP	O	DJ	appos	2	SENT_363	[p18l709t2311r801b2359],
6	.	.	O	.	_	0	SENT_363	[p18l709t2311r801b2359],

1	The	DT	O	the	det	2	SENT_364	[p18l829t2309r938b2359],
2	glutathione	NN	O	glutathione	_	0	SENT_364	[p18l964t2309r1680b2374],
3	.	.	O	.	_	0	SENT_364	[p18l964t2309r1680b2374],

1	—	NN	O	—	_	0	SENT_365	[p18l964t2309r1680b2374],
2	.	.	O	.	_	0	SENT_365	[p18l964t2309r1680b2374],

1	S	NN	O	s	_	0	SENT_366	[p18l964t2309r1680b2374],
2	.	.	O	.	_	0	SENT_366	[p18l964t2309r1680b2374],

1	—	NN	O	—	_	0	SENT_367	[p18l964t2309r1680b2374],
2	.	.	O	.	_	0	SENT_367	[p18l964t2309r1680b2374],

1	transferase	NN	O	transferase	nn	5	SENT_368	[p18l964t2309r1680b2374],
2	supergene	NN	O	supergene	nn	5	SENT_368	[p18l1708t2325r1993b2374],
3	family	NN	O	family	nn	5	SENT_368	[p18l2019t2309r2150b2359, p18l149t2384r585b2449],
4	—	NN	O	—	nn	5	SENT_368	[p18l2019t2309r2150b2359, p18l149t2384r585b2449],
5	regulation	NN	O	regulation	_	0	SENT_368	[p18l2019t2309r2150b2359, p18l149t2384r585b2449],
6	of	IN	O	of	_	0	SENT_368	[p18l620t2384r682b2434],
7	GST	NN	O	gst	prep_of	5	SENT_368	[p18l713t2385r845b2434],
8	and	CC	O	and	_	0	SENT_368	[p18l881t2384r982b2434],
9	the	DT	O	the	det	10	SENT_368	[p18l1016t2384r1101b2434],
10	contribution	NN	O	contribution	prep_of	5	SENT_368	[p18l1136t2384r1484b2434],
11	of	IN	O	of	_	0	SENT_368	[p18l1519t2384r1581b2434],
12	the	DT	O	the	det	13	SENT_368	[p18l1611t2384r1696b2434],
13	isoenzymes	NNS	O	isoenzyme	prep_of	5	SENT_368	[p18l1731t2384r2061b2449],
14	to	TO	O	to	_	0	SENT_368	[p18l2097t2392r2150b2434],
15	cancer	NN	O	cancer	nn	16	SENT_368	[p18l150t2475r336b2508],
16	chemoprotection	NN	O	chemoprotection	prep_to	13	SENT_368	[p18l361t2459r840b2523],
17	and	CC	O	and	_	0	SENT_368	[p18l868t2459r969b2508],
18	drug	NN	O	drug	nn	20	SENT_368	[p18l996t2459r1445b2523],
19	—	NN	O	—	nn	20	SENT_368	[p18l996t2459r1445b2523],
20	resistance	NN	O	resistance	prep_to	13	SENT_368	[p18l996t2459r1445b2523],
21	.	.	O	.	_	0	SENT_368	[p18l996t2459r1445b2523],

1	Crit	NNP	O	Crit	nn	5	SENT_369	[p18l1475t2459r1585b2509],
2	Rev	NN	O	rev	nn	5	SENT_369	[p18l1611t2460r1724b2508],
3	Biochem	NNP	O	Biochem	nn	5	SENT_369	[p18l1751t2459r2008b2508],
4	Mol	NNP	O	Mol	nn	5	SENT_369	[p18l2034t2459r2151b2508],
5	Biol	NNP	O	Biol	_	0	SENT_369	[p18l150t2534r270b2584],
6	1995	CD	DATE	1995	num	5	SENT_369	[p18l303t2534r822b2593],
7	;	:	O	;	_	0	SENT_369	[p18l303t2534r822b2593],
8	30:445	CD	NUMBER	30:445	number	9	SENT_369	[p18l303t2534r822b2593],
9	-600	CD	NUMBER	-600	dep	5	SENT_369	[p18l303t2534r822b2593],
10	.	.	O	.	_	0	SENT_369	[p18l303t2534r822b2593],

1	7	CD	NUMBER	7	_	0	SENT_370	[p18l7t2618r54b2666],
2	.	.	O	.	_	0	SENT_370	[p18l7t2618r54b2666],

1	Black	JJ	O	black	amod	2	SENT_371	[p18l150t2617r316b2666],
2	SM	NN	O	sm	_	0	SENT_371	[p18l342t2617r457b2676],
3	,	,	O	,	_	0	SENT_371	[p18l342t2617r457b2676],
4	Beggs	NNP	PERSON	Beggs	nn	5	SENT_371	[p18l486t2618r661b2681],
5	JD	NNP	O	JD	appos	2	SENT_371	[p18l688t2618r782b2675],
6	,	,	O	,	_	0	SENT_371	[p18l688t2618r782b2675],
7	Hayes	NNP	PERSON	Hayes	nn	8	SENT_371	[p18l810t2618r985b2681],
8	JD	NNP	O	JD	appos	5	SENT_371	[p18l1013t2618r1106b2676],
9	,	,	O	,	_	0	SENT_371	[p18l1013t2618r1106b2676],
10	Bartoszek	NNP	PERSON	Bartoszek	nn	11	SENT_371	[p18l1135t2617r1421b2666],
11	A	NNP	O	A	appos	5	SENT_371	[p18l1445t2617r1510b2675],
12	,	,	O	,	_	0	SENT_371	[p18l1445t2617r1510b2675],
13	Muramatsu	NNP	PERSON	Muramatsu	nn	14	SENT_371	[p18l1539t2618r1862b2666],
14	M	NNP	O	M	appos	5	SENT_371	[p18l1888t2618r1965b2675],
15	,	,	O	,	_	0	SENT_371	[p18l1888t2618r1965b2675],
16	Sakai	NNP	LOCATION	Sakai	nn	17	SENT_371	[p18l1996t2617r2151b2667],
17	M	NNP	O	M	appos	5	SENT_371	[p18l149t2694r226b2751],
18	,	,	O	,	_	0	SENT_371	[p18l149t2694r226b2751],
19	et	FW	O	et	nn	20	SENT_371	[p18l256t2700r307b2742],
20	al.	FW	O	al.	appos	5	SENT_371	[p18l333t2692r396b2742],
21	.	.	O	.	_	0	SENT_371	[p18l333t2692r396b2742],

1	Expression	NN	O	expression	nsubj	5	SENT_372	[p18l426t2692r743b2757],
2	of	IN	O	of	_	0	SENT_372	[p18l770t2692r832b2742],
3	human	JJ	O	human	amod	4	SENT_372	[p18l853t2692r1047b2742],
4	glutathione	NN	O	glutathione	prep_of	1	SENT_372	[p18l1074t2692r1393b2757],
5	S	NN	O	s	_	0	SENT_372	[p18l1422t2692r1818b2742],
6	—	CD	NUMBER	—	num	7	SENT_372	[p18l1422t2692r1818b2742],
7	transferases	NNS	O	transferase	dobj	5	SENT_372	[p18l1422t2692r1818b2742],
8	in	IN	O	in	_	0	SENT_372	[p18l1846t2692r1901b2741],
9	Saccha	FW	O	saccha	nn	12	SENT_372	[p18l1929t2692r2150b2742],
10	—	FW	O	—	nn	12	SENT_372	[p18l1929t2692r2150b2742],
11	romyces	FW	O	romyces	nn	12	SENT_372	[p18l149t2783r388b2831],
12	cerevisiae	FW	O	cerevisiae	prep_in	7	SENT_372	[p18l420t2767r703b2816],
13	confers	VBZ	O	confer	dep	12	SENT_372	[p18l734t2767r940b2817],
14	resistance	NN	O	resistance	dobj	13	SENT_372	[p18l970t2767r1251b2817],
15	to	TO	O	to	_	0	SENT_372	[p18l1280t2774r1333b2816],
16	the	DT	O	the	det	19	SENT_372	[p18l1364t2767r1449b2816],
17	anticancer	JJ	O	anticancer	amod	19	SENT_372	[p18l1480t2767r1772b2817],
18	drugs	NNS	O	drug	nn	19	SENT_372	[p18l1801t2767r1956b2831],
19	adriamycin	NN	O	adriamycin	prep_to	13	SENT_372	[p18l1988t2767r2150b2816, p18l149t2843r327b2907],
20	and	CC	O	and	_	0	SENT_372	[p18l354t2843r454b2892],
21	chlorambucil	NN	O	chlorambucil	prep_to	13	SENT_372	[p18l480t2842r869b2892],
22	.	.	O	.	_	0	SENT_372	[p18l480t2842r869b2892],

1	Biochem	NNP	O	Biochem	nn	3	SENT_373	[p18l898t2842r1156b2892],
2	J	NNP	O	J	nn	3	SENT_373	[p18l1180t2844r1207b2892],
3	l990	NN	O	l990	_	0	SENT_373	[p18l1239t2842r1758b2901],
4	;	:	O	;	_	0	SENT_373	[p18l1239t2842r1758b2901],
5	268:309	CD	NUMBER	268:309	number	6	SENT_373	[p18l1239t2842r1758b2901],
6	—	CD	NUMBER	—	num	7	SENT_373	[p18l1239t2842r1758b2901],
7	l5	NN	O	l5	dep	3	SENT_373	[p18l1239t2842r1758b2901],
8	.	.	O	.	_	0	SENT_373	[p18l1239t2842r1758b2901],

1	8	CD	NUMBER	8	_	0	SENT_374	[p18l9t2926r54b2975],
2	.	.	O	.	_	0	SENT_374	[p18l9t2926r54b2975],

1	Nakagawa	NNP	PERSON	Nakagawa	nn	2	SENT_375	[p18l149t2926r451b2990],
2	K	NNP	PERSON	K	_	0	SENT_375	[p18l471t2927r534b2984],
3	,	,	O	,	_	0	SENT_375	[p18l471t2927r534b2984],
4	Saijo	NNP	LOCATION	Saijo	nn	5	SENT_375	[p18l559t2926r702b2990],
5	N	NNP	LOCATION	N	appos	2	SENT_375	[p18l722t2927r788b2985],
6	,	,	O	,	_	0	SENT_375	[p18l722t2927r788b2985],
7	Tsuchida	NNP	LOCATION	Tsuchida	nn	8	SENT_375	[p18l810t2926r1072b2975],
8	S	NNP	LOCATION	S	appos	5	SENT_375	[p18l1092t2926r1144b2984],
9	,	,	O	,	_	0	SENT_375	[p18l1092t2926r1144b2984],
10	Sakai	NNP	LOCATION	Sakai	nn	11	SENT_375	[p18l1168t2926r1323b2975],
11	M	NNP	O	M	appos	5	SENT_375	[p18l1343t2927r1421b2984],
12	,	,	O	,	_	0	SENT_375	[p18l1343t2927r1421b2984],
13	Tsunokawa	NNP	O	Tsunokawa	nn	14	SENT_375	[p18l1443t2926r1772b2975],
14	Y	NN	O	y	appos	5	SENT_375	[p18l1791t2927r1856b2984],
15	,	,	O	,	_	0	SENT_375	[p18l1791t2927r1856b2984],
16	Yokota	NNP	PERSON	Yokota	nn	17	SENT_375	[p18l1879t2926r2089b2975],
17	J	NNP	PERSON	J	appos	5	SENT_375	[p18l2107t2927r2134b2975],
18	,	,	O	,	_	0	SENT_375	[p18l2139t2967r2149b2984],
19	et	FW	O	et	nn	20	SENT_375	[p18l150t3006r200b3048],
20	al.	FW	O	al.	appos	5	SENT_375	[p18l223t2998r285b3048],
21	.	.	O	.	_	0	SENT_375	[p18l223t2998r285b3048],

1	Glutathione	NN	O	glutathione	_	0	SENT_376	[p18l313t2998r1045b3048],
2	.	.	O	.	_	0	SENT_376	[p18l313t2998r1045b3048],

1	—	NN	O	—	_	0	SENT_377	[p18l313t2998r1045b3048],
2	.	.	O	.	_	0	SENT_377	[p18l313t2998r1045b3048],

1	S-transferase	NN	O	s-transferase	nn	2	SENT_378	[p18l313t2998r1045b3048],
2	pi	NN	O	pi	_	0	SENT_378	[p18l1067t2998r1121b3062],
3	as	IN	O	as	_	0	SENT_378	[p18l1146t3014r1200b3048],
4	a	DT	O	a	det	5	SENT_378	[p18l1226t3014r1255b3048],
5	determinant	NN	O	determinant	prep_as	2	SENT_378	[p18l1277t2998r1618b3048],
6	of	IN	O	of	_	0	SENT_378	[p18l1640t2998r1701b3048],
7	drug	NN	O	drug	nn	8	SENT_378	[p18l1720t2998r1848b3063],
8	resistance	NN	O	resistance	prep_of	5	SENT_378	[p18l1870t2998r2151b3048],
9	in	IN	O	in	_	0	SENT_378	[p18l150t3071r203b3120],
10	transfectant	JJ	O	transfectant	amod	12	SENT_378	[p18l229t3071r562b3121],
11	cell	NN	O	cell	nn	12	SENT_378	[p18l587t3071r688b3121],
12	lines	NNS	O	line	prep_in	2	SENT_378	[p18l714t3071r861b3121],
13	.	.	O	.	_	0	SENT_378	[p18l714t3071r861b3121],

1	J	NNP	O	J	nn	4	SENT_379	[p18l890t3072r916b3121],
2	Biol	NNP	O	Biol	nn	4	SENT_379	[p18l942t3071r1063b3121],
3	Chem	NNP	O	Chem	nn	4	SENT_379	[p18l1090t3071r1259b3121],
4	l990	NN	O	l990	_	0	SENT_379	[p18l1291t3071r1882b3130],
5	;	:	O	;	_	0	SENT_379	[p18l1291t3071r1882b3130],
6	265:4296	CD	NUMBER	265:4296	number	7	SENT_379	[p18l1291t3071r1882b3130],
7	—	CD	NUMBER	—	num	8	SENT_379	[p18l1291t3071r1882b3130],
8	30l	NN	O	30l	dep	4	SENT_379	[p18l1291t3071r1882b3130],
9	.	.	O	.	_	0	SENT_379	[p18l1291t3071r1882b3130],

1	9	CD	NUMBER	9	_	0	SENT_380	[p18l7t3145r54b3195],
2	.	.	O	.	_	0	SENT_380	[p18l7t3145r54b3195],

1	O’Brien	NN	O	o’brien	nn	2	SENT_381	[p18l151t3144r382b3194],
2	ML	NN	O	ml	_	0	SENT_381	[p18l403t3146r524b3203],
3	,	,	O	,	_	0	SENT_381	[p18l403t3146r524b3203],
4	Tew	NN	PERSON	tew	nn	5	SENT_381	[p18l547t3146r672b3194],
5	KD	NN	O	kd	appos	2	SENT_381	[p18l695t3146r809b3194],
6	.	.	O	.	_	0	SENT_381	[p18l695t3146r809b3194],

1	Glutathione	NN	O	glutathione	nn	4	SENT_382	[p18l835t3144r1169b3194],
2	and	CC	O	and	_	0	SENT_382	[p18l1192t3144r1293b3194],
3	related	JJ	O	related	nn	4	SENT_382	[p18l1312t3144r1507b3194],
4	enzymes	NNS	O	enzyme	_	0	SENT_382	[p18l1528t3160r1774b3209],
5	in	IN	O	in	_	0	SENT_382	[p18l1796t3144r1851b3193],
6	multidrug	JJ	O	multidrug	amod	7	SENT_382	[p18l1871t3144r2151b3209],
7	resistance	NN	O	resistance	prep_in	4	SENT_382	[p18l149t3217r444b3267],
8	.	.	O	.	_	0	SENT_382	[p18l149t3217r444b3267],

1	Eur	NNP	O	Eur	nn	4	SENT_383	[p18l473t3218r576b3267],
2	J	NNP	O	J	nn	4	SENT_383	[p18l600t3218r626b3267],
3	Cancer	NNP	O	Cancer	nn	4	SENT_383	[p18l653t3217r854b3267],
4	l996	NN	O	l996	_	0	SENT_383	[p18l885t3217r1412b3276],
5	;	:	O	;	_	0	SENT_383	[p18l885t3217r1412b3276],
6	32A	NN	O	32a	dep	4	SENT_383	[p18l885t3217r1412b3276],
7	:967	CD	NUMBER	:967	num	6	SENT_383	[p18l885t3217r1412b3276],
8	—	NN	O	—	dep	6	SENT_383	[p18l885t3217r1412b3276],
9	78	CD	NUMBER	78	num	8	SENT_383	[p18l885t3217r1412b3276],
10	.	.	O	.	_	0	SENT_383	[p18l885t3217r1412b3276],

1	10	CD	NUMBER	10	_	0	SENT_384	[p18l13t3291r90b3340],
2	.	.	O	.	_	0	SENT_384	[p18l13t3291r90b3340],

1	Ruetz	NNP	PERSON	Ruetz	nn	2	SENT_385	[p18l149t3292r314b3340],
2	S	NNP	O	S	_	0	SENT_385	[p18l337t3291r388b3349],
3	,	,	O	,	_	0	SENT_385	[p18l337t3291r388b3349],
4	Brault	NNP	PERSON	Brault	nn	5	SENT_385	[p18l411t3291r590b3340],
5	M	NNP	O	M	appos	2	SENT_385	[p18l609t3292r687b3350],
6	,	,	O	,	_	0	SENT_385	[p18l609t3292r687b3350],
7	Kast	NNP	PERSON	Kast	nn	8	SENT_385	[p18l711t3292r840b3340],
8	C	NNP	O	C	appos	5	SENT_385	[p18l860t3291r921b3349],
9	,	,	O	,	_	0	SENT_385	[p18l860t3291r921b3349],
10	Hemenway	NNP	PERSON	Hemenway	nn	11	SENT_385	[p18l944t3292r1268b3355],
11	C	NNP	O	C	appos	5	SENT_385	[p18l1290t3291r1350b3349],
12	,	,	O	,	_	0	SENT_385	[p18l1290t3291r1350b3349],
13	Heitman	NNP	PERSON	Heitman	nn	14	SENT_385	[p18l1373t3290r1618b3340],
14	J	NNP	PERSON	J	appos	5	SENT_385	[p18l1638t3292r1665b3340],
15	,	,	O	,	_	0	SENT_385	[p18l1670t3332r1680b3349],
16	Grant	NNP	PERSON	Grant	nn	17	SENT_385	[p18l1704t3291r1865b3340],
17	CE	NNP	O	CE	appos	5	SENT_385	[p18l1886t3291r1990b3349],
18	,	,	O	,	_	0	SENT_385	[p18l1886t3291r1990b3349],
19	et	FW	O	et	nn	20	SENT_385	[p18l2014t3298r2064b3340],
20	al.	FW	O	al.	appos	5	SENT_385	[p18l2085t3291r2148b3340],
21	.	.	O	.	_	0	SENT_385	[p18l2085t3291r2148b3340],

1	Functional	JJ	O	functional	amod	2	SENT_386	[p18l149t3363r453b3412],
2	expression	NN	O	expression	nsubj	8	SENT_386	[p18l482t3363r786b3427],
3	of	IN	O	of	_	0	SENT_386	[p18l816t3363r878b3412],
4	the	DT	O	the	det	7	SENT_386	[p18l901t3363r986b3413],
5	multidrug	JJ	O	multidrug	amod	7	SENT_386	[p18l1015t3363r1294b3427],
6	resistance	NN	O	resistance	nn	7	SENT_386	[p18l1323t3363r1923b3413],
7	—	NN	O	—	prep_of	2	SENT_386	[p18l1323t3363r1923b3413],
8	associated	VBN	O	associate	_	0	SENT_386	[p18l1323t3363r1923b3413],
9	protein	NN	O	protein	dobj	8	SENT_386	[p18l1950t3363r2152b3427],
10	in	IN	O	in	_	0	SENT_386	[p18l149t3437r204b3485],
11	the	DT	O	the	det	12	SENT_386	[p18l227t3437r312b3486],
12	yeast	NN	O	yeast	prep_in	9	SENT_386	[p18l336t3444r482b3501],
13	saccharomyces	JJ	O	saccharomyces	dep	15	SENT_386	[p18l507t3437r1261b3501],
14	—	FW	O	—	nn	15	SENT_386	[p18l507t3437r1261b3501],
15	cerevisiae	FW	O	cerevisiae	rcmod	12	SENT_386	[p18l507t3437r1261b3501],
16	.	.	O	.	_	0	SENT_386	[p18l507t3437r1261b3501],

1	J	NNP	O	J	nn	3	SENT_387	[p18l1288t3438r1314b3486],
2	Biol	NNP	O	Biol	nn	3	SENT_387	[p18l1337t3436r1459b3486],
3	Chem	NNP	O	Chem	_	0	SENT_387	[p18l1484t3437r1653b3486],
4	1996	CD	DATE	1996	num	3	SENT_387	[p18l1683t3436r2153b3495, p18l151t3508r233b3558],
5	;	:	O	;	_	0	SENT_387	[p18l1683t3436r2153b3495, p18l151t3508r233b3558],
6	271:415460	CD	NUMBER	271:415460	dep	3	SENT_387	[p18l1683t3436r2153b3495, p18l151t3508r233b3558],
7	.	.	O	.	_	0	SENT_387	[p18l1683t3436r2153b3495, p18l151t3508r233b3558],

1	Loe	NNP	PERSON	Loe	nn	2	SENT_388	[p19l149t19r258b67],
2	DW	NNP	O	DW	_	0	SENT_388	[p19l283t19r415b77],
3	,	,	O	,	_	0	SENT_388	[p19l283t19r415b77],
4	Almquist	NNP	PERSON	Almquist	nn	5	SENT_388	[p19l442t18r707b82],
5	KC	NNP	O	KC	appos	2	SENT_388	[p19l731t18r843b76],
6	,	,	O	,	_	0	SENT_388	[p19l731t18r843b76],
7	Deeley	NNP	PERSON	Deeley	nn	8	SENT_388	[p19l869t18r1069b82],
8	RG	NNP	O	RG	appos	2	SENT_388	[p19l1093t18r1206b76],
9	,	,	O	,	_	0	SENT_388	[p19l1093t18r1206b76],
10	Cole	NNP	O	Cole	nn	12	SENT_388	[p19l1234t18r1366b68],
11	SPC.	NNP	O	SPC.	nn	12	SENT_388	[p19l1392t18r1529b68],
12	Multidrug	NNP	O	Multidrug	appos	2	SENT_388	[p19l1557t18r2151b82],
13	—	NN	O	—	nn	18	SENT_388	[p19l1557t18r2151b82],
14	resistance	NN	O	resistance	nn	18	SENT_388	[p19l1557t18r2151b82],
15	protein	NN	O	protein	nn	18	SENT_388	[p19l149t91r351b156],
16	(	CD	NUMBER	(	num	18	SENT_388	[p19l375t91r856b153],
17	MRP	NN	O	mrp	nn	18	SENT_388	[p19l375t91r856b153],
18	)	NN	O	)	dep	12	SENT_388	[p19l375t91r856b153],
19	.	.	O	.	_	0	SENT_388	[p19l375t91r856b153],

1	—	NN	O	—	_	0	SENT_389	[p19l375t91r856b153],
2	.	.	O	.	_	0	SENT_389	[p19l375t91r856b153],

1	mediated	VBN	O	mediate	_	0	SENT_390	[p19l375t91r856b153],
2	transport	NN	O	transport	nsubj	11	SENT_390	[p19l878t99r1132b156],
3	of	IN	O	of	_	0	SENT_390	[p19l1154t91r1216b141],
4	leukotriene	NN	O	leukotriene	nn	5	SENT_390	[p19l1233t91r1553b141],
5	C-4	NN	O	c-4	prep_of	2	SENT_390	[p19l1576t92r1681b141],
6	and	CC	O	and	_	0	SENT_390	[p19l1705t91r1806b141],
7	chemotherapeutic-agents	NNS	O	chemotherapeutic-agent	conj_and	5	SENT_390	[p19l1828t91r2150b141, p19l151t164r559b228],
8	in	IN	O	in	_	0	SENT_390	[p19l584t164r638b213],
9	membrane-vesicles	NNS	O	membrane-vesicle	prep_in	5	SENT_390	[p19l662t164r1702b213],
10	—	CD	NUMBER	—	num	11	SENT_390	[p19l662t164r1702b213],
11	demonstration	NN	O	demonstration	xcomp	1	SENT_390	[p19l662t164r1702b213],
12	of	IN	O	of	_	0	SENT_390	[p19l1727t164r1788b213],
13	glutathionedependent	JJ	O	glutathionedependent	amod	15	SENT_390	[p19l1808t164r2150b228, p19l150t237r443b302],
14	vincristine	NN	O	vincristine	nn	15	SENT_390	[p19l467t237r767b287],
15	transport	NN	O	transport	prep_of	11	SENT_390	[p19l793t245r1060b302],
16	.	.	O	.	_	0	SENT_390	[p19l793t245r1060b302],

1	J	NNP	O	J	nn	3	SENT_391	[p19l1089t239r1115b287],
2	Biol	NNP	O	Biol	nn	3	SENT_391	[p19l1141t237r1262b287],
3	Chem	NNP	O	Chem	_	0	SENT_391	[p19l1289t237r1459b287],
4	1996	CD	DATE	1996	num	3	SENT_391	[p19l1490t237r1951b296],
5	;	:	O	;	_	0	SENT_391	[p19l1490t237r1951b296],
6	271:9675	CD	NUMBER	271:9675	number	7	SENT_391	[p19l1490t237r1951b296],
7	—	CD	NUMBER	—	dep	3	SENT_391	[p19l1490t237r1951b296],
8	82	CD	NUMBER	82	dep	7	SENT_391	[p19l1964t238r2045b287],
9	.	.	O	.	_	0	SENT_391	[p19l1964t238r2045b287],

1	Priebe	NNP	PERSON	Priebe	nn	2	SENT_392	[p19l149t310r330b359],
2	W	NNP	O	W	nsubj	32	SENT_392	[p19l349t311r431b369],
3	,	,	O	,	_	0	SENT_392	[p19l349t311r431b369],
4	Krawczyk	NNP	PERSON	Krawczyk	nn	5	SENT_392	[p19l455t310r748b374],
5	M	NNP	O	M	conj_and	2	SENT_392	[p19l766t311r843b369],
6	,	,	O	,	_	0	SENT_392	[p19l766t311r843b369],
7	Kuo	NNP	LOCATION	Kuo	nn	8	SENT_392	[p19l867t311r986b359],
8	MT	NNP	LOCATION	MT	conj_and	2	SENT_392	[p19l1007t311r1128b369],
9	,	,	O	,	_	0	SENT_392	[p19l1007t311r1128b369],
10	Yamane	NNP	PERSON	Yamane	nn	11	SENT_392	[p19l1151t311r1387b359],
11	Y	NN	PERSON	y	conj_and	2	SENT_392	[p19l1408t311r1472b369],
12	,	,	O	,	_	0	SENT_392	[p19l1408t311r1472b369],
13	Savaraj	NNP	PERSON	Savaraj	nn	14	SENT_392	[p19l1497t310r1703b374],
14	N	NNP	O	N	conj_and	2	SENT_392	[p19l1728t311r1793b369],
15	,	,	O	,	_	0	SENT_392	[p19l1728t311r1793b369],
16	Ishikawa	NNP	PERSON	Ishikawa	nn	19	SENT_392	[p19l1816t310r2073b360],
17	T.	NNP	O	T.	nn	19	SENT_392	[p19l2092t311r2148b359],
18	Doxorubicin	NNP	O	Doxorubicin	nn	19	SENT_392	[p19l149t384r531b433],
19	—	NN	O	—	conj_and	2	SENT_392	[p19l149t384r531b433],
20	and	CC	O	and	_	0	SENT_392	[p19l568t384r668b433],
21	daunorubicin	NN	O	daunorubicin	conj_and	2	SENT_392	[p19l702t384r1423b448],
22	—	CD	NUMBER	—	num	24	SENT_392	[p19l702t384r1423b448],
23	glutathione	NN	O	glutathione	nn	24	SENT_392	[p19l702t384r1423b448],
24	conjugates	NNS	O	conjugate	dep	2	SENT_392	[p19l1457t384r1776b448],
25	,	,	O	,	_	0	SENT_392	[p19l1457t384r1776b448],
26	but	CC	O	but	_	0	SENT_392	[p19l1811t384r1903b433],
27	not	RB	O	not	_	0	SENT_392	[p19l1935t391r2026b433],
28	unconjugated	JJ	O	unconjugated	amod	29	SENT_392	[p19l2057t399r2150b433, p19l150t456r462b521],
29	drugs	NNS	O	drug	nsubj	32	SENT_392	[p19l484t456r655b521],
30	,	,	O	,	_	0	SENT_392	[p19l484t456r655b521],
31	competitively	RB	O	competitively	advmod	32	SENT_392	[p19l680t456r1071b521],
32	inhibit	VBP	O	inhibit	_	0	SENT_392	[p19l1093t456r1279b506],
33	leukotriene	NN	O	leukotriene	nn	35	SENT_392	[p19l1299t456r1619b506],
34	C-4	NN	O	c-4	nn	35	SENT_392	[p19l1642t457r1746b506],
35	transport	NN	O	transport	dobj	32	SENT_392	[p19l1767t464r2022b520],
36	mediated	VBN	O	mediate	partmod	35	SENT_392	[p19l2042t472r2149b506, p19l150t530r323b579],
37	by	IN	O	by	_	0	SENT_392	[p19l342t530r412b594],
38	MRP/GS	NN	O	mrp/gs	agent	36	SENT_392	[p19l433t530r769b579],
39	.	.	O	.	_	0	SENT_392	[p19l433t530r769b579],

1	—	NN	O	—	_	0	SENT_393	[p19l433t530r769b579],
2	.	.	O	.	_	0	SENT_393	[p19l433t530r769b579],

1	X	NN	O	x	_	0	SENT_394	[p19l433t530r769b579],
2	pump	NN	O	pump	dep	1	SENT_394	[p19l789t545r965b594],
3	.	.	O	.	_	0	SENT_394	[p19l789t545r965b594],

1	Biochem	NNP	ORGANIZATION	Biochem	nn	4	SENT_395	[p19l989t530r1247b579],
2	Biophys	NNP	ORGANIZATION	Biophys	nn	4	SENT_395	[p19l1266t530r1501b594],
3	Res	NNP	ORGANIZATION	Res	nn	4	SENT_395	[p19l1524t531r1627b579],
4	Comm	NNP	ORGANIZATION	Comm	_	0	SENT_395	[p19l1650t530r1844b579],
5	1998	CD	DATE	1998	num	4	SENT_395	[p19l1870t530r2147b588],
6	;	:	O	;	_	0	SENT_395	[p19l1870t530r2147b588],
7	247	CD	NUMBER	247	num	9	SENT_395	[p19l1870t530r2147b588],
8	:	:	O	:	_	0	SENT_395	[p19l1870t530r2147b588],
9	859-63	CD	NUMBER	859-63	dep	4	SENT_395	[p19l152t601r394b651],
10	.	.	O	.	_	0	SENT_395	[p19l152t601r394b651],

1	Bentley	NNP	PERSON	Bentley	nn	2	SENT_396	[p19l149t674r370b738],
2	P	NN	PERSON	p	_	0	SENT_396	[p19l408t675r461b733],
3	,	,	O	,	_	0	SENT_396	[p19l408t675r461b733],
4	Thomas	NNP	PERSON	Thomas	nn	5	SENT_396	[p19l502t674r729b723],
5	A	NNP	PERSON	A	appos	2	SENT_396	[p19l768t674r833b733],
6	,	,	O	,	_	0	SENT_396	[p19l768t674r833b733],
7	Thomas	NNP	PERSON	Thomas	nn	9	SENT_396	[p19l874t674r1101b723],
8	J.	NNP	PERSON	J.	nn	9	SENT_396	[p19l1140t675r1181b724],
9	Failure	NN	PERSON	failure	appos	2	SENT_396	[p19l1222t674r1423b723],
10	to	TO	O	to	aux	11	SENT_396	[p19l1461t681r1514b723],
11	induce	VB	O	induce	infmod	9	SENT_396	[p19l1553t674r1741b723],
12	resistance	NN	O	resistance	dobj	11	SENT_396	[p19l1778t674r2060b723],
13	to	TO	O	to	_	0	SENT_396	[p19l2098t681r2151b723],
14	cytotoxic	JJ	O	cytotoxic	amod	15	SENT_396	[p19l150t747r412b811],
15	drugs	NNS	O	drug	prep_to	11	SENT_396	[p19l471t747r625b812],
16	in	IN	O	in	_	0	SENT_396	[p19l683t747r737b796],
17	normal	JJ	O	normal	amod	18	SENT_396	[p19l793t747r994b797],
18	lymphocytes	NNS	O	lymphocyte	prep_in	15	SENT_396	[p19l1050t747r1428b812],
19	.	.	O	.	_	0	SENT_396	[p19l1050t747r1428b812],

1	Leukemia	NN	O	leukemia	_	0	SENT_397	[p19l1487t747r1773b797],
2	Res	NNP	O	Res	dep	1	SENT_397	[p19l1829t748r1932b797],
3	1996	CD	DATE	1996	num	2	SENT_397	[p19l1997t747r2148b806],
4	;	:	O	;	_	0	SENT_397	[p19l1997t747r2148b806],
5	20:645	CD	NUMBER	20:645	number	6	SENT_397	[p19l151t819r441b869],
6	—	CD	NUMBER	—	dep	1	SENT_397	[p19l151t819r441b869],
7	8	CD	NUMBER	8	dep	6	SENT_397	[p19l151t819r441b869],
8	.	.	O	.	_	0	SENT_397	[p19l151t819r441b869],

1	Abe	NNP	O	Abe	nn	2	SENT_398	[p19l149t892r266b942],
2	Y	NN	O	y	_	0	SENT_398	[p19l293t893r358b951],
3	,	,	O	,	_	0	SENT_398	[p19l293t893r358b951],
4	Ohnishi	NNP	PERSON	Ohnishi	nn	5	SENT_398	[p19l389t892r612b943],
5	Y	NN	PERSON	y	appos	2	SENT_398	[p19l639t893r704b951],
6	,	,	O	,	_	0	SENT_398	[p19l639t893r704b951],
7	Yoshimura	NNP	PERSON	Yoshimura	nn	8	SENT_398	[p19l733t892r1050b942],
8	M	NNP	O	M	appos	5	SENT_398	[p19l1075t893r1153b951],
9	,	,	O	,	_	0	SENT_398	[p19l1075t893r1153b951],
10	Ota	NNP	PERSON	Ota	nn	11	SENT_398	[p19l1183t893r1285b943],
11	E	NNP	O	E	appos	5	SENT_398	[p19l1309t893r1367b951],
12	,	,	O	,	_	0	SENT_398	[p19l1309t893r1367b951],
13	Ozeki	NNP	PERSON	Ozeki	nn	14	SENT_398	[p19l1397t892r1565b943],
14	Y	NN	PERSON	y	appos	5	SENT_398	[p19l1592t893r1657b951],
15	,	,	O	,	_	0	SENT_398	[p19l1592t893r1657b951],
16	Oshika	FW	LOCATION	oshika	appos	5	SENT_398	[p19l1687t892r1888b943],
17	Y	NN	O	y	dep	16	SENT_398	[p19l1914t893r1978b951],
18	,	,	O	,	_	0	SENT_398	[p19l1914t893r1978b951],
19	et	FW	O	et	nn	20	SENT_398	[p19l2008t900r2059b942],
20	al.	FW	O	al.	appos	5	SENT_398	[p19l2085t892r2148b942],
21	.	.	O	.	_	0	SENT_398	[p19l2085t892r2148b942],

1	P-glycoprotein	NN	O	p-glycoprotein	nn	2	SENT_399	[p19l149t966r860b1030],
2	—	NN	O	—	nsubj	3	SENT_399	[p19l149t966r860b1030],
3	mediated	VBD	O	mediate	_	0	SENT_399	[p19l149t966r860b1030],
4	acquired	VBN	O	acquire	amod	6	SENT_399	[p19l879t966r1123b1030],
5	multidrug	JJ	O	multidrug	amod	6	SENT_399	[p19l1140t966r1420b1030],
6	resistance	NN	O	resistance	dobj	3	SENT_399	[p19l1439t966r1719b1015],
7	of	IN	O	of	_	0	SENT_399	[p19l1739t965r1801b1015],
8	human	JJ	O	human	amod	11	SENT_399	[p19l1814t966r2008b1015],
9	lung	NN	O	lung	nn	11	SENT_399	[p19l2026t966r2151b1030],
10	cancer	NN	O	cancer	nn	11	SENT_399	[p19l150t1054r336b1088],
11	cells	NNS	O	cell	prep_of	6	SENT_399	[p19l360t1038r488b1088],
12	in	FW	O	in	prep	6	SENT_399	[p19l515t1038r569b1088],
13	vivo	FW	O	vivo	pobj	12	SENT_399	[p19l594t1038r734b1088],
14	.	.	O	.	_	0	SENT_399	[p19l594t1038r734b1088],

1	Br	NN	O	br	nn	3	SENT_400	[p19l763t1039r835b1088],
2	J	NN	O	j	nn	3	SENT_400	[p19l858t1039r884b1089],
3	Cancer	NN	O	cancer	_	0	SENT_400	[p19l911t1039r1113b1089],
4	1996	CD	DATE	1996	dep	3	SENT_400	[p19l1144t1038r1663b1097],
5	;	:	O	;	_	0	SENT_400	[p19l1144t1038r1663b1097],
6	74:1929	CD	NUMBER	74:1929	number	7	SENT_400	[p19l1144t1038r1663b1097],
7	—	CD	NUMBER	—	dep	3	SENT_400	[p19l1144t1038r1663b1097],
8	34	CD	NUMBER	34	dep	7	SENT_400	[p19l1144t1038r1663b1097],
9	.	.	O	.	_	0	SENT_400	[p19l1144t1038r1663b1097],

1	Moscow	NNP	LOCATION	Moscow	nn	2	SENT_401	[p19l149t1113r393b1161],
2	JA	NNP	O	JA	_	0	SENT_401	[p19l420t1112r513b1170],
3	,	,	O	,	_	0	SENT_401	[p19l420t1112r513b1170],
4	Townsend	NNP	PERSON	Townsend	nn	5	SENT_401	[p19l542t1112r839b1161],
5	AJ	NNP	PERSON	AJ	appos	2	SENT_401	[p19l865t1112r958b1170],
6	,	,	O	,	_	0	SENT_401	[p19l865t1112r958b1170],
7	Cowan	NNP	ORGANIZATION	Cowan	nn	8	SENT_401	[p19l988t1112r1188b1161],
8	KH	NNP	ORGANIZATION	KH	appos	5	SENT_401	[p19l1215t1113r1330b1161],
9	.	.	O	.	_	0	SENT_401	[p19l1215t1113r1330b1161],

1	Elevation	NN	O	elevation	_	0	SENT_402	[p19l1359t1112r1633b1161],
2	of	IN	O	of	_	0	SENT_402	[p19l1659t1111r1721b1161],
3	pi	NN	O	pi	nn	5	SENT_402	[p19l1742t1111r1796b1176],
4	class	NN	O	class	nn	5	SENT_402	[p19l1823t1112r1959b1161],
5	glutaGLUTATHIONE	NN	O	glutaglutathione	prep_of	1	SENT_402	[p19l1987t1112r2150b1176, p19l244t1257r450b1277],

1	S	NN	O	s	_	0	SENT_403	[p19l460t1257r703b1277],
2	.	.	O	.	_	0	SENT_403	[p19l460t1257r703b1277],

1	—	NN	O	—	_	0	SENT_404	[p19l460t1257r703b1277],
2	.	.	O	.	_	0	SENT_404	[p19l460t1257r703b1277],

1	TRANSFERASES	NNPS	O	TRANSFERASES	_	0	SENT_405	[p19l460t1257r703b1277],
2	AND	CC	O	and	_	0	SENT_405	[p19l715t1257r777b1277],
3	DRUG	NN	O	drug	nn	4	SENT_405	[p19l788t1257r870b1277],
4	TRANSPORTERS	NN	O	transporter	conj_and	1	SENT_405	[p19l880t1257r1102b1277],
5	IN	IN	O	in	_	0	SENT_405	[p19l1113t1257r1144b1277],
6	DOXORUBICIN	NNP	O	DOXORUBICIN	prep_in	4	SENT_405	[p19l1154t1257r1357b1277],
7	RESISTANCE	NN	O	resistance	dep	1	SENT_405	[p19l1368t1257r1544b1277],
8	783	CD	NUMBER	783	num	7	SENT_405	[p19l1863t1251r1916b1277],

1	thione	NN	O	thione	nsubj	2	SENT_406	[p19l149t1383r325b1433],
2	S	NN	O	s	_	0	SENT_406	[p19l349t1383r718b1433],
3	—	CD	NUMBER	—	num	5	SENT_406	[p19l349t1383r718b1433],
4	transferase	NN	O	transferase	nn	5	SENT_406	[p19l349t1383r718b1433],
5	activity	NN	O	activity	dobj	2	SENT_406	[p19l741t1383r951b1448],
6	in	IN	O	in	_	0	SENT_406	[p19l973t1383r1027b1432],
7	human	JJ	O	human	amod	10	SENT_406	[p19l1047t1383r1241b1433],
8	breast	NN	O	breast	nn	10	SENT_406	[p19l1261t1383r1432b1433],
9	cancer	NN	O	cancer	nn	10	SENT_406	[p19l1453t1399r1638b1433],
10	cells	NNS	O	cell	prep_in	5	SENT_406	[p19l1659t1383r1786b1433],
11	by	IN	O	by	_	0	SENT_406	[p19l1808t1383r1878b1448],
12	transfec	NN	O	transfec	nn	14	SENT_406	[p19l1899t1383r2145b1433],
13	—	CD	NUMBER	—	num	14	SENT_406	[p19l1899t1383r2145b1433],
14	tion	NN	O	tion	prep_by	2	SENT_406	[p19l149t1453r259b1503],
15	of	IN	O	of	_	0	SENT_406	[p19l288t1453r350b1503],
16	the	DT	O	the	det	19	SENT_406	[p19l373t1453r458b1503],
17	GST	NN	O	gst	nn	19	SENT_406	[p19l489t1454r621b1503],
18	pi	NN	O	pi	nn	19	SENT_406	[p19l649t1453r703b1518],
19	gene	NN	O	gene	prep_of	14	SENT_406	[p19l733t1469r865b1518],
20	and	CC	O	and	_	0	SENT_406	[p19l896t1453r996b1503],
21	its	PRP$	O	its	poss	22	SENT_406	[p19l1024t1453r1088b1503],
22	effect	NN	O	effect	conj_and	14	SENT_406	[p19l1120t1453r1281b1503],
23	on	IN	O	on	_	0	SENT_406	[p19l1310t1469r1379b1503],
24	sensitivity	NN	O	sensitivity	prep_on	22	SENT_406	[p19l1409t1453r1699b1518],
25	to	TO	O	to	_	0	SENT_406	[p19l1728t1461r1780b1503],
26	toxins	NNS	O	toxin	prep_to	24	SENT_406	[p19l1810t1453r1997b1503],
27	.	.	O	.	_	0	SENT_406	[p19l1810t1453r1997b1503],

1	Mol	NNP	ORGANIZATION	Mol	nn	2	SENT_407	[p19l2030t1453r2147b1503],
2	Pharmacol	NNP	O	Pharmacol	_	0	SENT_407	[p19l149t1524r452b1574],
3	1989	CD	DATE	1989	num	2	SENT_407	[p19l485t1524r896b1583],
4	;	:	O	;	_	0	SENT_407	[p19l485t1524r896b1583],
5	36:22	CD	NUMBER	36:22	number	6	SENT_407	[p19l485t1524r896b1583],
6	—	CD	NUMBER	—	dep	2	SENT_407	[p19l485t1524r896b1583],
7	8	CD	NUMBER	8	dep	6	SENT_407	[p19l485t1524r896b1583],
8	.	.	O	.	_	0	SENT_407	[p19l485t1524r896b1583],

1	Fairchild	NNP	O	Fairchild	nn	2	SENT_408	[p19l148t1594r406b1644],
2	CR	NN	O	cr	_	0	SENT_408	[p19l428t1595r535b1653],
3	,	,	O	,	_	0	SENT_408	[p19l428t1595r535b1653],
4	Moscow	NNP	LOCATION	Moscow	nn	5	SENT_408	[p19l560t1596r803b1644],
5	JA	NNP	O	JA	appos	2	SENT_408	[p19l825t1595r918b1653],
6	,	,	O	,	_	0	SENT_408	[p19l825t1595r918b1653],
7	O’Brien	NNP	O	O’Brien	nn	8	SENT_408	[p19l944t1594r1175b1644],
8	EE	NNP	O	EE	appos	2	SENT_408	[p19l1196t1596r1297b1653],
9	,	,	O	,	_	0	SENT_408	[p19l1196t1596r1297b1653],
10	Cowan	NNP	ORGANIZATION	Cowan	nn	11	SENT_408	[p19l1323t1595r1522b1644],
11	KH	NNP	ORGANIZATION	KH	appos	2	SENT_408	[p19l1545t1596r1659b1644],
12	.	.	O	.	_	0	SENT_408	[p19l1545t1596r1659b1644],

1	Multidrug	JJ	O	multidrug	amod	2	SENT_409	[p19l1685t1594r1972b1659],
2	resistance	NN	O	resistance	nsubj	5	SENT_409	[p19l1993t1594r2145b1644, p19l149t1671r297b1714],
3	in	IN	O	in	_	0	SENT_409	[p19l331t1664r384b1713],
4	cells	NNS	O	cell	prep_in	2	SENT_409	[p19l418t1664r545b1714],
5	transfected	VBN	O	transfect	_	0	SENT_409	[p19l579t1664r891b1714],
6	with	IN	O	with	_	0	SENT_409	[p19l924t1664r1049b1714],
7	human	JJ	O	human	amod	8	SENT_409	[p19l1081t1664r1274b1714],
8	genes	NNS	O	gene	prep_with	5	SENT_409	[p19l1308t1680r1466b1729],
9	encoding	VBG	O	encode	partmod	8	SENT_409	[p19l1501t1664r1760b1729],
10	a	DT	O	a	det	12	SENT_409	[p19l1795t1680r1824b1714],
11	variant	JJ	O	variant	amod	12	SENT_409	[p19l1856t1664r2054b1714],
12	Pglycoprotein	NN	O	pglycoprotein	dobj	9	SENT_409	[p19l2085t1665r2145b1713, p19l150t1734r509b1798],
13	and	CC	O	and	_	0	SENT_409	[p19l538t1734r638b1783],
14	glutathione	NN	O	glutathione	nn	15	SENT_409	[p19l667t1734r985b1798],
15	S-transferase-pi	NN	O	s-transferase-pi	conj_and	12	SENT_409	[p19l1015t1734r1478b1798],
16	.	.	O	.	_	0	SENT_409	[p19l1015t1734r1478b1798],

1	Mol	NNP	ORGANIZATION	Mol	nn	2	SENT_410	[p19l1509t1734r1626b1783],
2	Pharmacol	NNP	O	Pharmacol	_	0	SENT_410	[p19l1655t1734r1958b1783],
3	1990	CD	DATE	1990	num	2	SENT_410	[p19l1993t1734r2145b1793],
4	;	:	O	;	_	0	SENT_410	[p19l1993t1734r2145b1793],
5	37:801	CD	NUMBER	37:801	number	6	SENT_410	[p19l151t1805r431b1855],
6	—	CD	NUMBER	—	dep	2	SENT_410	[p19l151t1805r431b1855],
7	9	CD	NUMBER	9	dep	6	SENT_410	[p19l151t1805r431b1855],
8	.	.	O	.	_	0	SENT_410	[p19l151t1805r431b1855],

1	Beaumont	NNP	O	Beaumont	nn	2	SENT_411	[p19l149t1875r442b1924],
2	PO	NNP	O	PO	_	0	SENT_411	[p19l460t1875r564b1933],
3	,	,	O	,	_	0	SENT_411	[p19l460t1875r564b1933],
4	Moore	NNP	PERSON	Moore	nn	5	SENT_411	[p19l586t1875r775b1924],
5	MJ	NNP	PERSON	MJ	appos	2	SENT_411	[p19l794t1875r899b1933],
6	,	,	O	,	_	0	SENT_411	[p19l794t1875r899b1933],
7	Ahmad	NNP	PERSON	Ahmad	nn	8	SENT_411	[p19l921t1874r1130b1924],
8	K	NNP	PERSON	K	appos	5	SENT_411	[p19l1150t1875r1213b1933],
9	,	,	O	,	_	0	SENT_411	[p19l1150t1875r1213b1933],
10	Payne	NNP	ORGANIZATION	Payne	nn	11	SENT_411	[p19l1235t1875r1407b1939],
11	MM	NN	ORGANIZATION	mm	appos	5	SENT_411	[p19l1427t1875r1567b1933],
12	,	,	O	,	_	0	SENT_411	[p19l1427t1875r1567b1933],
13	Lee	NNP	PERSON	Lee	nn	14	SENT_411	[p19l1589t1875r1694b1924],
14	C	NNP	O	C	appos	5	SENT_411	[p19l1715t1875r1775b1933],
15	,	,	O	,	_	0	SENT_411	[p19l1715t1875r1775b1933],
16	Riddick	NNP	O	Riddick	nn	17	SENT_411	[p19l1796t1874r2023b1924],
17	DS	NN	O	d	appos	5	SENT_411	[p19l2040t1875r2144b1924],
18	.	.	O	.	_	0	SENT_411	[p19l2040t1875r2144b1924],

1	Role	NN	O	role	_	0	SENT_412	[p19l149t1944r281b1993],
2	of	IN	O	of	_	0	SENT_412	[p19l312t1944r374b1993],
3	glutathione	NN	O	glutathione	nn	4	SENT_412	[p19l399t1944r717b2008],
4	S-transferases	NNS	O	s-transferase	prep_of	1	SENT_412	[p19l749t1944r1144b1994],
5	in	IN	O	in	_	0	SENT_412	[p19l1175t1944r1229b1993],
6	the	DT	O	the	det	7	SENT_412	[p19l1258t1944r1343b1993],
7	resistance	NN	O	resistance	prep_in	1	SENT_412	[p19l1372t1944r1652b1993],
8	of	IN	O	of	_	0	SENT_412	[p19l1683t1944r1744b1993],
9	human	JJ	O	human	amod	13	SENT_412	[p19l1768t1944r1961b1993],
10	colon	NN	O	colon	nn	13	SENT_412	[p19l1991t1944r2148b1993],
11	cancer	NN	O	cancer	nn	13	SENT_412	[p19l150t2031r335b2065],
12	cell	NN	O	cell	nn	13	SENT_412	[p19l360t2015r460b2065],
13	lines	NNS	O	line	prep_of	7	SENT_412	[p19l486t2015r617b2065],
14	to	TO	O	to	_	0	SENT_412	[p19l644t2023r697b2065],
15	doxorubicin	NN	O	doxorubicin	prep_to	13	SENT_412	[p19l725t2015r1082b2065],
16	.	.	O	.	_	0	SENT_412	[p19l725t2015r1082b2065],

1	Cancer	NNP	O	Cancer	nn	2	SENT_413	[p19l1112t2016r1313b2066],
2	Res	NNP	O	Res	_	0	SENT_413	[p19l1337t2017r1441b2065],
3	1998	CD	DATE	1998	num	2	SENT_413	[p19l1475t2015r1949b2074],
4	;	:	O	;	_	0	SENT_413	[p19l1475t2015r1949b2074],
5	58:947	CD	NUMBER	58:947	number	6	SENT_413	[p19l1475t2015r1949b2074],
6	—	CD	NUMBER	—	dep	2	SENT_413	[p19l1475t2015r1949b2074],
7	55	CD	NUMBER	55	dep	6	SENT_413	[p19l1475t2015r1949b2074],
8	.	.	O	.	_	0	SENT_413	[p19l1475t2015r1949b2074],

1	Doroshow	NNP	O	Doroshow	nn	2	SENT_414	[p19l149t2086r444b2136],
2	JH	NNP	O	JH	_	0	SENT_414	[p19l486t2087r579b2145],
3	,	,	O	,	_	0	SENT_414	[p19l486t2087r579b2145],
4	Metz	NNP	ORGANIZATION	Metz	nn	8	SENT_414	[p19l623t2087r768b2136],
5	MZ	JJ	ORGANIZATION	mz	amod	8	SENT_414	[p19l810t2087r931b2145],
6	,	,	O	,	_	0	SENT_414	[p19l810t2087r931b2145],
7	Matsumoto	NNP	ORGANIZATION	Matsumoto	dep	8	SENT_414	[p19l975t2087r1298b2136],
8	L	NNP	ORGANIZATION	L	appos	2	SENT_414	[p19l1341t2087r1398b2145],
9	,	,	O	,	_	0	SENT_414	[p19l1341t2087r1398b2145],
10	Winters	NNP	ORGANIZATION	Winters	nn	11	SENT_414	[p19l1441t2086r1665b2137],
11	KA	NN	ORGANIZATION	ka	appos	8	SENT_414	[p19l1709t2087r1825b2145],
12	,	,	O	,	_	0	SENT_414	[p19l1709t2087r1825b2145],
13	Sakai	NNP	LOCATION	Sakai	nn	14	SENT_414	[p19l1871t2086r2026b2137],
14	M	NNP	O	M	appos	8	SENT_414	[p19l2068t2087r2145b2145],
15	,	,	O	,	_	0	SENT_414	[p19l2068t2087r2145b2145],
16	Muramatsu	NNP	PERSON	Muramatsu	nn	17	SENT_414	[p19l149t2158r472b2207],
17	M	NNP	O	M	appos	8	SENT_414	[p19l494t2158r572b2216],
18	,	,	O	,	_	0	SENT_414	[p19l494t2158r572b2216],
19	et	FW	O	et	nn	20	SENT_414	[p19l597t2164r648b2207],
20	al.	FW	O	al.	appos	8	SENT_414	[p19l671t2157r733b2207],
21	.	.	O	.	_	0	SENT_414	[p19l671t2157r733b2207],

1	Transduction	NN	O	transduction	_	0	SENT_415	[p19l759t2157r1134b2207],
2	of	IN	O	of	_	0	SENT_415	[p19l1158t2157r1219b2207],
3	NIH	NN	ORGANIZATION	nih	nn	5	SENT_415	[p19l1237t2158r1362b2207],
4	3T3	NN	O	3t3	nn	5	SENT_415	[p19l1386t2157r1494b2207],
5	cells	NNS	O	cell	prep_of	1	SENT_415	[p19l1521t2157r1648b2207],
6	with	IN	O	with	_	0	SENT_415	[p19l1672t2157r1797b2207],
7	a	DT	O	a	det	8	SENT_415	[p19l1821t2173r1850b2207],
8	retrovirus	NN	O	retrovirus	prep_with	5	SENT_415	[p19l1871t2157r2146b2207],
9	carrying	VBG	O	carry	partmod	1	SENT_415	[p19l150t2227r384b2292],
10	both	CC	O	both	preconj	12	SENT_415	[p19l407t2227r533b2277],
11	human	JJ	O	human	amod	12	SENT_415	[p19l554t2227r748b2277],
12	Mdrl	NN	O	mdrl	dobj	9	SENT_415	[p19l770t2227r921b2277],
13	and	CC	O	and	_	0	SENT_415	[p19l951t2227r1052b2277],
14	glutathione	NN	O	glutathione	conj_and	12	SENT_415	[p19l1074t2227r1868b2292],
15	.	.	O	.	_	0	SENT_415	[p19l1074t2227r1868b2292],

1	—	NN	O	—	_	0	SENT_416	[p19l1074t2227r1868b2292],
2	.	.	O	.	_	0	SENT_416	[p19l1074t2227r1868b2292],

1	S	NN	O	s	_	0	SENT_417	[p19l1074t2227r1868b2292],
2	.	.	O	.	_	0	SENT_417	[p19l1074t2227r1868b2292],

1	—	NN	O	—	_	0	SENT_418	[p19l1074t2227r1868b2292],
2	.	.	O	.	_	0	SENT_418	[p19l1074t2227r1868b2292],

1	transferase	NN	O	transferase	_	0	SENT_419	[p19l1074t2227r1868b2292],
2	.	.	O	.	_	0	SENT_419	[p19l1074t2227r1868b2292],

1	—	NN	O	—	_	0	SENT_420	[p19l1074t2227r1868b2292],
2	.	.	O	.	_	0	SENT_420	[p19l1074t2227r1868b2292],

1	pi	NN	O	pi	nsubj	2	SENT_421	[p19l1074t2227r1868b2292],
2	produces	VBZ	O	produce	_	0	SENT_421	[p19l1891t2227r2146b2292],
3	broad	JJ	O	broad	amod	8	SENT_421	[p19l148t2297r492b2362],
4	—	NN	O	—	nn	8	SENT_421	[p19l148t2297r492b2362],
5	range	NN	O	range	nn	8	SENT_421	[p19l148t2297r492b2362],
6	multidrug	JJ	O	multidrug	amod	8	SENT_421	[p19l518t2297r1117b2361],
7	—	NN	O	—	nn	8	SENT_421	[p19l518t2297r1117b2361],
8	resistance	NN	O	resistance	dobj	2	SENT_421	[p19l518t2297r1117b2361],
9	.	.	O	.	_	0	SENT_421	[p19l518t2297r1117b2361],

1	Cancer	NNP	O	Cancer	nn	3	SENT_422	[p19l1147t2298r1348b2347],
2	Res	NNP	O	Res	nn	3	SENT_422	[p19l1373t2298r1476b2347],
3	l995	NN	O	l995	_	0	SENT_422	[p19l1510t2297r1993b2356],
4	;	:	O	;	_	0	SENT_422	[p19l1510t2297r1993b2356],
5	55:4073	CD	NUMBER	55:4073	number	6	SENT_422	[p19l1510t2297r1993b2356],
6	—	CD	NUMBER	—	dep	3	SENT_422	[p19l1510t2297r1993b2356],
7	8	CD	NUMBER	8	dep	6	SENT_422	[p19l1510t2297r1993b2356],
8	.	.	O	.	_	0	SENT_422	[p19l1510t2297r1993b2356],

1	Niitsu	FW	MISC	niitsu	_	0	SENT_423	[p19l149t2367r322b2416],
2	Y	NN	O	y	dep	1	SENT_423	[p19l348t2368r412b2425],
3	,	,	O	,	_	0	SENT_423	[p19l348t2368r412b2425],
4	Takahashi	NNP	PERSON	Takahashi	nn	5	SENT_423	[p19l440t2367r731b2416],
5	Y	NN	PERSON	y	appos	2	SENT_423	[p19l758t2368r822b2426],
6	,	,	O	,	_	0	SENT_423	[p19l758t2368r822b2426],
7	Ban	NN	ORGANIZATION	ban	nn	8	SENT_423	[p19l850t2368r964b2416],
8	N	NN	ORGANIZATION	n	appos	2	SENT_423	[p19l988t2368r1054b2426],
9	,	,	O	,	_	0	SENT_423	[p19l988t2368r1054b2426],
10	Takayama	NNP	PERSON	Takayama	nn	11	SENT_423	[p19l1082t2367r1379b2431],
11	T	NN	O	t	appos	2	SENT_423	[p19l1403t2368r1460b2426],
12	,	,	O	,	_	0	SENT_423	[p19l1403t2368r1460b2426],
13	Saito	NNP	ORGANIZATION	Saito	nn	14	SENT_423	[p19l1490t2367r1632b2417],
14	T	NN	ORGANIZATION	t	appos	2	SENT_423	[p19l1658t2368r1715b2426],
15	,	,	O	,	_	0	SENT_423	[p19l1658t2368r1715b2426],
16	Katahira	NNP	ORGANIZATION	Katahira	nn	17	SENT_423	[p19l1744t2367r1988b2416],
17	T	NN	ORGANIZATION	t	appos	2	SENT_423	[p19l2013t2368r2070b2426],
18	,	,	O	,	_	0	SENT_423	[p19l2013t2368r2070b2426],
19	et	FW	O	et	nn	20	SENT_423	[p19l2098t2374r2148b2416],
20	al.	FW	O	al.	appos	2	SENT_423	[p19l150t2437r213b2487],
21	.	.	O	.	_	0	SENT_423	[p19l150t2437r213b2487],

1	A	DT	O	a	det	2	SENT_424	[p19l234t2438r284b2486],
2	proof	NN	O	proof	nsubj	11	SENT_424	[p19l301t2437r459b2502],
3	of	IN	O	of	_	0	SENT_424	[p19l473t2437r534b2487],
4	glutathione	NN	O	glutathione	nn	5	SENT_424	[p19l548t2437r866b2502],
5	S	NN	O	s	prep_of	2	SENT_424	[p19l886t2437r1553b2502],
6	—	CD	NUMBER	—	num	5	SENT_424	[p19l886t2437r1553b2502],
7	transferase	NN	O	transferase	nn	10	SENT_424	[p19l886t2437r1553b2502],
8	—	CD	NUMBER	—	num	10	SENT_424	[p19l886t2437r1553b2502],
9	pi	NN	O	pi	nn	10	SENT_424	[p19l886t2437r1553b2502],
10	—	NN	O	—	dep	2	SENT_424	[p19l886t2437r1553b2502],
11	related	JJ	O	related	_	0	SENT_424	[p19l886t2437r1553b2502],
12	multidrug	JJ	O	multidrug	amod	13	SENT_424	[p19l1570t2437r1849b2502],
13	resistance	NN	O	resistance	dobj	11	SENT_424	[p19l1867t2437r2147b2487],
14	by	IN	O	by	_	0	SENT_424	[p19l148t2507r218b2571],
15	transfer	NN	O	transfer	prep_by	13	SENT_424	[p19l245t2507r463b2557],
16	of	IN	O	of	_	0	SENT_424	[p19l489t2507r550b2557],
17	antisense	JJ	O	antisense	amod	18	SENT_424	[p19l573t2507r831b2557],
18	gene	NN	O	gene	prep_of	15	SENT_424	[p19l859t2523r991b2572],
19	to	TO	O	to	_	0	SENT_424	[p19l1017t2515r1070b2557],
20	cancer	NN	O	cancer	nn	21	SENT_424	[p19l1098t2523r1283b2557],
21	cells	NNS	O	cell	prep_to	11	SENT_424	[p19l1309t2507r1436b2557],
22	and	CC	O	and	_	0	SENT_424	[p19l1465t2507r1566b2557],
23	sense	NN	O	sense	nn	24	SENT_424	[p19l1594t2523r1744b2557],
24	gene	NN	O	gene	conj_and	21	SENT_424	[p19l1772t2523r1903b2572],
25	to	TO	O	to	_	0	SENT_424	[p19l1930t2515r1983b2557],
26	bone	NN	O	bone	nn	29	SENT_424	[p19l2009t2507r2147b2557],
27	marrow	NN	O	marrow	nn	29	SENT_424	[p19l149t2594r368b2628],
28	stem	NN	O	stem	nn	29	SENT_424	[p19l397t2585r529b2628],
29	cell	NN	O	cell	prep_to	11	SENT_424	[p19l554t2578r669b2628],
30	.	.	O	.	_	0	SENT_424	[p19l554t2578r669b2628],

1	Chem	NNP	ORGANIZATION	Chem	nn	4	SENT_425	[p19l699t2578r868b2628],
2	Biol	NNP	O	Biol	nn	4	SENT_425	[p19l893t2578r1013b2628],
3	Interact	NNP	O	Interact	nn	4	SENT_425	[p19l1040t2579r1257b2628],
4	l998	NN	O	l998	_	0	SENT_425	[p19l1288t2578r1636b2637],
5	;	:	O	;	_	0	SENT_425	[p19l1288t2578r1636b2637],
6	lll	NN	O	lll	nn	7	SENT_425	[p19l1288t2578r1636b2637],
7	—	NN	O	—	dep	4	SENT_425	[p19l1288t2578r1636b2637],
8	2	CD	NUMBER	2	dep	4	SENT_425	[p19l1288t2578r1636b2637],
9	,	,	O	,	_	0	SENT_425	[p19l1288t2578r1636b2637],
10	325-32	CD	NUMBER	325-32	appos	4	SENT_425	[p19l1666t2578r1891b2628],
11	.	.	O	.	_	0	SENT_425	[p19l1666t2578r1891b2628],

1	Redmond	NNP	PERSON	Redmond	nn	2	SENT_426	[p19l149t2648r426b2698],
2	A	NNP	O	A	_	0	SENT_426	[p19l459t2649r525b2707],
3	,	,	O	,	_	0	SENT_426	[p19l459t2649r525b2707],
4	Moran	NNP	PERSON	Moran	nn	5	SENT_426	[p19l562t2650r751b2698],
5	E	NNP	O	E	appos	2	SENT_426	[p19l785t2650r842b2707],
6	,	,	O	,	_	0	SENT_426	[p19l785t2650r842b2707],
7	Clynes	NNP	O	Clynes	nn	8	SENT_426	[p19l880t2648r1074b2713],
8	M	NNP	O	M	appos	2	SENT_426	[p19l1110t2650r1188b2707],
9	,	,	O	,	_	0	SENT_426	[p19l1110t2650r1188b2707],
10	Multiple	JJ	O	multiple	amod	13	SENT_426	[p19l1225t2648r1623b2713],
11	—	NN	O	—	nn	13	SENT_426	[p19l1225t2648r1623b2713],
12	drug	NN	O	drug	nn	13	SENT_426	[p19l1225t2648r1623b2713],
13	resistance	NN	O	resistance	appos	2	SENT_426	[p19l1658t2648r1938b2698],
14	in	IN	O	in	_	0	SENT_426	[p19l1973t2648r2028b2697],
15	the	DT	O	the	det	21	SENT_426	[p19l2062t2648r2147b2698],
16	human	JJ	O	human	amod	21	SENT_426	[p19l148t2719r342b2769],
17	ovarian-carcinoma	NN	O	ovarian-carcinoma	nn	21	SENT_426	[p19l361t2719r895b2769],
18	cell	NN	O	cell	nn	21	SENT_426	[p19l913t2719r1145b2769],
19	—	NN	O	—	nn	21	SENT_426	[p19l913t2719r1145b2769],
20	1ine	NN	O	1ine	nn	21	SENT_426	[p19l913t2719r1145b2769],
21	Oaw42-a	NN	O	oaw42-a	prep_in	13	SENT_426	[p19l1165t2720r1438b2770],
22	.	.	O	.	_	0	SENT_426	[p19l1165t2720r1438b2770],

1	Eur	NNP	O	Eur	nn	4	SENT_427	[p19l1460t2720r1563b2769],
2	J	NNP	O	J	nn	4	SENT_427	[p19l1580t2720r1606b2770],
3	Cancer	NNP	O	Cancer	nn	4	SENT_427	[p19l1626t2720r1826b2770],
4	l993	NN	O	l993	_	0	SENT_427	[p19l1851t2720r2143b2778],
5	;	:	O	;	_	0	SENT_427	[p19l1851t2720r2143b2778],
6	29A	NN	O	29a	dep	4	SENT_427	[p19l1851t2720r2143b2778],
7	:	:	O	:	_	0	SENT_427	[p19l1851t2720r2143b2778],
8	1078-81	CD	NUMBER	1078-81	dep	6	SENT_427	[p19l156t2789r428b2839],
9	.	.	O	.	_	0	SENT_427	[p19l156t2789r428b2839],

1	Sieuwerts	NNP	ORGANIZATION	Sieuwerts	nn	2	SENT_428	[p19l151t2859r427b2909],
2	AM	NNP	ORGANIZATION	AM	_	0	SENT_428	[p19l452t2860r581b2918],
3	,	,	O	,	_	0	SENT_428	[p19l452t2860r581b2918],
4	Klijn	NNP	PERSON	Klijn	nn	6	SENT_428	[p19l608t2859r752b2924],
5	J	NNP	PERSON	J	nn	6	SENT_428	[p19l775t2861r801b2909],
6	GM	NNP	PERSON	GM	appos	2	SENT_428	[p19l804t2860r931b2918],
7	,	,	O	,	_	0	SENT_428	[p19l804t2860r931b2918],
8	Peters	NNP	ORGANIZATION	Peters	nn	9	SENT_428	[p19l957t2861r1128b2909],
9	HA	NNP	ORGANIZATION	HA	appos	2	SENT_428	[p19l1153t2860r1269b2918],
10	,	,	O	,	_	0	SENT_428	[p19l1153t2860r1269b2918],
11	Foekens	NNP	O	Foekens	nn	12	SENT_428	[p19l1295t2859r1530b2909],
12	JA	NNP	O	JA	appos	2	SENT_428	[p19l1555t2860r1647b2909],
13	.	.	O	.	_	0	SENT_428	[p19l1555t2860r1647b2909],

1	The	DT	O	the	det	4	SENT_429	[p19l1674t2859r1783b2909],
2	Mtt	NNP	O	Mtt	nn	4	SENT_429	[p19l1806t2861r1909b2909],
3	tetrazo	NN	O	tetrazo	nn	4	SENT_429	[p19l1931t2867r2146b2909],
4	—	NN	O	—	nsubj	8	SENT_429	[p19l1931t2867r2146b2909],
5	lium	NN	O	lium	nn	7	SENT_429	[p19l149t2929r279b2979],
6	salt	NN	O	salt	nn	7	SENT_429	[p19l300t2929r396b2979],
7	assay	NN	O	assay	dep	4	SENT_429	[p19l416t2945r568b2993],
8	scrutinized	VBD	O	scrutinize	_	0	SENT_429	[p19l590t2929r1101b2979],
9	—	CD	NUMBER	—	dobj	8	SENT_429	[p19l590t2929r1101b2979],
10	how	WRB	O	how	advmod	12	SENT_429	[p19l590t2929r1101b2979],
11	to	TO	O	to	aux	12	SENT_429	[p19l1121t2936r1174b2979],
12	use	VB	O	use	xcomp	8	SENT_429	[p19l1194t2945r1288b2979],
13	this	DT	O	this	det	14	SENT_429	[p19l1308t2929r1408b2979],
14	assay	NN	O	assay	dobj	12	SENT_429	[p19l1431t2945r1581b2994],
15	reliably	RB	O	reliably	advmod	12	SENT_429	[p19l1601t2929r1818b2993],
16	to	TO	O	to	aux	17	SENT_429	[p19l1838t2936r1891b2979],
17	measure	VB	O	measure	xcomp	12	SENT_429	[p19l1911t2945r2147b2979],
18	metabolic-activity	NN	O	metabolic-activity	dobj	17	SENT_429	[p19l149t2999r666b3063],
19	of	IN	O	of	_	0	SENT_429	[p19l713t2999r775b3048],
20	cell-cultures	NNS	O	cell-culture	prep_of	18	SENT_429	[p19l817t2999r1165b3048],
21	in-vitro	FW	O	in-vitro	advmod	18	SENT_429	[p19l1212t2999r1424b3048],
22	for	IN	O	for	_	0	SENT_429	[p19l1471t2999r1553b3048],
23	the	DT	O	the	det	24	SENT_429	[p19l1598t2999r1683b3048],
24	assessment	NN	O	assessment	prep_for	21	SENT_429	[p19l1730t3006r2045b3048],
25	of	IN	O	of	_	0	SENT_429	[p19l2091t2999r2152b3048],
26	growth	NN	O	growth	prep_of	24	SENT_429	[p19l150t3069r797b3134],
27	—	CD	NUMBER	—	num	28	SENT_429	[p19l150t3069r797b3134],
28	characteristics	NNS	O	characteristic	dep	18	SENT_429	[p19l150t3069r797b3134],
29	,	,	O	,	_	0	SENT_429	[p19l150t3069r797b3134],
30	Ic50	NN	O	ic50	nn	32	SENT_429	[p19l818t3069r1147b3119],
31	—	NN	O	—	nn	32	SENT_429	[p19l818t3069r1147b3119],
32	values	NNS	O	value	conj_and	28	SENT_429	[p19l818t3069r1147b3119],
33	and	CC	O	and	_	0	SENT_429	[p19l1168t3069r1269b3119],
34	cell	NN	O	cell	nn	36	SENT_429	[p19l1286t3069r1655b3119],
35	—	NN	O	—	nn	36	SENT_429	[p19l1286t3069r1655b3119],
36	survival	NN	O	survival	conj_and	28	SENT_429	[p19l1286t3069r1655b3119],
37	.	.	O	.	_	0	SENT_429	[p19l1286t3069r1655b3119],

1	Eur	NNP	ORGANIZATION	Eur	nn	7	SENT_430	[p19l1676t3071r1779b3119],
2	J	NNP	ORGANIZATION	J	nn	7	SENT_430	[p19l1795t3071r1822b3119],
3	Clin	NNP	ORGANIZATION	Clin	nn	7	SENT_430	[p19l1840t3069r1961b3119],
4	Chem	NNP	ORGANIZATION	Chem	nn	7	SENT_430	[p19l1979t3069r2149b3119],
5	Clin	NNP	O	Clin	nn	7	SENT_430	[p19l150t3140r270b3191],
6	Biochem	NNP	O	Biochem	nn	7	SENT_430	[p19l296t3140r553b3190],
7	l995	NN	O	l995	_	0	SENT_430	[p19l584t3140r1058b3199],
8	;	:	O	;	_	0	SENT_430	[p19l584t3140r1058b3199],
9	33:8	CD	NUMBER	33:8	num	10	SENT_430	[p19l584t3140r1058b3199],
10	l3	NN	O	l3	dep	7	SENT_430	[p19l584t3140r1058b3199],
11	—	CD	NUMBER	—	number	12	SENT_430	[p19l584t3140r1058b3199],
12	23	CD	NUMBER	23	dep	10	SENT_430	[p19l584t3140r1058b3199],
13	.	.	O	.	_	0	SENT_430	[p19l584t3140r1058b3199],

1	Lee	NNP	PERSON	Lee	nn	2	SENT_431	[p19l149t3212r254b3261],
2	JS	NNP	O	JS	_	0	SENT_431	[p19l287t3211r368b3270],
3	,	,	O	,	_	0	SENT_431	[p19l287t3211r368b3270],
4	Paull	NNP	PERSON	Paull	nn	5	SENT_431	[p19l403t3211r548b3261],
5	K	NNP	PERSON	K	appos	2	SENT_431	[p19l582t3212r646b3270],
6	,	,	O	,	_	0	SENT_431	[p19l582t3212r646b3270],
7	Alvarez	NNP	PERSON	Alvarez	nn	8	SENT_431	[p19l682t3211r905b3261],
8	M	NN	O	m	appos	5	SENT_431	[p19l939t3212r1016b3270],
9	,	,	O	,	_	0	SENT_431	[p19l939t3212r1016b3270],
10	Hose	NN	O	hose	nn	11	SENT_431	[p19l1051t3212r1196b3261],
11	C	NN	O	c	appos	5	SENT_431	[p19l1230t3211r1290b3270],
12	,	,	O	,	_	0	SENT_431	[p19l1230t3211r1290b3270],
13	Monks	NNPS	MISC	Monks	nn	14	SENT_431	[p19l1325t3211r1521b3261],
14	A	NNP	O	A	appos	5	SENT_431	[p19l1555t3211r1620b3270],
15	,	,	O	,	_	0	SENT_431	[p19l1555t3211r1620b3270],
16	Grever	NNP	O	Grever	nn	17	SENT_431	[p19l1657t3211r1853b3261],
17	M	NNP	O	M	appos	5	SENT_431	[p19l1884t3212r1961b3270],
18	,	,	O	,	_	0	SENT_431	[p19l1884t3212r1961b3270],
19	et	FW	O	et	nn	20	SENT_431	[p19l1998t3218r2048b3261],
20	al.	FW	O	al.	appos	5	SENT_431	[p19l2081t3211r2144b3261],
21	.	.	O	.	_	0	SENT_431	[p19l2081t3211r2144b3261],

1	Rhodamine	NN	O	rhodamine	nn	3	SENT_432	[p19l149t3281r476b3331],
2	efﬂux	NN	O	efﬂux	nn	3	SENT_432	[p19l512t3281r676b3331],
3	patterns	NNS	O	pattern	nsubj	4	SENT_432	[p19l710t3289r933b3346],
4	predict	VBP	O	predict	_	0	SENT_432	[p19l969t3281r1168b3346],
5	P	NN	O	p	nsubj	8	SENT_432	[p19l1201t3281r1624b3346],
6	—	CD	NUMBER	—	num	8	SENT_432	[p19l1201t3281r1624b3346],
7	glycoprotein	NN	O	glycoprotein	nn	8	SENT_432	[p19l1201t3281r1624b3346],
8	substrates	NNS	O	substrate	xcomp	4	SENT_432	[p19l1661t3281r1937b3331],
9	in	IN	O	in	_	0	SENT_432	[p19l1973t3281r2028b3330],
10	the	DT	O	the	det	15	SENT_432	[p19l2062t3281r2147b3331],
11	National	NNP	ORGANIZATION	National	nn	15	SENT_432	[p19l149t3351r393b3401],
12	Cancer	NNP	ORGANIZATION	Cancer	nn	15	SENT_432	[p19l419t3352r620b3401],
13	Institute	NNP	ORGANIZATION	Institute	nn	15	SENT_432	[p19l644t3351r876b3401],
14	drug	NN	O	drug	nn	15	SENT_432	[p19l903t3351r1030b3416],
15	screen	NN	O	screen	prep_in	8	SENT_432	[p19l1059t3367r1251b3401],
16	.	.	O	.	_	0	SENT_432	[p19l1059t3367r1251b3401],

1	Mol	NNP	ORGANIZATION	Mol	nn	2	SENT_433	[p19l1280t3351r1398b3401],
2	Pharmacol	NNP	O	Pharmacol	_	0	SENT_433	[p19l1423t3351r1727b3401],
3	1994	CD	DATE	1994	num	2	SENT_433	[p19l1759t3351r2149b3410, p19l151t3421r233b3471],
4	;	:	O	;	_	0	SENT_433	[p19l1759t3351r2149b3410, p19l151t3421r233b3471],
5	46:62738	CD	NUMBER	46:62738	dep	2	SENT_433	[p19l1759t3351r2149b3410, p19l151t3421r233b3471],
6	.	.	O	.	_	0	SENT_433	[p19l1759t3351r2149b3410, p19l151t3421r233b3471],

1	Habig	NNP	PERSON	Habig	nn	2	SENT_434	[p19l149t3491r321b3556],
2	WH	NNP	PERSON	WH	_	0	SENT_434	[p19l341t3493r474b3550],
3	,	,	O	,	_	0	SENT_434	[p19l341t3493r474b3550],
4	Pabst	NNP	ORGANIZATION	Pabst	nn	5	SENT_434	[p19l496t3491r651b3541],
5	MJ	NNP	ORGANIZATION	MJ	appos	2	SENT_434	[p19l669t3493r774b3550],
6	,	,	O	,	_	0	SENT_434	[p19l669t3493r774b3550],
7	J	NNP	O	J	appos	2	SENT_434	[p19l796t3493r823b3541],
8	akoby	IN	O	akoby	_	0	SENT_434	[p19l826t3491r997b3556],
9	WB	NNP	O	WB	prep_akoby	7	SENT_434	[p19l1016t3493r1145b3541],
10	.	.	O	.	_	0	SENT_434	[p19l1016t3493r1145b3541],

1	Glutathione	NN	O	glutathione	nn	2	SENT_435	[p19l1169t3491r1503b3541],
2	S	NN	O	s	_	0	SENT_435	[p19l1526t3491r1910b3550],
3	—	CD	NUMBER	—	num	4	SENT_435	[p19l1526t3491r1910b3550],
4	transferase	NN	O	transferase	dep	2	SENT_435	[p19l1526t3491r1910b3550],
5	,	,	O	,	_	0	SENT_435	[p19l1526t3491r1910b3550],
6	the	DT	O	the	det	9	SENT_435	[p19l1932t3491r2018b3541],
7	ﬁrst	JJ	O	ﬁrst	amod	9	SENT_435	[p19l2039t3491r2149b3541],
8	enzymatic	JJ	O	enzymatic	amod	9	SENT_435	[p19l150t3561r440b3625],
9	step	NN	O	step	appos	4	SENT_435	[p19l463t3568r573b3625],
10	in	IN	O	in	_	0	SENT_435	[p19l594t3561r648b3610],
11	mercapturic	JJ	O	mercapturic	amod	13	SENT_435	[p19l668t3561r1006b3625],
12	acid	NN	O	acid	nn	13	SENT_435	[p19l1029t3561r1146b3611],
13	formation	NN	O	formation	prep_in	9	SENT_435	[p19l1165t3561r1459b3611],
14	.	.	O	.	_	0	SENT_435	[p19l1165t3561r1459b3611],

1	J	NNP	O	J	nn	3	SENT_436	[p19l1482t3562r1509b3611],
2	Biol	NNP	O	Biol	nn	3	SENT_436	[p19l1529t3561r1650b3611],
3	Chem	NNP	O	Chem	_	0	SENT_436	[p19l1671t3561r1840b3611],
4	1974	CD	DATE	1974	num	3	SENT_436	[p19l1866t3562r2142b3620],
5	;	:	O	;	_	0	SENT_436	[p19l1866t3562r2142b3620],
6	249	CD	NUMBER	249	dep	3	SENT_436	[p19l1866t3562r2142b3620],
7	:	:	O	:	_	0	SENT_436	[p19l1866t3562r2142b3620],
8	7	CD	NUMBER	7	number	9	SENT_436	[p19l149t3632r181b3680],
9	130-9	CD	NUMBER	130-9	dep	6	SENT_436	[p19l192t3631r384b3681],
10	.	.	O	.	_	0	SENT_436	[p19l192t3631r384b3681],

1	Gerrnann	NNP	ORGANIZATION	Gerrnann	nn	2	SENT_437	[p19l150t3702r413b3751],
2	UA	NNP	ORGANIZATION	UA	_	0	SENT_437	[p19l441t3702r558b3760],
3	,	,	O	,	_	0	SENT_437	[p19l441t3702r558b3760],
4	Gottesman	NNP	PERSON	Gottesman	nn	5	SENT_437	[p19l591t3702r897b3751],
5	MM	NN	O	mm	appos	2	SENT_437	[p19l925t3703r1066b3760],
6	,	,	O	,	_	0	SENT_437	[p19l925t3703r1066b3760],
7	Pastan	NNP	PERSON	Pastan	appos	5	SENT_437	[p19l1097t3703r1282b3751],
8	1	CD	NUMBER	1	num	7	SENT_437	[p19l1310t3703r1346b3751],
9	.	.	O	.	_	0	SENT_437	[p19l1310t3703r1346b3751],

1	Expression	NN	O	expression	_	0	SENT_438	[p19l1378t3701r1695b3766],
2	of	IN	O	of	_	0	SENT_438	[p19l1724t3701r1785b3751],
3	a	DT	O	a	det	10	SENT_438	[p19l1811t3717r1840b3751],
4	multidrug	JJ	O	multidrug	amod	10	SENT_438	[p19l1868t3701r2147b3766],
5	resistance	NN	O	resistance	nn	10	SENT_438	[p20l148t9r738b59],
6	—	NN	O	—	nn	10	SENT_438	[p20l148t9r738b59],
7	adenosine	NN	O	adenosine	nn	10	SENT_438	[p20l148t9r738b59],
8	deaminase	NN	O	deaminase	nn	10	SENT_438	[p20l764t9r1063b59],
9	fusion	NN	O	fusion	nn	10	SENT_438	[p20l1089t9r1266b59],
10	gene	NN	O	gene	prep_of	1	SENT_438	[p20l1292t25r1438b74],
11	.	.	O	.	_	0	SENT_438	[p20l1292t25r1438b74],

1	J	NNP	O	J	nn	3	SENT_439	[p20l1467t10r1493b59],
2	Biol	NNP	O	Biol	nn	3	SENT_439	[p20l1519t9r1640b59],
3	Chem	NNP	O	Chem	_	0	SENT_439	[p20l1666t9r1835b59],
4	1989	CD	DATE	1989	num	3	SENT_439	[p20l1867t9r2142b68],
5	;	:	O	;	_	0	SENT_439	[p20l1867t9r2142b68],
6	264	CD	NUMBER	264	num	8	SENT_439	[p20l1867t9r2142b68],
7	:	:	O	:	_	0	SENT_439	[p20l1867t9r2142b68],
8	7418-24	CD	NUMBER	7418-24	dep	3	SENT_439	[p20l149t79r420b129],
9	.	.	O	.	_	0	SENT_439	[p20l149t79r420b129],

1	Van	NNP	O	Van	nn	3	SENT_440	[p20l149t151r267b199],
2	Iersel	NNP	O	Iersel	nn	3	SENT_440	[p20l295t149r452b199],
3	M	NNP	O	M	_	0	SENT_440	[p20l480t151r557b208],
4	,	,	O	,	_	0	SENT_440	[p20l480t151r557b208],
5	Ploemen	NNP	PERSON	Ploemen	nn	6	SENT_440	[p20l589t149r837b199],
6	J	NNP	PERSON	J	appos	3	SENT_440	[p20l865t151r907b208],
7	,	,	O	,	_	0	SENT_440	[p20l865t151r907b208],
8	Struik	NNP	PERSON	Struik	appos	3	SENT_440	[p20l940t149r1113b199],
9	I	PRP	O	I	dep	8	SENT_440	[p20l1140t151r1177b208],
10	,	,	O	,	_	0	SENT_440	[p20l1140t151r1177b208],
11	Van	NNP	LOCATION	Van	nn	13	SENT_440	[p20l1208t151r1326b199],
12	Amersfoort	NNP	LOCATION	Amersfoort	nn	13	SENT_440	[p20l1354t149r1683b199],
13	C	NNP	O	C	appos	3	SENT_440	[p20l1711t150r1772b208],
14	,	,	O	,	_	0	SENT_440	[p20l1711t150r1772b208],
15	Keyzer	NNP	ORGANIZATION	Keyzer	nn	16	SENT_440	[p20l1804t151r2009b214],
16	AE	NNP	ORGANIZATION	AE	appos	3	SENT_440	[p20l2036t150r2145b208],
17	,	,	O	,	_	0	SENT_440	[p20l2036t150r2145b208],
18	Schefferlie	NNP	O	Schefferlie	nn	19	SENT_440	[p20l151t219r460b269],
19	JG	NNP	O	JG	appos	3	SENT_440	[p20l480t220r573b278],
20	,	,	O	,	_	0	SENT_440	[p20l480t220r573b278],
21	et	FW	O	et	nn	22	SENT_440	[p20l596t226r647b269],
22	al.	FW	O	al.	appos	3	SENT_440	[p20l667t219r729b269],
23	.	.	O	.	_	0	SENT_440	[p20l667t219r729b269],

1	Inhibition	NN	O	inhibition	_	0	SENT_441	[p20l753t219r1033b269],
2	of	IN	O	of	_	0	SENT_441	[p20l1054t219r1115b269],
3	glutathione	NN	O	glutathione	nn	5	SENT_441	[p20l1132t219r1450b284],
4	S-transferase	NN	MISC	s-transferase	nn	5	SENT_441	[p20l1472t219r1841b269],
5	activity	NN	O	activity	prep_of	1	SENT_441	[p20l1863t219r2073b284],
6	in	IN	O	in	_	0	SENT_441	[p20l2094t219r2148b268],
7	human	JJ	O	human	amod	9	SENT_441	[p20l148t289r342b338],
8	melanoma	NN	O	melanoma	nn	9	SENT_441	[p20l379t289r675b338],
9	cells	NNS	O	cell	prep_in	5	SENT_441	[p20l711t289r838b338],
10	by	IN	O	by	_	0	SENT_441	[p20l876t289r946b353],
11	alpha,beta-unsaturated	JJ	O	alpha,beta-unsaturated	amod	13	SENT_441	[p20l984t289r1626b353],
12	carbonyl	NN	O	carbonyl	nn	13	SENT_441	[p20l1663t289r1910b353],
13	derivatives	NNS	O	derivative	prep_by	1	SENT_441	[p20l1948t289r2145b338, p20l149t359r296b409],
14	.	.	O	.	_	0	SENT_441	[p20l1948t289r2145b338, p20l149t359r296b409],

1	Effects	NNS	O	effect	_	0	SENT_442	[p20l340t359r539b409],
2	of	IN	O	of	_	0	SENT_442	[p20l581t359r643b409],
3	acrolein	NN	O	acrolein	nn	14	SENT_442	[p20l680t359r921b418],
4	,	,	O	,	_	0	SENT_442	[p20l680t359r921b418],
5	cinnamaldehyde	NN	O	cinnamaldehyde	dep	14	SENT_442	[p20l965t359r1446b424],
6	,	,	O	,	_	0	SENT_442	[p20l965t359r1446b424],
7	citral	NN	O	citral	dep	14	SENT_442	[p20l1489t359r1648b418],
8	,	,	O	,	_	0	SENT_442	[p20l1489t359r1648b418],
9	crotonaldehyde	NN	O	crotonaldehyde	dep	14	SENT_442	[p20l1691t359r2145b424],
10	,	,	O	,	_	0	SENT_442	[p20l1691t359r2145b424],
11	curcumin	NN	O	curcumin	dep	14	SENT_442	[p20l150t429r432b488],
12	,	,	O	,	_	0	SENT_442	[p20l150t429r432b488],
13	ethacrynic	JJ	O	ethacrynic	amod	14	SENT_442	[p20l466t429r759b493],
14	acid	NN	O	acid	prep_of	1	SENT_442	[p20l793t429r924b488],
15	,	,	O	,	_	0	SENT_442	[p20l793t429r924b488],
16	and	CC	O	and	_	0	SENT_442	[p20l958t429r1059b479],
17	trans	JJ	O	trans	amod	18	SENT_442	[p20l1089t429r1546b479],
18	—	NN	O	—	prep_of	1	SENT_442	[p20l1089t429r1546b479],
19	2	CD	NUMBER	2	num	21	SENT_442	[p20l1089t429r1546b479],
20	—	NN	O	—	nn	21	SENT_442	[p20l1089t429r1546b479],
21	hexenal	NN	O	hexenal	dep	18	SENT_442	[p20l1089t429r1546b479],
22	.	.	O	.	_	0	SENT_442	[p20l1089t429r1546b479],

1	Chem	NNP	ORGANIZATION	Chem	nn	3	SENT_443	[p20l1581t429r1750b479],
2	Biol	NNP	O	Biol	nn	3	SENT_443	[p20l1779t429r1900b479],
3	Interact	NNP	O	Interact	_	0	SENT_443	[p20l1931t430r2148b479],
4	1996	CD	DATE	1996	num	3	SENT_443	[p20l156t500r665b559],
5	;	:	O	;	_	0	SENT_443	[p20l156t500r665b559],
6	102:117	CD	NUMBER	102:117	number	7	SENT_443	[p20l156t500r665b559],
7	—	CD	NUMBER	—	dep	3	SENT_443	[p20l156t500r665b559],
8	32	CD	NUMBER	32	dep	7	SENT_443	[p20l156t500r665b559],
9	.	.	O	.	_	0	SENT_443	[p20l156t500r665b559],

1	Awasthi	NNP	PERSON	Awasthi	nn	2	SENT_444	[p20l149t570r385b620],
2	S	NNP	O	S	_	0	SENT_444	[p20l414t571r465b629],
3	,	,	O	,	_	0	SENT_444	[p20l414t571r465b629],
4	Pandya	NNP	PERSON	Pandya	nn	5	SENT_444	[p20l494t570r704b635],
5	U	NNP	PERSON	U	appos	2	SENT_444	[p20l729t572r794b629],
6	,	,	O	,	_	0	SENT_444	[p20l729t572r794b629],
7	Singhal	NNP	PERSON	Singhal	nn	8	SENT_444	[p20l825t570r1040b635],
8	SS	NNP	O	SS	appos	5	SENT_444	[p20l1069t571r1160b629],
9	,	,	O	,	_	0	SENT_444	[p20l1069t571r1160b629],
10	Lin	NNP	PERSON	Lin	nn	11	SENT_444	[p20l1189t570r1287b619],
11	JT	NNP	O	JT	appos	5	SENT_444	[p20l1313t572r1398b629],
12	,	,	O	,	_	0	SENT_444	[p20l1313t572r1398b629],
13	Thiviyanathan	NNP	O	Thiviyanathan	nn	14	SENT_444	[p20l1427t570r1838b635],
14	V	NNP	O	V	appos	5	SENT_444	[p20l1865t572r1929b629],
15	,	,	O	,	_	0	SENT_444	[p20l1865t572r1929b629],
16	Seifert	NNP	PERSON	Seifert	nn	17	SENT_444	[p20l1961t570r2149b620],
17	WE	NNP	O	WE	appos	5	SENT_444	[p20l148t641r273b699],
18	,	,	O	,	_	0	SENT_444	[p20l148t641r273b699],
19	et	FW	O	et	nn	20	SENT_444	[p20l304t648r354b690],
20	al.	FW	O	al.	appos	5	SENT_444	[p20l382t640r444b690],
21	.	.	O	.	_	0	SENT_444	[p20l382t640r444b690],

1	Curcumin	NN	O	curcumin	_	0	SENT_445	[p20l477t640r1104b704],
2	—	CD	NUMBER	—	num	4	SENT_445	[p20l477t640r1104b704],
3	glutathione	NN	O	glutathione	nn	4	SENT_445	[p20l477t640r1104b704],
4	interactions	NNS	O	interaction	dep	1	SENT_445	[p20l1132t640r1462b690],
5	and	CC	O	and	_	0	SENT_445	[p20l1493t640r1593b690],
6	the	DT	O	the	det	7	SENT_445	[p20l1620t640r1705b690],
7	role	NN	O	role	conj_and	4	SENT_445	[p20l1732t640r1842b690],
8	of	IN	O	of	_	0	SENT_445	[p20l1870t640r1932b690],
9	human	JJ	O	human	amod	12	SENT_445	[p20l1954t640r2148b690],
10	glutathione	NN	O	glutathione	nn	12	SENT_445	[p20l150t710r468b774],
11	S-transferase	NN	O	s-transferase	nn	12	SENT_445	[p20l496t710r865b760],
12	P1-1	NN	O	p1-1	prep_of	1	SENT_445	[p20l891t710r1038b759],
13	.	.	O	.	_	0	SENT_445	[p20l891t710r1038b759],

1	Chem	NNP	ORGANIZATION	Chem	nn	3	SENT_446	[p20l1068t710r1237b760],
2	Biol	NNP	O	Biol	nn	3	SENT_446	[p20l1262t710r1383b759],
3	Interact	NNP	O	Interact	_	0	SENT_446	[p20l1408t711r1626b759],
4	2000	CD	DATE	2000	num	3	SENT_446	[p20l1651t710r2140b768],
5	;	:	O	;	_	0	SENT_446	[p20l1651t710r2140b768],
6	128:19	CD	NUMBER	128:19	number	7	SENT_446	[p20l1651t710r2140b768],
7	—	CD	NUMBER	—	dep	3	SENT_446	[p20l1651t710r2140b768],
8	38	CD	NUMBER	38	dep	7	SENT_446	[p20l1651t710r2140b768],
9	.	.	O	.	_	0	SENT_446	[p20l1651t710r2140b768],

1	Muller	NNP	PERSON	Muller	nn	2	SENT_447	[p20l148t780r343b830],
2	M	NNP	O	M	_	0	SENT_447	[p20l364t782r441b839],
3	,	,	O	,	_	0	SENT_447	[p20l364t782r441b839],
4	Meijer	NNP	ORGANIZATION	Meijer	nn	5	SENT_447	[p20l467t780r657b845],
5	C	NNP	ORGANIZATION	C	appos	2	SENT_447	[p20l680t781r740b839],
6	,	,	O	,	_	0	SENT_447	[p20l680t781r740b839],
7	Zaman	NNP	PERSON	Zaman	nn	8	SENT_447	[p20l765t782r963b830],
8	GJ	NNP	O	GJ	appos	5	SENT_447	[p20l986t781r1078b839],
9	,	,	O	,	_	0	SENT_447	[p20l986t781r1078b839],
10	Borst	NNP	ORGANIZATION	Borst	nn	11	SENT_447	[p20l1103t782r1258b830],
11	P	NN	ORGANIZATION	p	appos	5	SENT_447	[p20l1279t782r1333b839],
12	,	,	O	,	_	0	SENT_447	[p20l1279t782r1333b839],
13	Scheper	NNP	PERSON	Scheper	nn	14	SENT_447	[p20l1360t780r1588b845],
14	RJ	NN	PERSON	rj	appos	5	SENT_447	[p20l1610t782r1698b839],
15	,	,	O	,	_	0	SENT_447	[p20l1610t782r1698b839],
16	Mulder	NNP	PERSON	Mulder	nn	17	SENT_447	[p20l1723t780r1934b830],
17	NH	NNP	O	NH	appos	5	SENT_447	[p20l1955t782r2072b839],
18	,	,	O	,	_	0	SENT_447	[p20l1955t782r2072b839],
19	et	FW	O	et	nn	20	SENT_447	[p20l2098t788r2149b830],
20	al.	FW	O	al.	appos	5	SENT_447	[p20l150t850r213b900],
21	.	.	O	.	_	0	SENT_447	[p20l150t850r213b900],

1	Overexpression	NN	O	overexpression	nsubj	10	SENT_448	[p20l253t850r698b915],
2	of	IN	O	of	_	0	SENT_448	[p20l734t850r795b900],
3	the	DT	O	the	det	4	SENT_448	[p20l825t850r910b900],
4	gene	NN	O	gene	prep_of	1	SENT_448	[p20l947t866r1078b915],
5	encoding	VBG	O	encode	partmod	4	SENT_448	[p20l1114t850r1373b915],
6	the	DT	O	the	det	9	SENT_448	[p20l1408t850r1493b900],
7	multidrug	JJ	O	multidrug	amod	9	SENT_448	[p20l1529t850r1808b915],
8	resistanceassociated	JJ	O	resistanceassociated	amod	9	SENT_448	[p20l1843t850r2145b900, p20l150t920r441b969],
9	protein	NN	O	protein	dobj	5	SENT_448	[p20l478t920r680b984],
10	results	VBZ	O	result	_	0	SENT_448	[p20l717t920r901b969],
11	in	IN	O	in	_	0	SENT_448	[p20l941t920r995b969],
12	increased	VBN	O	increase	amod	14	SENT_448	[p20l1033t920r1301b969],
13	ATP-dependent	JJ	O	atp-dependent	amod	14	SENT_448	[p20l1339t920r1790b984],
14	glutathione	NN	O	glutathione	prep_in	10	SENT_448	[p20l1829t920r2147b984],
15	S	NN	O	s	nn	18	SENT_448	[p20l151t990r488b1055],
16	—	CD	NUMBER	—	num	18	SENT_448	[p20l151t990r488b1055],
17	conjugate	NN	O	conjugate	nn	18	SENT_448	[p20l151t990r488b1055],
18	transport	NN	O	transport	dep	14	SENT_448	[p20l514t998r780b1055],
19	.	.	O	.	_	0	SENT_448	[p20l514t998r780b1055],

1	Proc	NNP	ORGANIZATION	Proc	nn	5	SENT_449	[p20l809t992r937b1040],
2	Natl	NNP	ORGANIZATION	Natl	nn	5	SENT_449	[p20l964t990r1085b1040],
3	Acad	NNP	ORGANIZATION	Acad	nn	5	SENT_449	[p20l1111t990r1261b1040],
4	Sci	NNP	ORGANIZATION	Sci	nn	5	SENT_449	[p20l1287t990r1374b1040],
5	USA	NNP	ORGANIZATION	USA	_	0	SENT_449	[p20l1400t991r1542b1040],
6	1994	CD	DATE	1994	num	5	SENT_449	[p20l1574t991r2084b1049],
7	;	:	O	;	_	0	SENT_449	[p20l1574t991r2084b1049],
8	91:13033	CD	NUMBER	91:13033	num	9	SENT_449	[p20l1574t991r2084b1049],
9	—	NN	O	—	dep	5	SENT_449	[p20l1574t991r2084b1049],
10	7	CD	NUMBER	7	dep	9	SENT_449	[p20l1574t991r2084b1049],
11	.	.	O	.	_	0	SENT_449	[p20l1574t991r2084b1049],

1	Muller	NNP	PERSON	Muller	nn	2	SENT_450	[p20l149t1062r343b1112],
2	I	NNP	O	I	_	0	SENT_450	[p20l362t1064r399b1121],
3	,	,	O	,	_	0	SENT_450	[p20l362t1064r399b1121],
4	Jenner	NNP	PERSON	Jenner	nn	5	SENT_450	[p20l422t1064r608b1113],
5	A	NNP	O	A	appos	2	SENT_450	[p20l626t1063r692b1121],
6	,	,	O	,	_	0	SENT_450	[p20l626t1063r692b1121],
7	Bruchelt	NNP	O	Bruchelt	nn	8	SENT_450	[p20l714t1062r960b1112],
8	G	NNP	O	G	appos	2	SENT_450	[p20l980t1063r1044b1121],
9	,	,	O	,	_	0	SENT_450	[p20l980t1063r1044b1121],
10	Niethammer	NN	PERSON	niethammer	nn	11	SENT_450	[p20l1066t1062r1423b1113],
11	D	NN	O	d	appos	2	SENT_450	[p20l1442t1064r1507b1121],
12	,	,	O	,	_	0	SENT_450	[p20l1442t1064r1507b1121],
13	Halliwell	NNP	PERSON	Halliwell	nn	15	SENT_450	[p20l1530t1062r1794b1113],
14	B.	NNP	O	B.	nn	15	SENT_450	[p20l1814t1064r1874b1113],
15	Effect	NN	O	effect	appos	2	SENT_450	[p20l1898t1062r2072b1113],
16	of	IN	O	of	_	0	SENT_450	[p20l2092t1062r2153b1113],
17	concentration	NN	O	concentration	prep_of	15	SENT_450	[p20l150t1134r537b1183],
18	on	IN	O	on	_	0	SENT_450	[p20l566t1149r635b1183],
19	the	DT	O	the	det	21	SENT_450	[p20l664t1134r749b1183],
20	cytotoxic	JJ	O	cytotoxic	amod	21	SENT_450	[p20l779t1134r1041b1198],
21	mechanism	NN	O	mechanism	prep_on	17	SENT_450	[p20l1071t1134r1396b1183],
22	of	IN	O	of	_	0	SENT_450	[p20l1425t1133r1487b1183],
23	doxorubicin	NN	O	doxorubicin	nn	25	SENT_450	[p20l1512t1133r2147b1198],
24	—	CD	NUMBER	—	num	25	SENT_450	[p20l1512t1133r2147b1198],
25	apoptosis	NN	O	apoptosis	prep_of	21	SENT_450	[p20l1512t1133r2147b1198],
26	and	CC	O	and	_	0	SENT_450	[p20l151t1204r251b1254],
27	oxidative	JJ	O	oxidative	amod	29	SENT_450	[p20l272t1204r535b1254],
28	DNA	NN	O	dna	nn	29	SENT_450	[p20l555t1205r709b1254],
29	damage	NN	O	damage	prep_of	21	SENT_450	[p20l729t1205r963b1269],
30	.	.	O	.	_	0	SENT_450	[p20l729t1205r963b1269],

1	Biochem	NNP	ORGANIZATION	Biochem	nn	4	SENT_451	[p20l988t1205r1245b1254],
2	Biophys	NNP	ORGANIZATION	Biophys	nn	4	SENT_451	[p20l1264t1205r1499b1269],
3	Res	NNP	ORGANIZATION	Res	nn	4	SENT_451	[p20l1521t1206r1625b1254],
4	Comm	NNP	ORGANIZATION	Comm	_	0	SENT_451	[p20l1648t1205r1841b1254],
5	1997	CD	DATE	1997	num	4	SENT_451	[p20l1867t1205r2143b1263],
6	;	:	O	;	_	0	SENT_451	[p20l1867t1205r2143b1263],
7	230	CD	NUMBER	230	dep	4	SENT_451	[p20l1867t1205r2143b1263],
8	:	:	O	:	_	0	SENT_451	[p20l1867t1205r2143b1263],
9	254	CD	NUMBER	254	number	10	SENT_451	[p20l150t1275r254b1325],
10	-7	CD	NUMBER	-7	dep	7	SENT_451	[p20l264t1276r349b1324],
11	.	.	O	.	_	0	SENT_451	[p20l264t1276r349b1324],

1	Hao	NNP	PERSON	Hao	nn	2	SENT_452	[p20l149t1348r266b1396],
2	XY	NN	O	xy	nsubjpass	30	SENT_452	[p20l296t1348r414b1406],
3	,	,	O	,	_	0	SENT_452	[p20l296t1348r414b1406],
4	Bergh	NNP	PERSON	Bergh	nn	5	SENT_452	[p20l447t1347r620b1411],
5	J	NNP	PERSON	J	appos	2	SENT_452	[p20l650t1348r691b1405],
6	,	,	O	,	_	0	SENT_452	[p20l650t1348r691b1405],
7	Brodin	NNP	PERSON	Brodin	nn	8	SENT_452	[p20l725t1347r922b1396],
8	O	NNP	PERSON	O	appos	2	SENT_452	[p20l953t1347r1017b1406],
9	,	,	O	,	_	0	SENT_452	[p20l953t1347r1017b1406],
10	Hellman	NNP	PERSON	Hellman	nn	11	SENT_452	[p20l1051t1347r1295b1396],
11	U	NNP	PERSON	U	appos	2	SENT_452	[p20l1325t1348r1390b1405],
12	,	,	O	,	_	0	SENT_452	[p20l1325t1348r1390b1405],
13	Mannervik	NNP	PERSON	Mannervik	nn	15	SENT_452	[p20l1423t1347r1737b1396],
14	B.	NNP	PERSON	B.	nn	15	SENT_452	[p20l1766t1348r1826b1396],
15	Acquiredresistance	NNP	PERSON	Acquiredresistance	appos	2	SENT_452	[p20l1860t1347r2146b1411, p20l148t1419r429b1468],
16	to	TO	O	to	_	0	SENT_452	[p20l464t1426r517b1468],
17	cisplatin	NN	O	cisplatin	prep_to	15	SENT_452	[p20l554t1419r794b1483],
18	and	CC	O	and	_	0	SENT_452	[p20l830t1419r931b1468],
19	doxorubicin	NN	O	doxorubicin	prep_to	15	SENT_452	[p20l966t1419r1309b1469],
20	in	IN	O	in	_	0	SENT_452	[p20l1344t1419r1398b1468],
21	a	DT	O	a	det	27	SENT_452	[p20l1434t1435r1464b1468],
22	small	JJ	O	small	amod	27	SENT_452	[p20l1500t1419r1777b1469],
23	—	NN	O	—	nn	27	SENT_452	[p20l1500t1419r1777b1469],
24	cell	NN	O	cell	nn	27	SENT_452	[p20l1500t1419r1777b1469],
25	lung	NN	O	lung	nn	27	SENT_452	[p20l1813t1419r2150b1483],
26	—	NN	O	—	nn	27	SENT_452	[p20l1813t1419r2150b1483],
27	cancer	NN	O	cancer	prep_in	2	SENT_452	[p20l1813t1419r2150b1483],
28	cell-line	JJ	O	cell-line	amod	2	SENT_452	[p20l150t1491r381b1540],
29	is	VBZ	O	be	auxpass	30	SENT_452	[p20l419t1491r463b1540],
30	correlated	VBN	O	correlate	_	0	SENT_452	[p20l503t1491r787b1540],
31	to	TO	O	to	_	0	SENT_452	[p20l824t1499r877b1540],
32	elevated	JJ	O	elevated	amod	33	SENT_452	[p20l916t1491r1152b1541],
33	expression	NN	O	expression	prep_to	30	SENT_452	[p20l1190t1491r1493b1555],
34	of	IN	O	of	_	0	SENT_452	[p20l1532t1491r1594b1540],
35	glutathione-linked	JJ	O	glutathione-linked	amod	37	SENT_452	[p20l1627t1491r2149b1555],
36	detoxiﬁcation	NN	O	detoxiﬁcation	nn	37	SENT_452	[p20l150t1563r540b1613],
37	enzymes	NNS	O	enzyme	prep_of	33	SENT_452	[p20l567t1579r828b1627],
38	.	.	O	.	_	0	SENT_452	[p20l567t1579r828b1627],

1	Carcinogenesis	NN	O	carcinogenesis	nn	2	SENT_453	[p20l858t1563r1290b1627],
2	l994	NN	O	l994	_	0	SENT_453	[p20l1325t1563r1835b1622],
3	;	:	O	;	_	0	SENT_453	[p20l1325t1563r1835b1622],
4	l5	NN	O	l5	dep	2	SENT_453	[p20l1325t1563r1835b1622],
5	:	:	O	:	_	0	SENT_453	[p20l1325t1563r1835b1622],
6	l167	CD	NUMBER	l167	dep	4	SENT_453	[p20l1325t1563r1835b1622],
7	—	CD	NUMBER	—	number	8	SENT_453	[p20l1325t1563r1835b1622],
8	73	CD	NUMBER	73	dep	6	SENT_453	[p20l1325t1563r1835b1622],
9	.	.	O	.	_	0	SENT_453	[p20l1325t1563r1835b1622],

1	Wang	NNP	PERSON	Wang	nn	2	SENT_454	[p20l148t1635r317b1699],
2	K	NNP	PERSON	K	_	0	SENT_454	[p20l355t1635r419b1693],
3	,	,	O	,	_	0	SENT_454	[p20l355t1635r419b1693],
4	Ramji	NNP	PERSON	Ramji	nn	5	SENT_454	[p20l458t1634r630b1698],
5	S	NNP	PERSON	S	appos	2	SENT_454	[p20l669t1635r720b1693],
6	,	,	O	,	_	0	SENT_454	[p20l669t1635r720b1693],
7	Bhathena	NNP	PERSON	Bhathena	nn	8	SENT_454	[p20l759t1634r1028b1684],
8	A	NNP	O	A	appos	2	SENT_454	[p20l1063t1635r1128b1693],
9	,	,	O	,	_	0	SENT_454	[p20l1063t1635r1128b1693],
10	Lee	NNP	PERSON	Lee	nn	11	SENT_454	[p20l1167t1635r1272b1684],
11	C	NNP	O	C	appos	2	SENT_454	[p20l1309t1635r1370b1693],
12	,	,	O	,	_	0	SENT_454	[p20l1309t1635r1370b1693],
13	Riddick	NNP	O	Riddick	nn	14	SENT_454	[p20l1409t1634r1634b1684],
14	DS	NN	O	d	appos	2	SENT_454	[p20l1669t1635r1773b1684],
15	.	.	O	.	_	0	SENT_454	[p20l1669t1635r1773b1684],

1	Glutathione	NN	O	glutathione	nn	2	SENT_455	[p20l1814t1634r2148b1684],
2	S	NN	O	s	_	0	SENT_455	[p20l151t1705r546b1755],
3	—	CD	NUMBER	—	num	4	SENT_455	[p20l151t1705r546b1755],
4	transferases	NNS	O	transferase	dep	2	SENT_455	[p20l151t1705r546b1755],
5	in	IN	O	in	_	0	SENT_455	[p20l576t1705r630b1754],
6	wild	JJ	O	wild	amod	8	SENT_455	[p20l657t1705r929b1769],
7	—	NN	O	—	nn	8	SENT_455	[p20l657t1705r929b1769],
8	type	NN	O	type	prep_in	4	SENT_455	[p20l657t1705r929b1769],
9	and	CC	O	and	_	0	SENT_455	[p20l959t1705r1059b1755],
10	doxorubicin	NN	O	doxorubicin	npadvmod	12	SENT_455	[p20l1087t1705r1693b1755],
11	—	CD	NUMBER	—	num	10	SENT_455	[p20l1087t1705r1693b1755],
12	resistant	JJ	O	resistant	amod	14	SENT_455	[p20l1087t1705r1693b1755],
13	MCF	NN	O	mcf	nn	14	SENT_455	[p20l1719t1706r1926b1755],
14	—	NN	O	—	conj_and	4	SENT_455	[p20l1719t1706r1926b1755],
15	7	CD	NUMBER	7	num	20	SENT_455	[p20l1719t1706r1926b1755],
16	human	JJ	O	human	amod	20	SENT_455	[p20l1955t1705r2149b1755],
17	breast	NN	O	breast	nn	20	SENT_455	[p20l148t1777r319b1827],
18	cancer	NN	O	cancer	nn	20	SENT_455	[p20l344t1793r529b1827],
19	cell	NN	O	cell	nn	20	SENT_455	[p20l555t1777r655b1827],
20	lines	NNS	O	line	dep	14	SENT_455	[p20l681t1777r828b1827],
21	.	.	O	.	_	0	SENT_455	[p20l681t1777r828b1827],

1	Xenobiotica	NNP	O	Xenobiotica	_	0	SENT_456	[p20l857t1777r1206b1827],
2	1999	CD	DATE	1999	num	1	SENT_456	[p20l1237t1777r1711b1836],
3	;	:	O	;	_	0	SENT_456	[p20l1237t1777r1711b1836],
4	29:155	CD	NUMBER	29:155	number	5	SENT_456	[p20l1237t1777r1711b1836],
5	—	CD	NUMBER	—	dep	1	SENT_456	[p20l1237t1777r1711b1836],
6	70	CD	NUMBER	70	dep	5	SENT_456	[p20l1237t1777r1711b1836],
7	.	.	O	.	_	0	SENT_456	[p20l1237t1777r1711b1836],

1	Gaudiano	NNP	O	Gaudiano	nn	2	SENT_457	[p20l150t1848r424b1898],
2	G	NNP	O	G	_	0	SENT_457	[p20l444t1849r508b1907],
3	,	,	O	,	_	0	SENT_457	[p20l444t1849r508b1907],
4	Resing	NNP	O	Resing	nn	5	SENT_457	[p20l528t1848r724b1913],
5	K	NNP	O	K	appos	2	SENT_457	[p20l743t1850r807b1907],
6	,	,	O	,	_	0	SENT_457	[p20l743t1850r807b1907],
7	Koch	NNP	PERSON	Koch	nn	8	SENT_457	[p20l828t1848r981b1898],
8	TH	NN	O	th	appos	5	SENT_457	[p20l998t1850r1105b1898],
9	.	.	O	.	_	0	SENT_457	[p20l998t1850r1105b1898],

1	Reaction	NN	O	reaction	_	0	SENT_458	[p20l1126t1848r1379b1898],
2	of	IN	O	of	_	0	SENT_458	[p20l1397t1848r1459b1898],
3	anthracycline	NN	O	anthracycline	nn	5	SENT_458	[p20l1473t1848r1854b1913],
4	antitumor	NN	O	antitumor	nn	5	SENT_458	[p20l1874t1848r2150b1898],
5	drugs	NNS	O	drug	prep_of	1	SENT_458	[p20l150t1920r304b1984],
6	with	IN	O	with	_	0	SENT_458	[p20l342t1920r468b1969],
7	reduced	VBN	O	reduce	amod	10	SENT_458	[p20l502t1919r728b1969],
8	glutathione	NN	O	glutathione	nn	10	SENT_458	[p20l765t1919r1437b1984],
9	—	NN	O	—	nn	10	SENT_458	[p20l765t1919r1437b1984],
10	formation	NN	O	formation	prep_with	5	SENT_458	[p20l765t1919r1437b1984],
11	of	IN	O	of	_	0	SENT_458	[p20l1473t1919r1535b1969],
12	aglycon	NN	O	aglycon	nn	13	SENT_458	[p20l1568t1920r1791b1984],
13	conjugates	NNS	O	conjugate	prep_of	10	SENT_458	[p20l1827t1920r2145b1984],
14	.	.	O	.	_	0	SENT_458	[p20l1827t1920r2145b1984],

1	J	NNP	O	J	nn	5	SENT_459	[p20l149t1993r175b2042],
2	Amer	NNP	O	Amer	nn	5	SENT_459	[p20l201t1992r363b2042],
3	Chem	NNP	O	Chem	nn	5	SENT_459	[p20l388t1992r557b2042],
4	Soc	NNP	O	Soc	nn	5	SENT_459	[p20l584t1992r686b2042],
5	l994	NN	O	l994	_	0	SENT_459	[p20l720t1991r1273b2050],
6	;	:	O	;	_	0	SENT_459	[p20l720t1991r1273b2050],
7	116:6537	CD	NUMBER	116:6537	number	8	SENT_459	[p20l720t1991r1273b2050],
8	—	CD	NUMBER	—	dep	5	SENT_459	[p20l720t1991r1273b2050],
9	44	CD	NUMBER	44	dep	8	SENT_459	[p20l720t1991r1273b2050],
10	.	.	O	.	_	0	SENT_459	[p20l720t1991r1273b2050],

1	Ogretmen	NN	O	ogretman	nn	2	SENT_460	[p20l151t2063r434b2127],
2	B	NN	O	b	_	0	SENT_460	[p20l464t2064r525b2121],
3	,	,	O	,	_	0	SENT_460	[p20l464t2064r525b2121],
4	Bahadori	NNP	PERSON	Bahadori	nn	5	SENT_460	[p20l558t2062r818b2112],
5	HR	NNP	DURATION	HR	appos	2	SENT_460	[p20l849t2064r962b2121],
6	,	,	O	,	_	0	SENT_460	[p20l849t2064r962b2121],
7	McCauley	NNP	PERSON	McCauley	nn	8	SENT_460	[p20l995t2063r1291b2127],
8	MD	NNP	O	MD	appos	5	SENT_460	[p20l1322t2064r1451b2121],
9	,	,	O	,	_	0	SENT_460	[p20l1322t2064r1451b2121],
10	Boylan	NNP	PERSON	Boylan	nn	11	SENT_460	[p20l1484t2063r1689b2127],
11	A	NNP	O	A	appos	5	SENT_460	[p20l1719t2063r1784b2121],
12	,	,	O	,	_	0	SENT_460	[p20l1719t2063r1784b2121],
13	Green	NNP	PERSON	Green	nn	14	SENT_460	[p20l1819t2063r1991b2112],
14	MR	NN	PERSON	mr	appos	5	SENT_460	[p20l2021t2064r2146b2121],
15	,	,	O	,	_	0	SENT_460	[p20l2021t2064r2146b2121],
16	Safa	NNP	O	Safa	nn	17	SENT_460	[p20l151t2134r275b2184],
17	AR	NNS	O	ar	appos	5	SENT_460	[p20l312t2134r424b2183],
18	.	.	O	.	_	0	SENT_460	[p20l312t2134r424b2183],

1	Co	NNP	O	Co	nsubj	17	SENT_461	[p20l466t2134r841b2184],
2	—	CD	NUMBER	—	num	1	SENT_461	[p20l466t2134r841b2184],
3	ordinated	VBN	O	ordinate	partmod	1	SENT_461	[p20l466t2134r841b2184],
4	over-expression	NN	O	over-expression	dobj	3	SENT_461	[p20l879t2134r1333b2198],
5	of	IN	O	of	_	0	SENT_461	[p20l1372t2134r1433b2183],
6	the	DT	O	the	det	7	SENT_461	[p20l1467t2134r1552b2183],
7	MRP	NN	ORGANIZATION	mrp	prep_of	4	SENT_461	[p20l1589t2135r1739b2183],
8	and	CC	O	and	_	0	SENT_461	[p20l1778t2134r1879b2183],
9	gammaglutamylcysteine	NN	O	gammaglutamylcysteine	nn	11	SENT_461	[p20l1917t2150r2146b2198, p20l150t2206r635b2270],
10	synthetase	NN	O	synthetase	nn	11	SENT_461	[p20l673t2206r966b2270],
11	genes	NNS	O	gene	prep_of	4	SENT_461	[p20l1002t2222r1177b2270],
12	,	,	O	,	_	0	SENT_461	[p20l1002t2222r1177b2270],
13	but	CC	O	but	_	0	SENT_461	[p20l1214t2206r1305b2255],
14	not	RB	O	not	_	0	SENT_461	[p20l1339t2213r1429b2255],
15	MDR1	NN	O	mdr1	conj_negcc	4	SENT_461	[p20l1462t2206r1675b2265],
16	,	,	O	,	_	0	SENT_461	[p20l1462t2206r1675b2265],
17	correlates	VBZ	O	correlate	_	0	SENT_461	[p20l1713t2206r1986b2255],
18	with	IN	O	with	_	0	SENT_461	[p20l2023t2206r2149b2255],
19	doxorubicin	NN	O	doxorubicin	nn	20	SENT_461	[p20l150t2278r493b2327],
20	resistance	NN	O	resistance	prep_with	17	SENT_461	[p20l519t2278r800b2328],
21	in	IN	O	in	_	0	SENT_461	[p20l828t2278r882b2327],
22	human	JJ	O	human	amod	26	SENT_461	[p20l909t2278r1102b2327],
23	malignant	JJ	O	malignant	amod	26	SENT_461	[p20l1130t2278r1415b2342],
24	mesothelioma	NN	O	mesothelioma	nn	26	SENT_461	[p20l1441t2278r1842b2328],
25	cell	NN	O	cell	nn	26	SENT_461	[p20l1869t2278r1969b2327],
26	lines	NNS	O	line	prep_in	20	SENT_461	[p20l1997t2278r2145b2328],
27	.	.	O	.	_	0	SENT_461	[p20l1997t2278r2145b2328],

1	Int	NN	O	int	nn	3	SENT_462	[p20l149t2351r228b2400],
2	J	NN	O	j	nn	3	SENT_462	[p20l252t2351r278b2400],
3	Cancer	NN	O	cancer	_	0	SENT_462	[p20l305t2350r506b2400],
4	1998	CD	DATE	1998	dep	3	SENT_462	[p20l537t2350r1019b2409],
5	;	:	O	;	_	0	SENT_462	[p20l537t2350r1019b2409],
6	75:757	CD	NUMBER	75:757	number	7	SENT_462	[p20l537t2350r1019b2409],
7	—	CD	NUMBER	—	dep	3	SENT_462	[p20l537t2350r1019b2409],
8	6l	NN	O	6l	dep	7	SENT_462	[p20l537t2350r1019b2409],
9	.	.	O	.	_	0	SENT_462	[p20l537t2350r1019b2409],

1	O’Brien	NN	O	o’brien	nn	2	SENT_463	[p20l151t2422r381b2473],
2	M	NN	O	m	_	0	SENT_463	[p20l405t2423r482b2481],
3	,	,	O	,	_	0	SENT_463	[p20l405t2423r482b2481],
4	Kruh	NNP	PERSON	Kruh	nn	5	SENT_463	[p20l509t2422r654b2472],
5	GD	NN	O	gd	appos	2	SENT_463	[p20l678t2422r793b2481],
6	,	,	O	,	_	0	SENT_463	[p20l678t2422r793b2481],
7	Tew	NN	PERSON	tew	nn	8	SENT_463	[p20l819t2423r944b2472],
8	KD	NN	O	kd	appos	5	SENT_463	[p20l969t2423r1084b2472],
9	.	.	O	.	_	0	SENT_463	[p20l969t2423r1084b2472],

1	The	DT	O	the	det	2	SENT_464	[p20l1111t2422r1220b2472],
2	inﬂuence	NN	O	inﬂuence	_	0	SENT_464	[p20l1244t2422r1504b2472],
3	of	IN	O	of	_	0	SENT_464	[p20l1528t2422r1590b2472],
4	coordinate	JJ	O	coordinate	amod	5	SENT_464	[p20l1609t2422r1908b2472],
5	overexpression	NN	O	overexpression	prep_of	2	SENT_464	[p20l1933t2438r2147b2472, p20l148t2493r386b2557],
6	of	IN	O	of	_	0	SENT_464	[p20l410t2493r471b2543],
7	glutathione	NN	O	glutathione	nn	8	SENT_464	[p20l491t2493r809b2558],
8	phase	NN	O	phase	prep_of	5	SENT_464	[p20l832t2493r994b2557],
9	II	CD	NUMBER	ii	num	12	SENT_464	[p20l1018t2494r1063b2542],
10	detoxiﬁcation	NN	O	detoxiﬁcation	nn	12	SENT_464	[p20l1088t2493r1479b2543],
11	gene	NN	O	gene	nn	12	SENT_464	[p20l1502t2509r1634b2558],
12	products	NNS	O	product	dep	2	SENT_464	[p20l1657t2493r1901b2558],
13	on	IN	O	on	_	0	SENT_464	[p20l1927t2509r1996b2543],
14	drug	NN	O	drug	nn	15	SENT_464	[p20l2020t2493r2147b2558],
15	resistance	NN	O	resistance	prep_on	12	SENT_464	[p20l148t2564r443b2614],
16	.	.	O	.	_	0	SENT_464	[p20l148t2564r443b2614],

1	J	NNP	O	J	nn	4	SENT_465	[p20l472t2565r498b2614],
2	Pharmacol	NNP	O	Pharmacol	nn	4	SENT_465	[p20l524t2564r828b2614],
3	Exp	NNP	O	Exp	nn	4	SENT_465	[p20l853t2565r966b2628],
4	Therap	NNP	O	Therap	_	0	SENT_465	[p20l992t2564r1192b2628],
5	2000	CD	DATE	2000	num	4	SENT_465	[p20l1219t2565r1613b2623],
6	;	:	O	;	_	0	SENT_465	[p20l1219t2565r1613b2623],
7	294:480	CD	NUMBER	294:480	number	8	SENT_465	[p20l1219t2565r1613b2623],
8	-7	CD	NUMBER	-7	dep	4	SENT_465	[p20l1623t2565r1708b2614],
9	.	.	O	.	_	0	SENT_465	[p20l1623t2565r1708b2614],

1	Townsend	NNP	PERSON	Townsend	nn	2	SENT_466	[p20l149t2635r446b2685],
2	AJ	NNP	PERSON	AJ	_	0	SENT_466	[p20l479t2636r572b2694],
3	,	,	O	,	_	0	SENT_466	[p20l479t2636r572b2694],
4	Tu	NNP	O	Tu	nn	5	SENT_466	[p20l609t2637r686b2685],
5	CPD	NNP	O	CPD	appos	2	SENT_466	[p20l722t2636r873b2694],
6	,	,	O	,	_	0	SENT_466	[p20l722t2636r873b2694],
7	Cowan	NNP	ORGANIZATION	Cowan	nn	8	SENT_466	[p20l911t2636r1111b2685],
8	KH	NNP	ORGANIZATION	KH	appos	5	SENT_466	[p20l1146t2637r1260b2685],
9	.	.	O	.	_	0	SENT_466	[p20l1146t2637r1260b2685],

1	Expression	NN	O	expression	nsubj	9	SENT_467	[p20l1298t2635r1614b2700],
2	of	IN	O	of	_	0	SENT_467	[p20l1649t2635r1711b2685],
3	human	JJ	O	human	amod	4	SENT_467	[p20l1739t2635r1933b2685],
4	mu	NN	O	mu	prep_of	1	SENT_467	[p20l1967t2651r2056b2685],
5	or	CC	O	or	_	0	SENT_467	[p20l2092t2651r2150b2685],
6	alpha	NN	O	alpha	nn	8	SENT_467	[p20l151t2706r303b2771],
7	class	NN	O	class	nn	8	SENT_467	[p20l340t2706r475b2756],
8	glutathione	NN	O	glutathione	conj_or	4	SENT_467	[p20l515t2706r834b2771],
9	S	NN	O	s	_	0	SENT_467	[p20l874t2706r1269b2756],
10	—	CD	NUMBER	—	num	11	SENT_467	[p20l874t2706r1269b2756],
11	transferases	NNS	O	transferase	dobj	9	SENT_467	[p20l874t2706r1269b2756],
12	in	IN	O	in	_	0	SENT_467	[p20l1308t2706r1362b2755],
13	stably	RB	O	stably	advmod	14	SENT_467	[p20l1402t2706r1568b2771],
14	transfected	VBN	O	transfect	prepc_in	11	SENT_467	[p20l1606t2706r1919b2756],
15	human	JJ	O	human	amod	20	SENT_467	[p20l1955t2706r2149b2756],
16	Mcf	NN	O	mcf	nn	20	SENT_467	[p20l149t2777r323b2827],
17	—	NN	O	—	nn	20	SENT_467	[p20l149t2777r323b2827],
18	7	CD	NUMBER	7	num	20	SENT_467	[p20l149t2777r323b2827],
19	breast	NN	O	breast	nn	20	SENT_467	[p20l351t2778r732b2827],
20	—	NN	O	—	dobj	14	SENT_467	[p20l351t2778r732b2827],
21	cancer	NN	O	cancer	nn	22	SENT_467	[p20l351t2778r732b2827],
22	cells	NNS	O	cell	nsubj	23	SENT_467	[p20l757t2778r958b2827],
23	—	VBP	O	—	rcmod	20	SENT_467	[p20l757t2778r958b2827],
24	effect	NN	O	effect	dobj	23	SENT_467	[p20l968t2777r1129b2827],
25	on	IN	O	on	_	0	SENT_467	[p20l1155t2793r1224b2827],
26	cellular	JJ	O	cellular	amod	28	SENT_467	[p20l1249t2777r1779b2842],
27	—	NN	O	—	nn	28	SENT_467	[p20l1249t2777r1779b2842],
28	sensitivity	NN	O	sensitivity	prep_on	24	SENT_467	[p20l1249t2777r1779b2842],
29	to	TO	O	to	_	0	SENT_467	[p20l1805t2785r1857b2827],
30	cytotoxic	JJ	O	cytotoxic	amod	31	SENT_467	[p20l1885t2778r2147b2842],
31	agents	NNS	O	agent	prep_to	14	SENT_467	[p20l151t2856r344b2913],
32	.	.	O	.	_	0	SENT_467	[p20l151t2856r344b2913],

1	Mol	NNP	ORGANIZATION	Mol	nn	2	SENT_468	[p20l373t2849r491b2898],
2	Pharmacol	NNP	O	Pharmacol	_	0	SENT_468	[p20l516t2849r820b2898],
3	1992	CD	DATE	1992	num	2	SENT_468	[p20l853t2848r1308b2907],
4	;	:	O	;	_	0	SENT_468	[p20l853t2848r1308b2907],
5	41:230	CD	NUMBER	41:230	number	6	SENT_468	[p20l853t2848r1308b2907],
6	—	CD	NUMBER	—	dep	2	SENT_468	[p20l853t2848r1308b2907],
7	6	CD	NUMBER	6	dep	6	SENT_468	[p20l853t2848r1308b2907],
8	.	.	O	.	_	0	SENT_468	[p20l853t2848r1308b2907],

1	Raghu	NNP	PERSON	Raghu	nn	2	SENT_469	[p20l149t2920r334b2984],
2	G	NNP	PERSON	G	_	0	SENT_469	[p20l372t2920r436b2979],
3	,	,	O	,	_	0	SENT_469	[p20l372t2920r436b2979],
4	Pierre	NNP	PERSON	Pierre	appos	2	SENT_469	[p20l476t2920r875b2970],
5	.	.	O	.	_	0	SENT_469	[p20l476t2920r875b2970],

1	—	NN	O	—	_	0	SENT_470	[p20l476t2920r875b2970],
2	.	.	O	.	_	0	SENT_470	[p20l476t2920r875b2970],

1	Jerome	NNP	PERSON	Jerome	nn	2	SENT_471	[p20l476t2920r875b2970],
2	M	NNP	PERSON	M	_	0	SENT_471	[p20l912t2921r990b2978],
3	,	,	O	,	_	0	SENT_471	[p20l912t2921r990b2978],
4	Dordal	NNP	O	Dordal	nn	5	SENT_471	[p20l1029t2920r1226b2969],
5	MS	NN	O	m	appos	2	SENT_471	[p20l1263t2920r1380b2979],
6	,	,	O	,	_	0	SENT_471	[p20l1263t2920r1380b2979],
7	Simonian	NNP	PERSON	Simonian	nn	8	SENT_471	[p20l1422t2920r1692b2970],
8	P	NN	PERSON	p	appos	2	SENT_471	[p20l1730t2921r1783b2978],
9	,	,	O	,	_	0	SENT_471	[p20l1730t2921r1783b2978],
10	Bauer	NNP	PERSON	Bauer	nn	11	SENT_471	[p20l1823t2921r1993b2969],
11	KD	NN	O	kd	appos	2	SENT_471	[p20l2030t2921r2146b2979],
12	,	,	O	,	_	0	SENT_471	[p20l2030t2921r2146b2979],
13	Winter	NNP	DATE	Winter	nn	14	SENT_471	[p20l148t2992r347b3041],
14	JN	NN	O	jn	appos	2	SENT_471	[p20l369t2993r461b3042],
15	.	.	O	.	_	0	SENT_471	[p20l369t2993r461b3042],

1	P-glycoprotein	NN	O	p-glycoprotein	dep	8	SENT_472	[p20l488t2992r912b3056],
2	and	CC	O	and	_	0	SENT_472	[p20l936t2992r1037b3041],
3	alterations	NNS	O	alteration	dep	8	SENT_472	[p20l1062t2992r1355b3041],
4	in	IN	O	in	_	0	SENT_472	[p20l1380t2992r1434b3041],
5	the	DT	O	the	det	7	SENT_472	[p20l1457t2992r1542b3041],
6	glutathione/glutathione-peroxidase	JJ	O	glutathione/glutathione-peroxidase	amod	7	SENT_472	[p20l1567t2992r2146b3056, p20l150t3064r583b3128],
7	cycle	NN	O	cycle	prep_in	8	SENT_472	[p20l613t3064r761b3128],
8	underlie	VBP	O	underlie	_	0	SENT_472	[p20l789t3064r1021b3113],
9	doxorubicin	NN	O	doxorubicin	nn	10	SENT_472	[p20l1051t3064r1394b3113],
10	resistance	NN	O	resistance	dobj	8	SENT_472	[p20l1421t3064r1701b3113],
11	in	IN	O	in	_	0	SENT_472	[p20l1730t3064r1784b3113],
12	HL-60-R	NN	O	hl-60-r	prep_in	8	SENT_472	[p20l1812t3064r2088b3123],
13	,	,	O	,	_	0	SENT_472	[p20l1812t3064r2088b3123],
14	a	DT	O	a	det	15	SENT_472	[p20l2120t3080r2150b3113],
15	subclone	NN	O	subclone	appos	12	SENT_472	[p20l152t3136r401b3186],
16	of	IN	O	of	_	0	SENT_472	[p20l427t3136r489b3186],
17	the	DT	O	the	det	19	SENT_472	[p20l509t3136r594b3186],
18	HL	NN	O	hl	nn	19	SENT_472	[p20l619t3136r807b3186],
19	—	NN	O	—	prep_of	15	SENT_472	[p20l619t3136r807b3186],
20	60	CD	NUMBER	60	num	24	SENT_472	[p20l619t3136r807b3186],
21	human	JJ	O	human	amod	24	SENT_472	[p20l832t3136r1025b3186],
22	leukemia	NN	O	leukemia	nn	24	SENT_472	[p20l1050t3136r1311b3186],
23	cell	NN	O	cell	nn	24	SENT_472	[p20l1335t3136r1436b3186],
24	line	NN	O	line	nsubj	8	SENT_472	[p20l1461t3136r1580b3186],
25	.	.	O	.	_	0	SENT_472	[p20l1461t3136r1580b3186],

1	Int	NN	O	int	nn	3	SENT_473	[p20l1609t3137r1688b3186],
2	J	NN	O	j	nn	3	SENT_473	[p20l1711t3137r1737b3186],
3	Cancer	NN	O	cancer	_	0	SENT_473	[p20l1763t3136r1964b3186],
4	1993	CD	DATE	1993	num	6	SENT_473	[p20l1994t3136r2145b3195],
5	;	:	O	;	_	0	SENT_473	[p20l1994t3136r2145b3195],
6	53	CD	NUMBER	53	dep	3	SENT_473	[p20l150t3207r215b3257],
7	:	:	O	:	_	0	SENT_473	[p20l225t3223r234b3257],
8	804	CD	NUMBER	804	number	9	SENT_473	[p20l244t3207r345b3257],
9	-1	CD	NUMBER	-1	dep	3	SENT_473	[p20l355t3207r419b3256],
10	1	CD	NUMBER	1	dep	9	SENT_473	[p20l435t3208r476b3256],
11	.	.	O	.	_	0	SENT_473	[p20l435t3208r476b3256],

1	Sato	NNP	PERSON	Sato	nn	2	SENT_474	[p21l151t18r273b67],
2	H	NNP	O	H	_	0	SENT_474	[p21l306t18r371b76],
3	,	,	O	,	_	0	SENT_474	[p21l306t18r371b76],
4	Preisler	NNP	PERSON	Preisler	nn	5	SENT_474	[p21l405t17r623b67],
5	H	NNP	O	H	appos	2	SENT_474	[p21l653t18r717b76],
6	,	,	O	,	_	0	SENT_474	[p21l653t18r717b76],
7	Day	NNP	DURATION	Day	nn	8	SENT_474	[p21l751t18r868b82],
8	R	NNP	O	R	appos	5	SENT_474	[p21l900t18r961b76],
9	,	,	O	,	_	0	SENT_474	[p21l900t18r961b76],
10	Raza	NNP	LOCATION	Raza	nn	11	SENT_474	[p21l995t18r1137b67],
11	A	NNP	LOCATION	A	appos	5	SENT_474	[p21l1168t18r1232b76],
12	,	,	O	,	_	0	SENT_474	[p21l1168t18r1232b76],
13	Larson	NNP	PERSON	Larson	nn	14	SENT_474	[p21l1266t18r1463b67],
14	R	NNP	O	R	appos	5	SENT_474	[p21l1495t18r1555b76],
15	,	,	O	,	_	0	SENT_474	[p21l1495t18r1555b76],
16	Browman	NNP	O	Browman	nn	17	SENT_474	[p21l1589t18r1870b67],
17	G	NNP	O	G	appos	5	SENT_474	[p21l1902t17r1966b76],
18	,	,	O	,	_	0	SENT_474	[p21l1902t17r1966b76],
19	et	FW	O	et	nn	20	SENT_474	[p21l2001t25r2050b67],
20	al.	FW	O	al.	appos	5	SENT_474	[p21l2082t17r2145b67],
21	.	.	O	.	_	0	SENT_474	[p21l2082t17r2145b67],

1	MDR1	NN	O	mdr1	nn	3	SENT_475	[p21l149t89r340b137],
2	transcript	NN	O	transcript	nn	3	SENT_475	[p21l372t88r641b153],
3	levels	NNS	O	level	_	0	SENT_475	[p21l666t88r829b138],
4	as	IN	O	as	_	0	SENT_475	[p21l859t104r913b138],
5	an	DT	O	a	det	6	SENT_475	[p21l943t104r1007b138],
6	indication	NN	O	indication	prep_as	3	SENT_475	[p21l1033t88r1317b138],
7	of	IN	O	of	_	0	SENT_475	[p21l1344t88r1405b138],
8	resistant	JJ	O	resistant	amod	9	SENT_475	[p21l1426t88r1664b138],
9	disease	NN	O	disease	prep_of	6	SENT_475	[p21l1690t88r1893b138],
10	in	IN	O	in	_	0	SENT_475	[p21l1919t88r1974b137],
11	acute	JJ	O	acute	amod	13	SENT_475	[p21l2001t95r2148b138],
12	myelogenous	JJ	O	myelogenous	amod	13	SENT_475	[p21l149t159r527b223],
13	leukaemia	NN	O	leukaemia	prep_in	3	SENT_475	[p21l554t159r860b209],
14	.	.	O	.	_	0	SENT_475	[p21l554t159r860b209],

1	Br	NN	O	br	nn	3	SENT_476	[p21l889t160r960b208],
2	J	NN	O	j	nn	3	SENT_476	[p21l984t160r1011b209],
3	Haematol	NN	O	haematol	_	0	SENT_476	[p21l1036t159r1312b209],
4	1990	CD	DATE	1990	dep	3	SENT_476	[p21l1345t159r1792b218],
5	;	:	O	;	_	0	SENT_476	[p21l1345t159r1792b218],
6	75:340	CD	NUMBER	75:340	number	7	SENT_476	[p21l1345t159r1792b218],
7	—	CD	NUMBER	—	dep	3	SENT_476	[p21l1345t159r1792b218],
8	5	CD	NUMBER	5	dep	7	SENT_476	[p21l1345t159r1792b218],
9	.	.	O	.	_	0	SENT_476	[p21l1345t159r1792b218],

1	Cheng	NNP	O	Cheng	nn	2	SENT_477	[p21l150t230r333b295],
2	XS	NNP	O	XS	_	0	SENT_477	[p21l355t231r461b289],
3	,	,	O	,	_	0	SENT_477	[p21l355t231r461b289],
4	Kigawa	NNP	PERSON	Kigawa	nn	5	SENT_477	[p21l486t230r707b295],
5	J	NNP	PERSON	J	appos	2	SENT_477	[p21l727t231r768b289],
6	,	,	O	,	_	0	SENT_477	[p21l727t231r768b289],
7	Minagawa	NNP	PERSON	Minagawa	nn	8	SENT_477	[p21l793t230r1094b295],
8	Y	NN	O	y	appos	5	SENT_477	[p21l1115t231r1180b289],
9	,	,	O	,	_	0	SENT_477	[p21l1115t231r1180b289],
10	Kanamori	NNP	PERSON	Kanamori	nn	11	SENT_477	[p21l1206t230r1488b280],
11	Y	NN	PERSON	y	appos	5	SENT_477	[p21l1511t231r1575b289],
12	,	,	O	,	_	0	SENT_477	[p21l1511t231r1575b289],
13	Itamochi	NN	O	itamochus	nn	14	SENT_477	[p21l1600t230r1852b280],
14	H	NN	O	h	appos	5	SENT_477	[p21l1874t231r1939b289],
15	,	,	O	,	_	0	SENT_477	[p21l1874t231r1939b289],
16	Okada	NNP	PERSON	Okada	nn	17	SENT_477	[p21l1965t230r2150b280],
17	M	NNP	O	M	appos	5	SENT_477	[p21l149t302r226b360],
18	,	,	O	,	_	0	SENT_477	[p21l149t302r226b360],
19	et	FW	O	et	nn	20	SENT_477	[p21l271t309r321b351],
20	al.	FW	O	al.	appos	5	SENT_477	[p21l363t301r425b351],
21	.	.	O	.	_	0	SENT_477	[p21l363t301r425b351],

1	Glutathione	NN	O	glutathione	nsubj	2	SENT_478	[p21l472t301r806b351],
2	S	NN	O	s	conj_and	2	SENT_478	[p21l850t301r1298b365],
3	—	CD	NUMBER	—	num	4	SENT_478	[p21l850t301r1298b365],
4	transferase	NN	O	transferase	dobj	2	SENT_478	[p21l850t301r1298b365],
5	—	CD	NUMBER	—	num	7	SENT_478	[p21l850t301r1298b365],
6	pi	NN	O	pi	nn	7	SENT_478	[p21l850t301r1298b365],
7	expression	NN	O	expression	dep	4	SENT_478	[p21l1341t301r1644b366],
8	and	CC	O	and	_	0	SENT_478	[p21l1687t301r1788b351],
9	glutathione	NN	O	glutathione	nn	10	SENT_478	[p21l1829t301r2148b366],
10	concentration	NN	O	concentration	conj_and	4	SENT_478	[p21l150t372r537b422],
11	in	IN	O	in	_	0	SENT_478	[p21l567t372r621b421],
12	ovarian	JJ	O	ovarian	amod	13	SENT_478	[p21l653t372r865b422],
13	carcinoma	NN	O	carcinoma	prep_in	10	SENT_478	[p21l897t372r1193b422],
14	before	IN	O	before	_	0	SENT_478	[p21l1222t372r1403b422],
15	and	CC	O	and	_	0	SENT_478	[p21l1436t372r1537b422],
16	after	IN	O	after	_	0	SENT_478	[p21l1569t372r1698b422],
17	chemotherapy	NN	O	chemotherapy	prep_before	2	SENT_478	[p21l1728t372r2145b437],
18	.	.	O	.	_	0	SENT_478	[p21l1728t372r2145b437],

1	Cancer	NN	O	cancer	_	0	SENT_479	[p21l150t445r351b495],
2	1997	CD	DATE	1997	num	1	SENT_479	[p21l382t444r820b503],
3	;	:	O	;	_	0	SENT_479	[p21l382t444r820b503],
4	79:521	CD	NUMBER	79:521	num	5	SENT_479	[p21l382t444r820b503],
5	—	NN	O	—	dep	1	SENT_479	[p21l382t444r820b503],
6	7	CD	NUMBER	7	dep	5	SENT_479	[p21l382t444r820b503],
7	.	.	O	.	_	0	SENT_479	[p21l382t444r820b503],

1	Ling	NNP	PERSON	Ling	nn	4	SENT_480	[p21l149t515r282b580],
2	V.	NNP	PERSON	V.	nn	4	SENT_480	[p21l320t516r384b565],
3	Multidrug	NNP	PERSON	Multidrug	nn	4	SENT_480	[p21l425t515r713b580],
4	resistance	NN	O	resistance	_	0	SENT_480	[p21l751t515r1046b565],
5	:	:	O	:	_	0	SENT_480	[p21l751t515r1046b565],
6	molecular	JJ	O	molecular	amod	7	SENT_480	[p21l1089t515r1375b565],
7	mechanisms	NNS	O	mechanism	dep	4	SENT_480	[p21l1411t515r1761b565],
8	and	CC	O	and	_	0	SENT_480	[p21l1802t515r1902b565],
9	clinical	JJ	O	clinical	amod	10	SENT_480	[p21l1940t515r2148b565],
10	relevance	NN	O	relevance	dep	4	SENT_480	[p21l148t587r435b638],
11	.	.	O	.	_	0	SENT_480	[p21l148t587r435b638],

1	Cancer	NNP	O	Cancer	nn	4	SENT_481	[p21l466t588r666b638],
2	Chemother	NNP	O	Chemother	nn	4	SENT_481	[p21l692t587r1008b638],
3	Pharmacol	NNP	O	Pharmacol	nn	4	SENT_481	[p21l1032t587r1335b637],
4	l997	NN	O	l997	_	0	SENT_481	[p21l1368t588r1814b646],
5	;	:	O	;	_	0	SENT_481	[p21l1368t588r1814b646],
6	40	CD	NUMBER	40	dep	4	SENT_481	[p21l1368t588r1814b646],
7	:	:	O	:	_	0	SENT_481	[p21l1368t588r1814b646],
8	S3	NN	O	s3	dep	6	SENT_481	[p21l1368t588r1814b646],
9	.	.	O	.	_	0	SENT_481	[p21l1368t588r1814b646],

1	—	NN	O	—	_	0	SENT_482	[p21l1368t588r1814b646],
2	.	.	O	.	_	0	SENT_482	[p21l1368t588r1814b646],

1	S8	NN	O	s8	_	0	SENT_483	[p21l1368t588r1814b646],
2	.	.	O	.	_	0	SENT_483	[p21l1368t588r1814b646],

1	Sonneveld	JJ	ORGANIZATION	sonneveld	amod	2	SENT_484	[p21l151t659r450b710],
2	P	NN	ORGANIZATION	p	_	0	SENT_484	[p21l474t660r527b718],
3	,	,	O	,	_	0	SENT_484	[p21l474t660r527b718],
4	Durie	NNP	ORGANIZATION	Durie	nn	5	SENT_484	[p21l556t659r716b709],
5	BG	NNP	ORGANIZATION	BG	appos	2	SENT_484	[p21l741t660r854b718],
6	,	,	O	,	_	0	SENT_484	[p21l741t660r854b718],
7	Lokhorst	NNP	ORGANIZATION	Lokhorst	nn	8	SENT_484	[p21l882t659r1139b709],
8	HM	NNS	ORGANIZATION	hm	appos	5	SENT_484	[p21l1164t660r1292b718],
9	,	,	O	,	_	0	SENT_484	[p21l1164t660r1292b718],
10	Marie	NNP	PERSON	Marie	nn	11	SENT_484	[p21l1320t659r1489b709],
11	JP	NNP	PERSON	JP	appos	5	SENT_484	[p21l1514t660r1595b718],
12	,	,	O	,	_	0	SENT_484	[p21l1514t660r1595b718],
13	Solbu	NNP	O	Solbu	nn	14	SENT_484	[p21l1625t659r1788b710],
14	G	NNP	O	G	appos	5	SENT_484	[p21l1814t660r1878b718],
15	,	,	O	,	_	0	SENT_484	[p21l1814t660r1878b718],
16	Suciu	NNP	O	Suciu	nn	17	SENT_484	[p21l1908t659r2067b710],
17	S	NNP	O	S	appos	5	SENT_484	[p21l2095t660r2146b718],
18	,	,	O	,	_	0	SENT_484	[p21l2095t660r2146b718],
19	et	FW	O	et	nn	20	SENT_484	[p21l150t738r200b780],
20	al.	FW	O	al.	appos	5	SENT_484	[p21l226t730r288b780],
21	.	.	O	.	_	0	SENT_484	[p21l226t730r288b780],

1	Modulation	NN	O	modulation	_	0	SENT_485	[p21l317t730r649b780],
2	of	IN	O	of	_	0	SENT_485	[p21l675t730r737b780],
3	multidrug	JJ	O	multidrug	amod	4	SENT_485	[p21l757t730r1301b795],
4	—	NN	O	—	prep_of	1	SENT_485	[p21l757t730r1301b795],
5	resistant	JJ	O	resistant	amod	6	SENT_485	[p21l757t730r1301b795],
6	multiple	JJ	O	multiple	amod	7	SENT_485	[p21l1325t730r1561b794],
7	myeloma	NN	O	myeloma	dep	1	SENT_485	[p21l1587t730r1852b794],
8	by	IN	O	by	_	0	SENT_485	[p21l1875t730r1945b794],
9	cyclosporin	NN	O	cyclosporin	prep_by	7	SENT_485	[p21l1972t730r2146b794, p21l152t801r340b865],
10	.	.	O	.	_	0	SENT_485	[p21l1972t730r2146b794, p21l152t801r340b865],

1	The	DT	O	the	det	3	SENT_486	[p21l370t801r480b851],
2	Leukaemia	NNP	O	Leukaemia	nn	3	SENT_486	[p21l506t801r823b851],
3	Group	NNP	O	Group	nsubj	11	SENT_486	[p21l850t802r1029b865],
4	of	IN	O	of	_	0	SENT_486	[p21l1057t801r1119b851],
5	the	DT	O	the	det	6	SENT_486	[p21l1141t801r1226b851],
6	EORTC	NN	O	eortc	prep_of	3	SENT_486	[p21l1252t801r1484b851],
7	and	CC	O	and	_	0	SENT_486	[p21l1514t801r1614b851],
8	the	DT	O	the	det	9	SENT_486	[p21l1640t801r1725b851],
9	HOVON	NNP	O	HOVON	prep_of	3	SENT_486	[p21l1753t802r2009b851],
10	[	CD	NUMBER	[	num	9	SENT_486	[p21l2040t802r2148b861],
11	see	VB	O	see	_	0	SENT_486	[p21l2040t802r2148b861],
12	comments	NNS	O	comment	dobj	11	SENT_486	[p21l150t874r479b933],
13	]	CD	NUMBER	]	dep	12	SENT_486	[p21l150t874r479b933],
14	.	.	O	.	_	0	SENT_486	[p21l150t874r479b933],

1	Lancet	NNP	O	Lancet	_	0	SENT_487	[p21l508t874r702b923],
2	1992	CD	DATE	1992	num	1	SENT_487	[p21l734t873r1207b932],
3	;	:	O	;	_	0	SENT_487	[p21l734t873r1207b932],
4	340:255	CD	NUMBER	340:255	number	5	SENT_487	[p21l734t873r1207b932],
5	—	CD	NUMBER	—	dep	1	SENT_487	[p21l734t873r1207b932],
6	9	CD	NUMBER	9	dep	5	SENT_487	[p21l734t873r1207b932],
7	.	.	O	.	_	0	SENT_487	[p21l734t873r1207b932],

1	Gupta	NNP	PERSON	Gupta	nn	2	SENT_488	[p21l150t945r323b1008],
2	V	NNP	O	V	_	0	SENT_488	[p21l355t945r420b1003],
3	,	,	O	,	_	0	SENT_488	[p21l355t945r420b1003],
4	Jani	NNP	PERSON	Jani	nn	5	SENT_488	[p21l455t944r568b994],
5	JP	NNP	PERSON	JP	appos	2	SENT_488	[p21l601t945r682b1003],
6	,	,	O	,	_	0	SENT_488	[p21l601t945r682b1003],
7	Jacobs	NNP	PERSON	Jacobs	nn	8	SENT_488	[p21l717t944r905b994],
8	S	NNP	O	S	appos	5	SENT_488	[p21l941t945r992b1003],
9	,	,	O	,	_	0	SENT_488	[p21l941t945r992b1003],
10	Levitt	NNP	PERSON	Levitt	nn	11	SENT_488	[p21l1027t944r1198b994],
11	M	NNP	O	M	appos	5	SENT_488	[p21l1229t945r1306b1003],
12	,	,	O	,	_	0	SENT_488	[p21l1229t945r1306b1003],
13	Fields	NNP	O	Fields	nn	14	SENT_488	[p21l1341t944r1513b994],
14	L	NNP	O	L	appos	5	SENT_488	[p21l1547t945r1604b1003],
15	,	,	O	,	_	0	SENT_488	[p21l1547t945r1604b1003],
16	Awasthi	NNP	PERSON	Awasthi	nn	17	SENT_488	[p21l1640t944r1876b994],
17	S	NNP	O	S	appos	5	SENT_488	[p21l1912t945r1962b1003],
18	,	,	O	,	_	0	SENT_488	[p21l1912t945r1962b1003],
19	et	FW	O	et	nn	20	SENT_488	[p21l1999t952r2049b994],
20	al.	FW	O	al.	appos	5	SENT_488	[p21l2082t944r2145b994],
21	.	.	O	.	_	0	SENT_488	[p21l2082t944r2145b994],

1	Activity	NN	O	activity	nsubj	10	SENT_489	[p21l149t1015r381b1079],
2	of	IN	O	of	_	0	SENT_489	[p21l415t1015r477b1065],
3	melphalan	NN	O	melphalan	prep_of	1	SENT_489	[p21l504t1015r800b1079],
4	in	IN	O	in	_	0	SENT_489	[p21l833t1015r887b1064],
5	combination	NN	O	combination	prep_in	3	SENT_489	[p21l920t1015r1275b1065],
6	with	IN	O	with	_	0	SENT_489	[p21l1307t1015r1433b1065],
7	the	DT	O	the	det	8	SENT_489	[p21l1465t1015r1550b1065],
8	glutathione	NN	O	glutathione	prep_with	5	SENT_489	[p21l1584t1015r1903b1080],
9	s	VBZ	O	s	cop	10	SENT_489	[p21l1938t1023r2146b1065],
10	—	CD	NUMBER	—	_	0	SENT_489	[p21l1938t1023r2146b1065],
11	trans	JJ	O	trans	amod	10	SENT_489	[p21l1938t1023r2146b1065],
12	—	NN	O	—	nn	14	SENT_489	[p21l1938t1023r2146b1065],
13	ferase	NN	O	ferase	nn	14	SENT_489	[p21l149t1086r317b1136],
14	inhibitor	NN	O	inhibitor	tmod	11	SENT_489	[p21l343t1086r603b1145],
15	,	,	O	,	_	0	SENT_489	[p21l343t1086r603b1145],
16	sulphasalazine	NN	O	sulphasalazine	appos	14	SENT_489	[p21l634t1086r1061b1151],
17	.	.	O	.	_	0	SENT_489	[p21l634t1086r1061b1151],

1	Cancer	NNP	O	Cancer	nn	3	SENT_490	[p21l1091t1087r1292b1136],
2	Chemother	NNP	O	Chemother	nn	3	SENT_490	[p21l1317t1086r1633b1136],
3	Pharmacol	NNP	O	Pharmacol	_	0	SENT_490	[p21l1658t1086r1961b1136],
4	1995	CD	DATE	1995	num	3	SENT_490	[p21l1994t1086r2146b1145],
5	;	:	O	;	_	0	SENT_490	[p21l1994t1086r2146b1145],
6	36213-9	CD	NUMBER	36213-9	dep	3	SENT_490	[p21l151t1157r395b1207],
7	.	.	O	.	_	0	SENT_490	[p21l151t1157r395b1207],

